Target Label,Prioritised Features,Entropy Value,Entropy Conf,Gini Index Value,Gini Index Conf,Category,Best Conf,Significant,PlotSig
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Metabolic Component Category - Signaling Pathway Regulators (6),0.0327,0.0001000100010001,0.02374,0.0004000400040004,Best Maturation,0.0001000100010001,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.01864,0.0017001700170017,0.02186,0.0008000800080008,Best Maturation,0.0008000800080008,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Electrophysiology Analysis Method - Patch Clamp (59),0.01689,0.0062006200620062,0.01343,0.004000400040004,Best Maturation,0.004000400040004,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),T-tubule Structures - Yes (18),0.01473,0.0065006500650065,0.0114,0.012001200120012,Best Maturation,0.0065006500650065,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.01287,0.0081008100810081,0.01316,0.0077007700770077,Best Maturation,0.0077007700770077,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Journal - Tissue Eng Part C Methods (6),0.0117,0.0136013601360136,0.01399,0.0069006900690069,Best Maturation,0.0069006900690069,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.01153,0.0084008400840084,0.01037,0.0162016201620162,Best Maturation,0.0084008400840084,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Calcium Handling Analysis Method - Seahorse (35),0.01096,0.0237023702370237,0.00704,0.0935093509350935,Best Maturation,0.0237023702370237,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),hiPSC-CM Media Supplement - Rare (5),0.01092,0.0121012101210121,0.00977,0.0192019201920192,Best Maturation,0.0121012101210121,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Publication Year - 2019 (57),0.01088,0.0324032403240324,0.00663,0.1243124312431243,Best Maturation,0.0324032403240324,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Cell Line - Cellapy (4),0.00999,0.0138013801380138,0.00378,0.1399139913991399,Best Maturation,0.0138013801380138,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.00972,0.0167016701670167,0.00813,0.0401040104010401,Best Maturation,0.0167016701670167,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00964,0.0307030703070307,0.00454,0.1455145514551455,Best Maturation,0.0307030703070307,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),3D Tissue Media - RPMI-1640 (72),0.00957,0.0476047604760476,0.00996,0.0199019901990199,Best Maturation,0.0199019901990199,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Metabolic Component - Palmitic Acid (11),0.0092,0.0281028102810281,0.01023,0.0216021602160216,Best Maturation,0.0216021602160216,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),hiPSC-CM Media Supplement - GlutaMax (8),0.0092,0.0309030903090309,0.01184,0.0152015201520152,Best Maturation,0.0152015201520152,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Insulin Start Day - 6 (20),0.00913,0.0333033303330333,0.01116,0.0165016501650165,Best Maturation,0.0165016501650165,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),3D Platform - Collagen (38),0.00902,0.0492049204920492,0.00516,0.1819181918191819,Best Maturation,0.0492049204920492,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Journal - Biosens Bioelectron (4),0.00901,0.0157015701570157,0.01088,0.011001100110011,Best Maturation,0.011001100110011,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Wnt Inhibitor - IWP (112),0.00884,0.0904090409040904,0.00975,0.0201020102010201,Best Maturation,0.0201020102010201,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.00881,0.0535053505350535,0.01089,0.0177017701770177,Best Maturation,0.0177017701770177,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00839,0.0284028402840284,0.01254,0.0108010801080108,Best Maturation,0.0108010801080108,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.00787,0.0444044404440444,0.00494,0.109010901090109,Best Maturation,0.0444044404440444,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Pharmacological Intervention - Caffeine (4),0.00784,0.0265026502650265,0.00885,0.026002600260026,Best Maturation,0.026002600260026,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.00771,0.0292029202920292,0.00924,0.019001900190019,Best Maturation,0.019001900190019,True,True
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.00741,0.0488048804880488,0.00554,0.0879087908790879,Best Maturation,0.0488048804880488,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Journal - Nat Commun (13),0.007,0.0522052205220522,0.00773,0.0415041504150415,Best Maturation,0.0415041504150415,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),Metabolic Component Category - Kinase Inhibitors (3),0.00685,0.0403040304030403,0.00755,0.0444044404440444,Best Maturation,0.0403040304030403,True,False
Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),hiPSC-CM Purification Duration (days) - 6 days (10),0.00645,0.0481048104810481,0.00473,0.1066106610661066,Best Maturation,0.0481048104810481,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.0271,0.0,0.02625,0.0,Best Maturation,0.0,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Number of Cell Lines - 2 (50),0.01976,0.0049004900490049,0.00893,0.0762076207620762,Best Maturation,0.0049004900490049,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01704,0.0052005200520052,0.01235,0.0133013301330133,Best Maturation,0.0052005200520052,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Coating for Replating - Rare (6),0.01521,0.0053005300530053,0.01223,0.0104010401040104,Best Maturation,0.0053005300530053,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Journal - Acta Biomater (10),0.01506,0.0092009200920092,0.01242,0.0162016201620162,Best Maturation,0.0092009200920092,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.01459,0.0061006100610061,0.01733,0.0055005500550055,Best Maturation,0.0055005500550055,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.01425,0.006000600060006,0.01391,0.0064006400640064,Best Maturation,0.006000600060006,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Gene Analysis Method - RNA (169),0.01224,0.0101010101010101,0.00491,0.4607460746074607,Best Maturation,0.0101010101010101,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01147,0.0197019701970197,0.00626,0.2776277627762776,Best Maturation,0.0197019701970197,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Insulin Start Day - 6 (20),0.01115,0.0239023902390239,0.00944,0.0292029202920292,Best Maturation,0.0239023902390239,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01111,0.0135013501350135,0.00732,0.0634063406340634,Best Maturation,0.0135013501350135,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Calcium Handling Analysis Method - Seahorse (35),0.01092,0.0219021902190219,0.00763,0.0603060306030603,Best Maturation,0.0219021902190219,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Cell Line - Cellapy (4),0.0109,0.0085008500850085,0.01351,0.0062006200620062,Best Maturation,0.0062006200620062,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Wnt Induction Duration (days) - 3 days (38),0.01089,0.0243024302430243,0.00826,0.0596059605960596,Best Maturation,0.0243024302430243,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),2D Surface - ECM-coated (115),0.01071,0.0359035903590359,0.00773,0.0692069206920692,Best Maturation,0.0359035903590359,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.01065,0.022002200220022,0.01068,0.0188018801880188,Best Maturation,0.0188018801880188,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Number of Cell Lines - 1 (225),0.01062,0.0388038803880388,0.00662,0.1685168516851685,Best Maturation,0.0388038803880388,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Seeding Confluency 2D (%) - 80 to 84 (5),0.01056,0.0155015501550155,0.00671,0.0697069706970697,Best Maturation,0.0155015501550155,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Cell Line - Rare (132),0.01034,0.0493049304930493,0.00527,0.4345434543454345,Best Maturation,0.0493049304930493,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Wnt Inhibitor - IWP (112),0.00935,0.0387038703870387,0.0123,0.0042004200420042,Best Maturation,0.0042004200420042,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00915,0.0328032803280328,0.00859,0.0439043904390439,Best Maturation,0.0328032803280328,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),hiPSC-CM Media Supplement - Rare (5),0.00881,0.0376037603760376,0.00856,0.0477047704770477,Best Maturation,0.0376037603760376,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.00869,0.0378037803780378,0.01095,0.0221022102210221,Best Maturation,0.0221022102210221,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Metabolic Component - Insulin-Transferrin-Selenium (3),0.00839,0.0262026202620262,0.00988,0.0227022702270227,Best Maturation,0.0227022702270227,True,True
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),2D Surface - Microparticle/fluid (3),0.00748,0.0421042104210421,0.00908,0.0311031103110311,Best Maturation,0.0311031103110311,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),hiPSC-CM Media Supplement - GlutaMax (8),0.00717,0.039003900390039,0.00736,0.0427042704270427,Best Maturation,0.039003900390039,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Contractile Analysis Method - Rare (7),0.00692,0.047004700470047,0.00525,0.0972097209720972,Best Maturation,0.047004700470047,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.00645,0.0586058605860586,0.00881,0.0301030103010301,Best Maturation,0.0301030103010301,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Wnt Inhibitor - XAV939 (24),0.00562,0.1384138413841384,0.00956,0.0393039303930393,Best Maturation,0.0393039303930393,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.00493,0.1069106910691069,0.00791,0.0457045704570457,Best Maturation,0.0457045704570457,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.00467,0.1375137513751375,0.00821,0.0479047904790479,Best Maturation,0.0479047904790479,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),hiPSC-CM Purification Duration (days) - 7 days (6),0.0042,0.1292129212921292,0.00719,0.0483048304830483,Best Maturation,0.0483048304830483,True,False
Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00412,0.1476147614761476,0.01033,0.0184018401840184,Best Maturation,0.0184018401840184,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Tissue Media - Iscove (5),0.03301,0.0002000200020002,0.03451,0.0,Best Maturation,0.0,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Cell Line - BJ1 (7),0.02326,0.0007000700070007,0.01933,0.0019001900190019,Best Maturation,0.0007000700070007,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Maturation Strategy - Tension (64),0.02052,0.001000100010001,0.0084,0.0683068306830683,Best Maturation,0.001000100010001,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.01989,0.0032003200320032,0.0079,0.077007700770077,Best Maturation,0.0032003200320032,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Contractile Analysis Method - Force Transducer (27),0.01786,0.004000400040004,0.01797,0.0014001400140014,Best Maturation,0.0014001400140014,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.01565,0.0063006300630063,0.01104,0.02000200020002,Best Maturation,0.0063006300630063,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Wnt Inhibitor - IWP (112),0.01563,0.0069006900690069,0.00776,0.0895089508950895,Best Maturation,0.0069006900690069,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Journal - Circulation (11),0.01522,0.009000900090009,0.01893,0.0032003200320032,Best Maturation,0.0032003200320032,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Number of Cell Lines - 3 (29),0.01446,0.009000900090009,0.01583,0.0031003100310031,Best Maturation,0.0031003100310031,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.01377,0.0133013301330133,0.00743,0.0631063106310631,Best Maturation,0.0133013301330133,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),hiPSC-CM Purification Duration (days) - <3 days (31),0.01365,0.0178017801780178,0.0126,0.0119011901190119,Best Maturation,0.0119011901190119,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Number of Cell Lines - 1 (225),0.01227,0.0229022902290229,0.00574,0.2664266426642664,Best Maturation,0.0229022902290229,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Stromal Cell Source - Human Fibroblast (38),0.01181,0.0248024802480248,0.00414,0.2845284528452845,Best Maturation,0.0248024802480248,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Tissue Media - Growth Factor (12),0.01154,0.0153015301530153,0.01025,0.021002100210021,Best Maturation,0.0153015301530153,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),hiPSC Backbone Media - Conditioned (12),0.01097,0.0272027202720272,0.00788,0.0498049804980498,Best Maturation,0.0272027202720272,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01093,0.0403040304030403,0.00592,0.1628162816281628,Best Maturation,0.0403040304030403,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Platform - Collagen (38),0.01087,0.0362036203620362,0.00828,0.0654065406540654,Best Maturation,0.0362036203620362,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Insulin Start Day - 11 (3),0.01039,0.0283028302830283,0.01123,0.03000300030003,Best Maturation,0.0283028302830283,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),3D Platform - Matrigel (33),0.01003,0.0324032403240324,0.01189,0.0146014601460146,Best Maturation,0.0146014601460146,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Gene Analysis Method - RNA (169),0.00909,0.0743074307430743,0.01292,0.0002000200020002,Best Maturation,0.0002000200020002,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Disease Modelling - Genetic Disorders (18),0.00877,0.0434043404340434,0.00541,0.1248124812481248,Best Maturation,0.0434043404340434,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Journal - J Mol Cell Card (6),0.00871,0.036003600360036,0.00956,0.0289028902890289,Best Maturation,0.0289028902890289,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Wnt Inhibitor Duration (days) - >6 days (12),0.00865,0.0355035503550355,0.0076,0.0491049104910491,Best Maturation,0.0355035503550355,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Pharmacological Intervention - T3 (3),0.0086,0.0586058605860586,0.01111,0.0443044304430443,Best Maturation,0.0443044304430443,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Publication Year - 2014 (3),0.00833,0.0387038703870387,0.00782,0.055005500550055,Best Maturation,0.0387038703870387,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00819,0.0367036703670367,0.01168,0.0137013701370137,Best Maturation,0.0137013701370137,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.0079,0.0436043604360436,0.00891,0.0363036303630363,Best Maturation,0.0363036303630363,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),hiPSC Backbone Media - DMEM (10),0.00767,0.0439043904390439,0.01021,0.024002400240024,Best Maturation,0.024002400240024,True,True
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Pharmacological Intervention - Isoproterenol (71),0.00716,0.1264126412641264,0.00966,0.0338033803380338,Best Maturation,0.0338033803380338,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Electrophysiology Analysis Method - Optical Mapping (39),0.00706,0.1045104510451045,0.00968,0.044004400440044,Best Maturation,0.044004400440044,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),Publication Year - 2015 (19),0.00676,0.0841084108410841,0.00857,0.0487048704870487,Best Maturation,0.0487048704870487,True,False
Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),hiPSC-CM Purification Duration (days) - 5 days (6),0.00392,0.1515151515151515,0.00939,0.0356035603560356,Best Maturation,0.0356035603560356,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Contractile Analysis Method - Force Transducer (27),0.03443,0.0,0.0332,0.0,Best Maturation,0.0,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.02646,0.0006000600060006,0.01704,0.0027002700270027,Best Maturation,0.0006000600060006,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Cell Line - BJ1 (7),0.02386,0.0011001100110011,0.02988,0.0002000200020002,Best Maturation,0.0002000200020002,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - Adrenaline (83),0.01518,0.0144014401440144,0.01018,0.0343034303430343,Best Maturation,0.0144014401440144,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Seeding Confluency 3D (%) - 95 to 100 (13),0.01507,0.01000100010001,0.01238,0.0148014801480148,Best Maturation,0.01000100010001,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Day of Insulin Addition - not 22 (12),0.01491,0.009000900090009,0.01408,0.0093009300930093,Best Maturation,0.009000900090009,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.01381,0.0142014201420142,0.01682,0.0038003800380038,Best Maturation,0.0038003800380038,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01346,0.0161016101610161,0.01506,0.0045004500450045,Best Maturation,0.0045004500450045,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Purification Protocol - Glucose and Lactate (85),0.01337,0.0175017501750175,0.00637,0.1868186818681868,Best Maturation,0.0175017501750175,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Number of Cell Lines - 2 (50),0.01284,0.022002200220022,0.00688,0.131013101310131,Best Maturation,0.022002200220022,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Insulin Start Day - 7 (85),0.01268,0.0228022802280228,0.00754,0.085008500850085,Best Maturation,0.0228022802280228,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Maturation Strategy - Tension (64),0.01262,0.0235023502350235,0.00629,0.144014401440144,Best Maturation,0.0235023502350235,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - Isoproterenol (71),0.01198,0.023002300230023,0.00582,0.2017201720172017,Best Maturation,0.023002300230023,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01193,0.0107010701070107,0.00665,0.0663066306630663,Best Maturation,0.0107010701070107,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Day of Insulin Addition - not 23 (10),0.01171,0.0224022402240224,0.0103,0.0243024302430243,Best Maturation,0.0224022402240224,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Day of Insulin Addition - not 20 (15),0.01168,0.0238023802380238,0.01297,0.0118011801180118,Best Maturation,0.0118011801180118,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Wnt Inhibitor - IWP (112),0.01151,0.0398039803980398,0.00271,0.8261826182618262,Best Maturation,0.0398039803980398,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Publication Year - 2021 (43),0.01127,0.0381038103810381,0.01313,0.012001200120012,Best Maturation,0.012001200120012,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),hiPSC Backbone Media - StemFlex (5),0.01107,0.0133013301330133,0.00776,0.056005600560056,Best Maturation,0.0133013301330133,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Day of Insulin Addition - not 24 (9),0.01106,0.016001600160016,0.01182,0.0149014901490149,Best Maturation,0.0149014901490149,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Electrophysiology Analysis Method - Optical Mapping (39),0.0107,0.0383038303830383,0.00949,0.0573057305730573,Best Maturation,0.0383038303830383,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01054,0.0394039403940394,0.00297,0.8355835583558355,Best Maturation,0.0394039403940394,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),0.01008,0.0467046704670467,0.01165,0.0122012201220122,Best Maturation,0.0122012201220122,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),2D Surface - Hydrogel (17),0.00999,0.036003600360036,0.00773,0.0557055705570557,Best Maturation,0.036003600360036,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Seeding Confluency (%) - 95 to 100 (23),0.00969,0.0392039203920392,0.00462,0.1907190719071907,Best Maturation,0.0392039203920392,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - Verapamil (27),0.00918,0.041004100410041,0.01192,0.0132013201320132,Best Maturation,0.0132013201320132,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.00905,0.0559055905590559,0.01162,0.0169016901690169,Best Maturation,0.0169016901690169,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),0.00878,0.0575057505750575,0.0095,0.0384038403840384,Best Maturation,0.0384038403840384,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Cell Line - Cor.4U (16),0.00852,0.0458045804580458,0.00955,0.0329032903290329,Best Maturation,0.0329032903290329,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),3D Tissue Media - High-glucose DMEM (9),0.00748,0.0536053605360536,0.00859,0.0409040904090409,Best Maturation,0.0409040904090409,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),0.00737,0.0871087108710871,0.00992,0.0304030403040304,Best Maturation,0.0304030403040304,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Pharmacological Intervention - T3 (3),0.00737,0.06000600060006,0.01067,0.0409040904090409,Best Maturation,0.0409040904090409,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Journal - Circulation (11),0.00728,0.0497049704970497,0.01048,0.0233023302330233,Best Maturation,0.0233023302330233,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.00663,0.0652065206520652,0.00759,0.0493049304930493,Best Maturation,0.0493049304930493,True,False
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),hiPSC Backbone Media - Embryonic Stem Cell (127),0.0064,0.2341234123412341,0.00918,0.019001900190019,Best Maturation,0.019001900190019,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),Differentiation Purity Assessment - Visual Inspection (6),0.00606,0.0873087308730873,0.01176,0.0169016901690169,Best Maturation,0.0169016901690169,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),hiPSC-CM Purification Duration (days) - 7 days (6),0.00418,0.1123112311231123,0.0126,0.0082008200820082,Best Maturation,0.0082008200820082,True,True
Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),hiPSC-CM Purification Duration (days) Quantiles - Q1 (>4 and ≤20) (31),0.00267,0.3689368936893689,0.00974,0.0343034303430343,Best Maturation,0.0343034303430343,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.02176,0.0033003300330033,0.01475,0.0119011901190119,Best Maturation,0.0033003300330033,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Cell Line Ancestry - Asian (28),0.01653,0.0128012801280128,0.00735,0.1045104510451045,Best Maturation,0.0128012801280128,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Cell Coculture - Stromal Cell (78),0.01521,0.0147014701470147,0.00562,0.2771277127712771,Best Maturation,0.0147014701470147,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Cell Line - WTC11 (30),0.01498,0.0119011901190119,0.00834,0.0686068606860686,Best Maturation,0.0119011901190119,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Electrophysiology Analysis Method - Patch Clamp (59),0.01383,0.0221022102210221,0.00962,0.072007200720072,Best Maturation,0.0221022102210221,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Journal - Tissue Eng Part C Methods (6),0.01337,0.0134013401340134,0.00868,0.0537053705370537,Best Maturation,0.0134013401340134,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.013,0.0182018201820182,0.01462,0.0121012101210121,Best Maturation,0.0121012101210121,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.01298,0.0237023702370237,0.01304,0.0172017201720172,Best Maturation,0.0172017201720172,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.0122,0.0186018601860186,0.00898,0.044004400440044,Best Maturation,0.0186018601860186,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.01215,0.0193019301930193,0.01529,0.0071007100710071,Best Maturation,0.0071007100710071,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.0111,0.0342034203420342,0.00811,0.0668066806680668,Best Maturation,0.0342034203420342,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),0.01092,0.0252025202520252,0.01142,0.0204020402040204,Best Maturation,0.0204020402040204,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Purification Protocol - Glucose and Lactate (85),0.0108,0.0403040304030403,0.00594,0.2368236823682368,Best Maturation,0.0403040304030403,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Metabolic Component - Palmitic Acid (11),0.01079,0.0268026802680268,0.00585,0.106010601060106,Best Maturation,0.0268026802680268,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Journal - Sci Transl Med (3),0.01075,0.0329032903290329,0.01373,0.0212021202120212,Best Maturation,0.0212021202120212,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Contractile Analysis Method - Motion Tracking (93),0.01039,0.0445044504450445,0.01196,0.0105010501050105,Best Maturation,0.0105010501050105,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01008,0.0235023502350235,0.01254,0.0126012601260126,Best Maturation,0.0126012601260126,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),0.01004,0.0338033803380338,0.01011,0.035003500350035,Best Maturation,0.0338033803380338,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Journal - ACS Biomater Sci Eng (3),0.00957,0.0343034303430343,0.01472,0.0106010601060106,Best Maturation,0.0106010601060106,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Journal - Acta Biomater (10),0.00912,0.0425042504250425,0.00734,0.0745074507450745,Best Maturation,0.0425042504250425,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Metabolic Component - Fatty Acid (13),0.00896,0.046004600460046,0.01001,0.0381038103810381,Best Maturation,0.0381038103810381,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.00864,0.0533053305330533,0.01745,0.0034003400340034,Best Maturation,0.0034003400340034,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Cell Line - BJ RiPS (4),0.00854,0.045004500450045,0.00973,0.0448044804480448,Best Maturation,0.0448044804480448,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.0079,0.0527052705270527,0.01265,0.0144014401440144,Best Maturation,0.0144014401440144,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Journal - Biomater Sci (7),0.0067,0.0737073707370737,0.0111,0.0211021102110211,Best Maturation,0.0211021102110211,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.00652,0.115011501150115,0.0109,0.0318031803180318,Best Maturation,0.0318031803180318,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.00618,0.0822082208220822,0.01053,0.0453045304530453,Best Maturation,0.0453045304530453,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.05089,0.0,0.05507,0.0,Best Maturation,0.0,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Calcium Handling Analysis Method - Visual (104),0.02304,0.0007000700070007,0.01314,0.0029002900290029,Best Maturation,0.0007000700070007,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.02182,0.003000300030003,0.0171,0.0088008800880088,Best Maturation,0.003000300030003,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Journal - Cell Stem Cell (6),0.01941,0.0045004500450045,0.01993,0.0034003400340034,Best Maturation,0.0034003400340034,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Calcium Handling Analysis Method - Seahorse (35),0.01696,0.0038003800380038,0.00808,0.0662066206620662,Best Maturation,0.0038003800380038,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Purification Protocol - Glucose and Lactate (85),0.01462,0.013001300130013,0.00875,0.0623062306230623,Best Maturation,0.013001300130013,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.01402,0.0139013901390139,0.01126,0.0223022302230223,Best Maturation,0.0139013901390139,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Metabolic Component - Fatty Acid (13),0.01389,0.0092009200920092,0.01511,0.0054005400540054,Best Maturation,0.0054005400540054,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Coating for Replating - Matrigel (65),0.01334,0.0169016901690169,0.00687,0.151015101510151,Best Maturation,0.0169016901690169,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Publication Year - 2017 (43),0.01331,0.0192019201920192,0.00855,0.0667066706670667,Best Maturation,0.0192019201920192,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Metabolic Component Category - Metabolic Modulation (20),0.01289,0.0228022802280228,0.012,0.0171017101710171,Best Maturation,0.0171017101710171,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.01278,0.0075007500750075,0.00986,0.021002100210021,Best Maturation,0.0075007500750075,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Metabolic Component Category - Fatty Acids and Lipids (21),0.01268,0.0134013401340134,0.00975,0.0243024302430243,Best Maturation,0.0134013401340134,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Electrophysiology Analysis Method - Optical Mapping (39),0.01214,0.0267026702670267,0.01464,0.0092009200920092,Best Maturation,0.0092009200920092,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.012,0.0237023702370237,0.01304,0.0115011501150115,Best Maturation,0.0115011501150115,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Publication Year - 2015 (19),0.0116,0.0205020502050205,0.00991,0.0324032403240324,Best Maturation,0.0205020502050205,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Metabolic Component Category - Sugars and Carbohydrates (9),0.01143,0.0168016801680168,0.01342,0.0097009700970097,Best Maturation,0.0097009700970097,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Journal - Circ Res (5),0.01066,0.0136013601360136,0.0137,0.0067006700670067,Best Maturation,0.0067006700670067,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Gene Analysis Method - Rare (5),0.01043,0.0148014801480148,0.01151,0.0148014801480148,Best Maturation,0.0148014801480148,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Electrophysiology Analysis Method - Genetical (3),0.01033,0.0215021502150215,0.01127,0.0244024402440244,Best Maturation,0.0215021502150215,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Journal - Stem Cells (11),0.0103,0.0236023602360236,0.01151,0.0159015901590159,Best Maturation,0.0159015901590159,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Fatty Acid Metabolism Assessed - Yes (20),0.01014,0.0241024102410241,0.01058,0.0216021602160216,Best Maturation,0.0216021602160216,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),hiPSC-CM Purification Duration (days) - >9 days (5),0.00971,0.0174017401740174,0.00795,0.0473047304730473,Best Maturation,0.0174017401740174,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Disease Modelling - Dilated Cardiomyopathy (6),0.00954,0.0281028102810281,0.00836,0.0458045804580458,Best Maturation,0.0281028102810281,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Metabolic Component - Palmitic Acid (11),0.00909,0.0358035803580358,0.01063,0.0222022202220222,Best Maturation,0.0222022202220222,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.00873,0.0876087608760876,0.01163,0.0202020202020202,Best Maturation,0.0202020202020202,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Insulin Start Day - 1 (19),0.0084,0.0542054205420542,0.0113,0.0233023302330233,Best Maturation,0.0233023302330233,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),0.00787,0.0438043804380438,0.01009,0.0272027202720272,Best Maturation,0.0272027202720272,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Coating for Replating - Gelatin (43),0.00748,0.1003100310031003,0.0129,0.0126012601260126,Best Maturation,0.0126012601260126,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.00724,0.0463046304630463,0.00674,0.0603060306030603,Best Maturation,0.0463046304630463,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.00719,0.0514051405140514,0.00933,0.0384038403840384,Best Maturation,0.0384038403840384,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Seeding Confluency 2D (%) - 85 to 89 (26),0.00601,0.1017101710171017,0.01055,0.0223022302230223,Best Maturation,0.0223022302230223,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),Insulin Withdrawal Duration (days) Quantiles - Q1 (>4 and ≤10) (11),0.00432,0.1487148714871487,0.00934,0.0348034803480348,Best Maturation,0.0348034803480348,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Journal - Cell Stem Cell (6),0.0275,0.0004000400040004,0.02401,0.0006000600060006,Best Maturation,0.0004000400040004,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC Matrix Coating - Rare (8),0.02665,0.0006000600060006,0.02314,0.0005000500050005,Best Maturation,0.0005000500050005,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - Isoproterenol (71),0.02299,0.0018001800180018,0.00982,0.0256025602560256,Best Maturation,0.0018001800180018,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),0.02093,0.0012001200120012,0.00771,0.0874087408740874,Best Maturation,0.0012001200120012,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Cell Line - 253G1 (10),0.02092,0.0018001800180018,0.01202,0.0155015501550155,Best Maturation,0.0018001800180018,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Insulin Withdrawal Duration (days) - 3 days (6),0.01757,0.0033003300330033,0.01439,0.0086008600860086,Best Maturation,0.0033003300330033,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.01662,0.0044004400440044,0.01351,0.0082008200820082,Best Maturation,0.0044004400440044,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - Adrenaline (83),0.01501,0.0078007800780078,0.00747,0.1029102910291029,Best Maturation,0.0078007800780078,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Purification Protocol - Metabolic (8),0.01339,0.0078007800780078,0.01192,0.0117011701170117,Best Maturation,0.0078007800780078,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Journal - Biomaterials (16),0.01232,0.0095009500950095,0.00511,0.1241124112411241,Best Maturation,0.0095009500950095,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC-CM Purification Duration (days) - <3 days (31),0.01215,0.0235023502350235,0.01132,0.021002100210021,Best Maturation,0.021002100210021,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),0.01184,0.0107010701070107,0.01262,0.0088008800880088,Best Maturation,0.0088008800880088,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Seeding Confluency 3D (%) - 95 to 100 (13),0.01127,0.0114011401140114,0.00672,0.0626062606260626,Best Maturation,0.0114011401140114,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Differentiation Purity Assessment - Visual Inspection (6),0.01111,0.0131013101310131,0.00879,0.0283028302830283,Best Maturation,0.0131013101310131,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Contractile Analysis Method - Deflection (39),0.01109,0.0326032603260326,0.00678,0.1143114311431143,Best Maturation,0.0326032603260326,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Wnt Inhibitor - IWR (56),0.01087,0.0305030503050305,0.00672,0.1324132413241324,Best Maturation,0.0305030503050305,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.0102,0.0437043704370437,0.00586,0.1991199119911991,Best Maturation,0.0437043704370437,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),3D Tissue Media - Rare (13),0.00998,0.0281028102810281,0.00713,0.063006300630063,Best Maturation,0.0281028102810281,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC Backbone Media - Rare (19),0.00956,0.035003500350035,0.00798,0.0587058705870587,Best Maturation,0.035003500350035,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - QT-Prolonging Drugs (36),0.00941,0.0579057905790579,0.00941,0.0383038303830383,Best Maturation,0.0383038303830383,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC Matrix Coating - Vitronectin (10),0.00933,0.037003700370037,0.01085,0.0236023602360236,Best Maturation,0.0236023602360236,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - Other Antiarrhythmic Agents (13),0.00931,0.0391039103910391,0.00954,0.0327032703270327,Best Maturation,0.0327032703270327,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),3D Platform - Extracellular Scaffold (18),0.00898,0.0425042504250425,0.00849,0.0442044204420442,Best Maturation,0.0425042504250425,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Publication Year - 2024 (7),0.00859,0.0307030703070307,0.01289,0.0098009800980098,Best Maturation,0.0098009800980098,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Insulin Start Day - 7 (85),0.00829,0.0963096309630963,0.00921,0.0453045304530453,Best Maturation,0.0453045304530453,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Pharmacological Intervention - Carbamylcholine (6),0.00806,0.0317031703170317,0.00945,0.0217021702170217,Best Maturation,0.0217021702170217,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Number of Cell Lines - 1 (225),0.00727,0.1431143114311431,0.00893,0.0433043304330433,Best Maturation,0.0433043304330433,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Disease Modelling - Dilated Cardiomyopathy (6),0.00703,0.0614061406140614,0.00919,0.0293029302930293,Best Maturation,0.0293029302930293,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Insulin Start Day - 8 (15),0.00647,0.08000800080008,0.01196,0.0134013401340134,Best Maturation,0.0134013401340134,True,True
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),hiPSC Backbone Media - StemFit (5),0.00639,0.057005700570057,0.00808,0.0366036603660366,Best Maturation,0.0366036603660366,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),3D Platform - Nanotechnology (3),0.00529,0.0719071907190719,0.00922,0.0324032403240324,Best Maturation,0.0324032403240324,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Seeding Confluency (%) - 95 to 100 (23),0.00463,0.1703170317031703,0.00971,0.0329032903290329,Best Maturation,0.0329032903290329,True,False
Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),Maturation Strategy - ECM (21),0.0037,0.2193219321932193,0.00852,0.0452045204520452,Best Maturation,0.0452045204520452,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Seeding Confluency (%) - 80 to 84 (12),0.03215,0.0003000300030003,0.02271,0.0006000600060006,Best Maturation,0.0003000300030003,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.02889,0.0002000200020002,0.02414,0.0005000500050005,Best Maturation,0.0002000200020002,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Seeding Confluency 2D (%) - 80 to 84 (5),0.02351,0.0016001600160016,0.0274,0.0006000600060006,Best Maturation,0.0006000600060006,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Publication Year - 2015 (19),0.02234,0.0009000900090009,0.01966,0.0012001200120012,Best Maturation,0.0009000900090009,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Handling Analysis Method - Visual (104),0.02077,0.0014001400140014,0.00878,0.0674067406740674,Best Maturation,0.0014001400140014,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.02034,0.0007000700070007,0.01633,0.0027002700270027,Best Maturation,0.0007000700070007,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Journal - Nano Lett (3),0.01892,0.0023002300230023,0.01786,0.0046004600460046,Best Maturation,0.0023002300230023,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),hiPSC Matrix Coating - Geltrex (33),0.01608,0.0107010701070107,0.00893,0.0663066306630663,Best Maturation,0.0107010701070107,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.01559,0.0079007900790079,0.01554,0.0061006100610061,Best Maturation,0.0061006100610061,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),2D Surface - Hydrogel (17),0.01553,0.0068006800680068,0.01202,0.0131013101310131,Best Maturation,0.0068006800680068,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Maturation Strategy - ECM (21),0.01426,0.013001300130013,0.01505,0.0067006700670067,Best Maturation,0.0067006700670067,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),hiPSC Backbone Media - mTeSR (106),0.01134,0.0371037103710371,0.0086,0.0527052705270527,Best Maturation,0.0371037103710371,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.01107,0.0187018701870187,0.00919,0.0285028502850285,Best Maturation,0.0187018701870187,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Journal - Stem Cells (11),0.01099,0.0217021702170217,0.00965,0.0286028602860286,Best Maturation,0.0217021702170217,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.01094,0.0233023302330233,0.01165,0.0154015401540154,Best Maturation,0.0154015401540154,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Seeding Confluency 2D (%) - 70 to 79 (6),0.01093,0.0194019401940194,0.01325,0.0127012701270127,Best Maturation,0.0127012701270127,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Wnt Inhibitor - IWR (56),0.01028,0.0391039103910391,0.00748,0.108010801080108,Best Maturation,0.0391039103910391,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.0102,0.0247024702470247,0.00876,0.0324032403240324,Best Maturation,0.0247024702470247,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),hiPSC-CM Media Supplement - Mercaptoethanol (10),0.01013,0.0228022802280228,0.01063,0.0204020402040204,Best Maturation,0.0204020402040204,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.01003,0.0186018601860186,0.01149,0.0119011901190119,Best Maturation,0.0119011901190119,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.00982,0.0202020202020202,0.00783,0.0405040504050405,Best Maturation,0.0202020202020202,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.00975,0.0313031303130313,0.00877,0.0385038503850385,Best Maturation,0.0313031303130313,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00965,0.0354035403540354,0.01138,0.0263026302630263,Best Maturation,0.0263026302630263,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Sacromere or Cellular Alignment Analysis - Yes (72),0.00952,0.0655065506550655,0.01001,0.0323032303230323,Best Maturation,0.0323032303230323,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.00934,0.0482048204820482,0.00989,0.0512051205120512,Best Maturation,0.0482048204820482,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Journal - J Mol Cell Cardiol (4),0.00902,0.0509050905090509,0.01022,0.0428042804280428,Best Maturation,0.0428042804280428,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),2D Surface - Electrospun (13),0.00853,0.0481048104810481,0.00539,0.1204120412041204,Best Maturation,0.0481048104810481,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00789,0.0465046504650465,0.00543,0.1135113511351135,Best Maturation,0.0465046504650465,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Publication Year - 2018 (45),0.00726,0.1019101910191019,0.0101,0.0332033203320332,Best Maturation,0.0332033203320332,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Pharmacological Intervention - Caffeine (4),0.0071,0.0659065906590659,0.01045,0.0286028602860286,Best Maturation,0.0286028602860286,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Wnt Inhibitor Duration (days) - 5 days (6),0.00672,0.0844084408440844,0.00885,0.0471047104710471,Best Maturation,0.0471047104710471,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Journal - PLoS One (9),0.00655,0.0615061506150615,0.00971,0.0261026102610261,Best Maturation,0.0261026102610261,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Coating for Replating - Matrigel (65),0.00634,0.1729172917291729,0.01164,0.0221022102210221,Best Maturation,0.0221022102210221,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.00633,0.0583058305830583,0.01014,0.0195019501950195,Best Maturation,0.0195019501950195,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Calcium Handling Analysis Method - Rare (4),0.00595,0.0725072507250725,0.01239,0.0099009900990099,Best Maturation,0.0099009900990099,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),2D Surface - ECM-coated (115),0.00544,0.4225422542254225,0.00903,0.0413041304130413,Best Maturation,0.0413041304130413,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),Seeding Confluency 2D (%) - 90 to 94 (12),0.00429,0.1753175317531753,0.00975,0.0302030203020302,Best Maturation,0.0302030203020302,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.03268,0.0013001300130013,0.03498,0.0003000300030003,Best Maturation,0.0003000300030003,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),hiPSC-CM Media Supplement - GlutaMax (8),0.02742,0.001000100010001,0.02531,0.0016001600160016,Best Maturation,0.001000100010001,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Calcium Handling Analysis Method - Visual (104),0.02606,0.0017001700170017,0.01063,0.0456045604560456,Best Maturation,0.0017001700170017,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),hiPSC Matrix Coating - MEF feeder cells (8),0.02482,0.0046004600460046,0.01663,0.0185018501850185,Best Maturation,0.0046004600460046,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.02419,0.0045004500450045,0.02377,0.0047004700470047,Best Maturation,0.0045004500450045,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Day of Insulin Addition - not 11 (5),0.02264,0.0079007900790079,0.01957,0.0142014201420142,Best Maturation,0.0079007900790079,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Coating for Replating - Gelatin (43),0.02129,0.0079007900790079,0.02273,0.0028002800280028,Best Maturation,0.0028002800280028,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Journal - PNAS (3),0.0204,0.0189018901890189,0.03191,0.0034003400340034,Best Maturation,0.0034003400340034,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Publication Year - 2017 (43),0.02018,0.0082008200820082,0.01648,0.0173017301730173,Best Maturation,0.0082008200820082,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01792,0.0215021502150215,0.01133,0.0854085408540854,Best Maturation,0.0215021502150215,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),hiPSC Backbone Media - DMEM (10),0.0145,0.0283028302830283,0.01575,0.0226022602260226,Best Maturation,0.0226022602260226,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.01449,0.031003100310031,0.01715,0.0148014801480148,Best Maturation,0.0148014801480148,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Differentiation Purity Assessment - IHC cTnT (7),0.01431,0.0379037903790379,0.01278,0.0408040804080408,Best Maturation,0.0379037903790379,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Journal - Biomater Sci (7),0.01396,0.0265026502650265,0.0129,0.031003100310031,Best Maturation,0.0265026502650265,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Disease Modelling - Rare (4),0.01375,0.0374037403740374,0.01301,0.0392039203920392,Best Maturation,0.0374037403740374,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.01348,0.0281028102810281,0.00896,0.0716071607160716,Best Maturation,0.0281028102810281,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Pharmacological Intervention - E4031 (22),0.0125,0.0255025502550255,0.0162,0.0105010501050105,Best Maturation,0.0105010501050105,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Insulin Start Day - 0 (7),0.0122,0.0469046904690469,0.01521,0.0273027302730273,Best Maturation,0.0273027302730273,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Cell Line Ancestry - Caucasian (41),0.01188,0.0465046504650465,0.00933,0.0949094909490949,Best Maturation,0.0465046504650465,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Electron Imaging - Transmission (62),0.01103,0.0496049604960496,0.01234,0.0224022402240224,Best Maturation,0.0224022402240224,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Cell Coculture - Stromal Cell (78),0.01049,0.0486048604860486,0.00559,0.2571257125712571,Best Maturation,0.0486048604860486,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.0084,0.0809080908090809,0.01339,0.0247024702470247,Best Maturation,0.0247024702470247,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),hiPSC Backbone Media - iCell Maintenance (86),0.00822,0.1322132213221322,0.01192,0.0485048504850485,Best Maturation,0.0485048504850485,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),3D Tissue Media - Iscove (5),0.00811,0.0499049904990499,0.01109,0.0359035903590359,Best Maturation,0.0359035903590359,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),Pharmacological Intervention - Statins (Lipid-Lowering Agents) (3),0.00154,0.0496049604960496,0.00398,0.0495049504950495,Best Maturation,0.0495049504950495,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Disease Modelling - Arrhythmic (15),0.03422,0.0021002100210021,0.03605,0.0007000700070007,Best Maturation,0.0007000700070007,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.02897,0.0014001400140014,0.03219,0.0009000900090009,Best Maturation,0.0009000900090009,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Disease Modelling - Genetic Disorders (18),0.02786,0.0018001800180018,0.02532,0.0014001400140014,Best Maturation,0.0014001400140014,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.02323,0.0026002600260026,0.02131,0.0042004200420042,Best Maturation,0.0026002600260026,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Journal - Biosens Bioelectron (4),0.02045,0.013001300130013,0.01528,0.0322032203220322,Best Maturation,0.013001300130013,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.02029,0.011001100110011,0.01751,0.0184018401840184,Best Maturation,0.011001100110011,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Calcium Handling Analysis Method - Visual (104),0.01936,0.0033003300330033,0.00978,0.0446044604460446,Best Maturation,0.0033003300330033,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.01873,0.0107010701070107,0.01072,0.0514051405140514,Best Maturation,0.0107010701070107,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Cell Line - BJ RiPS (4),0.01834,0.025002500250025,0.01531,0.0392039203920392,Best Maturation,0.025002500250025,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01812,0.0217021702170217,0.00741,0.1985198519851985,Best Maturation,0.0217021702170217,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Journal - Circ Res (5),0.01789,0.0172017201720172,0.01201,0.0469046904690469,Best Maturation,0.0172017201720172,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01595,0.018001800180018,0.01646,0.0145014501450145,Best Maturation,0.0145014501450145,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Coating for Replating - Fibronectin (32),0.01509,0.0324032403240324,0.01589,0.0187018701870187,Best Maturation,0.0187018701870187,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Journal - Acta Biomater (10),0.01434,0.0428042804280428,0.01918,0.0131013101310131,Best Maturation,0.0131013101310131,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Electrophysiology Analysis Method - Optical Mapping (39),0.01432,0.0345034503450345,0.02004,0.0052005200520052,Best Maturation,0.0052005200520052,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Publication Year - 2016 (32),0.0139,0.0312031203120312,0.01062,0.0713071307130713,Best Maturation,0.0312031203120312,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01377,0.0322032203220322,0.01037,0.0611061106110611,Best Maturation,0.0322032203220322,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Wnt Inhibitor Duration (days) - Rare (173),0.01365,0.0116011601160116,0.00515,0.3229322932293229,Best Maturation,0.0116011601160116,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),0.01362,0.0378037803780378,0.01534,0.0229022902290229,Best Maturation,0.0229022902290229,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Cell Line - iCell2 (8),0.01347,0.037003700370037,0.00522,0.1075107510751075,Best Maturation,0.037003700370037,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Insulin Start Day - 3 (5),0.01325,0.0287028702870287,0.01364,0.0326032603260326,Best Maturation,0.0287028702870287,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Coating for Replating - Laminin (5),0.01288,0.0327032703270327,0.01368,0.0292029202920292,Best Maturation,0.0292029202920292,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),0.01254,0.0352035203520352,0.01724,0.0143014301430143,Best Maturation,0.0143014301430143,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Publication Year - Late-2010s (196),0.01103,0.0502050205020502,0.01099,0.0265026502650265,Best Maturation,0.0265026502650265,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.01082,0.0494049404940494,0.00763,0.083008300830083,Best Maturation,0.0494049404940494,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.0098,0.0753075307530753,0.01402,0.0276027602760276,Best Maturation,0.0276027602760276,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Pharmacological Intervention - Propranolol (5),0.00974,0.0604060406040604,0.01382,0.0377037703770377,Best Maturation,0.0377037703770377,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.00914,0.0784078407840784,0.0144,0.0334033403340334,Best Maturation,0.0334033403340334,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Cell Line - iCell (47),0.00889,0.0867086708670867,0.01192,0.0429042904290429,Best Maturation,0.0429042904290429,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),0.00883,0.0736073607360736,0.01245,0.0358035803580358,Best Maturation,0.0358035803580358,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.00843,0.0384038403840384,0.01057,0.0263026302630263,Best Maturation,0.0263026302630263,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Contractile Analysis Method - Motion Tracking (93),0.00793,0.1496149614961496,0.01237,0.0255025502550255,Best Maturation,0.0255025502550255,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00688,0.077007700770077,0.01109,0.0472047204720472,Best Maturation,0.0472047204720472,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),hiPSC Backbone Media - iCell Maintenance (86),0.00638,0.2386238623862386,0.01143,0.0418041804180418,Best Maturation,0.0418041804180418,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Publication Year - 2021 (43),0.02683,0.002000200020002,0.01424,0.0153015301530153,Best Maturation,0.002000200020002,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.01691,0.0135013501350135,0.01135,0.0359035903590359,Best Maturation,0.0135013501350135,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.01653,0.0158015801580158,0.01572,0.0115011501150115,Best Maturation,0.0115011501150115,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.0145,0.0155015501550155,0.01976,0.0032003200320032,Best Maturation,0.0032003200320032,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Wnt Induction - Rare (4),0.01447,0.0099009900990099,0.01899,0.0047004700470047,Best Maturation,0.0047004700470047,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - Cisapride (8),0.01433,0.0123012301230123,0.01105,0.0281028102810281,Best Maturation,0.0123012301230123,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Maturation Strategy - ECM (21),0.01348,0.0171017101710171,0.00981,0.0362036203620362,Best Maturation,0.0171017101710171,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),0.01337,0.0233023302330233,0.01016,0.0514051405140514,Best Maturation,0.0233023302330233,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - QT-Prolonging Drugs (36),0.01304,0.0296029602960296,0.00968,0.0566056605660566,Best Maturation,0.0296029602960296,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.01278,0.0251025102510251,0.01262,0.0257025702570257,Best Maturation,0.0251025102510251,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Sacromere or Cellular Alignment Analysis - Yes (72),0.01234,0.0331033103310331,0.0074,0.1378137813781378,Best Maturation,0.0331033103310331,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Wnt Inhibitor - VEGF (3),0.01229,0.0261026102610261,0.00728,0.0607060706070607,Best Maturation,0.0261026102610261,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Contractile Analysis Method - Force Transducer (27),0.01175,0.0381038103810381,0.01057,0.0473047304730473,Best Maturation,0.0381038103810381,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - Isoproterenol (71),0.01091,0.043004300430043,0.0096,0.0511051105110511,Best Maturation,0.043004300430043,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01048,0.0272027202720272,0.01419,0.0124012401240124,Best Maturation,0.0124012401240124,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01034,0.0333033303330333,0.01647,0.0047004700470047,Best Maturation,0.0047004700470047,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),0.01017,0.0534053405340534,0.01543,0.0112011201120112,Best Maturation,0.0112011201120112,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Electrophysiology Analysis Method - Patch Clamp (59),0.0097,0.0634063406340634,0.01188,0.024002400240024,Best Maturation,0.024002400240024,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.00955,0.0497049704970497,0.00916,0.0579057905790579,Best Maturation,0.0497049704970497,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Wnt Induction - CHIR99021 (184),0.00948,0.0855085508550855,0.00913,0.0473047304730473,Best Maturation,0.0473047304730473,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),0.00929,0.0572057205720572,0.01229,0.0202020202020202,Best Maturation,0.0202020202020202,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Metabolic Component Category - Kinase Inhibitors (3),0.00859,0.0445044504450445,0.00865,0.0501050105010501,Best Maturation,0.0445044504450445,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Coating for Replating - Rare (6),0.0075,0.0821082108210821,0.01125,0.0379037903790379,Best Maturation,0.0379037903790379,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),Maturation Strategy - Electrical (39),0.00668,0.1523152315231523,0.01144,0.0396039603960396,Best Maturation,0.0396039603960396,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.03618,0.0,0.01723,0.001000100010001,Best Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.03315,0.0,0.02109,0.0011001100110011,Best Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.02788,0.0006000600060006,0.02983,0.0004000400040004,Best Maturation,0.0004000400040004,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.02763,0.0005000500050005,0.02864,0.0004000400040004,Best Maturation,0.0004000400040004,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.02142,0.001000100010001,0.02189,0.0011001100110011,Best Maturation,0.001000100010001,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Calcium Handling Analysis Method - Seahorse (35),0.01806,0.0055005500550055,0.01318,0.0123012301230123,Best Maturation,0.0055005500550055,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),2D Surface - Nanotopography (6),0.01799,0.005000500050005,0.01817,0.0052005200520052,Best Maturation,0.005000500050005,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.01759,0.004000400040004,0.00864,0.0462046204620462,Best Maturation,0.004000400040004,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Electron Imaging - Transmission (62),0.01752,0.0067006700670067,0.00729,0.1461146114611461,Best Maturation,0.0067006700670067,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),T-tubule Structures - Yes (18),0.01525,0.0111011101110111,0.0133,0.0132013201320132,Best Maturation,0.0111011101110111,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01389,0.0067006700670067,0.01359,0.0074007400740074,Best Maturation,0.0067006700670067,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Cell Coculture - Cardiomyocyte (157),0.0132,0.0201020102010201,0.00528,0.4358435843584358,Best Maturation,0.0201020102010201,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Metabolic Component Category - Signaling Pathway Regulators (6),0.0132,0.0097009700970097,0.01218,0.0136013601360136,Best Maturation,0.0097009700970097,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Number of Cell Lines - 3 (29),0.01198,0.0187018701870187,0.00659,0.1117111711171117,Best Maturation,0.0187018701870187,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Metabolic Component Category - Kinase Inhibitors (3),0.01176,0.0084008400840084,0.01259,0.0106010601060106,Best Maturation,0.0084008400840084,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.01031,0.0306030603060306,0.0116,0.02000200020002,Best Maturation,0.02000200020002,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Coating for Replating - Matrigel (65),0.01021,0.0457045704570457,0.0076,0.1001100110011001,Best Maturation,0.0457045704570457,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.0095,0.0237023702370237,0.00967,0.0245024502450245,Best Maturation,0.0237023702370237,True,True
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Coating for Replating - Synthemax (3),0.00939,0.0348034803480348,0.01082,0.0329032903290329,Best Maturation,0.0329032903290329,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Coating for Replating - Rare (6),0.00871,0.0432043204320432,0.00792,0.0625062506250625,Best Maturation,0.0432043204320432,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Journal - Stem Cell Res (8),0.00866,0.0384038403840384,0.00835,0.0415041504150415,Best Maturation,0.0384038403840384,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),0.00802,0.0344034403440344,0.00733,0.0485048504850485,Best Maturation,0.0344034403440344,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),hiPSC Backbone Media - Commercial CM Kit (12),0.00794,0.0496049604960496,0.00685,0.0757075707570757,Best Maturation,0.0496049604960496,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Publication Year - 2018 (45),0.00709,0.1152115211521152,0.0092,0.047004700470047,Best Maturation,0.047004700470047,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Seeding Confluency 2D (%) - 95 to 100 (6),0.0062,0.0911091109110911,0.0102,0.0274027402740274,Best Maturation,0.0274027402740274,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),Insulin Start Day - 4 (11),0.00574,0.0943094309430943,0.00977,0.0274027402740274,Best Maturation,0.0274027402740274,True,False
Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),hiPSC Backbone Media - Conditioned (12),0.00387,0.1608160816081608,0.00857,0.0308030803080308,Best Maturation,0.0308030803080308,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Electrophysiology Analysis Method - Patch Clamp (59),0.06667,0.0,0.03196,0.0,Best Maturation,0.0,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.03854,0.0001000100010001,0.04121,0.0,Best Maturation,0.0,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.0223,0.001000100010001,0.0197,0.0015001500150015,Best Maturation,0.001000100010001,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.0165,0.0029002900290029,0.01426,0.0046004600460046,Best Maturation,0.0029002900290029,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Coating for Replating - Rare (6),0.01354,0.0086008600860086,0.01406,0.0074007400740074,Best Maturation,0.0074007400740074,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Day of Insulin Addition - Known (177),0.01156,0.0258025802580258,0.0096,0.02000200020002,Best Maturation,0.02000200020002,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Journal - Rare (104),0.01156,0.0204020402040204,0.00901,0.0357035703570357,Best Maturation,0.0204020402040204,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Pharmacological Intervention - E4031 (22),0.01128,0.0199019901990199,0.01082,0.0176017601760176,Best Maturation,0.0176017601760176,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01124,0.0125012501250125,0.01199,0.009000900090009,Best Maturation,0.009000900090009,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Number of Cell Lines - 3 (29),0.0111,0.0205020502050205,0.01126,0.0145014501450145,Best Maturation,0.0145014501450145,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),0.01055,0.0238023802380238,0.0114,0.0172017201720172,Best Maturation,0.0172017201720172,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.01031,0.0167016701670167,0.01384,0.0081008100810081,Best Maturation,0.0081008100810081,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Purification Protocol - Metabolic (8),0.00971,0.0203020302030203,0.01062,0.0148014801480148,Best Maturation,0.0148014801480148,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),0.00954,0.0285028502850285,0.00583,0.0823082308230823,Best Maturation,0.0285028502850285,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Immunofluorescent Imaging - Yes (268),0.00953,0.0471047104710471,0.00476,0.2687268726872687,Best Maturation,0.0471047104710471,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.00944,0.0225022502250225,0.01007,0.0161016101610161,Best Maturation,0.0161016101610161,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Cell Line - C25 (6),0.00894,0.0248024802480248,0.0105,0.0183018301830183,Best Maturation,0.0183018301830183,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),2D Surface - Nanotopography (6),0.00879,0.02000200020002,0.00635,0.0603060306030603,Best Maturation,0.02000200020002,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Metabolic Component - Lactate (4),0.00854,0.0331033103310331,0.01009,0.0219021902190219,Best Maturation,0.0219021902190219,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00853,0.0348034803480348,0.00851,0.0428042804280428,Best Maturation,0.0348034803480348,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.00798,0.039003900390039,0.00566,0.0941094109410941,Best Maturation,0.039003900390039,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),hiPSC Backbone Media - Commercial CM Kit (12),0.00785,0.0453045304530453,0.00881,0.0363036303630363,Best Maturation,0.0363036303630363,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),hiPSC-CM Media Supplement - Lipids (9),0.00765,0.0433043304330433,0.00754,0.0455045504550455,Best Maturation,0.0433043304330433,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Publication Year - Late-2010s (196),0.00764,0.1485148514851485,0.00969,0.0125012501250125,Best Maturation,0.0125012501250125,True,True
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),New Media for Maturation - Commercial Kit (5),0.00732,0.0477047704770477,0.00638,0.0845084508450845,Best Maturation,0.0477047704770477,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.00711,0.0457045704570457,0.00757,0.0422042204220422,Best Maturation,0.0422042204220422,True,False
Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),Number of Cell Lines - 1 (225),0.00665,0.1904190419041904,0.0097,0.0211021102110211,Best Maturation,0.0211021102110211,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Stromal Cell Source - hiPSC-MuralC (3),0.04568,0.0,0.0469,0.0001000100010001,Best Maturation,0.0,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Cell Line - 201B6 (3),0.03259,0.0004000400040004,0.03381,0.0007000700070007,Best Maturation,0.0004000400040004,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Wnt Induction - Wnt3a (3),0.03013,0.0009000900090009,0.04626,0.0002000200020002,Best Maturation,0.0002000200020002,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Maturation Strategy - Tension (64),0.02297,0.0034003400340034,0.00554,0.2889288928892889,Best Maturation,0.0034003400340034,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Stromal Cell Source - Rare (4),0.02116,0.003000300030003,0.02369,0.0028002800280028,Best Maturation,0.0028002800280028,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),hiPSC Backbone Media - Conditioned (12),0.0188,0.0068006800680068,0.015,0.0133013301330133,Best Maturation,0.0068006800680068,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Maturation Strategy - Other Cells (80),0.01762,0.0089008900890089,0.00672,0.1898189818981898,Best Maturation,0.0089008900890089,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Cell Coculture - Endothelial Cell (35),0.01732,0.0131013101310131,0.01234,0.024002400240024,Best Maturation,0.0131013101310131,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Platform - Collagen (38),0.01703,0.0138013801380138,0.01051,0.0505050505050505,Best Maturation,0.0138013801380138,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.01641,0.0066006600660066,0.01793,0.0046004600460046,Best Maturation,0.0046004600460046,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.01632,0.0122012201220122,0.01552,0.0145014501450145,Best Maturation,0.0122012201220122,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.01498,0.0121012101210121,0.01391,0.016001600160016,Best Maturation,0.0121012101210121,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Platform - Matrigel (33),0.0131,0.032003200320032,0.01488,0.0172017201720172,Best Maturation,0.0172017201720172,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.01296,0.0398039803980398,0.01119,0.0494049404940494,Best Maturation,0.0398039803980398,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Wnt Inhibitor - VEGF (3),0.01286,0.017001700170017,0.01396,0.0185018501850185,Best Maturation,0.017001700170017,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Seeding Confluency 3D (%) - 95 to 100 (13),0.0125,0.0234023402340234,0.00929,0.0476047604760476,Best Maturation,0.0234023402340234,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Electrophysiology Analysis Method - Patch Clamp (59),0.01249,0.023002300230023,0.01268,0.0137013701370137,Best Maturation,0.0137013701370137,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Contractile Analysis Method - Force Transducer (27),0.0122,0.0396039603960396,0.01341,0.0221022102210221,Best Maturation,0.0221022102210221,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Cell Line - BJ1 (7),0.01214,0.0223022302230223,0.00914,0.0567056705670567,Best Maturation,0.0223022302230223,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Journal - Cell Stem Cell (6),0.01176,0.0419041904190419,0.01085,0.0503050305030503,Best Maturation,0.0419041904190419,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Cell Line Sex - Both (118),0.01132,0.0394039403940394,0.00727,0.1703170317031703,Best Maturation,0.0394039403940394,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.01126,0.0451045104510451,0.01259,0.0277027702770277,Best Maturation,0.0277027702770277,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.01098,0.0434043404340434,0.00713,0.1113111311131113,Best Maturation,0.0434043404340434,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Seeding Confluency (%) - 85 to 89 (43),0.01087,0.0432043204320432,0.01075,0.0357035703570357,Best Maturation,0.0357035703570357,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Metabolic Component - IGF-1 (3),0.01083,0.0397039703970397,0.01065,0.0459045904590459,Best Maturation,0.0397039703970397,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.01032,0.0338033803380338,0.00763,0.078007800780078,Best Maturation,0.0338033803380338,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),0.01018,0.0238023802380238,0.00485,0.1228122812281228,Best Maturation,0.0238023802380238,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00937,0.0533053305330533,0.01031,0.0372037203720372,Best Maturation,0.0372037203720372,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00874,0.0573057305730573,0.01201,0.0299029902990299,Best Maturation,0.0299029902990299,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Seeding Confluency 3D (%) - 85 to 89 (12),0.00846,0.0522052205220522,0.01294,0.0181018101810181,Best Maturation,0.0181018101810181,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),Wnt Inhibitor - Rare (3),0.00692,0.0488048804880488,0.00821,0.0448044804480448,Best Maturation,0.0448044804480448,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),New Media for Maturation - RPMI-1640 (30),0.00575,0.1482148214821482,0.01077,0.0341034103410341,Best Maturation,0.0341034103410341,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.06701,0.0,0.07571,0.0,Best Maturation,0.0,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.04065,0.0008000800080008,0.04709,0.0006000600060006,Best Maturation,0.0006000600060006,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Journal - Stem Cell Reports (23),0.02407,0.0088008800880088,0.01861,0.02000200020002,Best Maturation,0.0088008800880088,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Disease Modelling - Genetic Disorders (18),0.02384,0.0126012601260126,0.0178,0.0178017801780178,Best Maturation,0.0126012601260126,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.02107,0.0097009700970097,0.02152,0.0105010501050105,Best Maturation,0.0097009700970097,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.02024,0.0231023102310231,0.02033,0.0207020702070207,Best Maturation,0.0207020702070207,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Contractile Analysis Method - Rare (7),0.01997,0.0171017101710171,0.02216,0.0127012701270127,Best Maturation,0.0127012701270127,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Disease Modelling - Arrhythmic (15),0.01968,0.0131013101310131,0.01562,0.0272027202720272,Best Maturation,0.0131013101310131,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.01889,0.0175017501750175,0.01496,0.0426042604260426,Best Maturation,0.0175017501750175,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.0178,0.0211021102110211,0.01292,0.0528052805280528,Best Maturation,0.0211021102110211,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Publication Year - 2019 (57),0.01745,0.0259025902590259,0.00969,0.1149114911491149,Best Maturation,0.0259025902590259,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01685,0.0156015601560156,0.01386,0.0403040304030403,Best Maturation,0.0156015601560156,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),2D Surface - ECM-coated (115),0.01588,0.0189018901890189,0.01435,0.0093009300930093,Best Maturation,0.0093009300930093,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Publication Year - 2022 (20),0.01573,0.0352035203520352,0.01521,0.0443044304430443,Best Maturation,0.0352035203520352,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Maturation Strategy - Cell Alignment (59),0.01467,0.0321032103210321,0.01579,0.0198019801980198,Best Maturation,0.0198019801980198,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Maturation Strategy - Tension (64),0.01424,0.0266026602660266,0.01162,0.0561056105610561,Best Maturation,0.0266026602660266,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Insulin Start Day - 6 (20),0.01364,0.0316031603160316,0.00782,0.1113111311131113,Best Maturation,0.0316031603160316,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.01354,0.081008100810081,0.02129,0.015001500150015,Best Maturation,0.015001500150015,True,True
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.00764,0.0847084708470847,0.01312,0.0428042804280428,Best Maturation,0.0428042804280428,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Metabolic Component Category - Kinase Inhibitors (3),0.00089,0.0388038803880388,0.00176,0.0385038503850385,Best Maturation,0.0385038503850385,True,False
MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),Cell Line - 201B6 (3),0.00062,0.0461046104610461,0.00117,0.0461046104610461,Best Maturation,0.0461046104610461,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.05622,0.0,0.04789,0.0,Best Maturation,0.0,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Journal - Stem Cell Reports (23),0.04349,0.0001000100010001,0.03332,0.0006000600060006,Best Maturation,0.0001000100010001,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.03757,0.0009000900090009,0.03281,0.0031003100310031,Best Maturation,0.0009000900090009,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.0343,0.0013001300130013,0.0506,0.0003000300030003,Best Maturation,0.0003000300030003,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.02608,0.0024002400240024,0.02733,0.0053005300530053,Best Maturation,0.0024002400240024,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Number of Cell Lines - 3 (29),0.01786,0.0266026602660266,0.01388,0.038003800380038,Best Maturation,0.0266026602660266,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Seeding Confluency 2D (%) - 70 to 79 (6),0.01711,0.0436043604360436,0.01106,0.0569056905690569,Best Maturation,0.0436043604360436,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.01611,0.0247024702470247,0.01505,0.0353035303530353,Best Maturation,0.0247024702470247,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.01431,0.0398039803980398,0.01586,0.0299029902990299,Best Maturation,0.0299029902990299,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Maturation Strategy - ECM (21),0.01365,0.0336033603360336,0.01789,0.0136013601360136,Best Maturation,0.0136013601360136,True,True
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Insulin Start Day - 6 (20),0.01357,0.0318031803180318,0.01303,0.0561056105610561,Best Maturation,0.0318031803180318,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01357,0.0468046804680468,0.01305,0.0438043804380438,Best Maturation,0.0438043804380438,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Pharmacological Intervention - T3 (3),0.01339,0.0319031903190319,0.0153,0.0311031103110311,Best Maturation,0.0311031103110311,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01285,0.0463046304630463,0.01131,0.0663066306630663,Best Maturation,0.0463046304630463,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Number of Cell Lines - 1 (225),0.01285,0.0303030303030303,0.00798,0.155015501550155,Best Maturation,0.0303030303030303,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.01248,0.0469046904690469,0.01327,0.0459045904590459,Best Maturation,0.0459045904590459,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.0081,0.0939093909390939,0.01387,0.0418041804180418,Best Maturation,0.0418041804180418,True,False
MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),Calcium Handling Analysis Method - Rare (4),0.00579,0.0499049904990499,0.01018,0.0456045604560456,Best Maturation,0.0456045604560456,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.06338,0.0,0.05971,0.0,Best Maturation,0.0,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.05516,0.0002000200020002,0.05633,0.0002000200020002,Best Maturation,0.0002000200020002,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Journal - Stem Cell Reports (23),0.02902,0.0051005100510051,0.02748,0.0027002700270027,Best Maturation,0.0027002700270027,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.0248,0.0066006600660066,0.02528,0.0098009800980098,Best Maturation,0.0066006600660066,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Insulin Withdrawal Duration (days) Quantiles - Q2 (>2 and ≤4) (25),0.02084,0.0166016601660166,0.01099,0.0823082308230823,Best Maturation,0.0166016601660166,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),0.01795,0.0331033103310331,0.01291,0.0488048804880488,Best Maturation,0.0331033103310331,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Insulin Withdrawal Duration (days) - 4 days (18),0.01763,0.0155015501550155,0.01304,0.0499049904990499,Best Maturation,0.0155015501550155,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Journal - Tissue Eng Part A (4),0.01457,0.0412041204120412,0.01442,0.0416041604160416,Best Maturation,0.0412041204120412,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),3D Stromal Cell Source - Cardiac Fibroblast (32),0.01434,0.0323032303230323,0.01045,0.0742074207420742,Best Maturation,0.0323032303230323,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Calcium Handling Analysis Method - Visual (104),0.01389,0.0357035703570357,0.00763,0.1284128412841284,Best Maturation,0.0357035703570357,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01385,0.0352035203520352,0.00627,0.234023402340234,Best Maturation,0.0352035203520352,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),3D Stromal Cell Source - Human Fibroblast (38),0.01369,0.0337033703370337,0.01078,0.0603060306030603,Best Maturation,0.0337033703370337,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.01355,0.0379037903790379,0.01485,0.0317031703170317,Best Maturation,0.0317031703170317,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Disease Modelling - Ischemic Infarction (9),0.0128,0.0533053305330533,0.01915,0.0188018801880188,Best Maturation,0.0188018801880188,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.01239,0.0358035803580358,0.01037,0.0376037603760376,Best Maturation,0.0358035803580358,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),3D Tissue Media - RPMI-1640 (72),0.011,0.082008200820082,0.01372,0.048004800480048,Best Maturation,0.048004800480048,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Gene Analysis Method - RNA (169),0.01082,0.034003400340034,0.00912,0.1362136213621362,Best Maturation,0.034003400340034,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),hiPSC Backbone Media - mTeSR (106),0.01015,0.0638063806380638,0.01383,0.0148014801480148,Best Maturation,0.0148014801480148,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.00869,0.0834083408340834,0.01296,0.0395039503950395,Best Maturation,0.0395039503950395,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Publication Year - 2019 (57),0.00838,0.1221122112211221,0.01422,0.0353035303530353,Best Maturation,0.0353035303530353,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Day of Insulin Addition - not 22 (12),0.00781,0.0843084308430843,0.01231,0.0463046304630463,Best Maturation,0.0463046304630463,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),Cell Line - 201B6 (3),0.00062,0.0467046704670467,0.00117,0.0479047904790479,Best Maturation,0.0467046704670467,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.15909,0.0,0.1709,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.12067,0.0,0.10318,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Cell Coculture - Cardiomyocyte (157),0.06967,0.0,0.05247,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Deduced Culture Strategy - 3D Only (157),0.04193,0.0,0.03126,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Cell Coculture - Stromal Cell (78),0.03302,0.0,0.03325,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.02731,0.0,0.02719,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Maturation Strategy - Other Cells (80),0.02693,0.0,0.0299,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Deduced Culture Strategy - 2D Only (183),0.02152,0.0,0.01998,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Tissue Media - RPMI-1640 (72),0.01261,0.0025002500250025,0.01158,0.0022002200220022,Best Maturation,0.0022002200220022,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Cell Coculture - Endothelial Cell (35),0.01218,0.0003000300030003,0.01517,0.0,Best Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.01134,0.002000200020002,0.01099,0.0031003100310031,Best Maturation,0.002000200020002,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Platform - Scaffold Free (43),0.01071,0.0037003700370037,0.00956,0.0059005900590059,Best Maturation,0.0037003700370037,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Stromal Cell Source - Stromal Cell (35),0.01031,0.0045004500450045,0.00874,0.0101010101010101,Best Maturation,0.0045004500450045,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Platform - Fibrin (50),0.00937,0.0053005300530053,0.00993,0.0036003600360036,Best Maturation,0.0036003600360036,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Seeding Confluency 3D (%) - Rare (26),0.00865,0.0048004800480048,0.01087,0.0018001800180018,Best Maturation,0.0018001800180018,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Stromal Cell Source - Human Fibroblast (38),0.00686,0.0297029702970297,0.00894,0.0103010301030103,Best Maturation,0.0103010301030103,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.00673,0.0182018201820182,0.00578,0.0344034403440344,Best Maturation,0.0182018201820182,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.00592,0.0353035303530353,0.00528,0.0555055505550555,Best Maturation,0.0353035303530353,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00586,0.0262026202620262,0.00613,0.0251025102510251,Best Maturation,0.0251025102510251,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00551,0.0426042604260426,0.00672,0.0222022202220222,Best Maturation,0.0222022202220222,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),Seeding Confluency 3D (%) - 85 to 89 (12),0.00466,0.0305030503050305,0.00633,0.0201020102010201,Best Maturation,0.0201020102010201,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Cell Coculture - Endothelial Cell (35),0.15483,0.0,0.15316,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.09934,0.0,0.08296,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.05852,0.0,0.07486,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Cell Coculture - Stromal Cell (78),0.02674,0.0,0.02087,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Maturation Strategy - Other Cells (80),0.02437,0.0002000200020002,0.01954,0.0001000100010001,Best Maturation,0.0001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Cell Coculture - Cardiomyocyte (157),0.02385,0.0001000100010001,0.00758,0.0415041504150415,Best Maturation,0.0001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Deduced Culture Strategy - 3D Only (157),0.02347,0.0002000200020002,0.01085,0.0014001400140014,Best Maturation,0.0002000200020002,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.02061,0.0001000100010001,0.0244,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.01946,0.0002000200020002,0.03146,0.0,Best Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Deduced Culture Strategy - 2D Only (183),0.0155,0.0023002300230023,0.00664,0.1134113411341134,Best Maturation,0.0023002300230023,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.01285,0.0015001500150015,0.01595,0.0008000800080008,Best Maturation,0.0008000800080008,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Stromal Cell Source - Stromal Cell (35),0.01189,0.0039003900390039,0.01367,0.001000100010001,Best Maturation,0.001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.01112,0.012001200120012,0.00606,0.1101110111011101,Best Maturation,0.012001200120012,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),2D Surface - ECM-coated (115),0.01087,0.0219021902190219,0.00177,0.9990999099909992,Best Maturation,0.0219021902190219,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Pharmacological Intervention - Doxorubicin (17),0.00859,0.0131013101310131,0.00732,0.0243024302430243,Best Maturation,0.0131013101310131,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Platform - 3D printed (9),0.00833,0.0152015201520152,0.01241,0.0043004300430043,Best Maturation,0.0043004300430043,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00771,0.0272027202720272,0.0049,0.0964096409640964,Best Maturation,0.0272027202720272,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Stromal Cell Source - Cardiac Fibroblast (32),0.00762,0.0283028302830283,0.0066,0.0389038903890389,Best Maturation,0.0283028302830283,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Stromal Cell Source - Human Fibroblast (38),0.0068,0.0475047504750475,0.0047,0.1501150115011501,Best Maturation,0.0475047504750475,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Stromal Cell Source - hiPSC-MuralC (3),0.00582,0.022002200220022,0.00753,0.0217021702170217,Best Maturation,0.0217021702170217,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Tissue Media - MEM-α (60),0.00521,0.2197219721972197,0.00715,0.0445044504450445,Best Maturation,0.0445044504450445,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Endothelial Cell Source - Rare (3),0.00442,0.0332033203320332,0.0055,0.0319031903190319,Best Maturation,0.0319031903190319,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),3D Stromal Cell Source - hiPSC-SmoothMC (3),0.004,0.0364036403640364,0.00531,0.0299029902990299,Best Maturation,0.0299029902990299,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Journal - Front Cell Dev Biol (3),0.00136,0.2374237423742374,0.00625,0.0286028602860286,Best Maturation,0.0286028602860286,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),Cell Line - 201B6 (3),0.00135,0.2446244624462446,0.00497,0.0474047404740474,Best Maturation,0.0474047404740474,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.12533,0.0,0.12965,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Cell Coculture - Stromal Cell (78),0.06897,0.0,0.06091,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Stromal Cell Source - Stromal Cell (35),0.0451,0.0,0.04971,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Maturation Strategy - Other Cells (80),0.0439,0.0,0.03741,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Cell Coculture - Cardiomyocyte (157),0.03097,0.0,0.01466,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Stromal Cell Source - Human Fibroblast (38),0.02739,0.0,0.02775,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Cell Coculture - Endothelial Cell (35),0.02491,0.0,0.03073,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Deduced Culture Strategy - 2D Only (183),0.02305,0.0,0.01264,0.0,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.021,0.0,0.01047,0.0041004100410041,Best Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Deduced Culture Strategy - 3D Only (157),0.01774,0.0004000400040004,0.00808,0.0156015601560156,Best Maturation,0.0004000400040004,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Stromal Cell Source - Cardiac Fibroblast (32),0.01397,0.001000100010001,0.01453,0.0008000800080008,Best Maturation,0.0008000800080008,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.01306,0.0012001200120012,0.01996,0.0001000100010001,Best Maturation,0.0001000100010001,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01125,0.009000900090009,0.00492,0.4853485348534853,Best Maturation,0.009000900090009,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.00994,0.0027002700270027,0.01014,0.0038003800380038,Best Maturation,0.0027002700270027,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Platform - Collagen (38),0.00956,0.0089008900890089,0.00825,0.0121012101210121,Best Maturation,0.0089008900890089,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.00943,0.0072007200720072,0.00921,0.0077007700770077,Best Maturation,0.0072007200720072,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Maturation Strategy - Tension (64),0.0083,0.0282028202820282,0.00798,0.019001900190019,Best Maturation,0.019001900190019,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00829,0.0084008400840084,0.00636,0.0265026502650265,Best Maturation,0.0084008400840084,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.00743,0.0181018101810181,0.00536,0.0581058105810581,Best Maturation,0.0181018101810181,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Platform - Scaffold Free (43),0.00739,0.0307030703070307,0.0061,0.0497049704970497,Best Maturation,0.0307030703070307,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.00708,0.0138013801380138,0.01219,0.0027002700270027,Best Maturation,0.0027002700270027,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.00629,0.0252025202520252,0.00711,0.0221022102210221,Best Maturation,0.0221022102210221,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00421,0.0461046104610461,0.00427,0.0756075607560756,Best Maturation,0.0461046104610461,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),3D Stromal Cell Source - Dermal Fibroblast (7),0.00371,0.0678067806780678,0.00705,0.0196019601960196,Best Maturation,0.0196019601960196,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Platform - Collagen (38),0.02261,0.0,0.02222,0.0,Best Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Deduced Culture Strategy - 3D Only (157),0.01931,0.0007000700070007,0.00618,0.2255225522552255,Best Maturation,0.0007000700070007,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01864,0.0,0.01465,0.0004000400040004,Best Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Cell Coculture - Cardiomyocyte (157),0.01839,0.0002000200020002,0.00584,0.2877287728772877,Best Maturation,0.0002000200020002,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01734,0.0011001100110011,0.0074,0.0553055305530553,Best Maturation,0.0011001100110011,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Stromal Cell Source - Human Fibroblast (38),0.01699,0.0011001100110011,0.0175,0.0005000500050005,Best Maturation,0.0005000500050005,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.01675,0.0016001600160016,0.0174,0.0002000200020002,Best Maturation,0.0002000200020002,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Cell Line - BJ1 (7),0.01493,0.0015001500150015,0.01874,0.0007000700070007,Best Maturation,0.0007000700070007,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Journal - Biomaterials (16),0.0144,0.001000100010001,0.01235,0.0024002400240024,Best Maturation,0.001000100010001,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Platform - Fibrin (50),0.01288,0.0043004300430043,0.01156,0.0032003200320032,Best Maturation,0.0032003200320032,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.0128,0.0064006400640064,0.01136,0.0057005700570057,Best Maturation,0.0057005700570057,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Seeding Confluency (%) - 90 to 94 (26),0.01172,0.0067006700670067,0.00923,0.0143014301430143,Best Maturation,0.0067006700670067,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Insulin Start Day - 1 (19),0.01169,0.0056005600560056,0.01437,0.0018001800180018,Best Maturation,0.0018001800180018,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Stromal Cell Source - Cardiac Fibroblast (32),0.01169,0.0087008700870087,0.01401,0.0019001900190019,Best Maturation,0.0019001900190019,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Seeding Confluency 3D (%) - 85 to 89 (12),0.0114,0.0069006900690069,0.00851,0.0195019501950195,Best Maturation,0.0069006900690069,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),2D Surface - ECM-coated (115),0.01134,0.0144014401440144,0.00455,0.5752575257525753,Best Maturation,0.0144014401440144,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Seeding Confluency 3D (%) - 90 to 94 (13),0.0113,0.0058005800580058,0.01191,0.0044004400440044,Best Maturation,0.0044004400440044,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Contractile Analysis Method - Deflection (39),0.01102,0.0114011401140114,0.01361,0.002000200020002,Best Maturation,0.002000200020002,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Maturation Strategy - ECM (21),0.01036,0.0105010501050105,0.00781,0.0231023102310231,Best Maturation,0.0105010501050105,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Deduced Culture Strategy - 2D Only (183),0.01009,0.021002100210021,0.00396,0.8229822982298229,Best Maturation,0.021002100210021,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Maturation Strategy - Other Cells (80),0.00996,0.0233023302330233,0.0086,0.0219021902190219,Best Maturation,0.0219021902190219,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Cell Coculture - Stromal Cell (78),0.00966,0.0342034203420342,0.00821,0.0318031803180318,Best Maturation,0.0318031803180318,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Platform - Polyethylene Glycol (8),0.00916,0.0123012301230123,0.00855,0.0177017701770177,Best Maturation,0.0123012301230123,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Tissue Media - RPMI-1640 (72),0.00885,0.0417041704170417,0.00643,0.1065106510651065,Best Maturation,0.0417041704170417,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Maturation Strategy - Mechanical (36),0.00787,0.0309030903090309,0.00722,0.0406040604060406,Best Maturation,0.0309030903090309,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00647,0.0433043304330433,0.00522,0.0771077107710771,Best Maturation,0.0433043304330433,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Stromal Cell Source - hiPSC-CardiacF (8),0.00645,0.0292029202920292,0.00464,0.0785078507850785,Best Maturation,0.0292029202920292,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Pharmacological Intervention - Carbenoxolone (4),0.00634,0.0265026502650265,0.0073,0.0262026202620262,Best Maturation,0.0262026202620262,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Electron Imaging - Scanning (22),0.00614,0.0564056405640564,0.00639,0.0483048304830483,Best Maturation,0.0483048304830483,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Tissue Media - Rare (13),0.00578,0.0523052305230523,0.00682,0.0392039203920392,Best Maturation,0.0392039203920392,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Platform - Nanotechnology (3),0.00564,0.0201020102010201,0.00562,0.0404040404040404,Best Maturation,0.0201020102010201,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Cell Line - iCell (47),0.00549,0.141014101410141,0.00753,0.0398039803980398,Best Maturation,0.0398039803980398,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Journal - Biomater Sci (7),0.00505,0.0599059905990599,0.00763,0.0242024202420242,Best Maturation,0.0242024202420242,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Pharmacological Intervention - Cisapride (8),0.00504,0.0639063906390639,0.00692,0.0321032103210321,Best Maturation,0.0321032103210321,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Tissue Media - High-glucose DMEM (9),0.00462,0.0682068206820682,0.00604,0.0393039303930393,Best Maturation,0.0393039303930393,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.00445,0.0776077607760776,0.00747,0.0215021502150215,Best Maturation,0.0215021502150215,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),3D Tissue Media - Iscove (5),0.00443,0.064006400640064,0.00921,0.0214021402140214,Best Maturation,0.0214021402140214,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),hiPSC Matrix Coating - Matrigel (163),0.00408,0.9185918591859186,0.00889,0.0113011301130113,Best Maturation,0.0113011301130113,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.00336,0.1125112511251125,0.00597,0.0369036903690369,Best Maturation,0.0369036903690369,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),Disease Modelling - Fibrotic (4),0.00278,0.1383138313831383,0.00592,0.0366036603660366,Best Maturation,0.0366036603660366,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Deduced Culture Strategy - 3D Only (157),0.0373,0.0,0.0114,0.0002000200020002,Best Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.02932,0.0,0.01824,0.0,Best Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Cell Coculture - Cardiomyocyte (157),0.02536,0.0,0.00896,0.0055005500550055,Best Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.01784,0.0006000600060006,0.01693,0.0004000400040004,Best Maturation,0.0004000400040004,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Contractile Analysis Method - Force Transducer (27),0.01505,0.0013001300130013,0.01327,0.0017001700170017,Best Maturation,0.0013001300130013,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Deduced Culture Strategy - 2D Only (183),0.01479,0.0009000900090009,0.00706,0.0807080708070807,Best Maturation,0.0009000900090009,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.0133,0.0026002600260026,0.01159,0.0015001500150015,Best Maturation,0.0015001500150015,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Cell Line Ancestry - Caucasian (41),0.01251,0.0053005300530053,0.01202,0.0022002200220022,Best Maturation,0.0022002200220022,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Publication Year - 2021 (43),0.01136,0.0105010501050105,0.00828,0.0235023502350235,Best Maturation,0.0105010501050105,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.01079,0.0043004300430043,0.01352,0.0016001600160016,Best Maturation,0.0016001600160016,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Cell Line Sex - Female (40),0.01048,0.0147014701470147,0.0122,0.0048004800480048,Best Maturation,0.0048004800480048,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Stromal Cell Source - hiPSC-MuralC (3),0.01029,0.0111011101110111,0.01831,0.001000100010001,Best Maturation,0.001000100010001,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Platform - Fibrin (50),0.00991,0.0138013801380138,0.01189,0.0022002200220022,Best Maturation,0.0022002200220022,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Estimated Cell Density (mil cells/mL) Quantiles - Q2 (>10 and ≤21) (17),0.00912,0.0164016401640164,0.01393,0.0023002300230023,Best Maturation,0.0023002300230023,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Tissue Media - DMEM (53),0.00904,0.0248024802480248,0.00752,0.0371037103710371,Best Maturation,0.0248024802480248,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00887,0.0482048204820482,0.0068,0.0924092409240924,Best Maturation,0.0482048204820482,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Cell Line - 201B6 (3),0.00858,0.0089008900890089,0.00635,0.0248024802480248,Best Maturation,0.0089008900890089,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Seeding Confluency 3D (%) - 70 to 79 (3),0.00774,0.0149014901490149,0.00966,0.0146014601460146,Best Maturation,0.0146014601460146,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.00758,0.0377037703770377,0.00476,0.1286128612861286,Best Maturation,0.0377037703770377,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.00732,0.0304030403040304,0.00775,0.0209020902090209,Best Maturation,0.0209020902090209,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.0072,0.0328032803280328,0.00643,0.0476047604760476,Best Maturation,0.0328032803280328,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Wnt Induction - Wnt3a (3),0.00702,0.0194019401940194,0.01016,0.0154015401540154,Best Maturation,0.0154015401540154,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Maturation Strategy - Electrical (39),0.00674,0.0486048604860486,0.00678,0.0398039803980398,Best Maturation,0.0398039803980398,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Maturation Strategy - ECM (21),0.0066,0.0429042904290429,0.0068,0.0363036303630363,Best Maturation,0.0363036303630363,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Platform - Extracellular Scaffold (18),0.00565,0.0597059705970597,0.00689,0.0328032803280328,Best Maturation,0.0328032803280328,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Wnt Inhibitor - Others (9),0.00545,0.0482048204820482,0.00668,0.0347034703470347,Best Maturation,0.0347034703470347,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),hiPSC-CM Purification Duration (days) - 6 days (10),0.00519,0.0493049304930493,0.00555,0.0487048704870487,Best Maturation,0.0487048704870487,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00502,0.0511051105110511,0.0071,0.025002500250025,Best Maturation,0.025002500250025,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),hiPSC Backbone Media - iCell Maintenance (86),0.00499,0.4016401640164016,0.00749,0.0383038303830383,Best Maturation,0.0383038303830383,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00496,0.0564056405640564,0.00568,0.049004900490049,Best Maturation,0.049004900490049,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),hiPSC-CM Purification Duration (days) Quantiles - Q1 (>4 and ≤20) (31),0.00491,0.1184118411841184,0.00658,0.0462046204620462,Best Maturation,0.0462046204620462,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00472,0.0471047104710471,0.00425,0.0692069206920692,Best Maturation,0.0471047104710471,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.00451,0.1887188718871887,0.00738,0.0347034703470347,Best Maturation,0.0347034703470347,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Pharmacological Intervention - Phenylephrine (3),0.00446,0.0398039803980398,0.00597,0.0307030703070307,Best Maturation,0.0307030703070307,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Cell Line - C25 (6),0.00423,0.0709070907090709,0.00821,0.0155015501550155,Best Maturation,0.0155015501550155,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),3D Stromal Cell Source - hiPSC-SmoothMC (3),0.0036,0.0791079107910791,0.00598,0.0327032703270327,Best Maturation,0.0327032703270327,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),0.00348,0.1064106410641064,0.00581,0.0387038703870387,Best Maturation,0.0387038703870387,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),Journal - J Tissue Eng (4),0.00268,0.1581158115811581,0.00601,0.0409040904090409,Best Maturation,0.0409040904090409,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),hiPSC Backbone Media - Conditioned (12),0.00246,0.2285228522852285,0.0066,0.0383038303830383,Best Maturation,0.0383038303830383,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01588,0.0061006100610061,0.00976,0.0208020802080208,Worst Maturation,0.0061006100610061,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Sacromere or Cellular Alignment Analysis - Yes (72),0.01529,0.0093009300930093,0.0125,0.0057005700570057,Worst Maturation,0.0057005700570057,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Electron Imaging - Transmission (62),0.01339,0.0106010601060106,0.01401,0.0015001500150015,Worst Maturation,0.0015001500150015,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Wnt Induction Duration (days) Quantiles - Q2 (>1 and ≤2) (75),0.01254,0.0175017501750175,0.00591,0.1733173317331733,Worst Maturation,0.0175017501750175,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Journal - J Mol Cell Cardiol (4),0.01242,0.0097009700970097,0.00939,0.0293029302930293,Worst Maturation,0.0097009700970097,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Calcium Handling Analysis Method - Genetical (3),0.01242,0.0051005100510051,0.01445,0.0052005200520052,Worst Maturation,0.0051005100510051,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Publication Year - 2018 (45),0.01222,0.0162016201620162,0.01217,0.0088008800880088,Worst Maturation,0.0088008800880088,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Calcium Handling Analysis Method - Visual (104),0.01197,0.0189018901890189,0.01471,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.01191,0.0106010601060106,0.00701,0.053005300530053,Worst Maturation,0.0106010601060106,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),2D Surface - ECM-coated (115),0.01137,0.0245024502450245,0.00757,0.0939093909390939,Worst Maturation,0.0245024502450245,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Publication Year - 2022 (20),0.01078,0.0251025102510251,0.0106,0.0184018401840184,Worst Maturation,0.0184018401840184,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Seeding Confluency (%) - 70 to 79 (11),0.00999,0.022002200220022,0.00827,0.0347034703470347,Worst Maturation,0.022002200220022,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Calcium Handling Analysis Method - Rare (4),0.00986,0.0133013301330133,0.01103,0.0115011501150115,Worst Maturation,0.0115011501150115,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.00957,0.0245024502450245,0.00907,0.027002700270027,Worst Maturation,0.0245024502450245,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Publication Year - 2024 (7),0.00947,0.0245024502450245,0.01073,0.0174017401740174,Worst Maturation,0.0174017401740174,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00944,0.0209020902090209,0.01214,0.0071007100710071,Worst Maturation,0.0071007100710071,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.00928,0.0222022202220222,0.01093,0.0108010801080108,Worst Maturation,0.0108010801080108,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),hiPSC-CM Maturation Media - RPMI-1640 (153),0.009,0.0798079807980798,0.00998,0.0088008800880088,Worst Maturation,0.0088008800880088,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Journal - Rare (104),0.00884,0.0588058805880588,0.00879,0.0311031103110311,Worst Maturation,0.0311031103110311,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),hiPSC Backbone Media - Cor.4U Complete (6),0.00868,0.0264026402640264,0.00661,0.0507050705070507,Worst Maturation,0.0264026402640264,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),0.00862,0.0494049404940494,0.00421,0.2431243124312431,Worst Maturation,0.0494049404940494,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Differentiation Purity Assessment - IHC cTnT (7),0.00806,0.031003100310031,0.00549,0.0838083808380838,Worst Maturation,0.031003100310031,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Coating for Replating - Matrigel (65),0.007,0.1118111811181118,0.00975,0.026002600260026,Worst Maturation,0.026002600260026,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Journal - Stem Cell Res (8),0.00693,0.0507050705070507,0.00818,0.0408040804080408,Worst Maturation,0.0408040804080408,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),2D Surface - Electrospun (13),0.00689,0.0636063606360636,0.00749,0.0474047404740474,Worst Maturation,0.0474047404740474,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.0068,0.0609060906090609,0.00838,0.035003500350035,Worst Maturation,0.035003500350035,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Journal - Stem Cell Res Ther (3),0.00673,0.0586058605860586,0.00805,0.0489048904890489,Worst Maturation,0.0489048904890489,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Pharmacological Intervention - Verapamil (27),0.00668,0.0742074207420742,0.01045,0.0149014901490149,Worst Maturation,0.0149014901490149,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),0.00624,0.0496049604960496,0.00465,0.1171117111711171,Worst Maturation,0.0496049604960496,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00591,0.4369436943694369,0.00859,0.0365036503650365,Worst Maturation,0.0365036503650365,True,False
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Cell Line - Cellapy (4),0.00466,0.0966096609660966,0.01013,0.0147014701470147,Worst Maturation,0.0147014701470147,True,True
Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),Purification Protocol - Glucose and Lactate (85),0.00431,0.5648564856485648,0.00887,0.037003700370037,Worst Maturation,0.037003700370037,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Contractile Analysis Method - Traction Force Microscopy (9),0.01484,0.0053005300530053,0.01315,0.0084008400840084,Worst Maturation,0.0053005300530053,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.01481,0.0083008300830083,0.01176,0.0172017201720172,Worst Maturation,0.0083008300830083,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.01423,0.0053005300530053,0.01142,0.0139013901390139,Worst Maturation,0.0053005300530053,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),0.01248,0.0084008400840084,0.00763,0.0423042304230423,Worst Maturation,0.0084008400840084,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Publication Year - 2014 (3),0.01213,0.0038003800380038,0.01263,0.0047004700470047,Worst Maturation,0.0038003800380038,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Journal - J Mol Cell Card (6),0.01182,0.0112011201120112,0.01105,0.0146014601460146,Worst Maturation,0.0112011201120112,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.01167,0.0088008800880088,0.00814,0.0269026902690269,Worst Maturation,0.0088008800880088,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01152,0.0113011301130113,0.00748,0.0431043104310431,Worst Maturation,0.0113011301130113,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Cell Line - Gibco episomal (10),0.01124,0.0137013701370137,0.00762,0.0465046504650465,Worst Maturation,0.0137013701370137,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Electrophysiology Analysis Method - Patch Clamp (59),0.01101,0.0258025802580258,0.00736,0.0905090509050905,Worst Maturation,0.0258025802580258,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00979,0.0207020702070207,0.00795,0.0408040804080408,Worst Maturation,0.0207020702070207,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00949,0.0215021502150215,0.0078,0.0383038303830383,Worst Maturation,0.0215021502150215,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),0.00929,0.0202020202020202,0.00902,0.0225022502250225,Worst Maturation,0.0202020202020202,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Pharmacological Intervention - T3 (3),0.00919,0.0224022402240224,0.00894,0.042004200420042,Worst Maturation,0.0224022402240224,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Pharmacological Intervention - Caffeine (4),0.00912,0.0144014401440144,0.00657,0.0638063806380638,Worst Maturation,0.0144014401440144,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Seeding Confluency (%) - 90 to 94 (26),0.00889,0.0538053805380538,0.01383,0.0078007800780078,Worst Maturation,0.0078007800780078,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.00887,0.0315031503150315,0.01051,0.0177017701770177,Worst Maturation,0.0177017701770177,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Cell Line - IMR90 (19),0.00887,0.0352035203520352,0.01029,0.0168016801680168,Worst Maturation,0.0168016801680168,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Pharmacological Intervention - Phenylephrine (3),0.00883,0.0233023302330233,0.00771,0.0592059205920592,Worst Maturation,0.0233023302330233,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Number of Cell Lines - 4 (11),0.00824,0.0334033403340334,0.00465,0.1181118111811181,Worst Maturation,0.0334033403340334,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Insulin Start Day - 2 (4),0.00818,0.0328032803280328,0.00725,0.0639063906390639,Worst Maturation,0.0328032803280328,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Disease Modelling - Dilated Cardiomyopathy (6),0.00802,0.0304030403040304,0.00563,0.0905090509050905,Worst Maturation,0.0304030403040304,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Wnt Induction Duration (days) Quantiles - Q1 (>2 and ≤5) (61),0.00762,0.0946094609460946,0.00986,0.0265026502650265,Worst Maturation,0.0265026502650265,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),hiPSC-CM Media Supplement - HEPES (16),0.00758,0.0405040504050405,0.00607,0.0648064806480648,Worst Maturation,0.0405040504050405,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Wnt Inhibitor Duration (days) - 5 days (6),0.00757,0.0342034203420342,0.00573,0.0796079607960796,Worst Maturation,0.0342034203420342,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),New Media for Maturation - F12 (7),0.00747,0.0331033103310331,0.00772,0.0361036103610361,Worst Maturation,0.0331033103310331,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Day of Insulin Addition - not 25 (3),0.0069,0.0415041504150415,0.00744,0.0488048804880488,Worst Maturation,0.0415041504150415,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Journal - PLoS One (9),0.00664,0.0495049504950495,0.00538,0.0869086908690869,Worst Maturation,0.0495049504950495,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),hiPSC Backbone Media - Conditioned (12),0.00661,0.0677067706770677,0.00944,0.0271027102710271,Worst Maturation,0.0271027102710271,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Gene Analysis Method - RNA (169),0.0058,0.3627362736273627,0.00912,0.0144014401440144,Worst Maturation,0.0144014401440144,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.00577,0.0603060306030603,0.00681,0.0479047904790479,Worst Maturation,0.0479047904790479,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),3D Tissue Media - iCell Maintenance (12),0.00499,0.1044104410441044,0.00802,0.0377037703770377,Worst Maturation,0.0377037703770377,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00448,0.1105110511051105,0.01086,0.0128012801280128,Worst Maturation,0.0128012801280128,True,True
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00436,0.1128112811281128,0.00813,0.0321032103210321,Worst Maturation,0.0321032103210321,True,False
Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.0042,0.1282128212821282,0.00897,0.0287028702870287,Worst Maturation,0.0287028702870287,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Contractile Analysis Method - Traction Force Microscopy (9),0.04697,0.0,0.03619,0.0,Worst Maturation,0.0,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),New Media for Maturation - RPMI-1640 (30),0.02073,0.0025002500250025,0.01358,0.0084008400840084,Worst Maturation,0.0025002500250025,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Journal - Stem Cell Res Ther (3),0.01553,0.0044004400440044,0.01763,0.0042004200420042,Worst Maturation,0.0042004200420042,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Maturation Strategy - Cell Alignment (59),0.01446,0.0095009500950095,0.01375,0.0057005700570057,Worst Maturation,0.0057005700570057,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Journal - Stem Cell Res (8),0.01422,0.0175017501750175,0.00859,0.049004900490049,Worst Maturation,0.0175017501750175,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.01387,0.0075007500750075,0.02132,0.0027002700270027,Worst Maturation,0.0027002700270027,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),hiPSC Matrix Coating - Matrigel (163),0.01357,0.0177017701770177,0.0064,0.2685268526852685,Worst Maturation,0.0177017701770177,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.0127,0.0184018401840184,0.00445,0.2416241624162416,Worst Maturation,0.0184018401840184,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),2D Surface - Micropatterned (27),0.01255,0.0215021502150215,0.00993,0.0303030303030303,Worst Maturation,0.0215021502150215,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.01226,0.02000200020002,0.0148,0.0076007600760076,Worst Maturation,0.0076007600760076,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.01179,0.0197019701970197,0.01723,0.0036003600360036,Worst Maturation,0.0036003600360036,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.01163,0.0187018701870187,0.01257,0.0117011701170117,Worst Maturation,0.0117011701170117,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Journal - Stem Cell Reports (23),0.01115,0.024002400240024,0.01081,0.0238023802380238,Worst Maturation,0.0238023802380238,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Cell Line - WTC11 (30),0.0111,0.0275027502750275,0.00976,0.0339033903390339,Worst Maturation,0.0275027502750275,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Coating for Replating - Vitronectin (3),0.01074,0.0256025602560256,0.01379,0.0146014601460146,Worst Maturation,0.0146014601460146,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Gene Analysis Method - Rare (5),0.01019,0.0136013601360136,0.00781,0.0458045804580458,Worst Maturation,0.0136013601360136,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Calcium Handling Analysis Method - Seahorse (35),0.00948,0.0451045104510451,0.0055,0.1832183218321832,Worst Maturation,0.0451045104510451,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Seeding Confluency 2D (%) - 90 to 94 (12),0.00945,0.0424042404240424,0.00622,0.0988098809880988,Worst Maturation,0.0424042404240424,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Pharmacological Intervention - Positive Inotropes (9),0.00924,0.0346034603460346,0.01228,0.0155015501550155,Worst Maturation,0.0155015501550155,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Disease Modelling - Specialised (3),0.00904,0.0354035403540354,0.01503,0.0069006900690069,Worst Maturation,0.0069006900690069,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Seeding Confluency (%) - 90 to 94 (26),0.00895,0.0463046304630463,0.00556,0.1502150215021502,Worst Maturation,0.0463046304630463,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),2D Surface - ECM-coated (115),0.00874,0.0969096909690969,0.01256,0.0032003200320032,Worst Maturation,0.0032003200320032,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Wnt Inhibitor - Wnt-C59 (30),0.00825,0.0603060306030603,0.00879,0.0482048204820482,Worst Maturation,0.0482048204820482,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00813,0.0483048304830483,0.00965,0.0276027602760276,Worst Maturation,0.0276027602760276,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),hiPSC-CM Purification Duration (days) - 6 days (10),0.00759,0.0472047204720472,0.00515,0.1235123512351235,Worst Maturation,0.0472047204720472,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.00732,0.056005600560056,0.01185,0.0164016401640164,Worst Maturation,0.0164016401640164,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),hiPSC-CM Maturation Media - RPMI-1640 (153),0.0069,0.2802280228022802,0.01001,0.0187018701870187,Worst Maturation,0.0187018701870187,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Maturation Strategy - ECM (21),0.0068,0.0946094609460946,0.00978,0.0352035203520352,Worst Maturation,0.0352035203520352,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Insulin Start Day - 6 (20),0.00649,0.0922092209220922,0.00895,0.046004600460046,Worst Maturation,0.046004600460046,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Publication Year - 2024 (7),0.00562,0.1023102310231023,0.00913,0.0316031603160316,Worst Maturation,0.0316031603160316,True,False
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.0052,0.0958095809580958,0.01227,0.0116011601160116,Worst Maturation,0.0116011601160116,True,True
Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),Journal - Circ Res (5),0.00451,0.107010701070107,0.00811,0.0439043904390439,Worst Maturation,0.0439043904390439,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC-CM Purification Duration (days) - 4 days (29),0.01926,0.0043004300430043,0.00939,0.0366036603660366,Worst Maturation,0.0043004300430043,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.01922,0.0059005900590059,0.01857,0.0031003100310031,Worst Maturation,0.0031003100310031,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Cell Line - Gibco episomal (10),0.01851,0.0051005100510051,0.01467,0.0098009800980098,Worst Maturation,0.0051005100510051,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Journal - PLoS One (9),0.01663,0.0036003600360036,0.00951,0.0298029802980298,Worst Maturation,0.0036003600360036,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Seeding Confluency 3D (%) - 85 to 89 (12),0.01434,0.0103010301030103,0.00963,0.0312031203120312,Worst Maturation,0.0103010301030103,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Journal - Stem Cells Int (3),0.01399,0.0036003600360036,0.01462,0.0064006400640064,Worst Maturation,0.0036003600360036,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC Matrix Coating - Matrigel (163),0.01338,0.0197019701970197,0.00481,0.5670567056705671,Worst Maturation,0.0197019701970197,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Contractile Analysis Method - Force Transducer (27),0.01288,0.0181018101810181,0.00881,0.0537053705370537,Worst Maturation,0.0181018101810181,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.01277,0.0196019601960196,0.01025,0.0306030603060306,Worst Maturation,0.0196019601960196,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Publication Year - 2017 (43),0.01273,0.0148014801480148,0.00933,0.0445044504450445,Worst Maturation,0.0148014801480148,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Maturation Strategy - Tension (64),0.01205,0.028002800280028,0.00643,0.1494149414941494,Worst Maturation,0.028002800280028,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC Matrix Coating - Vitronectin (10),0.01177,0.0146014601460146,0.01366,0.0098009800980098,Worst Maturation,0.0098009800980098,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Platform - Collagen (38),0.01176,0.0235023502350235,0.00844,0.0541054105410541,Worst Maturation,0.0235023502350235,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Tissue Media - RPMI-1640 (72),0.0116,0.0303030303030303,0.00935,0.0513051305130513,Worst Maturation,0.0303030303030303,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Maturation Strategy - Elastomeric (33),0.01132,0.027002700270027,0.00804,0.0682068206820682,Worst Maturation,0.027002700270027,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC-CM Media Supplement - Ascorbic Acid (41),0.01127,0.036003600360036,0.00965,0.0431043104310431,Worst Maturation,0.036003600360036,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Cell Line - DF19-9-11T.H (16),0.01094,0.0184018401840184,0.01044,0.0222022202220222,Worst Maturation,0.0184018401840184,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Contractile Analysis Method - Traction Force Microscopy (9),0.01073,0.0216021602160216,0.01396,0.0094009400940094,Worst Maturation,0.0094009400940094,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.01063,0.0433043304330433,0.00911,0.0479047904790479,Worst Maturation,0.0433043304330433,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),New Media for Maturation - RPMI-1640 (30),0.0104,0.0325032503250325,0.00904,0.0411041104110411,Worst Maturation,0.0325032503250325,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Day of Insulin Addition - not 14 (15),0.01,0.0455045504550455,0.00454,0.1695169516951695,Worst Maturation,0.0455045504550455,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC-CM Purification Duration (days) - >9 days (5),0.00983,0.0176017601760176,0.00728,0.0548054805480548,Worst Maturation,0.0176017601760176,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC Backbone Media - Essential 8 (82),0.00939,0.0567056705670567,0.01055,0.0177017701770177,Worst Maturation,0.0177017701770177,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Stromal Cell Source - Cardiac Fibroblast (32),0.0091,0.0482048204820482,0.00535,0.1753175317531753,Worst Maturation,0.0482048204820482,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Insulin Start Day - 1 (19),0.00876,0.0459045904590459,0.01071,0.025002500250025,Worst Maturation,0.025002500250025,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.00873,0.0354035403540354,0.00758,0.0539053905390539,Worst Maturation,0.0354035403540354,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.00848,0.0481048104810481,0.01003,0.0304030403040304,Worst Maturation,0.0304030403040304,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),0.00844,0.0387038703870387,0.01202,0.0141014101410141,Worst Maturation,0.0141014101410141,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Tissue Media - High-glucose DMEM (9),0.00835,0.0425042504250425,0.00834,0.0444044404440444,Worst Maturation,0.0425042504250425,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Journal - Biomaterials (16),0.00816,0.0652065206520652,0.01403,0.01000100010001,Worst Maturation,0.01000100010001,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Electrophysiology Analysis Method - Genetical (3),0.00811,0.038003800380038,0.00848,0.0447044704470447,Worst Maturation,0.038003800380038,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Journal - Stem Cells Transl Med (3),0.0075,0.0749074907490749,0.01183,0.0422042204220422,Worst Maturation,0.0422042204220422,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Seeding Confluency (%) - 85 to 89 (43),0.00707,0.1187118711871187,0.01148,0.0221022102210221,Worst Maturation,0.0221022102210221,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Insulin Start Day - 3 (5),0.00661,0.0512051205120512,0.01224,0.0087008700870087,Worst Maturation,0.0087008700870087,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Platform - Gelatin (6),0.00635,0.0865086508650865,0.00815,0.049004900490049,Worst Maturation,0.049004900490049,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),hiPSC-CM Media Supplement - HEPES (16),0.00619,0.0743074307430743,0.0079,0.042004200420042,Worst Maturation,0.042004200420042,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),3D Platform - Polyethylene Glycol (8),0.00477,0.1234123412341234,0.0083,0.042004200420042,Worst Maturation,0.042004200420042,True,False
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Seeding Confluency 3D (%) - 70 to 79 (3),0.00297,0.0871087108710871,0.01196,0.0155015501550155,Worst Maturation,0.0155015501550155,True,True
Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),Journal - J Mol Cell Cardiol (4),0.00292,0.1147114711471147,0.00797,0.0419041904190419,Worst Maturation,0.0419041904190419,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Contractile Analysis Method - Motion Tracking (93),0.04644,0.0,0.02137,0.0,Worst Maturation,0.0,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC Matrix Coating - Geltrex (33),0.0172,0.0051005100510051,0.01199,0.0154015401540154,Worst Maturation,0.0051005100510051,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Journal - ACS Appl Mater Interfaces (4),0.01623,0.0036003600360036,0.02119,0.0018001800180018,Worst Maturation,0.0018001800180018,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Wnt Inhibitor - IWR (56),0.01551,0.0082008200820082,0.01179,0.0146014601460146,Worst Maturation,0.0082008200820082,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Insulin Start Day - 7 (85),0.01493,0.0139013901390139,0.00737,0.1176117611761176,Worst Maturation,0.0139013901390139,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC Backbone Media - Essential 8 (82),0.01187,0.0249024902490249,0.0074,0.0935093509350935,Worst Maturation,0.0249024902490249,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01132,0.0261026102610261,0.01137,0.021002100210021,Worst Maturation,0.021002100210021,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Gene Analysis Method - RNA (169),0.0112,0.0425042504250425,0.00697,0.1681168116811681,Worst Maturation,0.0425042504250425,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC-CM Purification Duration (days) - 3 days (13),0.01094,0.0252025202520252,0.01007,0.0261026102610261,Worst Maturation,0.0252025202520252,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Seeding Confluency (%) - 85 to 89 (43),0.0108,0.0349034903490349,0.01238,0.0128012801280128,Worst Maturation,0.0128012801280128,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Purification Protocol - Glucose and Lactate (85),0.01068,0.0272027202720272,0.00513,0.3059305930593059,Worst Maturation,0.0272027202720272,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Pharmacological Intervention - Carbamylcholine (6),0.01054,0.0193019301930193,0.00861,0.036003600360036,Worst Maturation,0.0193019301930193,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Maturation Strategy - Cell Alignment (59),0.01007,0.0452045204520452,0.00644,0.2000200020002,Worst Maturation,0.0452045204520452,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC-CM Purification Duration (days) - <3 days (31),0.01002,0.0339033903390339,0.00884,0.0369036903690369,Worst Maturation,0.0339033903390339,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Pharmacological Intervention - Other Antiarrhythmic Agents (13),0.00993,0.0385038503850385,0.0064,0.0922092209220922,Worst Maturation,0.0385038503850385,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC-CM Media Supplement - GlutaMax (8),0.0098,0.0293029302930293,0.00812,0.0438043804380438,Worst Maturation,0.0293029302930293,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Maturation Strategy - Mechanical (36),0.0089,0.0522052205220522,0.00999,0.0298029802980298,Worst Maturation,0.0298029802980298,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.00876,0.0337033703370337,0.00992,0.0285028502850285,Worst Maturation,0.0285028502850285,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Journal - Cell Stem Cell (6),0.0087,0.0305030503050305,0.01053,0.0193019301930193,Worst Maturation,0.0193019301930193,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Coating for Replating - Geltrex (10),0.00865,0.0351035103510351,0.00723,0.0581058105810581,Worst Maturation,0.0351035103510351,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),2D Surface - Electrospun (13),0.00861,0.048004800480048,0.00759,0.0622062206220622,Worst Maturation,0.048004800480048,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Seeding Confluency 2D (%) - 85 to 89 (26),0.0086,0.0475047504750475,0.00797,0.0479047904790479,Worst Maturation,0.0475047504750475,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Metabolic Component - Rare (4),0.00825,0.0434043404340434,0.00712,0.0753075307530753,Worst Maturation,0.0434043404340434,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),hiPSC-CM Purification Duration (days) - 6 days (10),0.00821,0.0395039503950395,0.00744,0.0556055605560556,Worst Maturation,0.0395039503950395,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Calcium Handling Analysis Method - Rare (4),0.00788,0.0377037703770377,0.00931,0.027002700270027,Worst Maturation,0.027002700270027,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Insulin Start Day - 6 (20),0.00774,0.0615061506150615,0.0111,0.0197019701970197,Worst Maturation,0.0197019701970197,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Day of Insulin Addition - not 22 (12),0.00773,0.0463046304630463,0.00493,0.1256125612561256,Worst Maturation,0.0463046304630463,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Differentiation Purity Assessment - IHC cTnT (7),0.00723,0.0461046104610461,0.00906,0.0278027802780278,Worst Maturation,0.0278027802780278,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),2D Surface - Microparticle/fluid (3),0.00719,0.0659065906590659,0.01231,0.0184018401840184,Worst Maturation,0.0184018401840184,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Sacromere or Cellular Alignment Analysis - Yes (72),0.00682,0.1372137213721372,0.00914,0.0409040904090409,Worst Maturation,0.0409040904090409,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Pharmacological Intervention - Metoprolol (5),0.00656,0.0583058305830583,0.00924,0.0244024402440244,Worst Maturation,0.0244024402440244,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),0.00614,0.0909090909090909,0.00897,0.0333033303330333,Worst Maturation,0.0333033303330333,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Insulin Withdrawal Duration (days) - 6 days (3),0.00595,0.0826082608260826,0.01118,0.0319031903190319,Worst Maturation,0.0319031903190319,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Cell Line Ancestry - Asian (28),0.0059,0.1332133213321332,0.01069,0.0253025302530253,Worst Maturation,0.0253025302530253,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.00537,0.2438243824382438,0.00916,0.0357035703570357,Worst Maturation,0.0357035703570357,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Journal - Biomater Sci (7),0.005,0.1026102610261026,0.01194,0.012001200120012,Worst Maturation,0.012001200120012,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Insulin Withdrawal Duration (days) - 8 days (3),0.00346,0.0958095809580958,0.00878,0.0428042804280428,Worst Maturation,0.0428042804280428,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),Calcium Handling Analysis Method - Flux Rates (13),0.00272,0.2512251225122512,0.00828,0.0367036703670367,Worst Maturation,0.0367036703670367,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - Stem Cell Reports (23),0.02338,0.0011001100110011,0.01646,0.0025002500250025,Worst Maturation,0.0011001100110011,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.02154,0.0022002200220022,0.01711,0.0042004200420042,Worst Maturation,0.0022002200220022,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Calcium Handling Analysis Method - Visual (104),0.01689,0.0039003900390039,0.0062,0.2585258525852585,Worst Maturation,0.0039003900390039,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.01411,0.0062006200620062,0.01385,0.0079007900790079,Worst Maturation,0.0062006200620062,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.01368,0.0134013401340134,0.01215,0.0157015701570157,Worst Maturation,0.0134013401340134,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01325,0.0069006900690069,0.0087,0.0292029202920292,Worst Maturation,0.0069006900690069,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Contractile Analysis Method - Deflection (39),0.01284,0.0204020402040204,0.00864,0.0567056705670567,Worst Maturation,0.0204020402040204,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.01164,0.0187018701870187,0.01337,0.0115011501150115,Worst Maturation,0.0115011501150115,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01093,0.0327032703270327,0.00965,0.0346034603460346,Worst Maturation,0.0327032703270327,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.01083,0.0172017201720172,0.01179,0.012001200120012,Worst Maturation,0.012001200120012,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Wnt Induction - BMP4 (74),0.01067,0.0437043704370437,0.00606,0.2075207520752075,Worst Maturation,0.0437043704370437,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01054,0.026002600260026,0.01055,0.0245024502450245,Worst Maturation,0.0245024502450245,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Maturation Strategy - Tension (64),0.01053,0.0283028302830283,0.00276,0.6420642064206421,Worst Maturation,0.0283028302830283,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),2D Surface - Micropatterned (27),0.0102,0.035003500350035,0.00737,0.0728072807280728,Worst Maturation,0.035003500350035,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Maturation Strategy - Other Cells (80),0.01008,0.0382038203820382,0.00251,0.7459745974597459,Worst Maturation,0.0382038203820382,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.00992,0.0247024702470247,0.0111,0.0186018601860186,Worst Maturation,0.0186018601860186,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Cell Line - ATCC (5),0.00987,0.0171017101710171,0.00702,0.0635063506350635,Worst Maturation,0.0171017101710171,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Cell Line - IMR90 (19),0.00932,0.036003600360036,0.00737,0.0657065706570657,Worst Maturation,0.036003600360036,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - Am J Physiol Heart Circ Physiol (4),0.00911,0.0245024502450245,0.00822,0.0507050705070507,Worst Maturation,0.0245024502450245,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.0088,0.0377037703770377,0.00671,0.0729072907290729,Worst Maturation,0.0377037703770377,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Wnt Induction - StemCell Diff Kit (4),0.00827,0.0494049404940494,0.00634,0.0959095909590959,Worst Maturation,0.0494049404940494,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.00799,0.0515051505150515,0.01084,0.0153015301530153,Worst Maturation,0.0153015301530153,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - J Mol Cell Card (6),0.00788,0.043004300430043,0.00692,0.0674067406740674,Worst Maturation,0.043004300430043,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Publication Year - 2014 (3),0.00786,0.0389038903890389,0.00594,0.0793079307930793,Worst Maturation,0.0389038903890389,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.00785,0.0448044804480448,0.01303,0.0079007900790079,Worst Maturation,0.0079007900790079,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - Circulation (11),0.0076,0.0443044304430443,0.00753,0.0519051905190519,Worst Maturation,0.0443044304430443,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Wnt Inhibitor - XAV939 (24),0.007,0.0746074607460746,0.0127,0.0083008300830083,Worst Maturation,0.0083008300830083,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),hiPSC Backbone Media - Conditioned (12),0.00691,0.0624062406240624,0.01,0.0248024802480248,Worst Maturation,0.0248024802480248,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.00647,0.0635063506350635,0.00821,0.0404040404040404,Worst Maturation,0.0404040404040404,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Calcium Handling Analysis Method - Seahorse (35),0.00504,0.169016901690169,0.00938,0.0387038703870387,Worst Maturation,0.0387038703870387,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - ACS Biomater Sci Eng (3),0.00502,0.0918091809180918,0.00906,0.0485048504850485,Worst Maturation,0.0485048504850485,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.0043,0.109010901090109,0.00871,0.036003600360036,Worst Maturation,0.036003600360036,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),Journal - Biomater Sci (7),0.004,0.1481148114811481,0.00945,0.0231023102310231,Worst Maturation,0.0231023102310231,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),2D Surface - Electrospun (13),0.03177,0.0001000100010001,0.02642,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Calcium Handling Analysis Method - Visual (104),0.02815,0.0004000400040004,0.01581,0.0006000600060006,Worst Maturation,0.0004000400040004,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Publication Year - 2022 (20),0.02791,0.0001000100010001,0.02083,0.0003000300030003,Worst Maturation,0.0001000100010001,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Phenylephrine (3),0.02101,0.0013001300130013,0.02452,0.0006000600060006,Worst Maturation,0.0006000600060006,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Number of Cell Lines - 4 (11),0.01647,0.0056005600560056,0.01311,0.0117011701170117,Worst Maturation,0.0056005600560056,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.01597,0.0054005400540054,0.01076,0.0186018601860186,Worst Maturation,0.0054005400540054,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Coating for Replating - Fibronectin (32),0.01516,0.0095009500950095,0.01373,0.005000500050005,Worst Maturation,0.005000500050005,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Publication Year - Late-2010s (196),0.01238,0.0204020402040204,0.00694,0.127012701270127,Worst Maturation,0.0204020402040204,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.01147,0.0161016101610161,0.0065,0.0578057805780578,Worst Maturation,0.0161016101610161,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Journal - Biomaterials (16),0.01062,0.0178017801780178,0.00577,0.094009400940094,Worst Maturation,0.0178017801780178,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Isoproterenol (71),0.01035,0.0391039103910391,0.00613,0.1583158315831583,Worst Maturation,0.0391039103910391,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),hiPSC Backbone Media - StemFit (5),0.01019,0.0128012801280128,0.00958,0.0202020202020202,Worst Maturation,0.0128012801280128,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),0.01009,0.0186018601860186,0.00661,0.0546054605460546,Worst Maturation,0.0186018601860186,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),hiPSC Matrix Coating - Geltrex (33),0.01004,0.038003800380038,0.00592,0.1667166716671667,Worst Maturation,0.038003800380038,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Electron Imaging - Scanning (22),0.00961,0.0335033503350335,0.01136,0.0152015201520152,Worst Maturation,0.0152015201520152,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Cell Line Sex - Both (118),0.00958,0.0746074607460746,0.00899,0.0308030803080308,Worst Maturation,0.0308030803080308,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Lidocaine (7),0.00869,0.0224022402240224,0.00876,0.024002400240024,Worst Maturation,0.0224022402240224,True,True
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),hiPSC-CM Maturation Media - iCell Maintenance (83),0.00867,0.0473047304730473,0.00687,0.1029102910291029,Worst Maturation,0.0473047304730473,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Purification Protocol - Metabolic (8),0.00864,0.0262026202620262,0.00582,0.0776077607760776,Worst Maturation,0.0262026202620262,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Seeding Confluency 3D (%) - 90 to 94 (13),0.00861,0.0353035303530353,0.00768,0.0451045104510451,Worst Maturation,0.0353035303530353,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Seeding Confluency (%) - 90 to 94 (26),0.0086,0.0501050105010501,0.00886,0.0425042504250425,Worst Maturation,0.0425042504250425,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Cardiotoxic Agents (3),0.00804,0.0462046204620462,0.00756,0.0664066406640664,Worst Maturation,0.0462046204620462,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00793,0.045004500450045,0.00772,0.0459045904590459,Worst Maturation,0.045004500450045,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),0.00776,0.0457045704570457,0.00738,0.0545054505450545,Worst Maturation,0.0457045704570457,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Insulin Start Day - 9 (10),0.00693,0.0499049904990499,0.008,0.0375037503750375,Worst Maturation,0.0375037503750375,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Journal - J Biomed Mater Res A (3),0.00607,0.0791079107910791,0.01016,0.032003200320032,Worst Maturation,0.032003200320032,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Journal - Biomater Sci (7),0.00597,0.0686068606860686,0.00795,0.0374037403740374,Worst Maturation,0.0374037403740374,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Pharmacological Intervention - Blebbistatin (5),0.00574,0.0648064806480648,0.0068,0.0484048404840484,Worst Maturation,0.0484048404840484,True,False
Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),Publication Year - 2015 (19),0.00455,0.1499149914991499,0.009,0.0352035203520352,Worst Maturation,0.0352035203520352,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Publication Year - 2021 (43),0.02806,0.0006000600060006,0.01779,0.0027002700270027,Worst Maturation,0.0006000600060006,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),3D Stromal Cell Source - Stromal Cell (35),0.01681,0.0083008300830083,0.01208,0.0146014601460146,Worst Maturation,0.0083008300830083,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.0162,0.0052005200520052,0.01434,0.0069006900690069,Worst Maturation,0.0052005200520052,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Journal - Biomater Sci (7),0.0161,0.0058005800580058,0.01382,0.0084008400840084,Worst Maturation,0.0058005800580058,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Sacromere or Cellular Alignment Analysis - Yes (72),0.01354,0.0202020202020202,0.00616,0.1803180318031803,Worst Maturation,0.0202020202020202,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Metabolic Component Category - Metabolic Modulation (20),0.01338,0.0212021202120212,0.00793,0.0661066106610661,Worst Maturation,0.0212021202120212,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Coating for Replating - Rare (6),0.01271,0.0091009100910091,0.01377,0.0088008800880088,Worst Maturation,0.0088008800880088,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Cell Line - IMR90 (19),0.01173,0.0196019601960196,0.00775,0.0628062806280628,Worst Maturation,0.0196019601960196,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Seeding Confluency (%) - 80 to 84 (12),0.01131,0.025002500250025,0.01335,0.0105010501050105,Worst Maturation,0.0105010501050105,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Metabolic Component - Palmitic Acid (11),0.01102,0.023002300230023,0.00914,0.033003300330033,Worst Maturation,0.023002300230023,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),T-tubule Structures - Yes (18),0.01035,0.0261026102610261,0.00836,0.0442044204420442,Worst Maturation,0.0261026102610261,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Cell Line - Gibco episomal (10),0.0097,0.0303030303030303,0.00865,0.0415041504150415,Worst Maturation,0.0303030303030303,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Calcium Handling Analysis Method - Genetical (23),0.00956,0.0347034703470347,0.00593,0.1202120212021202,Worst Maturation,0.0347034703470347,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Disease Modelling - Fibrotic (4),0.00948,0.0167016701670167,0.00601,0.0746074607460746,Worst Maturation,0.0167016701670167,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Calcium Handling Analysis Method - Seahorse (35),0.00943,0.047004700470047,0.00809,0.0755075507550755,Worst Maturation,0.047004700470047,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Journal - Cell Stem Cell (6),0.0093,0.034003400340034,0.00841,0.0497049704970497,Worst Maturation,0.034003400340034,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Metabolic Component - IGF-1 (3),0.0088,0.0453045304530453,0.00947,0.0481048104810481,Worst Maturation,0.0453045304530453,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Metabolic Component - Fatty Acid (13),0.00863,0.0404040404040404,0.00622,0.0892089208920892,Worst Maturation,0.0404040404040404,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.00854,0.0389038903890389,0.01323,0.0095009500950095,Worst Maturation,0.0095009500950095,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Seeding Confluency 3D (%) - 80 to 84 (5),0.00805,0.0429042904290429,0.00594,0.0883088308830883,Worst Maturation,0.0429042904290429,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Wnt Inhibitor Duration (days) - 5 days (6),0.00794,0.0495049504950495,0.00552,0.1114111411141114,Worst Maturation,0.0495049504950495,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),3D Stromal Cell Source - hiPSC-CardiacF (8),0.00756,0.0483048304830483,0.00964,0.0294029402940294,Worst Maturation,0.0294029402940294,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.00742,0.0455045504550455,0.00973,0.0245024502450245,Worst Maturation,0.0245024502450245,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),hiPSC-CM Purification Duration (days) - >9 days (5),0.00551,0.0939093909390939,0.00888,0.0342034203420342,Worst Maturation,0.0342034203420342,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),hiPSC-CM Maturation Media - RPMI-1640 (153),0.00496,0.6611661166116611,0.00968,0.0255025502550255,Worst Maturation,0.0255025502550255,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00493,0.1316131613161316,0.00932,0.0402040204020402,Worst Maturation,0.0402040204020402,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Maturation Strategy - ECM (21),0.02675,0.0009000900090009,0.02141,0.0027002700270027,Worst Maturation,0.0009000900090009,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.01787,0.0097009700970097,0.01322,0.0328032803280328,Worst Maturation,0.0097009700970097,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),0.01778,0.0152015201520152,0.01286,0.0357035703570357,Worst Maturation,0.0152015201520152,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.0172,0.0158015801580158,0.00956,0.067006700670067,Worst Maturation,0.0158015801580158,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Seeding Confluency 3D (%) - 80 to 84 (5),0.01535,0.019001900190019,0.01462,0.0226022602260226,Worst Maturation,0.019001900190019,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),3D Platform - Extracellular Scaffold (18),0.01532,0.0169016901690169,0.01331,0.0271027102710271,Worst Maturation,0.0169016901690169,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.01503,0.0202020202020202,0.01404,0.0293029302930293,Worst Maturation,0.0202020202020202,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01455,0.0164016401640164,0.01564,0.0138013801380138,Worst Maturation,0.0138013801380138,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),0.01447,0.0321032103210321,0.01262,0.0327032703270327,Worst Maturation,0.0321032103210321,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Journal - Tissue Eng Part A (4),0.01389,0.0378037803780378,0.01742,0.0195019501950195,Worst Maturation,0.0195019501950195,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),0.01273,0.0471047104710471,0.00938,0.1286128612861286,Worst Maturation,0.0471047104710471,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01261,0.0208020802080208,0.01532,0.0121012101210121,Worst Maturation,0.0121012101210121,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),2D Surface - Decellularized ECM (3),0.01244,0.0317031703170317,0.01198,0.0396039603960396,Worst Maturation,0.0317031703170317,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Metabolic Component Category - Signaling Pathway Regulators (6),0.01231,0.0368036803680368,0.00905,0.0681068106810681,Worst Maturation,0.0368036803680368,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),0.01176,0.048004800480048,0.00643,0.1548154815481548,Worst Maturation,0.048004800480048,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Cell Line Ancestry - Asian (28),0.01171,0.0375037503750375,0.00616,0.1479147914791479,Worst Maturation,0.0375037503750375,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Electron Imaging - Transmission (62),0.01169,0.03000300030003,0.01107,0.0267026702670267,Worst Maturation,0.0267026702670267,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.01061,0.0324032403240324,0.0159,0.0102010201020102,Worst Maturation,0.0102010201020102,True,True
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Insulin Start Day - 10 (6),0.0101,0.0592059205920592,0.01226,0.0409040904090409,Worst Maturation,0.0409040904090409,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.0097,0.0483048304830483,0.00832,0.08000800080008,Worst Maturation,0.0483048304830483,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),2D Surface - Hydrogel (17),0.00914,0.0538053805380538,0.01063,0.038003800380038,Worst Maturation,0.038003800380038,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Pharmacological Intervention - Carbenoxolone (4),0.0084,0.0555055505550555,0.01026,0.0454045404540454,Worst Maturation,0.0454045404540454,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.00814,0.0524052405240524,0.01131,0.0411041104110411,Worst Maturation,0.0411041104110411,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.00801,0.0815081508150815,0.013,0.0262026202620262,Worst Maturation,0.0262026202620262,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Calcium Handling Analysis Method - Genetical (23),0.00793,0.0742074207420742,0.01084,0.0397039703970397,Worst Maturation,0.0397039703970397,True,False
Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),Cell Line - IMR90 (19),0.00572,0.1301130113011301,0.01196,0.0301030103010301,Worst Maturation,0.0301030103010301,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),hiPSC-CM Purification Duration (days) - 5 days (6),0.02963,0.0025002500250025,0.03066,0.0024002400240024,Worst Maturation,0.0024002400240024,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Journal - J Biomed Mater Res A (3),0.02461,0.0059005900590059,0.01616,0.0269026902690269,Worst Maturation,0.0059005900590059,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Journal - Am J Physiol Heart Circ Physiol (4),0.02404,0.0086008600860086,0.02467,0.0123012301230123,Worst Maturation,0.0086008600860086,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Insulin Start Day - 5 (14),0.02267,0.0103010301030103,0.01757,0.0247024702470247,Worst Maturation,0.0103010301030103,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Calcium Handling Analysis Method - Visual (104),0.0226,0.0004000400040004,0.01041,0.0438043804380438,Worst Maturation,0.0004000400040004,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Publication Year - 2018 (45),0.02132,0.0203020302030203,0.01199,0.066006600660066,Worst Maturation,0.0203020302030203,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Differentiation Purity Assessment - IHC cTnT (7),0.02123,0.0087008700870087,0.02113,0.0094009400940094,Worst Maturation,0.0087008700870087,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),3D Tissue Media - iCell Maintenance (12),0.02084,0.0081008100810081,0.01842,0.0188018801880188,Worst Maturation,0.0081008100810081,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.02047,0.0109010901090109,0.01696,0.0182018201820182,Worst Maturation,0.0109010901090109,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Journal - Tissue Eng Part A (4),0.01815,0.0239023902390239,0.01431,0.0361036103610361,Worst Maturation,0.0239023902390239,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Publication Year - 2022 (20),0.01724,0.0163016301630163,0.02339,0.0055005500550055,Worst Maturation,0.0055005500550055,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.01641,0.018001800180018,0.02342,0.007000700070007,Worst Maturation,0.007000700070007,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Electron Imaging - Scanning (22),0.01591,0.0242024202420242,0.01215,0.0539053905390539,Worst Maturation,0.0242024202420242,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Cell Line - iCell2 (8),0.01563,0.0458045804580458,0.01458,0.0408040804080408,Worst Maturation,0.0408040804080408,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),0.01481,0.0333033303330333,0.01255,0.0529052905290529,Worst Maturation,0.0333033303330333,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),2D Surface - Electrospun (13),0.0145,0.0415041504150415,0.01103,0.0685068506850685,Worst Maturation,0.0415041504150415,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01422,0.0196019601960196,0.02024,0.0074007400740074,Worst Maturation,0.0074007400740074,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),hiPSC-CM Media Supplement - Rare (5),0.01409,0.043004300430043,0.00788,0.0585058505850585,Worst Maturation,0.043004300430043,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Disease Modelling - Arrhythmic (15),0.01355,0.0458045804580458,0.01798,0.02000200020002,Worst Maturation,0.02000200020002,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01326,0.0449044904490449,0.0147,0.0439043904390439,Worst Maturation,0.0439043904390439,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Sacromere or Cellular Alignment Analysis - Yes (72),0.01269,0.063006300630063,0.0134,0.0372037203720372,Worst Maturation,0.0372037203720372,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.00999,0.0899089908990899,0.01389,0.026002600260026,Worst Maturation,0.026002600260026,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Gene Analysis Method - RNA (169),0.00876,0.093009300930093,0.01047,0.0476047604760476,Worst Maturation,0.0476047604760476,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.00802,0.0616061606160616,0.01182,0.0202020202020202,Worst Maturation,0.0202020202020202,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Journal - Sci Transl Med (3),0.00528,0.0356035603560356,0.0117,0.0315031503150315,Worst Maturation,0.0315031503150315,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Insulin Start Day - 11 (3),0.00075,0.0409040904090409,0.0015,0.0405040504050405,Worst Maturation,0.0405040504050405,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),Disease Modelling - Specialised (3),0.00055,0.0459045904590459,0.00096,0.0458045804580458,Worst Maturation,0.0458045804580458,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Electrophysiology Analysis Method - Optical Mapping (39),0.02932,0.0004000400040004,0.02338,0.0005000500050005,Worst Maturation,0.0004000400040004,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Electron Imaging - Transmission (62),0.0218,0.0034003400340034,0.00778,0.1197119711971197,Worst Maturation,0.0034003400340034,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Maturation Strategy - Mechanical (36),0.01636,0.0107010701070107,0.00885,0.0655065506550655,Worst Maturation,0.0107010701070107,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),2D Surface - Micropatterned (27),0.01562,0.0094009400940094,0.00753,0.0917091709170917,Worst Maturation,0.0094009400940094,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Electron Imaging - Scanning (22),0.01544,0.0125012501250125,0.01688,0.0059005900590059,Worst Maturation,0.0059005900590059,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),0.01509,0.0163016301630163,0.01411,0.0229022902290229,Worst Maturation,0.0163016301630163,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Maturation Strategy - Electrical (39),0.01389,0.0252025202520252,0.01381,0.0161016101610161,Worst Maturation,0.0161016101610161,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.01339,0.0163016301630163,0.01275,0.0215021502150215,Worst Maturation,0.0163016301630163,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Journal - Cell Stem Cell (6),0.01311,0.0208020802080208,0.0102,0.0453045304530453,Worst Maturation,0.0208020802080208,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01265,0.0325032503250325,0.00961,0.0515051505150515,Worst Maturation,0.0325032503250325,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),3D Tissue Media - iCell Maintenance (12),0.0126,0.0204020402040204,0.00847,0.064006400640064,Worst Maturation,0.0204020402040204,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.01244,0.0234023402340234,0.01524,0.0163016301630163,Worst Maturation,0.0163016301630163,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),hiPSC-CM Purification Duration (days) - 6 days (10),0.01234,0.0204020402040204,0.01305,0.0225022502250225,Worst Maturation,0.0204020402040204,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),3D Tissue Media - High-glucose DMEM (9),0.0123,0.0387038703870387,0.0179,0.0105010501050105,Worst Maturation,0.0105010501050105,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),3D Platform - Scaffold Free (43),0.0123,0.0367036703670367,0.01379,0.0148014801480148,Worst Maturation,0.0148014801480148,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Publication Year - 2017 (43),0.01116,0.0353035303530353,0.01305,0.0191019101910191,Worst Maturation,0.0191019101910191,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Journal - ACS Appl Mater Interfaces (4),0.01069,0.0386038603860386,0.0157,0.0117011701170117,Worst Maturation,0.0117011701170117,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Journal - PLoS One (9),0.01045,0.0309030903090309,0.01011,0.04000400040004,Worst Maturation,0.0309030903090309,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Metabolic Component Category - Signaling Pathway Regulators (6),0.00928,0.046004600460046,0.00893,0.057005700570057,Worst Maturation,0.046004600460046,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),3D Tissue Media - Commercial Kit (21),0.00815,0.0711071107110711,0.01171,0.028002800280028,Worst Maturation,0.028002800280028,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00498,0.0765076507650765,0.01031,0.041004100410041,Worst Maturation,0.041004100410041,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),Cell Coculture - Cardiomyocyte (157),0.00433,0.6781678167816781,0.00919,0.0252025202520252,Worst Maturation,0.0252025202520252,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Electrophysiology Analysis Method - Patch Clamp (59),0.04967,0.0,0.02311,0.0,Worst Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.02583,0.0001000100010001,0.02562,0.0003000300030003,Worst Maturation,0.0001000100010001,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Gene Analysis Method - RNA (169),0.02474,0.0006000600060006,0.00446,0.6285628562856286,Worst Maturation,0.0006000600060006,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Cell Line - ATCC (5),0.01755,0.004000400040004,0.01443,0.0081008100810081,Worst Maturation,0.004000400040004,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Wnt Induction Duration (days) - 3 days (38),0.01593,0.0063006300630063,0.00906,0.0452045204520452,Worst Maturation,0.0063006300630063,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Publication Year - 2017 (43),0.0135,0.0091009100910091,0.01225,0.0076007600760076,Worst Maturation,0.0076007600760076,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Wnt Inhibitor - XAV939 (24),0.01349,0.0112011201120112,0.01425,0.0068006800680068,Worst Maturation,0.0068006800680068,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),hiPSC Backbone Media - Rare (19),0.01211,0.0177017701770177,0.01225,0.0108010801080108,Worst Maturation,0.0108010801080108,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Seeding Confluency 2D (%) - 85 to 89 (26),0.01205,0.0158015801580158,0.014,0.0047004700470047,Worst Maturation,0.0047004700470047,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Number of Cell Lines - 2 (50),0.01146,0.0272027202720272,0.01546,0.0024002400240024,Worst Maturation,0.0024002400240024,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Cell Line - BJ1 (7),0.01058,0.0189018901890189,0.01237,0.011001100110011,Worst Maturation,0.011001100110011,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Seeding Confluency (%) - 85 to 89 (43),0.00967,0.0481048104810481,0.01158,0.0153015301530153,Worst Maturation,0.0153015301530153,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.00961,0.0293029302930293,0.00487,0.1637163716371637,Worst Maturation,0.0293029302930293,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Coating for Replating - Gelatin (43),0.0095,0.0503050305030503,0.01368,0.0072007200720072,Worst Maturation,0.0072007200720072,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),hiPSC-CM Purification Duration (days) - 3 days (13),0.00931,0.0344034403440344,0.0075,0.0506050605060506,Worst Maturation,0.0344034403440344,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),0.00906,0.0333033303330333,0.00716,0.0544054405440544,Worst Maturation,0.0333033303330333,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Metabolic Component - Fatty Acid (13),0.00853,0.0429042904290429,0.0047,0.1393139313931393,Worst Maturation,0.0429042904290429,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00819,0.0343034303430343,0.00764,0.0404040404040404,Worst Maturation,0.0343034303430343,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.00812,0.0472047204720472,0.00851,0.0414041404140414,Worst Maturation,0.0414041404140414,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Day of Insulin Addition - Known (177),0.00771,0.1374137413741374,0.00788,0.0494049404940494,Worst Maturation,0.0494049404940494,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Number of Cell Lines - >5 (9),0.00749,0.0365036503650365,0.00503,0.0892089208920892,Worst Maturation,0.0365036503650365,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Number of Cell Lines - 1 (225),0.00733,0.1623162316231623,0.00941,0.0322032203220322,Worst Maturation,0.0322032203220322,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),hiPSC Matrix Coating - Vitronectin (10),0.00704,0.0484048404840484,0.00596,0.0815081508150815,Worst Maturation,0.0484048404840484,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),0.00694,0.0555055505550555,0.01065,0.0172017201720172,Worst Maturation,0.0172017201720172,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Metabolic Component Category - Sugars and Carbohydrates (9),0.00681,0.0487048704870487,0.00561,0.0758075807580758,Worst Maturation,0.0487048704870487,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00677,0.0595059505950595,0.00915,0.0253025302530253,Worst Maturation,0.0253025302530253,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Maturation Strategy - Electrical (39),0.00673,0.0974097409740974,0.01249,0.0079007900790079,Worst Maturation,0.0079007900790079,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),New Media for Maturation - Rare (4),0.00508,0.0944094409440944,0.00885,0.0295029502950295,Worst Maturation,0.0295029502950295,True,False
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00503,0.0932093209320932,0.00953,0.0241024102410241,Worst Maturation,0.0241024102410241,True,True
Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),Wnt Inhibitor Duration (days) - >6 days (12),0.00481,0.1233123312331233,0.00898,0.0385038503850385,Worst Maturation,0.0385038503850385,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Electrophysiology Analysis Method - Patch Clamp (59),0.05427,0.0,0.04208,0.0,Worst Maturation,0.0,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.03569,0.0002000200020002,0.03369,0.0002000200020002,Worst Maturation,0.0002000200020002,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Number of Cell Lines - 2 (50),0.02749,0.0006000600060006,0.01568,0.0047004700470047,Worst Maturation,0.0006000600060006,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),hiPSC Backbone Media - Conditioned (12),0.02272,0.0028002800280028,0.01379,0.0143014301430143,Worst Maturation,0.0028002800280028,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),hiPSC Backbone Media - DMEM (10),0.0144,0.0122012201220122,0.01645,0.005000500050005,Worst Maturation,0.005000500050005,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),3D Stromal Cell Source - hiPSC-MuralC (3),0.01341,0.028002800280028,0.01079,0.0631063106310631,Worst Maturation,0.028002800280028,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Journal - Nano Lett (3),0.01329,0.0117011701170117,0.0112,0.0337033703370337,Worst Maturation,0.0117011701170117,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.01314,0.0109010901090109,0.00986,0.0269026902690269,Worst Maturation,0.0109010901090109,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.01295,0.0198019801980198,0.01215,0.0342034203420342,Worst Maturation,0.0198019801980198,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01249,0.0309030903090309,0.00867,0.0635063506350635,Worst Maturation,0.0309030903090309,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Wnt Induction Duration (days) - 3 days (38),0.01206,0.0314031403140314,0.00944,0.0516051605160516,Worst Maturation,0.0314031403140314,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Wnt Induction - BMP4 (74),0.01187,0.0337033703370337,0.00778,0.1292129212921292,Worst Maturation,0.0337033703370337,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01164,0.0266026602660266,0.01546,0.007000700070007,Worst Maturation,0.007000700070007,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Insulin Start Day - 4 (11),0.01122,0.027002700270027,0.01119,0.0248024802480248,Worst Maturation,0.0248024802480248,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),0.01116,0.013001300130013,0.00571,0.0935093509350935,Worst Maturation,0.013001300130013,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),0.01031,0.0286028602860286,0.00573,0.1105110511051105,Worst Maturation,0.0286028602860286,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),2D Surface - Microelectrode Array (9),0.0103,0.0269026902690269,0.00982,0.0323032303230323,Worst Maturation,0.0269026902690269,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Pharmacological Intervention - Carbenoxolone (4),0.00993,0.0329032903290329,0.01159,0.0234023402340234,Worst Maturation,0.0234023402340234,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Publication Year - 2017 (43),0.0098,0.0522052205220522,0.01082,0.031003100310031,Worst Maturation,0.031003100310031,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.00885,0.0608060806080608,0.00947,0.0444044404440444,Worst Maturation,0.0444044404440444,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Electrophysiology Analysis Method - Microelectrode (31),0.00876,0.0588058805880588,0.01032,0.0339033903390339,Worst Maturation,0.0339033903390339,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Journal - ACS Appl Mater Interfaces (4),0.00824,0.0525052505250525,0.01608,0.0078007800780078,Worst Maturation,0.0078007800780078,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Cell Line - iCell2 (8),0.00822,0.0559055905590559,0.01347,0.0134013401340134,Worst Maturation,0.0134013401340134,True,True
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.00777,0.0499049904990499,0.00528,0.1108110811081108,Worst Maturation,0.0499049904990499,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Wnt Inhibitor - KY02111 (7),0.0076,0.0422042204220422,0.00896,0.0283028302830283,Worst Maturation,0.0283028302830283,True,False
Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.00709,0.0495049504950495,0.0066,0.0697069706970697,Worst Maturation,0.0495049504950495,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.02683,0.0007000700070007,0.0279,0.0012001200120012,Worst Maturation,0.0007000700070007,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),3D Platform - Collagen (38),0.02207,0.0029002900290029,0.01214,0.0193019301930193,Worst Maturation,0.0029002900290029,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC Backbone Media - StemPro-34 (14),0.02206,0.0032003200320032,0.02166,0.0014001400140014,Worst Maturation,0.0014001400140014,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Cell Line - Cor.4U (16),0.0186,0.0021002100210021,0.01655,0.0035003500350035,Worst Maturation,0.0021002100210021,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Maturation Strategy - Other Cells (80),0.01711,0.0073007300730073,0.00711,0.1151115111511151,Worst Maturation,0.0073007300730073,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),3D Stromal Cell Source - Human Fibroblast (38),0.01593,0.0105010501050105,0.00954,0.0496049604960496,Worst Maturation,0.0105010501050105,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Publication Year - 2018 (45),0.01525,0.0131013101310131,0.01522,0.0094009400940094,Worst Maturation,0.0094009400940094,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Immunofluorescent Imaging - Yes (268),0.01522,0.0132013201320132,0.01455,0.0071007100710071,Worst Maturation,0.0071007100710071,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC-CM Maturation Media - StemPro-34 (14),0.01356,0.0203020302030203,0.01118,0.0293029302930293,Worst Maturation,0.0203020302030203,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Journal - Lab Chip (4),0.01317,0.0094009400940094,0.01019,0.0407040704070407,Worst Maturation,0.0094009400940094,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Insulin Start Day - 10 (6),0.01274,0.0162016201620162,0.00968,0.0405040504050405,Worst Maturation,0.0162016201620162,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC-CM Media Supplement - Ascorbic Acid (41),0.01255,0.0312031203120312,0.00993,0.0549054905490549,Worst Maturation,0.0312031203120312,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC-CM Media Supplement - L-glutamine (19),0.01249,0.0215021502150215,0.00998,0.0347034703470347,Worst Maturation,0.0215021502150215,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Cell Coculture - Stromal Cell (78),0.01226,0.0197019701970197,0.00977,0.0306030603060306,Worst Maturation,0.0197019701970197,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Seeding Confluency 3D (%) - 70 to 79 (3),0.01121,0.0312031203120312,0.01655,0.0121012101210121,Worst Maturation,0.0121012101210121,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01111,0.0414041404140414,0.01193,0.0197019701970197,Worst Maturation,0.0197019701970197,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Wnt Induction Duration (days) - 4 days (15),0.0111,0.0333033303330333,0.00598,0.1245124512451245,Worst Maturation,0.0333033303330333,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Electrophysiology Analysis Method - Patch Clamp (59),0.01092,0.0341034103410341,0.01254,0.0136013601360136,Worst Maturation,0.0136013601360136,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC Backbone Media - Conditioned (12),0.01071,0.0289028902890289,0.00568,0.1164116411641164,Worst Maturation,0.0289028902890289,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),hiPSC-CM Maturation Media - Commercial Kit (27),0.01031,0.0485048504850485,0.00817,0.0857085708570857,Worst Maturation,0.0485048504850485,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),0.01018,0.0322032203220322,0.0118,0.0231023102310231,Worst Maturation,0.0231023102310231,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Maturation Strategy - Mechanical (36),0.00926,0.0727072707270727,0.01,0.0488048804880488,Worst Maturation,0.0488048804880488,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Journal - Stem Cells (11),0.00916,0.045004500450045,0.00874,0.052005200520052,Worst Maturation,0.045004500450045,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Seeding Confluency (%) - 70 to 79 (11),0.00915,0.034003400340034,0.0095,0.0372037203720372,Worst Maturation,0.034003400340034,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Journal - ACS Biomater Sci Eng (3),0.0088,0.0469046904690469,0.0086,0.0514051405140514,Worst Maturation,0.0469046904690469,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),0.00862,0.0461046104610461,0.01072,0.0281028102810281,Worst Maturation,0.0281028102810281,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Disease Modelling - Genetic Disorders (18),0.0081,0.0522052205220522,0.00955,0.035003500350035,Worst Maturation,0.035003500350035,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.00806,0.0439043904390439,0.01005,0.0369036903690369,Worst Maturation,0.0369036903690369,True,False
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Electrophysiology Analysis Method - Optical Mapping (39),0.00773,0.0882088208820882,0.01456,0.009000900090009,Worst Maturation,0.009000900090009,True,True
Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.00648,0.0603060306030603,0.0141,0.0081008100810081,Worst Maturation,0.0081008100810081,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.08869,0.0,0.08568,0.0,Worst Maturation,0.0,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.04835,0.0001000100010001,0.03947,0.0005000500050005,Worst Maturation,0.0001000100010001,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.03921,0.0006000600060006,0.03533,0.0023002300230023,Worst Maturation,0.0006000600060006,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Pharmacological Intervention - T3 (3),0.02353,0.0104010401040104,0.02176,0.0172017201720172,Worst Maturation,0.0104010401040104,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.01986,0.0183018301830183,0.02094,0.0191019101910191,Worst Maturation,0.0183018301830183,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Journal - Nat Biomed Eng (5),0.01856,0.03000300030003,0.0212,0.0201020102010201,Worst Maturation,0.0201020102010201,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Journal - Tissue Eng Part A (4),0.0182,0.0363036303630363,0.01451,0.042004200420042,Worst Maturation,0.0363036303630363,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01693,0.0268026802680268,0.01332,0.0401040104010401,Worst Maturation,0.0268026802680268,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),0.01541,0.0516051605160516,0.01475,0.032003200320032,Worst Maturation,0.032003200320032,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01346,0.0394039403940394,0.01813,0.0117011701170117,Worst Maturation,0.0117011701170117,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),3D Stromal Cell Source - Dermal Fibroblast (7),0.01329,0.0544054405440544,0.01687,0.0277027702770277,Worst Maturation,0.0277027702770277,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Sacromere or Cellular Alignment Analysis - Yes (72),0.01326,0.041004100410041,0.01281,0.0328032803280328,Worst Maturation,0.0328032803280328,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),hiPSC-CM Purification Duration (days) - 3 days (13),0.01265,0.0541054105410541,0.01723,0.0313031303130313,Worst Maturation,0.0313031303130313,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Gene Analysis Method - RNA (169),0.01082,0.034003400340034,0.01009,0.1065106510651065,Worst Maturation,0.034003400340034,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Calcium Handling Analysis Method - Seahorse (35),0.01013,0.064006400640064,0.01812,0.0132013201320132,Worst Maturation,0.0132013201320132,True,True
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Calcium Handling Analysis Method - Rare (4),0.00952,0.0444044404440444,0.01331,0.0372037203720372,Worst Maturation,0.0372037203720372,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Seeding Confluency 3D (%) - Rare (26),0.00718,0.1383138313831383,0.01348,0.0314031403140314,Worst Maturation,0.0314031403140314,True,False
MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),Publication Year - 2014 (3),0.00111,0.0366036603660366,0.00031,0.0672067206720672,Worst Maturation,0.0366036603660366,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.05926,0.0,0.06857,0.0,Worst Maturation,0.0,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.0492,0.0,0.04157,0.0003000300030003,Worst Maturation,0.0,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.04501,0.0001000100010001,0.05429,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.03909,0.0007000700070007,0.0339,0.0016001600160016,Worst Maturation,0.0007000700070007,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Disease Modelling - Genetic Disorders (18),0.02282,0.0096009600960096,0.01663,0.0173017301730173,Worst Maturation,0.0096009600960096,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Contractile Analysis Method - Rare (7),0.0225,0.01000100010001,0.01671,0.0307030703070307,Worst Maturation,0.01000100010001,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Publication Year - 2019 (57),0.02149,0.0119011901190119,0.01741,0.0184018401840184,Worst Maturation,0.0119011901190119,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Journal - Tissue Eng Part A (4),0.02041,0.0316031603160316,0.01764,0.0366036603660366,Worst Maturation,0.0316031603160316,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Disease Modelling - Arrhythmic (15),0.02014,0.013001300130013,0.01199,0.059005900590059,Worst Maturation,0.013001300130013,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.01664,0.0242024202420242,0.0213,0.0099009900990099,Worst Maturation,0.0099009900990099,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01491,0.025002500250025,0.01429,0.0318031803180318,Worst Maturation,0.025002500250025,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Disease Modelling - Ischemic Infarction (9),0.01473,0.0359035903590359,0.00701,0.0843084308430843,Worst Maturation,0.0359035903590359,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01372,0.0471047104710471,0.00832,0.1208120812081208,Worst Maturation,0.0471047104710471,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),3D Stromal Cell Source - Dermal Fibroblast (7),0.01245,0.0642064206420642,0.01592,0.0374037403740374,Worst Maturation,0.0374037403740374,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),3D Stromal Cell Source - Stromal Cell (35),0.01202,0.0424042404240424,0.01108,0.0763076307630763,Worst Maturation,0.0424042404240424,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Day of Insulin Addition - not 21 (14),0.01202,0.0499049904990499,0.00617,0.1228122812281228,Worst Maturation,0.0499049904990499,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Calcium Handling Analysis Method - Seahorse (35),0.01082,0.0576057605760576,0.0134,0.0401040104010401,Worst Maturation,0.0401040104010401,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.01079,0.0596059605960596,0.01512,0.0261026102610261,Worst Maturation,0.0261026102610261,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Seeding Confluency 3D (%) - Rare (26),0.01079,0.0591059105910591,0.01695,0.0173017301730173,Worst Maturation,0.0173017301730173,True,True
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Gene Analysis Method - RNA (169),0.01056,0.0352035203520352,0.01136,0.0471047104710471,Worst Maturation,0.0352035203520352,True,False
MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),Differentiation Purity Assessment - Rare (3),0.00115,0.0422042204220422,0.00237,0.0418041804180418,Worst Maturation,0.0418041804180418,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.07071,0.0,0.06216,0.0,Worst Maturation,0.0,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.04425,0.0002000200020002,0.0467,0.0004000400040004,Worst Maturation,0.0002000200020002,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.04238,0.0006000600060006,0.0332,0.0022002200220022,Worst Maturation,0.0006000600060006,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Disease Modelling - Genetic Disorders (18),0.02782,0.0062006200620062,0.01934,0.0098009800980098,Worst Maturation,0.0062006200620062,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.02505,0.0078007800780078,0.02143,0.0156015601560156,Worst Maturation,0.0078007800780078,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Pharmacological Intervention - T3 (3),0.0204,0.0172017201720172,0.0188,0.0252025202520252,Worst Maturation,0.0172017201720172,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Maturation Strategy - Cell Alignment (59),0.01973,0.0114011401140114,0.01137,0.0736073607360736,Worst Maturation,0.0114011401140114,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Disease Modelling - Arrhythmic (15),0.01912,0.0193019301930193,0.01491,0.0361036103610361,Worst Maturation,0.0193019301930193,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Metabolic Component Category - Fatty Acids and Lipids (21),0.01772,0.0212021202120212,0.01509,0.0426042604260426,Worst Maturation,0.0212021202120212,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Insulin Start Day - 0 (7),0.01764,0.0337033703370337,0.0218,0.0138013801380138,Worst Maturation,0.0138013801380138,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.01696,0.0189018901890189,0.01892,0.0154015401540154,Worst Maturation,0.0154015401540154,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Maturation Strategy - Mechanical (36),0.0165,0.0399039903990399,0.01119,0.0897089708970897,Worst Maturation,0.0399039903990399,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.01561,0.0291029102910291,0.01708,0.0301030103010301,Worst Maturation,0.0291029102910291,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Calcium Handling Analysis Method - Seahorse (35),0.01511,0.0253025302530253,0.0107,0.078007800780078,Worst Maturation,0.0253025302530253,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01506,0.0375037503750375,0.01386,0.0391039103910391,Worst Maturation,0.0375037503750375,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Publication Year - 2019 (57),0.01502,0.0336033603360336,0.0091,0.1194119411941194,Worst Maturation,0.0336033603360336,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.01229,0.0424042404240424,0.01045,0.056005600560056,Worst Maturation,0.0424042404240424,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Calcium Handling Analysis Method - Rare (4),0.01209,0.0347034703470347,0.01284,0.035003500350035,Worst Maturation,0.0347034703470347,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Gene Analysis Method - RNA (169),0.01062,0.027002700270027,0.01465,0.0081008100810081,Worst Maturation,0.0081008100810081,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.0103,0.0461046104610461,0.01396,0.0377037703770377,Worst Maturation,0.0377037703770377,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),2D Surface - Micropatterned (27),0.01001,0.0865086508650865,0.01488,0.0326032603260326,Worst Maturation,0.0326032603260326,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00746,0.1636163616361636,0.01229,0.0223022302230223,Worst Maturation,0.0223022302230223,True,True
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Publication Year - 2014 (3),0.00087,0.0436043604360436,0.00171,0.0431043104310431,Worst Maturation,0.0431043104310431,True,False
TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),Day of Insulin Addition - not 25 (3),0.00077,0.0393039303930393,0.0017,0.038003800380038,Worst Maturation,0.038003800380038,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.12058,0.0,0.13999,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.06146,0.0,0.0705,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Cell Coculture - Stromal Cell (78),0.06136,0.0,0.05451,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Cell Coculture - Endothelial Cell (35),0.0481,0.0,0.04769,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Maturation Strategy - Other Cells (80),0.03857,0.0,0.03084,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Stromal Cell Source - Stromal Cell (35),0.03092,0.0,0.03243,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Cell Coculture - Cardiomyocyte (157),0.0261,0.0,0.01536,0.0001000100010001,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Stromal Cell Source - Human Fibroblast (38),0.02597,0.0,0.02583,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Deduced Culture Strategy - 2D Only (183),0.02119,0.0,0.01418,0.0,Worst Maturation,0.0,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Deduced Culture Strategy - 3D Only (157),0.01899,0.0006000600060006,0.00837,0.0109010901090109,Worst Maturation,0.0006000600060006,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Platform - Collagen (38),0.01239,0.0023002300230023,0.01011,0.0054005400540054,Worst Maturation,0.0023002300230023,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Stromal Cell Source - Cardiac Fibroblast (32),0.01206,0.0022002200220022,0.01135,0.0031003100310031,Worst Maturation,0.0022002200220022,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.01123,0.0025002500250025,0.01168,0.0017001700170017,Worst Maturation,0.0017001700170017,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.01015,0.0027002700270027,0.01064,0.0027002700270027,Worst Maturation,0.0027002700270027,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.00892,0.0033003300330033,0.00918,0.0042004200420042,Worst Maturation,0.0033003300330033,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00887,0.0414041404140414,0.0057,0.271027102710271,Worst Maturation,0.0414041404140414,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Maturation Strategy - Tension (64),0.00757,0.0421042104210421,0.00437,0.2974297429742974,Worst Maturation,0.0421042104210421,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Platform - Matrigel (33),0.00723,0.0236023602360236,0.00671,0.0285028502850285,Worst Maturation,0.0236023602360236,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.00702,0.0185018501850185,0.00673,0.0237023702370237,Worst Maturation,0.0185018501850185,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.0065,0.0181018101810181,0.00717,0.0207020702070207,Worst Maturation,0.0181018101810181,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00641,0.0246024602460246,0.00444,0.0936093609360936,Worst Maturation,0.0246024602460246,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),hiPSC Backbone Media - Conditioned (12),0.00639,0.0204020402040204,0.00811,0.014001400140014,Worst Maturation,0.014001400140014,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.0055,0.0254025402540254,0.00846,0.0154015401540154,Worst Maturation,0.0154015401540154,True,True
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.00516,0.0406040604060406,0.00418,0.0832083208320832,Worst Maturation,0.0406040604060406,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Platform - 3D printed (9),0.00407,0.0629062906290629,0.00531,0.044004400440044,Worst Maturation,0.044004400440044,True,False
3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),3D Stromal Cell Source - Dermal Fibroblast (7),0.00378,0.0629062906290629,0.00813,0.0119011901190119,Worst Maturation,0.0119011901190119,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Cell Coculture - Cardiomyocyte (157),0.09873,0.0,0.08989,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Deduced Culture Strategy - 3D Only (157),0.09794,0.0,0.10091,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.07975,0.0,0.07775,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.06816,0.0,0.0674,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Deduced Culture Strategy - 2D Only (183),0.03249,0.0,0.03634,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Cell Coculture - Endothelial Cell (35),0.02866,0.0,0.02949,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Platform - Fibrin (50),0.01855,0.0,0.02277,0.0,Worst Maturation,0.0,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Maturation Strategy - Tension (64),0.01722,0.0001000100010001,0.01797,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Cell Coculture - Stromal Cell (78),0.01717,0.0001000100010001,0.01511,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),2D Surface - ECM-coated (115),0.01583,0.0002000200020002,0.01552,0.0005000500050005,Worst Maturation,0.0002000200020002,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Contractile Analysis Method - Deflection (39),0.01505,0.0001000100010001,0.01703,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.0136,0.0004000400040004,0.0106,0.0027002700270027,Worst Maturation,0.0004000400040004,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.01081,0.0013001300130013,0.00909,0.0039003900390039,Worst Maturation,0.0013001300130013,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.01013,0.0011001100110011,0.0125,0.0004000400040004,Worst Maturation,0.0004000400040004,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Tissue Media - RPMI-1640 (72),0.00964,0.0063006300630063,0.01205,0.0027002700270027,Worst Maturation,0.0027002700270027,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.00959,0.0013001300130013,0.01187,0.0008000800080008,Worst Maturation,0.0008000800080008,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Maturation Strategy - Other Cells (80),0.0092,0.009000900090009,0.00902,0.0121012101210121,Worst Maturation,0.009000900090009,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Platform - Collagen (38),0.00911,0.0043004300430043,0.01131,0.002000200020002,Worst Maturation,0.002000200020002,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.00889,0.002000200020002,0.01069,0.0013001300130013,Worst Maturation,0.0013001300130013,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.00838,0.0108010801080108,0.01207,0.002000200020002,Worst Maturation,0.002000200020002,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Platform - Scaffold Free (43),0.00829,0.0124012401240124,0.01031,0.0054005400540054,Worst Maturation,0.0054005400540054,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Platform - Matrigel (33),0.00793,0.0084008400840084,0.0074,0.0157015701570157,Worst Maturation,0.0084008400840084,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.00605,0.027002700270027,0.00829,0.0098009800980098,Worst Maturation,0.0098009800980098,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.00597,0.0426042604260426,0.00489,0.1086108610861086,Worst Maturation,0.0426042604260426,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00596,0.0261026102610261,0.00617,0.0271027102710271,Worst Maturation,0.0261026102610261,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.00534,0.0254025402540254,0.00542,0.0318031803180318,Worst Maturation,0.0254025402540254,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.00506,0.0113011301130113,0.00566,0.0121012101210121,Worst Maturation,0.0113011301130113,True,True
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Tissue Media - Commercial Kit (21),0.00471,0.044004400440044,0.0034,0.148014801480148,Worst Maturation,0.044004400440044,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),Seeding Confluency 3D (%) - 85 to 89 (12),0.00384,0.0433043304330433,0.00287,0.1154115411541154,Worst Maturation,0.0433043304330433,True,False
3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),3D Tissue Media - Iscove (5),0.00227,0.0487048704870487,0.00186,0.1052105210521052,Worst Maturation,0.0487048704870487,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.19921,0.0,0.18851,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.08002,0.0,0.08117,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Deduced Culture Strategy - 3D Only (157),0.05944,0.0,0.05067,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Cell Coculture - Cardiomyocyte (157),0.0573,0.0,0.04729,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Cell Coculture - Stromal Cell (78),0.04627,0.0,0.04874,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Maturation Strategy - Other Cells (80),0.03426,0.0,0.03329,0.0,Worst Maturation,0.0,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Deduced Culture Strategy - 2D Only (183),0.0179,0.0003000300030003,0.01419,0.0004000400040004,Worst Maturation,0.0003000300030003,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Stromal Cell Source - Human Fibroblast (38),0.01583,0.0004000400040004,0.01647,0.0005000500050005,Worst Maturation,0.0004000400040004,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Stromal Cell Source - Stromal Cell (35),0.01263,0.0019001900190019,0.00885,0.0111011101110111,Worst Maturation,0.0019001900190019,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Stromal Cell Source - Cardiac Fibroblast (32),0.0112,0.0023002300230023,0.0099,0.0062006200620062,Worst Maturation,0.0023002300230023,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.01082,0.0027002700270027,0.01248,0.0013001300130013,Worst Maturation,0.0013001300130013,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Seeding Confluency 3D (%) - Rare (26),0.01056,0.0023002300230023,0.00955,0.0048004800480048,Worst Maturation,0.0023002300230023,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Platform - Scaffold Free (43),0.00994,0.0059005900590059,0.01399,0.0009000900090009,Worst Maturation,0.0009000900090009,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Platform - Fibrin (50),0.00992,0.0043004300430043,0.01033,0.003000300030003,Worst Maturation,0.003000300030003,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Tissue Media - RPMI-1640 (72),0.00985,0.0071007100710071,0.00925,0.0059005900590059,Worst Maturation,0.0059005900590059,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.0098,0.0067006700670067,0.01191,0.0022002200220022,Worst Maturation,0.0022002200220022,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Cell Coculture - Endothelial Cell (35),0.00898,0.0042004200420042,0.00672,0.0193019301930193,Worst Maturation,0.0042004200420042,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.0086,0.0065006500650065,0.00739,0.0153015301530153,Worst Maturation,0.0065006500650065,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.00727,0.0143014301430143,0.00643,0.0256025602560256,Worst Maturation,0.0143014301430143,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Platform - Collagen (38),0.00635,0.0368036803680368,0.00484,0.0851085108510851,Worst Maturation,0.0368036803680368,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Maturation Strategy - Tension (64),0.00628,0.0713071307130713,0.00865,0.0085008500850085,Worst Maturation,0.0085008500850085,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.00557,0.0347034703470347,0.00724,0.0133013301330133,Worst Maturation,0.0133013301330133,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Seeding Confluency 3D (%) - 85 to 89 (12),0.00529,0.0208020802080208,0.00645,0.017001700170017,Worst Maturation,0.017001700170017,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.0048,0.0807080708070807,0.007,0.0189018901890189,Worst Maturation,0.0189018901890189,True,True
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00466,0.065006500650065,0.0056,0.0351035103510351,Worst Maturation,0.0351035103510351,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.00463,0.0383038303830383,0.00196,0.3573357335733573,Worst Maturation,0.0383038303830383,True,False
3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),Wnt Inhibitor - DS-I-7 (9),0.00456,0.0248024802480248,0.00462,0.0425042504250425,Worst Maturation,0.0248024802480248,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Platform - Scaffold Free (43),0.07048,0.0,0.05301,0.0,Worst Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.03221,0.0,0.02872,0.0,Worst Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Deduced Culture Strategy - 3D Only (157),0.0243,0.0,0.0086,0.0144014401440144,Worst Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Tissue Media - Commercial Kit (21),0.02388,0.0001000100010001,0.02741,0.0,Worst Maturation,0.0,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Cell Coculture - Cardiomyocyte (157),0.01919,0.0007000700070007,0.00807,0.021002100210021,Worst Maturation,0.0007000700070007,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Deduced Culture Strategy - 2D Only (183),0.01716,0.0008000800080008,0.00857,0.0141014101410141,Worst Maturation,0.0008000800080008,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01383,0.0059005900590059,0.01247,0.0033003300330033,Worst Maturation,0.0033003300330033,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Tissue Media - Growth Factor (12),0.01189,0.0048004800480048,0.01164,0.0045004500450045,Worst Maturation,0.0045004500450045,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Tissue Media - iCell Maintenance (12),0.01067,0.0074007400740074,0.01296,0.0039003900390039,Worst Maturation,0.0039003900390039,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Cell Coculture - Endothelial Cell (35),0.00967,0.0149014901490149,0.0085,0.0176017601760176,Worst Maturation,0.0149014901490149,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.00907,0.0312031203120312,0.00686,0.0694069406940694,Worst Maturation,0.0312031203120312,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Journal - Rare (104),0.00891,0.0497049704970497,0.00645,0.1319131913191319,Worst Maturation,0.0497049704970497,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.00868,0.0217021702170217,0.00924,0.0102010201020102,Worst Maturation,0.0102010201020102,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.00855,0.0623062306230623,0.00915,0.0114011401140114,Worst Maturation,0.0114011401140114,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Tissue Media - MEM-α (60),0.00852,0.0423042304230423,0.00881,0.0204020402040204,Worst Maturation,0.0204020402040204,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Publication Year - 2021 (43),0.00848,0.0344034403440344,0.00668,0.0662066206620662,Worst Maturation,0.0344034403440344,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Electron Imaging - Transmission (62),0.00845,0.0434043404340434,0.00888,0.018001800180018,Worst Maturation,0.018001800180018,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Stromal Cell Source - Cardiac Fibroblast (32),0.0081,0.0282028202820282,0.00901,0.0128012801280128,Worst Maturation,0.0128012801280128,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.00809,0.0242024202420242,0.00901,0.0157015701570157,Worst Maturation,0.0157015701570157,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.00747,0.0311031103110311,0.00929,0.0129012901290129,Worst Maturation,0.0129012901290129,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Stromal Cell Source - hiPSC-CardiacF (8),0.00727,0.0207020702070207,0.00976,0.0103010301030103,Worst Maturation,0.0103010301030103,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),hiPSC Matrix Coating - Rare (8),0.00718,0.0265026502650265,0.00755,0.0251025102510251,Worst Maturation,0.0251025102510251,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Stromal Cell Source - Human Fibroblast (38),0.00679,0.0602060206020602,0.00801,0.0268026802680268,Worst Maturation,0.0268026802680268,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.00651,0.0632063206320632,0.00861,0.017001700170017,Worst Maturation,0.017001700170017,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),hiPSC Backbone Media - StemFit (5),0.00607,0.0302030203020302,0.00355,0.114011401140114,Worst Maturation,0.0302030203020302,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Platform - 3D printed (9),0.00604,0.0394039403940394,0.00765,0.0233023302330233,Worst Maturation,0.0233023302330233,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Journal - Sci Rep (24),0.00595,0.0672067206720672,0.00705,0.036003600360036,Worst Maturation,0.036003600360036,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.0058,0.0307030703070307,0.00944,0.0205020502050205,Worst Maturation,0.0205020502050205,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Seeding Confluency 3D (%) - 85 to 89 (12),0.00571,0.0534053405340534,0.00772,0.025002500250025,Worst Maturation,0.025002500250025,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),hiPSC Backbone Media - Rare (10),0.00545,0.0632063206320632,0.00796,0.027002700270027,Worst Maturation,0.027002700270027,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Gene Analysis Method - RNA (169),0.00475,0.731073107310731,0.00822,0.0149014901490149,Worst Maturation,0.0149014901490149,True,True
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.00467,0.0737073707370737,0.00742,0.0259025902590259,Worst Maturation,0.0259025902590259,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Purification Protocol - Antibiotic (4),0.00411,0.0712071207120712,0.00585,0.0432043204320432,Worst Maturation,0.0432043204320432,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),Day of Insulin Addition - not 17 (12),0.00365,0.1245124512451245,0.00591,0.0423042304230423,Worst Maturation,0.0423042304230423,True,False
3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00363,0.0823082308230823,0.00727,0.0322032203220322,Worst Maturation,0.0322032203220322,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Platform - Scaffold Free (43),0.06463,0.0,0.06009,0.0,Worst Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Deduced Culture Strategy - 3D Only (157),0.033,0.0,0.01584,0.0,Worst Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.02836,0.0,0.0343,0.0,Worst Maturation,0.0,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.02223,0.0002000200020002,0.01614,0.0004000400040004,Worst Maturation,0.0002000200020002,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Tissue Media - Commercial Kit (21),0.02114,0.0003000300030003,0.02613,0.0001000100010001,Worst Maturation,0.0001000100010001,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01929,0.0004000400040004,0.00976,0.0058005800580058,Worst Maturation,0.0004000400040004,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Cell Coculture - Cardiomyocyte (157),0.01743,0.0007000700070007,0.01098,0.0002000200020002,Worst Maturation,0.0002000200020002,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.01339,0.0042004200420042,0.00969,0.0096009600960096,Worst Maturation,0.0042004200420042,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.01305,0.0036003600360036,0.01001,0.0063006300630063,Worst Maturation,0.0036003600360036,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Electron Imaging - Transmission (62),0.01192,0.0104010401040104,0.00858,0.0185018501850185,Worst Maturation,0.0104010401040104,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Estimated Cell Density (mil cells/mL) Quantiles - Q4 (>0.47 and ≤5) (25),0.01148,0.0057005700570057,0.00713,0.0287028702870287,Worst Maturation,0.0057005700570057,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Deduced Culture Strategy - 2D Only (183),0.00963,0.0285028502850285,0.00888,0.0087008700870087,Worst Maturation,0.0087008700870087,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Maturation Strategy - Other Cells (80),0.00957,0.0224022402240224,0.00888,0.0131013101310131,Worst Maturation,0.0131013101310131,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Contractile Analysis Method - Motion Tracking (93),0.0095,0.0318031803180318,0.00597,0.1739173917391739,Worst Maturation,0.0318031803180318,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Journal - Rare (104),0.00926,0.0356035603560356,0.00613,0.1583158315831583,Worst Maturation,0.0356035603560356,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Cell Line - WTC11 (30),0.00848,0.022002200220022,0.00518,0.0969096909690969,Worst Maturation,0.022002200220022,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.00832,0.0278027802780278,0.00512,0.1471147114711471,Worst Maturation,0.0278027802780278,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),hiPSC-CM Media Supplement - bFGF (3),0.00825,0.0112011201120112,0.00771,0.0209020902090209,Worst Maturation,0.0112011201120112,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Journal - Nat Biomed Eng (5),0.00812,0.0133013301330133,0.01134,0.0057005700570057,Worst Maturation,0.0057005700570057,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),hiPSC-CM Purification Duration (days) - <3 days (31),0.00748,0.0364036403640364,0.00486,0.1256125612561256,Worst Maturation,0.0364036403640364,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Tissue Media - iCell Maintenance (12),0.00721,0.0196019601960196,0.00995,0.0064006400640064,Worst Maturation,0.0064006400640064,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.0072,0.0222022202220222,0.01039,0.0067006700670067,Worst Maturation,0.0067006700670067,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),hiPSC-CM Media Supplement - VEGF (4),0.00717,0.0236023602360236,0.01188,0.0069006900690069,Worst Maturation,0.0069006900690069,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),hiPSC-CM Maturation Media - Commercial Kit (27),0.00693,0.0447044704470447,0.00718,0.0337033703370337,Worst Maturation,0.0337033703370337,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Calcium Handling Analysis Method - Flux Rates (13),0.00578,0.0482048204820482,0.00509,0.0717071707170717,Worst Maturation,0.0482048204820482,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.00542,0.0368036803680368,0.0059,0.0421042104210421,Worst Maturation,0.0368036803680368,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),3D Platform - 3D printed (9),0.00535,0.0435043504350435,0.00589,0.0397039703970397,Worst Maturation,0.0397039703970397,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.00484,0.1478147814781478,0.00846,0.0163016301630163,Worst Maturation,0.0163016301630163,True,True
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),0.00482,0.0617061706170617,0.00571,0.0454045404540454,Worst Maturation,0.0454045404540454,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Wnt Inhibitor Duration (days) - Rare (173),0.00463,0.787078707870787,0.00739,0.0496049604960496,Worst Maturation,0.0496049604960496,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Coating for Replating - Fibronectin (32),0.00446,0.1417141714171417,0.0064,0.0472047204720472,Worst Maturation,0.0472047204720472,True,False
3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),Pharmacological Intervention - Verapamil (27),0.00428,0.1399139913991399,0.00623,0.0489048904890489,Worst Maturation,0.0489048904890489,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Publication Year - Post 2020 (122),0.02087,0.0016001600160016,0.01212,0.0015001500150015,Average Maturation,0.0015001500150015,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Publication Year - 2020 (51),0.02054,0.0011001100110011,0.01525,0.0016001600160016,Average Maturation,0.0011001100110011,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Contractile Analysis Method - Traction Force Microscopy (9),0.0177,0.0018001800180018,0.01425,0.0038003800380038,Average Maturation,0.0018001800180018,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01763,0.0046004600460046,0.01025,0.0199019901990199,Average Maturation,0.0046004600460046,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Electrophysiology Analysis Method - Patch Clamp (59),0.01496,0.008000800080008,0.0109,0.0104010401040104,Average Maturation,0.008000800080008,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Publication Year - Late-2010s (196),0.01485,0.0069006900690069,0.00559,0.3114311431143114,Average Maturation,0.0069006900690069,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.01439,0.0056005600560056,0.01549,0.0052005200520052,Average Maturation,0.0052005200520052,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),T-tubule Structures - Yes (18),0.01347,0.0066006600660066,0.01028,0.0136013601360136,Average Maturation,0.0066006600660066,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),hiPSC-CM Purification Duration (days) - <3 days (31),0.01321,0.0121012101210121,0.00902,0.0342034203420342,Average Maturation,0.0121012101210121,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Sacromere or Cellular Alignment Analysis - Yes (72),0.01251,0.0183018301830183,0.01236,0.0048004800480048,Average Maturation,0.0048004800480048,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Journal - Acta Biomater (10),0.0113,0.0107010701070107,0.01391,0.0049004900490049,Average Maturation,0.0049004900490049,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.01099,0.0222022202220222,0.01507,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Journal - Rare (104),0.01057,0.0305030503050305,0.00345,0.7459745974597459,Average Maturation,0.0305030503050305,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),2D Surface - ECM-coated (115),0.01,0.0441044104410441,0.00881,0.028002800280028,Average Maturation,0.028002800280028,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.00995,0.022002200220022,0.01429,0.0081008100810081,Average Maturation,0.0081008100810081,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Maturation Strategy - Mechanical (36),0.00963,0.0287028702870287,0.01054,0.017001700170017,Average Maturation,0.017001700170017,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Wnt Induction Duration (days) Quantiles - Q2 (>1 and ≤2) (75),0.00958,0.0371037103710371,0.0065,0.1242124212421242,Average Maturation,0.0371037103710371,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),hiPSC Backbone Media - Conditioned (12),0.00952,0.0231023102310231,0.0085,0.0284028402840284,Average Maturation,0.0231023102310231,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Deduced Culture Strategy - 2D Only (183),0.00917,0.0494049404940494,0.00591,0.3000300030003,Average Maturation,0.0494049404940494,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),3D Tissue Media - Growth Factor (12),0.00905,0.0232023202320232,0.00756,0.0384038403840384,Average Maturation,0.0232023202320232,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Wnt Induction Duration (days) - 3 days (38),0.00886,0.0497049704970497,0.00904,0.0382038203820382,Average Maturation,0.0382038203820382,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),hiPSC-CM Media Supplement - Ascorbic Acid (41),0.00871,0.0411041104110411,0.00647,0.1061106110611061,Average Maturation,0.0411041104110411,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),0.0082,0.0245024502450245,0.00808,0.0269026902690269,Average Maturation,0.0245024502450245,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),2D Surface - Microparticle/fluid (3),0.0078,0.0224022402240224,0.00813,0.0326032603260326,Average Maturation,0.0224022402240224,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.0064,0.0487048704870487,0.00651,0.0504050405040504,Average Maturation,0.0487048704870487,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Journal - ACS Appl Mater Interfaces (4),0.00579,0.0696069606960696,0.00918,0.021002100210021,Average Maturation,0.021002100210021,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Deduced Culture Strategy - 3D Only (157),0.00575,0.5090509050905091,0.0102,0.0054005400540054,Average Maturation,0.0054005400540054,True,True
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.00536,0.0699069906990699,0.00827,0.0311031103110311,Average Maturation,0.0311031103110311,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.00375,0.8481848184818482,0.00806,0.0356035603560356,Average Maturation,0.0356035603560356,True,False
Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.00335,0.1848184818481848,0.00723,0.0489048904890489,Average Maturation,0.0489048904890489,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Sacromere or Cellular Alignment Analysis - Yes (72),0.0237,0.0011001100110011,0.01174,0.0068006800680068,Average Maturation,0.0011001100110011,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.0174,0.0026002600260026,0.01752,0.0025002500250025,Average Maturation,0.0025002500250025,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Insulin Start Day - 7 (85),0.01483,0.0082008200820082,0.00903,0.0303030303030303,Average Maturation,0.0082008200820082,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Cell Line - Gibco episomal (10),0.01422,0.0038003800380038,0.01393,0.0039003900390039,Average Maturation,0.0038003800380038,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.01277,0.0052005200520052,0.00995,0.0142014201420142,Average Maturation,0.0052005200520052,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),hiPSC Backbone Media - Commercial CM Kit (12),0.01231,0.0115011501150115,0.01024,0.0162016201620162,Average Maturation,0.0115011501150115,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),2D Surface - Micropatterned (27),0.01183,0.0185018501850185,0.01121,0.0143014301430143,Average Maturation,0.0143014301430143,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Disease Modelling - Dilated Cardiomyopathy (6),0.01052,0.0184018401840184,0.01078,0.0177017701770177,Average Maturation,0.0177017701770177,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01043,0.0196019601960196,0.00847,0.0353035303530353,Average Maturation,0.0196019601960196,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Metabolic Component - T3 (14),0.01041,0.0211021102110211,0.00407,0.153015301530153,Average Maturation,0.0211021102110211,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Deduced Culture Strategy - 2D Only (183),0.01,0.0297029702970297,0.00691,0.1583158315831583,Average Maturation,0.0297029702970297,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.00983,0.0227022702270227,0.0055,0.0873087308730873,Average Maturation,0.0227022702270227,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Wnt Inhibitor Duration (days) - 5 days (6),0.0098,0.02000200020002,0.01629,0.0042004200420042,Average Maturation,0.0042004200420042,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.00949,0.0135013501350135,0.00942,0.0197019701970197,Average Maturation,0.0135013501350135,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.00939,0.0205020502050205,0.00749,0.0368036803680368,Average Maturation,0.0205020502050205,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),hiPSC-CM Media Supplement - FBS (16),0.00917,0.0225022502250225,0.00445,0.1314131413141314,Average Maturation,0.0225022502250225,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.00869,0.0241024102410241,0.0062,0.0902090209020902,Average Maturation,0.0241024102410241,True,True
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Seeding Confluency (%) - 85 to 89 (43),0.00862,0.0582058205820582,0.00919,0.0352035203520352,Average Maturation,0.0352035203520352,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),hiPSC-CM Maturation Media - Commercial Kit (27),0.00826,0.0495049504950495,0.00694,0.0656065606560656,Average Maturation,0.0495049504950495,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),2D Surface - Decellularized ECM (3),0.00796,0.0447044704470447,0.00688,0.0876087608760876,Average Maturation,0.0447044704470447,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.00793,0.0307030703070307,0.00538,0.0755075507550755,Average Maturation,0.0307030703070307,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Journal - Circulation (11),0.00744,0.0397039703970397,0.00761,0.0375037503750375,Average Maturation,0.0375037503750375,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.00738,0.0342034203420342,0.00724,0.0507050705070507,Average Maturation,0.0342034203420342,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),2D Surface - ECM-coated (115),0.00731,0.1662166216621662,0.00861,0.0438043804380438,Average Maturation,0.0438043804380438,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Publication Year - 2014 (3),0.00706,0.0339033903390339,0.00669,0.06000600060006,Average Maturation,0.0339033903390339,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.00685,0.0552055205520552,0.00719,0.048004800480048,Average Maturation,0.048004800480048,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Metabolic Component Category - Sugars and Carbohydrates (9),0.00667,0.0453045304530453,0.00708,0.0417041704170417,Average Maturation,0.0417041704170417,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),3D Stromal Cell Source - Rare (4),0.00634,0.0511051105110511,0.00717,0.0483048304830483,Average Maturation,0.0483048304830483,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Calcium Handling Analysis Method - Visual (104),0.00613,0.2847284728472847,0.00798,0.0498049804980498,Average Maturation,0.0498049804980498,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Pharmacological Intervention - T3 (3),0.00595,0.0852085208520852,0.01014,0.0313031303130313,Average Maturation,0.0313031303130313,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Day of Insulin Addition - not 22 (12),0.0058,0.077007700770077,0.00864,0.0317031703170317,Average Maturation,0.0317031703170317,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Electron Imaging - Transmission (62),0.00546,0.2227222722272227,0.00893,0.0474047404740474,Average Maturation,0.0474047404740474,True,False
Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),Coating for Replating - Rare (6),0.00509,0.0717071707170717,0.00761,0.0287028702870287,Average Maturation,0.0287028702870287,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Sacromere or Cellular Alignment Analysis - Yes (72),0.02394,0.0009000900090009,0.01041,0.0142014201420142,Average Maturation,0.0009000900090009,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Wnt Inhibitor - XAV939 (24),0.01715,0.0029002900290029,0.01601,0.0021002100210021,Average Maturation,0.0021002100210021,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.01542,0.0034003400340034,0.01522,0.003000300030003,Average Maturation,0.003000300030003,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Cell Line - IMR90 (19),0.01412,0.0058005800580058,0.01214,0.0079007900790079,Average Maturation,0.0058005800580058,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Electron Imaging - Transmission (62),0.01387,0.0113011301130113,0.0097,0.0251025102510251,Average Maturation,0.0113011301130113,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Journal - Nano Lett (3),0.01357,0.0054005400540054,0.01469,0.0068006800680068,Average Maturation,0.0054005400540054,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Number of Cell Lines - 2 (50),0.01355,0.0108010801080108,0.01118,0.0123012301230123,Average Maturation,0.0108010801080108,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),3D Platform - Polyethylene Glycol (8),0.01342,0.0073007300730073,0.01277,0.0089008900890089,Average Maturation,0.0073007300730073,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),hiPSC-CM Purification Duration (days) - 6 days (10),0.01217,0.0077007700770077,0.0085,0.0297029702970297,Average Maturation,0.0077007700770077,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Calcium Handling Analysis Method - Visual (104),0.01191,0.0224022402240224,0.00721,0.0935093509350935,Average Maturation,0.0224022402240224,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Insulin Start Day - 7 (85),0.0118,0.0236023602360236,0.00932,0.0283028302830283,Average Maturation,0.0236023602360236,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.01134,0.0182018201820182,0.00921,0.0242024202420242,Average Maturation,0.0182018201820182,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.0112,0.0209020902090209,0.00735,0.0581058105810581,Average Maturation,0.0209020902090209,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Number of Cell Lines - 1 (225),0.00946,0.0489048904890489,0.00569,0.2505250525052505,Average Maturation,0.0489048904890489,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Journal - Acta Biomater (10),0.0094,0.0263026302630263,0.00793,0.0362036203620362,Average Maturation,0.0263026302630263,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00924,0.024002400240024,0.00592,0.067006700670067,Average Maturation,0.024002400240024,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),hiPSC-CM Maturation Media - iCell Maintenance (83),0.00922,0.0349034903490349,0.00566,0.2028202820282028,Average Maturation,0.0349034903490349,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),3D Tissue Media - RPMI-1640 (72),0.00904,0.0487048704870487,0.00882,0.0372037203720372,Average Maturation,0.0372037203720372,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.00802,0.0391039103910391,0.00787,0.0366036603660366,Average Maturation,0.0366036603660366,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Journal - ACS Appl Mater Interfaces (4),0.00717,0.0467046704670467,0.00656,0.0755075507550755,Average Maturation,0.0467046704670467,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.007,0.0507050705070507,0.00937,0.0237023702370237,Average Maturation,0.0237023702370237,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.00683,0.0641064106410641,0.00976,0.019001900190019,Average Maturation,0.019001900190019,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Wnt Inhibitor Duration (days) - Rare (173),0.00671,0.2767276727672767,0.00828,0.0364036403640364,Average Maturation,0.0364036403640364,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.00664,0.2107210721072107,0.01115,0.008000800080008,Average Maturation,0.008000800080008,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Day of Insulin Addition - Known (177),0.00493,0.695969596959696,0.00876,0.0349034903490349,Average Maturation,0.0349034903490349,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Publication Year - 2016 (32),0.00471,0.1707170717071707,0.00846,0.0421042104210421,Average Maturation,0.0421042104210421,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Wnt Inhibitor Duration (days) - 3 days (17),0.00407,0.1581158115811581,0.00899,0.0263026302630263,Average Maturation,0.0263026302630263,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Pharmacological Intervention - Propranolol (5),0.00397,0.111011101110111,0.00645,0.0469046904690469,Average Maturation,0.0469046904690469,True,False
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Cell Line - DF19-9-11T.H (16),0.00387,0.1677167716771677,0.01027,0.0185018501850185,Average Maturation,0.0185018501850185,True,True
Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.00372,0.1641164116411641,0.00703,0.0454045404540454,Average Maturation,0.0454045404540454,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.02114,0.0021002100210021,0.02086,0.0019001900190019,Average Maturation,0.0019001900190019,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Sacromere or Cellular Alignment Analysis - Yes (72),0.02003,0.0039003900390039,0.01189,0.0118011801180118,Average Maturation,0.0039003900390039,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Journal - Am J Physiol Heart Circ Physiol (4),0.01858,0.0029002900290029,0.01756,0.0041004100410041,Average Maturation,0.0029002900290029,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),hiPSC Backbone Media - mTeSR (106),0.01496,0.0068006800680068,0.00684,0.1491149114911491,Average Maturation,0.0068006800680068,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01392,0.0087008700870087,0.00885,0.0368036803680368,Average Maturation,0.0087008700870087,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Disease Modelling - Arrhythmic (15),0.01348,0.0156015601560156,0.00649,0.0949094909490949,Average Maturation,0.0156015601560156,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Number of Cell Lines - 1 (225),0.01332,0.0225022502250225,0.01199,0.0088008800880088,Average Maturation,0.0088008800880088,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Fatty Acid Metabolism Assessed - Yes (20),0.01309,0.0157015701570157,0.01124,0.0227022702270227,Average Maturation,0.0157015701570157,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Insulin Start Day - 7 (85),0.01294,0.0188018801880188,0.01161,0.0108010801080108,Average Maturation,0.0108010801080108,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),hiPSC Backbone Media - Embryonic Stem Cell (127),0.01263,0.0148014801480148,0.00378,0.6761676167616761,Average Maturation,0.0148014801480148,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Cell Line - IMR90 (19),0.01249,0.016001600160016,0.00933,0.0327032703270327,Average Maturation,0.016001600160016,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.01179,0.0268026802680268,0.00883,0.0644064406440644,Average Maturation,0.0268026802680268,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Calcium Handling Analysis Method - Mitochondrial (4),0.01176,0.0247024702470247,0.00803,0.0809080908090809,Average Maturation,0.0247024702470247,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Seeding Confluency (%) - 70 to 79 (11),0.01156,0.0198019801980198,0.00638,0.0793079307930793,Average Maturation,0.0198019801980198,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.0112,0.0204020402040204,0.00843,0.0515051505150515,Average Maturation,0.0204020402040204,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Journal - J Mol Cell Cardiol (4),0.01036,0.0258025802580258,0.00864,0.0556055605560556,Average Maturation,0.0258025802580258,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Pharmacological Intervention - Propranolol (5),0.01016,0.023002300230023,0.01268,0.0136013601360136,Average Maturation,0.0136013601360136,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Day of Insulin Addition - not 25 (3),0.00998,0.0228022802280228,0.01212,0.0146014601460146,Average Maturation,0.0146014601460146,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Coating for Replating - Matrigel (65),0.00994,0.0409040904090409,0.00601,0.1752175217521752,Average Maturation,0.0409040904090409,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00951,0.0309030903090309,0.00918,0.03000300030003,Average Maturation,0.03000300030003,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Seeding Confluency 2D (%) - 80 to 84 (5),0.00929,0.0324032403240324,0.01306,0.011001100110011,Average Maturation,0.011001100110011,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Journal - Cell Stem Cell (6),0.00883,0.0305030503050305,0.01116,0.0162016201620162,Average Maturation,0.0162016201620162,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Journal - Stem Cells Int (3),0.00881,0.0351035103510351,0.00743,0.0613061306130613,Average Maturation,0.0351035103510351,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),3D Stromal Cell Source - Rare (4),0.00846,0.0483048304830483,0.01661,0.0054005400540054,Average Maturation,0.0054005400540054,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Cell Line - DF19-9-11T.H (16),0.00845,0.0417041704170417,0.00538,0.117011701170117,Average Maturation,0.0417041704170417,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),0.0083,0.0316031603160316,0.00609,0.0766076607660766,Average Maturation,0.0316031603160316,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Publication Year - 2017 (43),0.00819,0.0756075607560756,0.00909,0.0468046804680468,Average Maturation,0.0468046804680468,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),T-tubule Structures - Yes (18),0.00814,0.0505050505050505,0.00855,0.0445044504450445,Average Maturation,0.0445044504450445,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Publication Year - Late-2010s (196),0.00799,0.1553155315531553,0.0107,0.0092009200920092,Average Maturation,0.0092009200920092,True,True
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Cell Line - Rare (132),0.00788,0.1531153115311531,0.00955,0.0269026902690269,Average Maturation,0.0269026902690269,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00711,0.0563056305630563,0.00817,0.0423042304230423,Average Maturation,0.0423042304230423,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Metabolic Component Category - Amino Acids and Derivatives (9),0.00692,0.0683068306830683,0.00893,0.0382038203820382,Average Maturation,0.0382038203820382,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Metabolic Component - Palmitic Acid (11),0.00529,0.0911091109110911,0.00766,0.0444044404440444,Average Maturation,0.0444044404440444,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),hiPSC Backbone Media - StemPro-34 (14),0.00512,0.1086108610861086,0.00833,0.041004100410041,Average Maturation,0.041004100410041,True,False
Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),Cell Line - PGP1 (11),0.00382,0.1944194419441944,0.00894,0.0388038803880388,Average Maturation,0.0388038803880388,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Contractile Analysis Method - Force Transducer (27),0.0268,0.0002000200020002,0.02171,0.0002000200020002,Average Maturation,0.0002000200020002,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Cell Line Sex - Both (118),0.02425,0.0012001200120012,0.00804,0.0723072307230723,Average Maturation,0.0012001200120012,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Media Supplement - FBS (16),0.02303,0.0011001100110011,0.01926,0.0017001700170017,Average Maturation,0.0011001100110011,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Journal - J Tissue Eng (4),0.02298,0.0029002900290029,0.02646,0.0024002400240024,Average Maturation,0.0024002400240024,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.02074,0.0029002900290029,0.01771,0.0027002700270027,Average Maturation,0.0027002700270027,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Cell Line - IMR90 (19),0.01801,0.0039003900390039,0.017,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Journal - J Tissue Eng Regen Med (3),0.01707,0.0026002600260026,0.02222,0.0019001900190019,Average Maturation,0.0019001900190019,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Cell Line - 201B7 (9),0.01626,0.0043004300430043,0.00998,0.0243024302430243,Average Maturation,0.0043004300430043,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC Backbone Media - DMEM (18),0.01505,0.0105010501050105,0.01752,0.0027002700270027,Average Maturation,0.0027002700270027,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Publication Year - 2018 (45),0.01486,0.0132013201320132,0.0092,0.0517051705170517,Average Maturation,0.0132013201320132,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Maturation Media - DMEM (35),0.01318,0.0164016401640164,0.01444,0.0046004600460046,Average Maturation,0.0046004600460046,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),3D Platform - Fibrin (50),0.01304,0.017001700170017,0.01248,0.013001300130013,Average Maturation,0.013001300130013,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Maturation Strategy - Other Cells (80),0.01229,0.0238023802380238,0.00571,0.2432243224322432,Average Maturation,0.0238023802380238,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Maturation Media - F12 (10),0.01218,0.021002100210021,0.00813,0.0482048204820482,Average Maturation,0.021002100210021,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC Matrix Coating - MEF feeder cells (8),0.01216,0.0155015501550155,0.01497,0.0067006700670067,Average Maturation,0.0067006700670067,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.01106,0.0309030903090309,0.01759,0.0023002300230023,Average Maturation,0.0023002300230023,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01104,0.0255025502550255,0.00995,0.0277027702770277,Average Maturation,0.0255025502550255,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),3D Stromal Cell Source - Rare (4),0.01084,0.0179017901790179,0.01079,0.0252025202520252,Average Maturation,0.0179017901790179,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Cell Line Sex - Female (40),0.01018,0.0479047904790479,0.00874,0.0522052205220522,Average Maturation,0.0479047904790479,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00929,0.0305030503050305,0.01321,0.0104010401040104,Average Maturation,0.0104010401040104,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.00923,0.0457045704570457,0.0051,0.1932193219321932,Average Maturation,0.0457045704570457,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),3D Platform - Polyethylene Glycol (8),0.00813,0.0462046204620462,0.00598,0.0898089808980898,Average Maturation,0.0462046204620462,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.00801,0.0325032503250325,0.00947,0.026002600260026,Average Maturation,0.026002600260026,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Media Supplement - Mercaptoethanol (10),0.00794,0.0375037503750375,0.0084,0.036003600360036,Average Maturation,0.036003600360036,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Journal - Stem Cells (11),0.00754,0.0493049304930493,0.00703,0.0609060906090609,Average Maturation,0.0493049304930493,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.00709,0.0416041604160416,0.00976,0.0189018901890189,Average Maturation,0.0189018901890189,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.00705,0.0489048904890489,0.00611,0.079007900790079,Average Maturation,0.0489048904890489,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.00698,0.0655065506550655,0.01341,0.0113011301130113,Average Maturation,0.0113011301130113,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.00694,0.1433143314331433,0.01156,0.0017001700170017,Average Maturation,0.0017001700170017,True,True
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.00648,0.0822082208220822,0.00893,0.0388038803880388,Average Maturation,0.0388038803880388,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Journal - Am J Physiol Heart Circ Physiol (4),0.00599,0.0851085108510851,0.00891,0.0453045304530453,Average Maturation,0.0453045304530453,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00548,0.1077107710771077,0.00941,0.0383038303830383,Average Maturation,0.0383038303830383,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Insulin Start Day - 8 (15),0.00485,0.1353135313531353,0.00991,0.0285028502850285,Average Maturation,0.0285028502850285,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),hiPSC-CM Media Supplement - B27 (180),0.00338,0.8802880288028803,0.00877,0.0267026702670267,Average Maturation,0.0267026702670267,True,False
Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),Journal - PLoS One (9),0.0022,0.2273227322732273,0.00791,0.0431043104310431,Average Maturation,0.0431043104310431,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Contractile Analysis Method - Deflection (39),0.03117,0.0004000400040004,0.02462,0.0002000200020002,Average Maturation,0.0002000200020002,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.02044,0.0016001600160016,0.01958,0.0016001600160016,Average Maturation,0.0016001600160016,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Publication Year - 2021 (43),0.01674,0.0112011201120112,0.01135,0.0251025102510251,Average Maturation,0.0112011201120112,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Wnt Inhibitor Duration (days) Quantiles - Q1 (>2 and ≤9) (58),0.01501,0.012001200120012,0.00838,0.0727072707270727,Average Maturation,0.012001200120012,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC Backbone Media - StemPro-34 (14),0.0149,0.0073007300730073,0.01214,0.0162016201620162,Average Maturation,0.0073007300730073,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Selenium (7),0.0138,0.0128012801280128,0.01507,0.0099009900990099,Average Maturation,0.0099009900990099,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Lipid Mix (5),0.01356,0.0077007700770077,0.01554,0.0062006200620062,Average Maturation,0.0062006200620062,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Tissue Media - MEM-α (60),0.01354,0.0142014201420142,0.00658,0.1239123912391239,Average Maturation,0.0142014201420142,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.01252,0.0176017601760176,0.01402,0.0071007100710071,Average Maturation,0.0071007100710071,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Maturation Media - StemPro-34 (14),0.01237,0.0172017201720172,0.01328,0.0093009300930093,Average Maturation,0.0093009300930093,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Transferrin (11),0.01221,0.0157015701570157,0.01299,0.0108010801080108,Average Maturation,0.0108010801080108,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Seeding Confluency (%) - Rare (43),0.01166,0.0276027602760276,0.00995,0.033003300330033,Average Maturation,0.0276027602760276,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Insulin Start Day - 6 (20),0.01159,0.0233023302330233,0.00748,0.0751075107510751,Average Maturation,0.0233023302330233,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.01142,0.0152015201520152,0.00848,0.046004600460046,Average Maturation,0.0152015201520152,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Tissue Media - DMEM (53),0.01109,0.0336033603360336,0.00732,0.1086108610861086,Average Maturation,0.0336033603360336,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.01083,0.0358035803580358,0.01152,0.0231023102310231,Average Maturation,0.0231023102310231,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Journal - Lab Chip (4),0.01052,0.0212021202120212,0.00616,0.0854085408540854,Average Maturation,0.0212021202120212,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.01051,0.0357035703570357,0.00961,0.0434043404340434,Average Maturation,0.0357035703570357,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Cell Line - BJ RiPS (4),0.00975,0.0292029202920292,0.00793,0.0681068106810681,Average Maturation,0.0292029202920292,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC Matrix Coating - EBs (18),0.00971,0.0424042404240424,0.00549,0.1296129612961296,Average Maturation,0.0424042404240424,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00953,0.0425042504250425,0.00119,0.9876987698769876,Average Maturation,0.0425042504250425,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Platform - Collagen (38),0.00937,0.06000600060006,0.01237,0.0125012501250125,Average Maturation,0.0125012501250125,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Maturation Media - Commercial Kit (27),0.00927,0.0438043804380438,0.00808,0.0526052605260526,Average Maturation,0.0438043804380438,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Insulin Start Day - After 11 (7),0.00921,0.0273027302730273,0.00931,0.0287028702870287,Average Maturation,0.0273027302730273,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.00897,0.0402040204020402,0.00555,0.1157115711571157,Average Maturation,0.0402040204020402,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Ascorbic Acid (41),0.00896,0.0455045504550455,0.01191,0.015001500150015,Average Maturation,0.015001500150015,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),hiPSC-CM Media Supplement - Lipids (9),0.00856,0.0342034203420342,0.0079,0.0515051505150515,Average Maturation,0.0342034203420342,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Contractile Analysis Method - Rare (7),0.00818,0.0491049104910491,0.0068,0.0765076507650765,Average Maturation,0.0491049104910491,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00815,0.0471047104710471,0.01163,0.0193019301930193,Average Maturation,0.0193019301930193,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Disease Modelling - Genetic Disorders (18),0.00808,0.0578057805780578,0.01274,0.0117011701170117,Average Maturation,0.0117011701170117,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.00782,0.0412041204120412,0.00621,0.0813081308130813,Average Maturation,0.0412041204120412,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.0068,0.087008700870087,0.00869,0.0485048504850485,Average Maturation,0.0485048504850485,True,False
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),Insulin Start Day - 3 (5),0.00661,0.0955095509550955,0.01248,0.019001900190019,Average Maturation,0.019001900190019,True,True
Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00634,0.1054105410541054,0.00906,0.0451045104510451,Average Maturation,0.0451045104510451,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Maturation Strategy - Tension (64),0.03346,0.0,0.01186,0.0192019201920192,Average Maturation,0.0,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Contractile Analysis Method - Deflection (39),0.03294,0.0004000400040004,0.01699,0.0031003100310031,Average Maturation,0.0004000400040004,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.02694,0.0011001100110011,0.0294,0.0004000400040004,Average Maturation,0.0004000400040004,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.02172,0.0045004500450045,0.02064,0.0024002400240024,Average Maturation,0.0024002400240024,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01649,0.0054005400540054,0.00399,0.6207620762076208,Average Maturation,0.0054005400540054,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Tissue Media - MEM-α (60),0.01632,0.0082008200820082,0.0079,0.0855085508550855,Average Maturation,0.0082008200820082,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Tissue Media - DMEM (53),0.01574,0.0133013301330133,0.01091,0.0296029602960296,Average Maturation,0.0133013301330133,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.01504,0.0104010401040104,0.0128,0.0154015401540154,Average Maturation,0.0104010401040104,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Insulin Withdrawal Duration (days) Quantiles - Q2 (>2 and ≤4) (25),0.01498,0.0145014501450145,0.01911,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Platform - Fibrin (50),0.01492,0.0102010201020102,0.00968,0.0478047804780478,Average Maturation,0.0102010201020102,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.01431,0.0164016401640164,0.01356,0.0147014701470147,Average Maturation,0.0147014701470147,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),hiPSC-CM Media Supplement - HEPES (16),0.01365,0.0138013801380138,0.00783,0.068006800680068,Average Maturation,0.0138013801380138,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Deduced Culture Strategy - 3D Only (157),0.01092,0.039003900390039,0.00204,0.9721972197219722,Average Maturation,0.039003900390039,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Journal - Stem Cell Reports (23),0.01085,0.0334033403340334,0.01167,0.0201020102010201,Average Maturation,0.0201020102010201,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Platform - Extracellular Scaffold (18),0.01066,0.0315031503150315,0.00506,0.1576157615761576,Average Maturation,0.0315031503150315,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Seeding Confluency 3D (%) - Rare (26),0.01062,0.0284028402840284,0.00798,0.065006500650065,Average Maturation,0.0284028402840284,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Insulin Start Day - 6 (20),0.01049,0.0358035803580358,0.00979,0.041004100410041,Average Maturation,0.0358035803580358,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.01033,0.0343034303430343,0.00993,0.0349034903490349,Average Maturation,0.0343034303430343,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Insulin Withdrawal Duration (days) - 4 days (18),0.00989,0.0292029202920292,0.00704,0.0752075207520752,Average Maturation,0.0292029202920292,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Insulin Withdrawal Duration (days) - 3 days (6),0.00912,0.0368036803680368,0.01306,0.0105010501050105,Average Maturation,0.0105010501050105,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Wnt Inhibitor - XAV939 (24),0.008,0.0613061306130613,0.00987,0.0379037903790379,Average Maturation,0.0379037903790379,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Journal - PNAS (3),0.00756,0.0568056805680568,0.00939,0.0482048204820482,Average Maturation,0.0482048204820482,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Gene Analysis Method - Rare (5),0.00666,0.0604060406040604,0.01036,0.0234023402340234,Average Maturation,0.0234023402340234,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Journal - Cell Stem Cell (6),0.00596,0.1086108610861086,0.00881,0.046004600460046,Average Maturation,0.046004600460046,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Journal - Circulation (11),0.00559,0.1029102910291029,0.01114,0.02000200020002,Average Maturation,0.02000200020002,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.00502,0.1315131513151315,0.01436,0.0091009100910091,Average Maturation,0.0091009100910091,True,True
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),3D Platform - Gelatin (6),0.00486,0.1272127212721272,0.00847,0.0473047304730473,Average Maturation,0.0473047304730473,True,False
Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),hiPSC-CM Media Supplement - 1-thioglycerol (14),0.0024,0.2976297629762976,0.01053,0.0353035303530353,Average Maturation,0.0353035303530353,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.03064,0.0007000700070007,0.01701,0.0038003800380038,Average Maturation,0.0007000700070007,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Maturation Strategy - Tension (64),0.02405,0.0016001600160016,0.01014,0.0213021302130213,Average Maturation,0.0016001600160016,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.02204,0.0046004600460046,0.01239,0.016001600160016,Average Maturation,0.0046004600460046,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Platform - Fibrin (50),0.01886,0.004000400040004,0.01255,0.0084008400840084,Average Maturation,0.004000400040004,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Cell Coculture - Stromal Cell (78),0.01742,0.0058005800580058,0.00792,0.1035103510351035,Average Maturation,0.0058005800580058,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Metabolic Component - Dexamethasone (7),0.01728,0.005000500050005,0.01533,0.0079007900790079,Average Maturation,0.005000500050005,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Seeding Confluency 3D (%) - 90 to 94 (13),0.01604,0.0077007700770077,0.0195,0.0026002600260026,Average Maturation,0.0026002600260026,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Tissue Media - RPMI-1640 (72),0.01591,0.0108010801080108,0.01316,0.0089008900890089,Average Maturation,0.0089008900890089,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Contractile Analysis Method - Deflection (39),0.01474,0.0116011601160116,0.01043,0.0331033103310331,Average Maturation,0.0116011601160116,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Stromal Cell Source - Dermal Fibroblast (7),0.01469,0.0074007400740074,0.01158,0.0157015701570157,Average Maturation,0.0074007400740074,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Stromal Cell Source - Cardiac Fibroblast (32),0.01416,0.013001300130013,0.01184,0.0188018801880188,Average Maturation,0.013001300130013,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Pharmacological Intervention - Adrenaline (83),0.013,0.0267026702670267,0.01251,0.0143014301430143,Average Maturation,0.0143014301430143,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.01289,0.0123012301230123,0.01158,0.016001600160016,Average Maturation,0.0123012301230123,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Platform - Extracellular Scaffold (18),0.01256,0.0202020202020202,0.01377,0.0099009900990099,Average Maturation,0.0099009900990099,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Cell Line - WTC11 (30),0.012,0.0244024402440244,0.01464,0.0054005400540054,Average Maturation,0.0054005400540054,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.01199,0.018001800180018,0.01117,0.0196019601960196,Average Maturation,0.018001800180018,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Metabolic Component - IGF-1 (3),0.01183,0.0173017301730173,0.01819,0.0038003800380038,Average Maturation,0.0038003800380038,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q3 (>5 and ≤10) (30),0.01167,0.0248024802480248,0.0084,0.0633063306330633,Average Maturation,0.0248024802480248,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Deduced Culture Strategy - 3D Only (157),0.01135,0.036003600360036,0.00333,0.7626762676267627,Average Maturation,0.036003600360036,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Cell Coculture - Cardiomyocyte (157),0.01133,0.0397039703970397,0.00104,0.9957995799579958,Average Maturation,0.0397039703970397,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01114,0.0346034603460346,0.00748,0.1339133913391339,Average Maturation,0.0346034603460346,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Publication Year - 2020 (51),0.01098,0.0389038903890389,0.00829,0.0716071607160716,Average Maturation,0.0389038903890389,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Maturation Strategy - Other Cells (80),0.01082,0.043004300430043,0.00354,0.5172517251725173,Average Maturation,0.043004300430043,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Journal - Nat Biomed Eng (5),0.01064,0.0229022902290229,0.01065,0.0296029602960296,Average Maturation,0.0229022902290229,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),3D Estimated Tissue Size (mm2) Quantiles - Q3 (>2 and ≤9.12) (21),0.01023,0.0375037503750375,0.01265,0.0161016101610161,Average Maturation,0.0161016101610161,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),0.00991,0.0301030103010301,0.01439,0.0109010901090109,Average Maturation,0.0109010901090109,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Metabolic Component Category - Hormonal Stimulation (14),0.00978,0.0335033503350335,0.01084,0.0228022802280228,Average Maturation,0.0228022802280228,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Contractile Analysis Method - Force Transducer (27),0.00914,0.0593059305930593,0.01295,0.0161016101610161,Average Maturation,0.0161016101610161,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Seeding Confluency (%) - 90 to 94 (26),0.00911,0.0561056105610561,0.01126,0.0233023302330233,Average Maturation,0.0233023302330233,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Number of Cell Lines - 4 (11),0.00895,0.0351035103510351,0.0104,0.0266026602660266,Average Maturation,0.0266026602660266,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.0087,0.0334033403340334,0.01016,0.0254025402540254,Average Maturation,0.0254025402540254,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Disease Modelling - Fibrotic (4),0.00869,0.0365036503650365,0.01593,0.0053005300530053,Average Maturation,0.0053005300530053,True,True
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Insulin Start Day - 3 (5),0.00813,0.0344034403440344,0.009,0.0328032803280328,Average Maturation,0.0328032803280328,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Journal - PLoS One (9),0.0063,0.0794079407940794,0.00879,0.0367036703670367,Average Maturation,0.0367036703670367,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Journal - ACS Biomater Sci Eng (3),0.00555,0.0715071507150715,0.00964,0.0366036603660366,Average Maturation,0.0366036603660366,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.00542,0.1368136813681368,0.00905,0.0498049804980498,Average Maturation,0.0498049804980498,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Journal - J Mol Cell Cardiol (4),0.00388,0.093009300930093,0.0085,0.0413041304130413,Average Maturation,0.0413041304130413,True,False
Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),Insulin Start Day - 11 (3),0.00361,0.0796079607960796,0.01109,0.0433043304330433,Average Maturation,0.0433043304330433,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q2 (>10 and ≤21) (17),0.03894,0.0,0.03715,0.0,Average Maturation,0.0,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Platform - Collagen (38),0.02515,0.001000100010001,0.02006,0.0005000500050005,Average Maturation,0.0005000500050005,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Stromal Cell Source - hiPSC-MuralC (3),0.02401,0.0016001600160016,0.02809,0.0012001200120012,Average Maturation,0.0012001200120012,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Platform - Matrigel (33),0.02193,0.0027002700270027,0.01178,0.0178017801780178,Average Maturation,0.0027002700270027,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Journal - Biosens Bioelectron (4),0.02124,0.0031003100310031,0.01367,0.015001500150015,Average Maturation,0.0031003100310031,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Coating for Replating - Laminin (5),0.02021,0.0019001900190019,0.01724,0.004000400040004,Average Maturation,0.0019001900190019,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Contractile Analysis Method - Force Transducer (27),0.02007,0.0026002600260026,0.02326,0.0005000500050005,Average Maturation,0.0005000500050005,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Wnt Induction - Activin A (80),0.01942,0.0018001800180018,0.0139,0.0021002100210021,Average Maturation,0.0018001800180018,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Cell Line - 201B6 (3),0.01847,0.003000300030003,0.02533,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Wnt Induction - Wnt3a (3),0.01798,0.002000200020002,0.02635,0.0007000700070007,Average Maturation,0.0007000700070007,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),hiPSC-CM Purification Duration (days) - 4 days (29),0.01744,0.008000800080008,0.00844,0.0707070707070707,Average Maturation,0.008000800080008,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Cell Coculture - Stromal Cell (78),0.0151,0.0137013701370137,0.00569,0.2639263926392639,Average Maturation,0.0137013701370137,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.01324,0.02000200020002,0.00917,0.0477047704770477,Average Maturation,0.02000200020002,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Publication Year - 2021 (43),0.01288,0.0227022702270227,0.00763,0.1003100310031003,Average Maturation,0.0227022702270227,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Cell Line Sex - Female (40),0.01265,0.0291029102910291,0.01349,0.0148014801480148,Average Maturation,0.0148014801480148,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.01222,0.0358035803580358,0.01086,0.0343034303430343,Average Maturation,0.0343034303430343,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Maturation Strategy - Tension (64),0.01208,0.0267026702670267,0.0056,0.2068206820682068,Average Maturation,0.0267026702670267,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Insulin Start Day - 5 (14),0.01121,0.0236023602360236,0.00717,0.0631063106310631,Average Maturation,0.0236023602360236,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01118,0.0467046704670467,0.00414,0.384038403840384,Average Maturation,0.0467046704670467,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.01113,0.0207020702070207,0.01223,0.016001600160016,Average Maturation,0.016001600160016,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Insulin Withdrawal Duration (days) Quantiles - Q2 (>2 and ≤4) (25),0.01097,0.0422042204220422,0.00891,0.0551055105510551,Average Maturation,0.0422042204220422,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Stromal Cell Source - Stromal Cell (35),0.01054,0.036003600360036,0.01016,0.0343034303430343,Average Maturation,0.0343034303430343,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01049,0.0392039203920392,0.01014,0.0375037503750375,Average Maturation,0.0375037503750375,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Insulin Withdrawal Duration (days) - 4 days (18),0.00987,0.0368036803680368,0.00754,0.0667066706670667,Average Maturation,0.0368036803680368,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.00973,0.0429042904290429,0.00471,0.2078207820782078,Average Maturation,0.0429042904290429,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Contractile Analysis Method - Traction Force Microscopy (9),0.0092,0.0288028802880288,0.00639,0.0854085408540854,Average Maturation,0.0288028802880288,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Journal - Sci Transl Med (3),0.00916,0.0441044104410441,0.01139,0.0317031703170317,Average Maturation,0.0317031703170317,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Cell Line - iCell2 (8),0.00905,0.036003600360036,0.00455,0.1484148414841484,Average Maturation,0.036003600360036,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Day of Insulin Addition - not 21 (14),0.00885,0.0475047504750475,0.00627,0.0992099209920992,Average Maturation,0.0475047504750475,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Wnt Inhibitor - XAV939 (24),0.00883,0.0549054905490549,0.01161,0.0224022402240224,Average Maturation,0.0224022402240224,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.00877,0.0752075207520752,0.01257,0.021002100210021,Average Maturation,0.021002100210021,True,True
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),0.00829,0.0476047604760476,0.00929,0.0393039303930393,Average Maturation,0.0393039303930393,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.00574,0.0942094209420942,0.00962,0.0306030603060306,Average Maturation,0.0306030603060306,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Seeding Confluency 3D (%) - 80 to 84 (5),0.00566,0.0863086308630863,0.00861,0.0443044304430443,Average Maturation,0.0443044304430443,True,False
Contractile Stress (mN/mm2) Quantiles - Q3 (>0.51 and ≤1.9) (9),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00218,0.1329132913291329,0.01246,0.0202020202020202,Average Maturation,0.0202020202020202,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Contractile Analysis Method - Motion Tracking (93),0.02128,0.0012001200120012,0.01362,0.0028002800280028,Average Maturation,0.0012001200120012,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),3D Platform - Gelatin (6),0.01654,0.0045004500450045,0.01959,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),0.01581,0.0064006400640064,0.01309,0.0127012701270127,Average Maturation,0.0064006400640064,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),3D Tissue Media - RPMI-1640 (72),0.01522,0.0078007800780078,0.00826,0.0978097809780978,Average Maturation,0.0078007800780078,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Publication Year - 2021 (43),0.01203,0.0298029802980298,0.00571,0.1973197319731973,Average Maturation,0.0298029802980298,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01192,0.0177017701770177,0.00845,0.0486048604860486,Average Maturation,0.0177017701770177,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Cell Line Sex - Both (118),0.01166,0.0278027802780278,0.00759,0.133013301330133,Average Maturation,0.0278027802780278,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Publication Year - Post 2020 (122),0.01142,0.0258025802580258,0.00838,0.0531053105310531,Average Maturation,0.0258025802580258,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Pharmacological Intervention - Verapamil (27),0.01107,0.0225022502250225,0.00892,0.0432043204320432,Average Maturation,0.0225022502250225,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Differentiation Purity Assessment - IHC cTnT (7),0.01107,0.0177017701770177,0.00755,0.0588058805880588,Average Maturation,0.0177017701770177,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01105,0.0282028202820282,0.0066,0.1789178917891789,Average Maturation,0.0282028202820282,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Journal - Biomaterials (16),0.01065,0.0341034103410341,0.00754,0.0734073407340734,Average Maturation,0.0341034103410341,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Wnt Induction Duration (days) Quantiles - Q2 (>1 and ≤2) (75),0.01037,0.0335033503350335,0.00845,0.0762076207620762,Average Maturation,0.0335033503350335,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.01026,0.0274027402740274,0.01036,0.0243024302430243,Average Maturation,0.0243024302430243,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Day of Insulin Addition - not 21 (14),0.00984,0.0371037103710371,0.00962,0.0309030903090309,Average Maturation,0.0309030903090309,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Journal - Nat Commun (13),0.00976,0.0361036103610361,0.00908,0.0412041204120412,Average Maturation,0.0361036103610361,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Journal - ACS Biomater Sci Eng (3),0.00974,0.0246024602460246,0.01113,0.0213021302130213,Average Maturation,0.0213021302130213,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Metabolic Component Category - Kinase Inhibitors (3),0.00949,0.0219021902190219,0.00641,0.0664066406640664,Average Maturation,0.0219021902190219,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Day of Insulin Addition - not 23 (10),0.00945,0.0318031803180318,0.00878,0.0378037803780378,Average Maturation,0.0318031803180318,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.0094,0.0501050105010501,0.00978,0.0376037603760376,Average Maturation,0.0376037603760376,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),3D Platform - 3D printed (9),0.00863,0.0353035303530353,0.01043,0.0232023202320232,Average Maturation,0.0232023202320232,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Day of Insulin Addition - not 24 (9),0.00863,0.0307030703070307,0.0078,0.0455045504550455,Average Maturation,0.0307030703070307,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.00846,0.0456045604560456,0.01192,0.0187018701870187,Average Maturation,0.0187018701870187,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Maturation Strategy - Elastomeric (33),0.00796,0.0764076407640764,0.00927,0.0411041104110411,Average Maturation,0.0411041104110411,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Pharmacological Intervention - Thalidomide (3),0.00794,0.0594059405940594,0.01123,0.0322032203220322,Average Maturation,0.0322032203220322,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Day of Insulin Addition - not 22 (12),0.00783,0.0491049104910491,0.00624,0.0978097809780978,Average Maturation,0.0491049104910491,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Seeding Confluency 2D (%) - 90 to 94 (12),0.00777,0.0497049704970497,0.00674,0.0632063206320632,Average Maturation,0.0497049704970497,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00755,0.0476047604760476,0.00503,0.114011401140114,Average Maturation,0.0476047604760476,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Pharmacological Intervention - Cardiotoxic Agents (3),0.00748,0.0489048904890489,0.00883,0.0423042304230423,Average Maturation,0.0423042304230423,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.0073,0.0598059805980598,0.01089,0.0191019101910191,Average Maturation,0.0191019101910191,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Publication Year - 2017 (43),0.00721,0.0919091909190919,0.01003,0.0313031303130313,Average Maturation,0.0313031303130313,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00662,0.0916091609160916,0.01029,0.0309030903090309,Average Maturation,0.0309030903090309,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Journal - J Mol Cell Card (6),0.00619,0.0579057905790579,0.00717,0.0497049704970497,Average Maturation,0.0497049704970497,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Coating for Replating - Matrigel (65),0.00607,0.1963196319631963,0.01117,0.0249024902490249,Average Maturation,0.0249024902490249,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q2 (>31.5 and ≤50) (10),Coating for Replating - Fibronectin (32),0.00472,0.2008200820082008,0.01055,0.0283028302830283,Average Maturation,0.0283028302830283,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Journal - Biomater Sci (7),0.03212,0.0004000400040004,0.03266,0.0004000400040004,Average Maturation,0.0004000400040004,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Sacromere or Cellular Alignment Analysis - Yes (72),0.02181,0.0037003700370037,0.01231,0.0174017401740174,Average Maturation,0.0037003700370037,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.01869,0.0109010901090109,0.01327,0.0274027402740274,Average Maturation,0.0109010901090109,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.01762,0.0117011701170117,0.01902,0.0076007600760076,Average Maturation,0.0076007600760076,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Cell Line - 253G1 (10),0.01759,0.0106010601060106,0.0141,0.0153015301530153,Average Maturation,0.0106010601060106,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01698,0.0109010901090109,0.02561,0.0009000900090009,Average Maturation,0.0009000900090009,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Insulin Start Day - 7 (85),0.01548,0.0211021102110211,0.01119,0.0329032903290329,Average Maturation,0.0211021102110211,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.01516,0.0143014301430143,0.01389,0.012001200120012,Average Maturation,0.012001200120012,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.01495,0.0155015501550155,0.02214,0.0028002800280028,Average Maturation,0.0028002800280028,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),2D Surface - Micropatterned (27),0.01436,0.0118011801180118,0.00847,0.0675067506750675,Average Maturation,0.0118011801180118,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),2D Surface - Decellularized ECM (3),0.0135,0.032003200320032,0.01665,0.0209020902090209,Average Maturation,0.0209020902090209,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),3D Tissue Media - DMEM (53),0.01333,0.0184018401840184,0.01157,0.0246024602460246,Average Maturation,0.0184018401840184,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Journal - Tissue Eng Part A (4),0.01261,0.0329032903290329,0.01209,0.0383038303830383,Average Maturation,0.0329032903290329,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Contractile Analysis Method - Motion Tracking (93),0.01201,0.0298029802980298,0.00728,0.1538153815381538,Average Maturation,0.0298029802980298,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Calcium Handling Analysis Method - Visual (104),0.01149,0.0464046404640464,0.00714,0.311031103110311,Average Maturation,0.0464046404640464,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Max Capture Rate of Paced CMs (Hz) Quantiles - Q2 (>1 and ≤2.9) (8),0.01144,0.0354035403540354,0.00839,0.0776077607760776,Average Maturation,0.0354035403540354,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Seeding Confluency 2D (%) - 85 to 89 (26),0.01061,0.0447044704470447,0.00514,0.2043204320432043,Average Maturation,0.0447044704470447,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.0104,0.0472047204720472,0.01067,0.0472047204720472,Average Maturation,0.0472047204720472,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Journal - Cell Stem Cell (6),0.01024,0.0435043504350435,0.00631,0.1005100510051005,Average Maturation,0.0435043504350435,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01018,0.0338033803380338,0.00701,0.0794079407940794,Average Maturation,0.0338033803380338,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Electron Imaging - Scanning (22),0.00972,0.0505050505050505,0.01391,0.0146014601460146,Average Maturation,0.0146014601460146,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),3D Platform - Polyethylene Glycol (8),0.00914,0.0554055405540554,0.01249,0.0215021502150215,Average Maturation,0.0215021502150215,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Cell Line - SCVI-273 (8),0.00863,0.0627062706270627,0.01129,0.0313031303130313,Average Maturation,0.0313031303130313,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Cell Coculture - Cardiomyocyte (157),0.00858,0.0969096909690969,0.01058,0.0065006500650065,Average Maturation,0.0065006500650065,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),2D Surface - ECM-coated (115),0.00741,0.1245124512451245,0.01367,0.0046004600460046,Average Maturation,0.0046004600460046,True,True
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Contractile Analysis Method - Rare (7),0.00631,0.0951095109510951,0.01031,0.0453045304530453,Average Maturation,0.0453045304530453,True,False
Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),Seeding Confluency 2D (%) - Rare (13),0.00581,0.1342134213421342,0.01172,0.0253025302530253,Average Maturation,0.0253025302530253,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.02528,0.0005000500050005,0.02017,0.001000100010001,Average Maturation,0.0005000500050005,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.02361,0.0014001400140014,0.02338,0.0006000600060006,Average Maturation,0.0006000600060006,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.01906,0.0055005500550055,0.02298,0.0001000100010001,Average Maturation,0.0001000100010001,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01766,0.0053005300530053,0.01413,0.009000900090009,Average Maturation,0.0053005300530053,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Electron Imaging - Scanning (22),0.01757,0.0045004500450045,0.01217,0.0123012301230123,Average Maturation,0.0045004500450045,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Electron Imaging - Transmission (62),0.01732,0.0052005200520052,0.01402,0.0055005500550055,Average Maturation,0.0052005200520052,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.0169,0.0089008900890089,0.00882,0.0517051705170517,Average Maturation,0.0089008900890089,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),3D Tissue Media - MEM-α (60),0.01401,0.0138013801380138,0.00693,0.115011501150115,Average Maturation,0.0138013801380138,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.01215,0.0108010801080108,0.00798,0.0455045504550455,Average Maturation,0.0108010801080108,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Calcium Handling Analysis Method - Flux Rates (13),0.01164,0.0277027702770277,0.01602,0.0062006200620062,Average Maturation,0.0062006200620062,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Publication Year - Late-2010s (196),0.01158,0.0333033303330333,0.00489,0.4608460846084608,Average Maturation,0.0333033303330333,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Publication Year - 2024 (7),0.01155,0.0162016201620162,0.01062,0.0208020802080208,Average Maturation,0.0162016201620162,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Sacromere or Cellular Alignment Analysis - Yes (72),0.01152,0.0343034303430343,0.0085,0.0598059805980598,Average Maturation,0.0343034303430343,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Journal - ACS Appl Mater Interfaces (4),0.01134,0.0163016301630163,0.0069,0.0743074307430743,Average Maturation,0.0163016301630163,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Journal - Acta Biomater (10),0.01066,0.0228022802280228,0.00971,0.0266026602660266,Average Maturation,0.0228022802280228,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Calcium Handling Analysis Method - Rare (4),0.01046,0.0128012801280128,0.00665,0.0643064306430643,Average Maturation,0.0128012801280128,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),3D Stromal Cell Source - Rare (4),0.01025,0.023002300230023,0.0106,0.023002300230023,Average Maturation,0.023002300230023,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Journal - PLoS One (9),0.01013,0.0209020902090209,0.00813,0.0396039603960396,Average Maturation,0.0209020902090209,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00931,0.0233023302330233,0.00887,0.0344034403440344,Average Maturation,0.0233023302330233,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Gene Analysis Method - RNA (169),0.00893,0.0683068306830683,0.01135,0.0013001300130013,Average Maturation,0.0013001300130013,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00888,0.0425042504250425,0.01495,0.0068006800680068,Average Maturation,0.0068006800680068,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Journal - Sci Adv (3),0.00794,0.0651065106510651,0.01056,0.0436043604360436,Average Maturation,0.0436043604360436,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Maturation Strategy - Cell Alignment (59),0.00776,0.0891089108910891,0.00957,0.0435043504350435,Average Maturation,0.0435043504350435,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.00765,0.0416041604160416,0.00819,0.0385038503850385,Average Maturation,0.0385038503850385,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Insulin Start Day - 9 (10),0.00762,0.0491049104910491,0.00608,0.0893089308930893,Average Maturation,0.0491049104910491,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00754,0.0522052205220522,0.00821,0.0474047404740474,Average Maturation,0.0474047404740474,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Calcium Handling Analysis Method - Genetical (3),0.00666,0.0612061206120612,0.00935,0.0452045204520452,Average Maturation,0.0452045204520452,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.00648,0.214021402140214,0.00802,0.041004100410041,Average Maturation,0.041004100410041,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),0.00635,0.0764076407640764,0.01078,0.0227022702270227,Average Maturation,0.0227022702270227,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00569,0.0894089408940894,0.01,0.0229022902290229,Average Maturation,0.0229022902290229,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00472,0.1241124112411241,0.00889,0.0362036203620362,Average Maturation,0.0362036203620362,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),Cell Coculture - Endothelial Cell (35),0.00387,0.2522252225222522,0.00988,0.0316031603160316,Average Maturation,0.0316031603160316,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Seeding Confluency 2D (%) - 80 to 84 (5),0.02215,0.0018001800180018,0.02179,0.0023002300230023,Average Maturation,0.0018001800180018,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01766,0.0038003800380038,0.0152,0.0066006600660066,Average Maturation,0.0038003800380038,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Cell Line - Rare (132),0.01663,0.007000700070007,0.01258,0.0011001100110011,Average Maturation,0.0011001100110011,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01611,0.0057005700570057,0.00889,0.0416041604160416,Average Maturation,0.0057005700570057,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.01599,0.0054005400540054,0.0085,0.0397039703970397,Average Maturation,0.0054005400540054,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Maturation Strategy - Other Cells (80),0.0152,0.0092009200920092,0.008,0.0726072607260726,Average Maturation,0.0092009200920092,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Cell Line - DF19-9-11T.H (16),0.01477,0.0102010201020102,0.00951,0.0376037603760376,Average Maturation,0.0102010201020102,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Calcium Handling Analysis Method - Visual (104),0.01331,0.0163016301630163,0.01008,0.032003200320032,Average Maturation,0.0163016301630163,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Platform - Scaffold Free (43),0.01311,0.0202020202020202,0.01209,0.0156015601560156,Average Maturation,0.0156015601560156,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Coating for Replating - Rare (6),0.01282,0.0094009400940094,0.0098,0.0222022202220222,Average Maturation,0.0094009400940094,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Publication Year - 2015 (19),0.01221,0.0182018201820182,0.00744,0.0727072707270727,Average Maturation,0.0182018201820182,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Journal - Tissue Eng Part A (4),0.01178,0.015001500150015,0.01869,0.0032003200320032,Average Maturation,0.0032003200320032,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Sacromere or Cellular Alignment Analysis - Yes (72),0.01166,0.0344034403440344,0.01396,0.0032003200320032,Average Maturation,0.0032003200320032,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.0115,0.0244024402440244,0.00815,0.0457045704570457,Average Maturation,0.0244024402440244,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Stromal Cell Source - Stromal Cell (35),0.01146,0.0304030403040304,0.00895,0.047004700470047,Average Maturation,0.0304030403040304,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Cell Line - 253G1 (10),0.01132,0.0204020402040204,0.00625,0.0864086408640864,Average Maturation,0.0204020402040204,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Journal - Nano Lett (3),0.01115,0.0193019301930193,0.01436,0.0123012301230123,Average Maturation,0.0123012301230123,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Calcium Handling Analysis Method - Genetical (23),0.01084,0.027002700270027,0.01041,0.0293029302930293,Average Maturation,0.027002700270027,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.01029,0.0321032103210321,0.01019,0.0273027302730273,Average Maturation,0.0273027302730273,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Cell Line - Gibco episomal (10),0.01008,0.0261026102610261,0.00677,0.0733073307330733,Average Maturation,0.0261026102610261,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Seeding Confluency (%) - 80 to 84 (12),0.00977,0.034003400340034,0.00831,0.0452045204520452,Average Maturation,0.034003400340034,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.00969,0.0367036703670367,0.00801,0.058005800580058,Average Maturation,0.0367036703670367,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Tissue Media - iCell Maintenance (12),0.00966,0.0271027102710271,0.00876,0.0349034903490349,Average Maturation,0.0271027102710271,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Journal - J Mol Cell Card (6),0.00951,0.0281028102810281,0.00859,0.0429042904290429,Average Maturation,0.0281028102810281,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.009,0.0309030903090309,0.00525,0.1169116911691169,Average Maturation,0.0309030903090309,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),MYH7 Percentage (MYH6) Quantiles - Q2 (>30.1 and ≤82.35) (4),0.00874,0.0438043804380438,0.00927,0.0448044804480448,Average Maturation,0.0438043804380438,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Wnt Inhibitor - BMP4 (7),0.00827,0.0322032203220322,0.00786,0.0399039903990399,Average Maturation,0.0322032203220322,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.00793,0.0577057705770577,0.01003,0.0329032903290329,Average Maturation,0.0329032903290329,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),2D Surface - Micropatterned (27),0.00731,0.0872087208720872,0.01095,0.0238023802380238,Average Maturation,0.0238023802380238,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),2D Surface - ECM-coated (115),0.00689,0.2221222122212221,0.0109,0.0158015801580158,Average Maturation,0.0158015801580158,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Gene Analysis Method - RNA (169),0.00655,0.2755275527552755,0.01026,0.0069006900690069,Average Maturation,0.0069006900690069,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),Wnt Inhibitor Duration (days) - 3 days (17),0.00571,0.0946094609460946,0.00909,0.0364036403640364,Average Maturation,0.0364036403640364,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),3D Tissue Media - High-glucose DMEM (9),0.00538,0.0991099109910991,0.00843,0.0417041704170417,Average Maturation,0.0417041704170417,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Metabolic Component - Dexamethasone (7),0.03136,0.0,0.02781,0.0001000100010001,Average Maturation,0.0,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Seeding Confluency (%) - 80 to 84 (12),0.01984,0.003000300030003,0.01664,0.0035003500350035,Average Maturation,0.003000300030003,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01952,0.0021002100210021,0.01249,0.0132013201320132,Average Maturation,0.0021002100210021,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Seeding Confluency 3D (%) - 80 to 84 (5),0.01875,0.0039003900390039,0.02127,0.0025002500250025,Average Maturation,0.0025002500250025,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Calcium Handling Analysis Method - Visual (104),0.01819,0.0037003700370037,0.00651,0.2232223222322232,Average Maturation,0.0037003700370037,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Journal - J Mol Cell Card (6),0.01734,0.0054005400540054,0.01718,0.0053005300530053,Average Maturation,0.0053005300530053,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01697,0.0056005600560056,0.01198,0.0185018501850185,Average Maturation,0.0056005600560056,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Maturation Strategy - ECM (21),0.01574,0.0081008100810081,0.01089,0.0255025502550255,Average Maturation,0.0081008100810081,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Metabolic Component - IGF-1 (3),0.01512,0.0048004800480048,0.0201,0.0028002800280028,Average Maturation,0.0028002800280028,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01401,0.0103010301030103,0.01753,0.0057005700570057,Average Maturation,0.0057005700570057,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Metabolic Component - T3 (14),0.01313,0.0177017701770177,0.00698,0.0756075607560756,Average Maturation,0.0177017701770177,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Publication Year - 2018 (45),0.01226,0.022002200220022,0.00706,0.1166116611661166,Average Maturation,0.022002200220022,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01202,0.0283028302830283,0.00826,0.0716071607160716,Average Maturation,0.0283028302830283,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Journal - Nat Biomed Eng (5),0.01163,0.0134013401340134,0.0109,0.0217021702170217,Average Maturation,0.0134013401340134,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Seeding Confluency 2D (%) - 90 to 94 (12),0.01157,0.0256025602560256,0.00979,0.0345034503450345,Average Maturation,0.0256025602560256,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Journal - Tissue Eng Part A (4),0.00994,0.0209020902090209,0.01104,0.0202020202020202,Average Maturation,0.0202020202020202,True,True
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.00992,0.0279027902790279,0.00748,0.0511051105110511,Average Maturation,0.0279027902790279,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.00984,0.0439043904390439,0.00621,0.1386138613861386,Average Maturation,0.0439043904390439,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.00962,0.0266026602660266,0.00609,0.0909090909090909,Average Maturation,0.0266026602660266,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Wnt Inhibitor - IWR (56),0.0095,0.0467046704670467,0.0075,0.0934093409340934,Average Maturation,0.0467046704670467,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),3D Platform - Extracellular Scaffold (18),0.00925,0.0445044504450445,0.00903,0.0395039503950395,Average Maturation,0.0395039503950395,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00918,0.0371037103710371,0.0071,0.0636063606360636,Average Maturation,0.0371037103710371,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Metabolic Component Category - Hormonal Stimulation (14),0.00895,0.038003800380038,0.00768,0.0527052705270527,Average Maturation,0.038003800380038,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Wnt Inhibitor - BMP4 (7),0.00773,0.037003700370037,0.00709,0.0591059105910591,Average Maturation,0.037003700370037,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Pharmacological Intervention - Epinephrine (11),0.00731,0.0493049304930493,0.00657,0.0665066506650665,Average Maturation,0.0493049304930493,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Pharmacological Intervention - Cisapride (8),0.00581,0.0821082108210821,0.00847,0.0357035703570357,Average Maturation,0.0357035703570357,True,False
Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),Maturation Strategy - Metabolic (33),0.00505,0.1614161416141614,0.00901,0.041004100410041,Average Maturation,0.041004100410041,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.02098,0.0016001600160016,0.01968,0.0017001700170017,Average Maturation,0.0016001600160016,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.02081,0.0007000700070007,0.0194,0.0019001900190019,Average Maturation,0.0007000700070007,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Journal - Biomater Sci (7),0.01879,0.0013001300130013,0.01974,0.0016001600160016,Average Maturation,0.0013001300130013,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01691,0.0029002900290029,0.01747,0.0022002200220022,Average Maturation,0.0022002200220022,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01533,0.0086008600860086,0.00883,0.0344034403440344,Average Maturation,0.0086008600860086,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),3D Tissue Media - Iscove (5),0.01284,0.0119011901190119,0.01208,0.0138013801380138,Average Maturation,0.0119011901190119,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.01258,0.0065006500650065,0.01266,0.007000700070007,Average Maturation,0.0065006500650065,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Calcium Handling Analysis Method - Visual (104),0.01224,0.0191019101910191,0.00747,0.1234123412341234,Average Maturation,0.0191019101910191,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),hiPSC Backbone Media - mTeSR (106),0.01142,0.0317031703170317,0.00883,0.0369036903690369,Average Maturation,0.0317031703170317,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01083,0.0191019101910191,0.00849,0.0341034103410341,Average Maturation,0.0191019101910191,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Wnt Induction - StemCell Diff Kit (4),0.01073,0.014001400140014,0.0093,0.0334033403340334,Average Maturation,0.014001400140014,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Journal - Circ Res (5),0.0101,0.0097009700970097,0.01575,0.0036003600360036,Average Maturation,0.0036003600360036,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),New Media for Maturation - Commercial Kit (5),0.01003,0.016001600160016,0.01054,0.0174017401740174,Average Maturation,0.016001600160016,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),hiPSC Backbone Media - Commercial CM Kit (12),0.01001,0.023002300230023,0.00956,0.024002400240024,Average Maturation,0.023002300230023,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Contractile Analysis Method - Motion Tracking (93),0.00927,0.0431043104310431,0.00452,0.3915391539153915,Average Maturation,0.0431043104310431,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Cell Line Sex - Both (118),0.00927,0.0682068206820682,0.0086,0.0343034303430343,Average Maturation,0.0343034303430343,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Pharmacological Intervention - Carbamylcholine (6),0.00904,0.0222022202220222,0.01162,0.0146014601460146,Average Maturation,0.0146014601460146,True,True
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.00841,0.04000400040004,0.00807,0.0375037503750375,Average Maturation,0.0375037503750375,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Contractile Analysis Method - Traction Force Microscopy (9),0.00758,0.042004200420042,0.0055,0.0794079407940794,Average Maturation,0.042004200420042,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.0073,0.0448044804480448,0.00466,0.1353135313531353,Average Maturation,0.0448044804480448,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Insulin Withdrawal Duration (days) - 4 days (18),0.00712,0.0557055705570557,0.00922,0.0273027302730273,Average Maturation,0.0273027302730273,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Differentiation Purity Assessment - IHC a-actinin (8),0.00708,0.044004400440044,0.00748,0.0426042604260426,Average Maturation,0.0426042604260426,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Seeding Confluency 2D (%) - 85 to 89 (26),0.0069,0.0644064406440644,0.0085,0.0356035603560356,Average Maturation,0.0356035603560356,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Cell Line - PGP1 (11),0.00673,0.0673067306730673,0.00885,0.0357035703570357,Average Maturation,0.0357035703570357,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),3D Tissue Media - High-glucose DMEM (9),0.00639,0.0465046504650465,0.00384,0.1525152515251525,Average Maturation,0.0465046504650465,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Cell Coculture - Cardiomyocyte (157),0.00591,0.3589358935893589,0.0083,0.0251025102510251,Average Maturation,0.0251025102510251,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Journal - Nat Biomed Eng (5),0.0051,0.0909090909090909,0.00802,0.0368036803680368,Average Maturation,0.0368036803680368,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Cell Line - BJ RiPS (4),0.00486,0.1042104210421042,0.00883,0.0292029202920292,Average Maturation,0.0292029202920292,True,False
Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),Seeding Confluency 2D (%) - 95 to 100 (6),0.00486,0.0956095609560956,0.00722,0.0425042504250425,Average Maturation,0.0425042504250425,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Publication Year - 2016 (32),0.02049,0.0012001200120012,0.01883,0.0005000500050005,Average Maturation,0.0005000500050005,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Pharmacological Intervention - Isoproterenol (71),0.01952,0.0031003100310031,0.01488,0.0016001600160016,Average Maturation,0.0016001600160016,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Seeding Confluency 2D (%) - 70 to 79 (6),0.01933,0.0021002100210021,0.01882,0.0029002900290029,Average Maturation,0.0021002100210021,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),3D Stromal Cell Source - Stromal Cell (35),0.01698,0.0066006600660066,0.01305,0.0097009700970097,Average Maturation,0.0066006600660066,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Calcium Handling Analysis Method - Visual (104),0.01608,0.006000600060006,0.00839,0.0791079107910791,Average Maturation,0.006000600060006,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),2D Surface - Micropatterned (27),0.01524,0.0107010701070107,0.01568,0.004000400040004,Average Maturation,0.004000400040004,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Pharmacological Intervention - Adrenaline (83),0.01465,0.007000700070007,0.00993,0.0256025602560256,Average Maturation,0.007000700070007,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Metabolic Component Category - Signaling Pathway Regulators (6),0.01345,0.0113011301130113,0.00869,0.0385038503850385,Average Maturation,0.0113011301130113,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Calcium Handling Analysis Method - Genetical (23),0.0134,0.0126012601260126,0.00856,0.0507050705070507,Average Maturation,0.0126012601260126,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),0.01226,0.0182018201820182,0.01316,0.0037003700370037,Average Maturation,0.0037003700370037,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),hiPSC Backbone Media - StemFlex (5),0.01209,0.0094009400940094,0.01378,0.0062006200620062,Average Maturation,0.0062006200620062,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Metabolic Component Category - Kinase Inhibitors (3),0.01125,0.0093009300930093,0.01677,0.0028002800280028,Average Maturation,0.0028002800280028,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.0111,0.025002500250025,0.00921,0.0377037703770377,Average Maturation,0.025002500250025,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),hiPSC-CM Purification Duration (days) - 5 days (6),0.01079,0.0194019401940194,0.00891,0.0389038903890389,Average Maturation,0.0194019401940194,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Maturation Strategy - Elastomeric (33),0.00987,0.042004200420042,0.01482,0.0049004900490049,Average Maturation,0.0049004900490049,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.00986,0.0286028602860286,0.01116,0.0191019101910191,Average Maturation,0.0191019101910191,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Seeding Confluency 3D (%) - 80 to 84 (5),0.00943,0.0268026802680268,0.00811,0.0538053805380538,Average Maturation,0.0268026802680268,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00938,0.0241024102410241,0.00828,0.0318031803180318,Average Maturation,0.0241024102410241,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Journal - Tissue Eng Part A (4),0.00923,0.0254025402540254,0.01007,0.0282028202820282,Average Maturation,0.0254025402540254,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00883,0.0403040304030403,0.00855,0.04000400040004,Average Maturation,0.04000400040004,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Wnt Induction Duration (days) Quantiles - Q2 (>1 and ≤2) (75),0.00854,0.0766076607660766,0.0089,0.0463046304630463,Average Maturation,0.0463046304630463,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00851,0.0368036803680368,0.00973,0.0283028302830283,Average Maturation,0.0283028302830283,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Time to Calcium Flux Peak (ms) Quantiles - Q5 (>2000 and ≤365) (10),0.00817,0.0447044704470447,0.00594,0.0899089908990899,Average Maturation,0.0447044704470447,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.00772,0.0437043704370437,0.00994,0.0266026602660266,Average Maturation,0.0266026602660266,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.00756,0.0778077807780778,0.01305,0.0119011901190119,Average Maturation,0.0119011901190119,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Insulin Withdrawal Duration (days) - 8 days (3),0.00699,0.0673067306730673,0.01071,0.0364036403640364,Average Maturation,0.0364036403640364,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Seeding Confluency 2D (%) - 90 to 94 (12),0.0066,0.0686068606860686,0.00937,0.0319031903190319,Average Maturation,0.0319031903190319,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Electrophysiology Analysis Method - Optical Mapping (39),0.00646,0.1151115111511151,0.00945,0.0412041204120412,Average Maturation,0.0412041204120412,True,False
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),Insulin Start Day - 2 (4),0.00518,0.0986098609860986,0.01042,0.0226022602260226,Average Maturation,0.0226022602260226,True,True
Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),2D Surface - Hydrogel (17),0.00112,0.4176417641764176,0.00833,0.046004600460046,Average Maturation,0.046004600460046,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.037,0.0001000100010001,0.02748,0.0001000100010001,Average Maturation,0.0001000100010001,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),3D Platform - Scaffold Free (43),0.02437,0.0006000600060006,0.01391,0.0069006900690069,Average Maturation,0.0006000600060006,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.02354,0.0005000500050005,0.02277,0.0004000400040004,Average Maturation,0.0004000400040004,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.02193,0.0032003200320032,0.02171,0.0009000900090009,Average Maturation,0.0009000900090009,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Coating for Replating - Vitronectin (3),0.0179,0.0026002600260026,0.01512,0.0096009600960096,Average Maturation,0.0026002600260026,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.01684,0.004000400040004,0.01149,0.0174017401740174,Average Maturation,0.004000400040004,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Cell Line Sex - Both (118),0.01538,0.0114011401140114,0.01079,0.0106010601060106,Average Maturation,0.0106010601060106,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),hiPSC Matrix Coating - Vitronectin (10),0.01417,0.0135013501350135,0.0101,0.0322032203220322,Average Maturation,0.0135013501350135,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Publication Year - 2018 (45),0.01347,0.0153015301530153,0.00793,0.0787078707870787,Average Maturation,0.0153015301530153,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),hiPSC Backbone Media - Essential 8 (82),0.01299,0.0197019701970197,0.00969,0.0326032603260326,Average Maturation,0.0197019701970197,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Wnt Inhibitor - IWR (56),0.01219,0.0203020302030203,0.01053,0.0249024902490249,Average Maturation,0.0203020302030203,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Seeding Confluency 3D (%) - 80 to 84 (5),0.0118,0.0124012401240124,0.01934,0.0043004300430043,Average Maturation,0.0043004300430043,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Cell Line - IMR90 (19),0.01119,0.0221022102210221,0.00717,0.0764076407640764,Average Maturation,0.0221022102210221,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Coating for Replating - Matrigel (65),0.01005,0.0459045904590459,0.00953,0.0459045904590459,Average Maturation,0.0459045904590459,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),3D Stromal Cell Source - Rare (4),0.00993,0.0287028702870287,0.00946,0.039003900390039,Average Maturation,0.0287028702870287,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Maturation Strategy - Other Cells (80),0.00967,0.045004500450045,0.00504,0.3197319731973197,Average Maturation,0.045004500450045,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Seeding Confluency 2D (%) - 70 to 79 (6),0.0091,0.0327032703270327,0.00721,0.0665066506650665,Average Maturation,0.0327032703270327,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Cell Line - ATCC (5),0.00899,0.0293029302930293,0.01075,0.0174017401740174,Average Maturation,0.0174017401740174,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Day of Insulin Addition - Known (177),0.0088,0.1007100710071007,0.00886,0.0401040104010401,Average Maturation,0.0401040104010401,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.0088,0.0401040104010401,0.00675,0.0721072107210721,Average Maturation,0.0401040104010401,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Seeding Confluency 3D (%) - Rare (26),0.00858,0.0472047204720472,0.00715,0.0807080708070807,Average Maturation,0.0472047204720472,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00852,0.0511051105110511,0.00939,0.0451045104510451,Average Maturation,0.0451045104510451,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Calcium Handling Analysis Method - Flux Rates (13),0.00848,0.0502050205020502,0.00901,0.0424042404240424,Average Maturation,0.0424042404240424,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Calcium Handling Analysis Method - Genetical (23),0.00848,0.0497049704970497,0.00433,0.1942194219421942,Average Maturation,0.0497049704970497,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Journal - Stem Cell Reports (23),0.00806,0.0656065606560656,0.01212,0.0165016501650165,Average Maturation,0.0165016501650165,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.00793,0.0429042904290429,0.00549,0.1013101310131013,Average Maturation,0.0429042904290429,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Pharmacological Intervention - Rare (3),0.00773,0.0468046804680468,0.01227,0.0154015401540154,Average Maturation,0.0154015401540154,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Fatty Acid Metabolism Assessed - Yes (20),0.00755,0.0549054905490549,0.01266,0.011001100110011,Average Maturation,0.011001100110011,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.00566,0.0761076107610761,0.00745,0.0448044804480448,Average Maturation,0.0448044804480448,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.0055,0.0949094909490949,0.01112,0.0179017901790179,Average Maturation,0.0179017901790179,True,True
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Journal - Stem Cells (11),0.00516,0.1003100310031003,0.00786,0.0452045204520452,Average Maturation,0.0452045204520452,True,False
Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),Journal - Cell Stem Cell (6),0.00262,0.1591159115911591,0.00911,0.0335033503350335,Average Maturation,0.0335033503350335,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Contractile Force (mN) Quantiles - Q3 (>0.16 and ≤0.43) (9),0.02382,0.0009000900090009,0.02545,0.0009000900090009,Average Maturation,0.0009000900090009,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Cell Coculture - Stromal Cell (78),0.01973,0.0039003900390039,0.00632,0.1687168716871687,Average Maturation,0.0039003900390039,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Seeding Confluency 2D (%) - 70 to 79 (6),0.01951,0.002000200020002,0.01749,0.0043004300430043,Average Maturation,0.002000200020002,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D Stromal Cell Source - Stromal Cell (35),0.01602,0.0083008300830083,0.01327,0.0086008600860086,Average Maturation,0.0083008300830083,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.01428,0.0048004800480048,0.01688,0.0038003800380038,Average Maturation,0.0038003800380038,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Pharmacological Intervention - Cisapride (8),0.0139,0.008000800080008,0.02022,0.0011001100110011,Average Maturation,0.0011001100110011,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.01317,0.0136013601360136,0.01115,0.0184018401840184,Average Maturation,0.0136013601360136,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Pharmacological Intervention - Isoproterenol (71),0.01202,0.0284028402840284,0.0072,0.1063106310631063,Average Maturation,0.0284028402840284,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Calcium Handling Analysis Method - Visual (104),0.01195,0.0215021502150215,0.00847,0.068006800680068,Average Maturation,0.0215021502150215,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Seeding Confluency 3D (%) - 90 to 94 (13),0.01186,0.0172017201720172,0.00907,0.0366036603660366,Average Maturation,0.0172017201720172,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.01178,0.0159015901590159,0.00999,0.022002200220022,Average Maturation,0.0159015901590159,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Contractile Analysis Method - Deflection (39),0.01152,0.0289028902890289,0.00462,0.2571257125712571,Average Maturation,0.0289028902890289,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.01023,0.0358035803580358,0.00551,0.1594159415941594,Average Maturation,0.0358035803580358,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Journal - Biomaterials (16),0.00949,0.0279027902790279,0.00982,0.026002600260026,Average Maturation,0.026002600260026,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.0092,0.0543054305430543,0.00922,0.0401040104010401,Average Maturation,0.0401040104010401,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Cell Line - BJ RiPS (4),0.00811,0.0444044404440444,0.00637,0.0862086208620862,Average Maturation,0.0444044404440444,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Metabolic Component - IGF-1 (3),0.00811,0.0447044704470447,0.00587,0.0873087308730873,Average Maturation,0.0447044704470447,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Pharmacological Intervention - QT-Prolonging Drugs (36),0.00803,0.0775077507750775,0.01072,0.0226022602260226,Average Maturation,0.0226022602260226,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00796,0.0494049404940494,0.00383,0.1941194119411941,Average Maturation,0.0494049404940494,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Wnt Induction Duration (days) - 3 days (38),0.00792,0.084008400840084,0.01348,0.008000800080008,Average Maturation,0.008000800080008,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.00744,0.0485048504850485,0.01008,0.0275027502750275,Average Maturation,0.0275027502750275,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D Platform - Nanotechnology (3),0.0071,0.0483048304830483,0.01168,0.014001400140014,Average Maturation,0.014001400140014,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.00645,0.0443044304430443,0.00601,0.0632063206320632,Average Maturation,0.0443044304430443,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Publication Year - 2020 (51),0.00572,0.197019701970197,0.00955,0.0378037803780378,Average Maturation,0.0378037803780378,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Calcium Handling Analysis Method - Genetical (23),0.0053,0.1254125412541254,0.01007,0.0239023902390239,Average Maturation,0.0239023902390239,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Metabolic Component Category - Kinase Inhibitors (3),0.0052,0.0808080808080808,0.01179,0.0156015601560156,Average Maturation,0.0156015601560156,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00401,0.1245124512451245,0.00811,0.0372037203720372,Average Maturation,0.0372037203720372,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.00395,0.4064406440644064,0.00911,0.0483048304830483,Average Maturation,0.0483048304830483,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00393,0.1721172117211721,0.00861,0.0402040204020402,Average Maturation,0.0402040204020402,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00286,0.2089208920892089,0.00754,0.0455045504550455,Average Maturation,0.0455045504550455,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Sacromere or Cellular Alignment Analysis - Yes (72),0.02118,0.004000400040004,0.00997,0.0359035903590359,Average Maturation,0.004000400040004,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Seeding Confluency 2D (%) - 90 to 94 (12),0.01908,0.0047004700470047,0.0177,0.0052005200520052,Average Maturation,0.0047004700470047,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Calcium Handling Analysis Method - Visual (104),0.01652,0.0061006100610061,0.01154,0.0128012801280128,Average Maturation,0.0061006100610061,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Day of Insulin Addition - not 15 (16),0.0164,0.0067006700670067,0.01396,0.0088008800880088,Average Maturation,0.0067006700670067,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Journal - Rare (104),0.01635,0.0066006600660066,0.01386,0.0026002600260026,Average Maturation,0.0026002600260026,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q3 (>0.9 and ≤1.6) (10),0.01499,0.0105010501050105,0.00839,0.0438043804380438,Average Maturation,0.0105010501050105,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),hiPSC Backbone Media - mTeSR (106),0.01432,0.0179017901790179,0.00687,0.1545154515451545,Average Maturation,0.0179017901790179,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.0138,0.0135013501350135,0.01258,0.0119011901190119,Average Maturation,0.0119011901190119,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Seeding Confluency (%) - 90 to 94 (26),0.01341,0.0194019401940194,0.0066,0.1244124412441244,Average Maturation,0.0194019401940194,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Calcium Handling Analysis Method - Rare (4),0.01257,0.0078007800780078,0.0121,0.0125012501250125,Average Maturation,0.0078007800780078,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01234,0.0201020102010201,0.01269,0.0156015601560156,Average Maturation,0.0156015601560156,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Cell Line Sex - Both (118),0.01227,0.0308030803080308,0.00762,0.105010501050105,Average Maturation,0.0308030803080308,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Insulin Start Day - 7 (85),0.01205,0.0278027802780278,0.00843,0.0683068306830683,Average Maturation,0.0278027802780278,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Maturation Strategy - Electrical (39),0.01153,0.0277027702770277,0.00822,0.0756075607560756,Average Maturation,0.0277027702770277,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Cell Coculture - Stromal Cell (78),0.01115,0.0412041204120412,0.00677,0.1509150915091509,Average Maturation,0.0412041204120412,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Publication Year - 2024 (7),0.01073,0.0226022602260226,0.01637,0.0069006900690069,Average Maturation,0.0069006900690069,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Day of Insulin Addition - not 16 (15),0.01072,0.0299029902990299,0.007,0.0773077307730773,Average Maturation,0.0299029902990299,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Wnt Induction - CHIR99021 (184),0.01034,0.039003900390039,0.00303,0.8923892389238924,Average Maturation,0.039003900390039,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),3D Tissue Media - Iscove (5),0.00984,0.0366036603660366,0.008,0.0753075307530753,Average Maturation,0.0366036603660366,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Differentiation Purity Assessment - Rare (3),0.00908,0.0395039503950395,0.01094,0.0346034603460346,Average Maturation,0.0346034603460346,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Day of Insulin Addition - not 12 (11),0.00871,0.036003600360036,0.00473,0.1384138413841384,Average Maturation,0.036003600360036,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Wnt Inhibitor - IWR (56),0.00848,0.0704070407040704,0.01466,0.005000500050005,Average Maturation,0.005000500050005,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.0084,0.0368036803680368,0.00674,0.072007200720072,Average Maturation,0.0368036803680368,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Insulin Start Day - 8 (15),0.00801,0.0557055705570557,0.01121,0.0234023402340234,Average Maturation,0.0234023402340234,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.00788,0.0505050505050505,0.01159,0.0198019801980198,Average Maturation,0.0198019801980198,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00762,0.1664166416641664,0.00941,0.019001900190019,Average Maturation,0.019001900190019,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),hiPSC-CM Purification Duration (days) - 5 days (6),0.0072,0.0862086208620862,0.00996,0.0422042204220422,Average Maturation,0.0422042204220422,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),hiPSC-CM Media Supplement - Ascorbic Acid (41),0.00618,0.1251125112511251,0.01096,0.0221022102210221,Average Maturation,0.0221022102210221,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Coating for Replating - Vitronectin (3),0.00596,0.072007200720072,0.01018,0.045004500450045,Average Maturation,0.045004500450045,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),2D Surface - ECM-coated (115),0.005,0.5345534553455346,0.01151,0.009000900090009,Average Maturation,0.009000900090009,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),TNNI3 Precentage (TTNI1) Quantiles - Q1 (>16.15 and ≤26) (4),0.00445,0.0959095909590959,0.01023,0.0313031303130313,Average Maturation,0.0313031303130313,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),Pharmacological Intervention - Carbamylcholine (6),0.00326,0.1475147514751475,0.00944,0.0355035503550355,Average Maturation,0.0355035503550355,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.07314,0.0,0.05472,0.0,Average Maturation,0.0,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.01834,0.0059005900590059,0.01331,0.0147014701470147,Average Maturation,0.0059005900590059,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Insulin Start Day - 0 (7),0.01614,0.0086008600860086,0.02207,0.003000300030003,Average Maturation,0.003000300030003,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Differentiation Purity Assessment - IHC a-actinin (8),0.01536,0.0096009600960096,0.01666,0.0056005600560056,Average Maturation,0.0056005600560056,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Journal - Stem Cells (11),0.0152,0.0104010401040104,0.01655,0.0058005800580058,Average Maturation,0.0058005800580058,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Purification Duration (days) - 3 days (13),0.01492,0.0138013801380138,0.0088,0.049004900490049,Average Maturation,0.0138013801380138,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Journal - Am J Physiol Heart Circ Physiol (4),0.01483,0.0085008500850085,0.01366,0.0168016801680168,Average Maturation,0.0085008500850085,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01353,0.0229022902290229,0.00736,0.118011801180118,Average Maturation,0.0229022902290229,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Disease Modelling - Dilated Cardiomyopathy (6),0.01309,0.0151015101510151,0.01439,0.0114011401140114,Average Maturation,0.0114011401140114,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.01282,0.017001700170017,0.01621,0.0091009100910091,Average Maturation,0.0091009100910091,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.01235,0.0203020302030203,0.00845,0.0643064306430643,Average Maturation,0.0203020302030203,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Pharmacological Intervention - Cisapride (8),0.0123,0.0155015501550155,0.00803,0.0649064906490649,Average Maturation,0.0155015501550155,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.01206,0.0204020402040204,0.01023,0.0315031503150315,Average Maturation,0.0204020402040204,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Insulin Start Day - 1 (19),0.01173,0.0255025502550255,0.01166,0.0248024802480248,Average Maturation,0.0248024802480248,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Gene Analysis Method - Rare (5),0.0117,0.0163016301630163,0.01431,0.0085008500850085,Average Maturation,0.0085008500850085,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Insulin Start Day - 10 (6),0.01109,0.0283028302830283,0.00673,0.0986098609860986,Average Maturation,0.0283028302830283,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Calcium Handling Analysis Method - Visual (104),0.01104,0.0413041304130413,0.01014,0.0397039703970397,Average Maturation,0.0397039703970397,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),New Media for Maturation - Commercial Kit (5),0.01096,0.031003100310031,0.0104,0.0444044404440444,Average Maturation,0.031003100310031,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Publication Year - 2020 (51),0.01091,0.0533053305330533,0.0106,0.0436043604360436,Average Maturation,0.0436043604360436,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Media Supplement - Lipids (9),0.01091,0.0253025302530253,0.0052,0.1365136513651365,Average Maturation,0.0253025302530253,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Journal - Nano Lett (3),0.01073,0.0401040104010401,0.01479,0.0175017501750175,Average Maturation,0.0175017501750175,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Journal - Cell Stem Cell (6),0.01057,0.0365036503650365,0.01114,0.0343034303430343,Average Maturation,0.0343034303430343,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Publication Year - 2015 (19),0.00995,0.0468046804680468,0.00901,0.0568056805680568,Average Maturation,0.0468046804680468,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Insulin Start Day - 11 (3),0.00948,0.0485048504850485,0.0108,0.0453045304530453,Average Maturation,0.0453045304530453,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Maturation Media - iCell Maintenance (83),0.00932,0.0454045404540454,0.00774,0.0918091809180918,Average Maturation,0.0454045404540454,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),hiPSC-CM Purification Duration (days) - <3 days (31),0.00896,0.074007400740074,0.01277,0.0213021302130213,Average Maturation,0.0213021302130213,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.00885,0.0525052505250525,0.00999,0.0358035803580358,Average Maturation,0.0358035803580358,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Journal - ACS Biomater Sci Eng (3),0.00877,0.0516051605160516,0.01645,0.0105010501050105,Average Maturation,0.0105010501050105,True,True
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.00825,0.0468046804680468,0.01022,0.0414041404140414,Average Maturation,0.0414041404140414,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Publication Year - Post 2020 (122),0.00712,0.223022302230223,0.00936,0.0319031903190319,Average Maturation,0.0319031903190319,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.00677,0.0722072207220722,0.01015,0.0345034503450345,Average Maturation,0.0345034503450345,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.00674,0.0609060906090609,0.00807,0.0473047304730473,Average Maturation,0.0473047304730473,True,False
Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),2D Surface - ECM-coated (115),0.00501,0.5271527152715272,0.01106,0.0158015801580158,Average Maturation,0.0158015801580158,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Journal - ACS Appl Mater Interfaces (4),0.02921,0.0008000800080008,0.0289,0.001000100010001,Average Maturation,0.0008000800080008,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Cell Line - Rare (132),0.02678,0.0,0.02183,0.0001000100010001,Average Maturation,0.0,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.02555,0.0035003500350035,0.02669,0.0026002600260026,Average Maturation,0.0026002600260026,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Gene Analysis Method - Rare (5),0.02535,0.003000300030003,0.01999,0.008000800080008,Average Maturation,0.003000300030003,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.02356,0.0039003900390039,0.02138,0.0055005500550055,Average Maturation,0.0039003900390039,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Seeding Confluency 3D (%) - 70 to 79 (3),0.02234,0.0033003300330033,0.02346,0.0053005300530053,Average Maturation,0.0033003300330033,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),2D Surface - Decellularized ECM (3),0.02164,0.0101010101010101,0.02156,0.0132013201320132,Average Maturation,0.0101010101010101,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01502,0.0145014501450145,0.01256,0.031003100310031,Average Maturation,0.0145014501450145,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),3D Stromal Cell Source - Dermal Fibroblast (7),0.01483,0.0256025602560256,0.02302,0.0032003200320032,Average Maturation,0.0032003200320032,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),hiPSC-CM Media Supplement - Mercaptoethanol (10),0.01403,0.0257025702570257,0.01692,0.0151015101510151,Average Maturation,0.0151015101510151,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.01311,0.0314031403140314,0.00836,0.0776077607760776,Average Maturation,0.0314031403140314,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Cell Line Ancestry - Caucasian (41),0.013,0.0353035303530353,0.0092,0.0852085208520852,Average Maturation,0.0353035303530353,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),hiPSC Backbone Media - mTeSR (106),0.01268,0.0288028802880288,0.00911,0.0978097809780978,Average Maturation,0.0288028802880288,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.01219,0.0494049404940494,0.0116,0.0573057305730573,Average Maturation,0.0494049404940494,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),0.01189,0.0451045104510451,0.00691,0.0975097509750975,Average Maturation,0.0451045104510451,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Contractile Stress (mN/mm2) Quantiles - Q4 (>0.07 and ≤0.51) (10),0.01172,0.0689068906890689,0.01275,0.042004200420042,Average Maturation,0.042004200420042,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),hiPSC-CM Purification Duration (days) - 8 days (4),0.01133,0.0435043504350435,0.00978,0.0495049504950495,Average Maturation,0.0435043504350435,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Seeding Confluency (%) - 85 to 89 (43),0.01078,0.0944094409440944,0.01659,0.0211021102110211,Average Maturation,0.0211021102110211,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),0.01069,0.0632063206320632,0.01303,0.0385038503850385,Average Maturation,0.0385038503850385,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Journal - Stem Cell Res (8),0.01055,0.0611061106110611,0.01327,0.0463046304630463,Average Maturation,0.0463046304630463,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),3D Platform - Gelatin (6),0.01013,0.0523052305230523,0.01248,0.0384038403840384,Average Maturation,0.0384038403840384,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Insulin Withdrawal Duration (days) - 8 days (3),0.00998,0.0345034503450345,0.01151,0.0329032903290329,Average Maturation,0.0329032903290329,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Journal - Stem Cell Res Ther (3),0.00956,0.0374037403740374,0.01579,0.0206020602060206,Average Maturation,0.0206020602060206,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.00947,0.0665066506650665,0.01608,0.0157015701570157,Average Maturation,0.0157015701570157,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),3D Tissue Media - DMEM (53),0.00792,0.1372137213721372,0.01267,0.0406040604060406,Average Maturation,0.0406040604060406,True,False
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.00779,0.1336133613361336,0.01216,0.0223022302230223,Average Maturation,0.0223022302230223,True,True
Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q3 (>1.5 and ≤8.53) (5),Deduced Culture Strategy - 2D Only (183),0.00278,0.828982898289829,0.00912,0.037003700370037,Average Maturation,0.037003700370037,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Purification Protocol - Cell Sorting (7),0.03359,0.0002000200020002,0.03852,0.0001000100010001,Average Maturation,0.0001000100010001,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),2D Surface - Microelectrode Array (9),0.03109,0.0005000500050005,0.02096,0.003000300030003,Average Maturation,0.0005000500050005,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),hiPSC-CM Media Supplement - B27 (180),0.01586,0.0078007800780078,0.01113,0.0126012601260126,Average Maturation,0.0078007800780078,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01541,0.0102010201020102,0.01316,0.0149014901490149,Average Maturation,0.0102010201020102,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),hiPSC-CM Media Supplement - Albumin (28),0.01527,0.013001300130013,0.00916,0.0425042504250425,Average Maturation,0.013001300130013,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Pharmacological Intervention - QT-Prolonging Drugs (36),0.01398,0.022002200220022,0.01252,0.0217021702170217,Average Maturation,0.0217021702170217,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Insulin Start Day - 2 (4),0.01387,0.009000900090009,0.01241,0.02000200020002,Average Maturation,0.009000900090009,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),2D Surface - Micropatterned (27),0.01337,0.0122012201220122,0.01094,0.0273027302730273,Average Maturation,0.0122012201220122,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Journal - Stem Cells Int (3),0.01319,0.0132013201320132,0.02062,0.0021002100210021,Average Maturation,0.0021002100210021,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Metabolic Component - Insulin-Transferrin-Selenium (3),0.01305,0.0278027802780278,0.00652,0.065006500650065,Average Maturation,0.0278027802780278,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Publication Year - 2014 (3),0.013,0.0263026302630263,0.01383,0.0259025902590259,Average Maturation,0.0259025902590259,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),hiPSC-CM Media Supplement - GlutaMax (8),0.01257,0.0168016801680168,0.00811,0.0601060106010601,Average Maturation,0.0168016801680168,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),3D Stromal Cell Source - hiPSC-SmoothMC (3),0.0125,0.0313031303130313,0.01201,0.0415041504150415,Average Maturation,0.0313031303130313,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.01247,0.0163016301630163,0.01256,0.0177017701770177,Average Maturation,0.0163016301630163,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Maturation Strategy - Mechanical (36),0.01218,0.0329032903290329,0.00939,0.06000600060006,Average Maturation,0.0329032903290329,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.01127,0.0291029102910291,0.01369,0.0124012401240124,Average Maturation,0.0124012401240124,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Contractile Analysis Method - Deflection (39),0.01051,0.0421042104210421,0.0086,0.0683068306830683,Average Maturation,0.0421042104210421,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Insulin Start Day - After 11 (7),0.0102,0.0414041404140414,0.00692,0.0986098609860986,Average Maturation,0.0414041404140414,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Metabolic Component Category - Fatty Acids and Lipids (21),0.01012,0.0378037803780378,0.00888,0.0562056205620562,Average Maturation,0.0378037803780378,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),hiPSC-CM Maturation Media - Cor.4U Complete (6),0.01004,0.0346034603460346,0.00882,0.052005200520052,Average Maturation,0.0346034603460346,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00989,0.0369036903690369,0.00984,0.0465046504650465,Average Maturation,0.0369036903690369,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Publication Year - 2018 (45),0.00941,0.0661066106610661,0.01243,0.0202020202020202,Average Maturation,0.0202020202020202,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.00908,0.0461046104610461,0.00887,0.0527052705270527,Average Maturation,0.0461046104610461,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),3D Tissue Media - Rare (13),0.00879,0.0545054505450545,0.00947,0.0384038403840384,Average Maturation,0.0384038403840384,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Disease Modelling - Specialised (3),0.00857,0.0414041404140414,0.0061,0.0622062206220622,Average Maturation,0.0414041404140414,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Metabolic Component - Dexamethasone (7),0.00844,0.0464046404640464,0.0119,0.0206020602060206,Average Maturation,0.0206020602060206,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Number of Cell Lines - 4 (11),0.00773,0.0604060406040604,0.01241,0.0175017501750175,Average Maturation,0.0175017501750175,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Calcium Handling Analysis Method - Genetical (3),0.00767,0.0553055305530553,0.00999,0.0471047104710471,Average Maturation,0.0471047104710471,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Journal - Circulation (11),0.0076,0.0479047904790479,0.00832,0.0486048604860486,Average Maturation,0.0479047904790479,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Journal - Biomaterials (16),0.007,0.0963096309630963,0.01337,0.0174017401740174,Average Maturation,0.0174017401740174,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Wnt Inhibitor Duration (days) - 6 days (4),0.00624,0.0775077507750775,0.01093,0.0311031103110311,Average Maturation,0.0311031103110311,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),Sacromere or Cellular Alignment Analysis - Yes (72),0.00551,0.2344234423442344,0.01038,0.0279027902790279,Average Maturation,0.0279027902790279,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),New Media for Maturation - F12 (7),0.00339,0.1418141814181418,0.00992,0.0318031803180318,Average Maturation,0.0318031803180318,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Differentiation Purity Assessment - IHC a-actinin (8),0.02424,0.006000600060006,0.01566,0.0193019301930193,Average Maturation,0.006000600060006,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Disease Modelling - Arrhythmic (15),0.02242,0.0041004100410041,0.02241,0.0035003500350035,Average Maturation,0.0035003500350035,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Insulin Start Day - 9 (10),0.01947,0.006000600060006,0.01985,0.0038003800380038,Average Maturation,0.0038003800380038,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01938,0.0138013801380138,0.01842,0.0088008800880088,Average Maturation,0.0088008800880088,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Journal - Biosens Bioelectron (4),0.0186,0.0155015501550155,0.02171,0.0082008200820082,Average Maturation,0.0082008200820082,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Day of Insulin Addition - not 9 (3),0.01824,0.0065006500650065,0.01277,0.0248024802480248,Average Maturation,0.0065006500650065,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Coating for Replating - Gelatin (43),0.01766,0.0152015201520152,0.01172,0.0376037603760376,Average Maturation,0.0152015201520152,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Electrophysiology Analysis Method - Optical Mapping (39),0.01763,0.0099009900990099,0.01691,0.0096009600960096,Average Maturation,0.0096009600960096,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Journal - Nano Lett (3),0.01641,0.0152015201520152,0.02229,0.0045004500450045,Average Maturation,0.0045004500450045,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01617,0.0108010801080108,0.01793,0.0094009400940094,Average Maturation,0.0094009400940094,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.01561,0.0243024302430243,0.01054,0.0582058205820582,Average Maturation,0.0243024302430243,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Cell Line - BJ1 (7),0.01511,0.0107010701070107,0.01578,0.0109010901090109,Average Maturation,0.0107010701070107,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Wnt Inhibitor - Rare (3),0.01464,0.0247024702470247,0.01284,0.0374037403740374,Average Maturation,0.0247024702470247,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Pharmacological Intervention - Carbenoxolone (4),0.01405,0.0208020802080208,0.01328,0.0264026402640264,Average Maturation,0.0208020802080208,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Journal - J Mol Cell Cardiol (4),0.01368,0.018001800180018,0.01544,0.0144014401440144,Average Maturation,0.0144014401440144,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),2D Surface - Microelectrode Array (9),0.01336,0.0259025902590259,0.00968,0.0578057805780578,Average Maturation,0.0259025902590259,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Publication Year - 2020 (51),0.0129,0.0339033903390339,0.02049,0.0017001700170017,Average Maturation,0.0017001700170017,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Maturation Strategy - ECM (21),0.01283,0.0303030303030303,0.00668,0.1122112211221122,Average Maturation,0.0303030303030303,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),T-tubule Structures - Yes (18),0.01243,0.0336033603360336,0.01065,0.0532053205320532,Average Maturation,0.0336033603360336,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Publication Year - Late-2010s (196),0.01177,0.0217021702170217,0.00602,0.2924292429242924,Average Maturation,0.0217021702170217,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Seeding Confluency 3D (%) - 80 to 84 (5),0.01166,0.0268026802680268,0.01104,0.0345034503450345,Average Maturation,0.0268026802680268,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Cell Line - iCell2 (8),0.01131,0.0424042404240424,0.00815,0.0787078707870787,Average Maturation,0.0424042404240424,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Coating for Replating - Laminin (5),0.01119,0.0369036903690369,0.01295,0.0309030903090309,Average Maturation,0.0309030903090309,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.01066,0.0436043604360436,0.00926,0.0655065506550655,Average Maturation,0.0436043604360436,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Calcium Handling Analysis Method - Visual (104),0.0106,0.0512051205120512,0.01122,0.0237023702370237,Average Maturation,0.0237023702370237,True,True
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),3D Stromal Cell Source - hiPSC-SmoothMC (3),0.01045,0.0482048204820482,0.01403,0.0387038703870387,Average Maturation,0.0387038703870387,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Pharmacological Intervention - QT-Prolonging Drugs (36),0.00832,0.1074107410741074,0.01266,0.0302030203020302,Average Maturation,0.0302030203020302,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),Metabolic Component - IGF-1 (3),0.00674,0.0525052505250525,0.01247,0.0292029202920292,Average Maturation,0.0292029202920292,True,False
Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),3D Platform - Matrigel (33),0.00571,0.1765176517651765,0.01027,0.044004400440044,Average Maturation,0.044004400440044,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.0542,0.0,0.03851,0.0,Average Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.04219,0.0,0.01975,0.0002000200020002,Average Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Journal - Cell Stem Cell (6),0.0195,0.0046004600460046,0.02099,0.003000300030003,Average Maturation,0.003000300030003,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.01838,0.0044004400440044,0.01401,0.0123012301230123,Average Maturation,0.0044004400440044,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Pharmacological Intervention - E4031 (22),0.01542,0.0083008300830083,0.01182,0.0137013701370137,Average Maturation,0.0083008300830083,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Pharmacological Intervention - QT-Prolonging Drugs (36),0.0151,0.0119011901190119,0.00896,0.0507050705070507,Average Maturation,0.0119011901190119,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Cell Line - C25 (6),0.01462,0.0094009400940094,0.0188,0.0035003500350035,Average Maturation,0.0035003500350035,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.01229,0.0161016101610161,0.01272,0.015001500150015,Average Maturation,0.015001500150015,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Wnt Induction Duration (days) - 3 days (38),0.01209,0.0274027402740274,0.00772,0.091009100910091,Average Maturation,0.0274027402740274,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),0.01201,0.0211021102110211,0.00875,0.0396039603960396,Average Maturation,0.0211021102110211,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.01162,0.0209020902090209,0.01048,0.0247024702470247,Average Maturation,0.0209020902090209,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.01148,0.0165016501650165,0.00886,0.0296029602960296,Average Maturation,0.0165016501650165,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),hiPSC-CM Media Supplement - Lipids (9),0.01082,0.022002200220022,0.00628,0.0805080508050805,Average Maturation,0.022002200220022,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Number of Cell Lines - 3 (29),0.01078,0.0282028202820282,0.00993,0.032003200320032,Average Maturation,0.0282028202820282,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Cell Line Sex - Both (118),0.01044,0.0485048504850485,0.01114,0.013001300130013,Average Maturation,0.013001300130013,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),hiPSC Backbone Media - DMEM (10),0.00933,0.0312031203120312,0.00909,0.0336033603360336,Average Maturation,0.0312031203120312,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),T-tubule Structures - Yes (18),0.00932,0.0436043604360436,0.01016,0.0316031603160316,Average Maturation,0.0316031603160316,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),hiPSC-CM Media Supplement - Lipid Mix (5),0.00919,0.041004100410041,0.00879,0.0511051105110511,Average Maturation,0.041004100410041,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Insulin Start Day - 4 (11),0.00918,0.0305030503050305,0.00676,0.0635063506350635,Average Maturation,0.0305030503050305,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.00885,0.0315031503150315,0.00998,0.0238023802380238,Average Maturation,0.0238023802380238,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.00869,0.0503050305030503,0.00873,0.0471047104710471,Average Maturation,0.0471047104710471,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Calcium Handling Analysis Method - Rare (4),0.00868,0.0386038603860386,0.01123,0.0205020502050205,Average Maturation,0.0205020502050205,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.0085,0.0434043404340434,0.0045,0.1565156515651565,Average Maturation,0.0434043404340434,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Journal - Stem Cells (11),0.00798,0.0389038903890389,0.0113,0.0161016101610161,Average Maturation,0.0161016101610161,True,True
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Wnt Inhibitor - KY02111 (7),0.00774,0.054005400540054,0.00915,0.0345034503450345,Average Maturation,0.0345034503450345,True,False
Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),Publication Year - 2018 (45),0.0075,0.0929092909290929,0.01062,0.0277027702770277,Average Maturation,0.0277027702770277,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Electrophysiology Analysis Method - Patch Clamp (59),0.03335,0.0,0.0131,0.0093009300930093,Average Maturation,0.0,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Journal - Int J Mol Sci (3),0.0195,0.0016001600160016,0.0192,0.0028002800280028,Average Maturation,0.0016001600160016,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Insulin Start Day - 2 (4),0.01787,0.0029002900290029,0.02177,0.0019001900190019,Average Maturation,0.0019001900190019,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.01678,0.0024002400240024,0.01437,0.0048004800480048,Average Maturation,0.0024002400240024,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.01653,0.0023002300230023,0.01582,0.0045004500450045,Average Maturation,0.0023002300230023,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),hiPSC Matrix Coating - Matrigel (163),0.01589,0.0069006900690069,0.0075,0.1187118711871187,Average Maturation,0.0069006900690069,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Purification Protocol - Cell Sorting (7),0.01572,0.0058005800580058,0.01691,0.004000400040004,Average Maturation,0.004000400040004,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Number of Cell Lines - 4 (11),0.01412,0.0109010901090109,0.00851,0.0405040504050405,Average Maturation,0.0109010901090109,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Electrophysiology Analysis Method - Microelectrode (31),0.01406,0.0114011401140114,0.01375,0.0072007200720072,Average Maturation,0.0072007200720072,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Wnt Induction - Rare (4),0.01221,0.0085008500850085,0.01428,0.0073007300730073,Average Maturation,0.0073007300730073,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Cell Line - iCell (47),0.01135,0.02000200020002,0.00997,0.0308030803080308,Average Maturation,0.02000200020002,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),2D Surface - Microelectrode Array (9),0.01133,0.0228022802280228,0.01152,0.0188018801880188,Average Maturation,0.0188018801880188,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),hiPSC-CM Media Supplement - Lipids (9),0.01116,0.0175017501750175,0.00942,0.0257025702570257,Average Maturation,0.0175017501750175,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Number of Cell Lines - 1 (225),0.0107,0.0378037803780378,0.00482,0.4114411441144114,Average Maturation,0.0378037803780378,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Seeding Confluency (%) - 70 to 79 (11),0.01068,0.0164016401640164,0.00997,0.0199019901990199,Average Maturation,0.0164016401640164,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.0098,0.0254025402540254,0.01044,0.0196019601960196,Average Maturation,0.0196019601960196,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),New Media for Maturation - Commercial Kit (5),0.00971,0.0221022102210221,0.00891,0.0339033903390339,Average Maturation,0.0221022102210221,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),hiPSC-CM Maturation Media - F12 (10),0.00934,0.03000300030003,0.0057,0.102010201020102,Average Maturation,0.03000300030003,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.0092,0.0311031103110311,0.00653,0.0723072307230723,Average Maturation,0.0311031103110311,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),2D Surface - Electrospun (13),0.00918,0.0454045404540454,0.00937,0.0411041104110411,Average Maturation,0.0411041104110411,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.00887,0.0321032103210321,0.01006,0.0291029102910291,Average Maturation,0.0291029102910291,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Journal - Rare (104),0.00861,0.1098109810981098,0.00994,0.0274027402740274,Average Maturation,0.0274027402740274,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Cell Line - iCell2 (8),0.00857,0.0432043204320432,0.00745,0.0621062106210621,Average Maturation,0.0432043204320432,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.00795,0.0368036803680368,0.0112,0.0169016901690169,Average Maturation,0.0169016901690169,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Purification Protocol - Metabolic (8),0.00793,0.0484048404840484,0.00856,0.0405040504050405,Average Maturation,0.0405040504050405,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),0.00779,0.0409040904090409,0.00805,0.0372037203720372,Average Maturation,0.0372037203720372,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.00753,0.0463046304630463,0.0062,0.09000900090009,Average Maturation,0.0463046304630463,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Pharmacological Intervention - E4031 (22),0.00739,0.0688068806880688,0.00864,0.0405040504050405,Average Maturation,0.0405040504050405,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Wnt Inhibitor - IWP (112),0.00671,0.2482248224822482,0.01052,0.0159015901590159,Average Maturation,0.0159015901590159,True,True
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.00617,0.1147114711471147,0.01073,0.026002600260026,Average Maturation,0.026002600260026,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Metabolic Component - Dexamethasone (7),0.0058,0.0954095409540954,0.00843,0.0355035503550355,Average Maturation,0.0355035503550355,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.00554,0.1014101410141014,0.00817,0.0411041104110411,Average Maturation,0.0411041104110411,True,False
Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),Disease Modelling - Arrhythmic (15),0.00491,0.1343134313431343,0.013,0.0116011601160116,Average Maturation,0.0116011601160116,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Electrophysiology Analysis Method - Patch Clamp (59),0.05412,0.0,0.03308,0.0,Average Maturation,0.0,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),hiPSC-CM Maturation Media - RPMI-1640 (153),0.02317,0.0001000100010001,0.00695,0.2222222222222222,Average Maturation,0.0001000100010001,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.02096,0.0022002200220022,0.02157,0.0016001600160016,Average Maturation,0.0016001600160016,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Contraction Upstroke Velocity (um/s) Quantiles - Q1 (>50 and ≤1300) (8),0.01523,0.0098009800980098,0.01449,0.0114011401140114,Average Maturation,0.0098009800980098,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Journal - Tissue Eng Part C Methods (6),0.01488,0.0107010701070107,0.01668,0.008000800080008,Average Maturation,0.008000800080008,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Pharmacological Intervention - Lidocaine (7),0.0141,0.0103010301030103,0.0072,0.0663066306630663,Average Maturation,0.0103010301030103,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Seeding Confluency (%) - Rare (43),0.0138,0.0189018901890189,0.02033,0.0012001200120012,Average Maturation,0.0012001200120012,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),hiPSC Matrix Coating - EBs (18),0.01245,0.0254025402540254,0.01124,0.0254025402540254,Average Maturation,0.0254025402540254,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Calcium Handling Analysis Method - Genetical (23),0.01232,0.0177017701770177,0.0117,0.0202020202020202,Average Maturation,0.0177017701770177,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),hiPSC Matrix Coating - Geltrex (33),0.01199,0.033003300330033,0.01131,0.035003500350035,Average Maturation,0.033003300330033,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Pharmacological Intervention - Other Antiarrhythmic Agents (13),0.01193,0.0267026702670267,0.0123,0.017001700170017,Average Maturation,0.017001700170017,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),hiPSC Backbone Media - RPMI-1640 (167),0.01096,0.036003600360036,0.00393,0.696969696969697,Average Maturation,0.036003600360036,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00985,0.0397039703970397,0.007,0.0797079707970797,Average Maturation,0.0397039703970397,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.00983,0.0396039603960396,0.0091,0.0495049504950495,Average Maturation,0.0396039603960396,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Wnt Induction - Activin A (80),0.00972,0.0494049404940494,0.00339,0.5782578257825782,Average Maturation,0.0494049404940494,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.00965,0.036003600360036,0.01781,0.0037003700370037,Average Maturation,0.0037003700370037,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Publication Year - 2015 (19),0.00952,0.0432043204320432,0.00807,0.0578057805780578,Average Maturation,0.0432043204320432,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.00875,0.0478047804780478,0.00778,0.0714071407140714,Average Maturation,0.0478047804780478,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),hiPSC-CM Media Supplement - Rare (5),0.00834,0.047004700470047,0.00925,0.0458045804580458,Average Maturation,0.0458045804580458,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Coating for Replating - Synthemax (3),0.00832,0.0455045504550455,0.01122,0.0298029802980298,Average Maturation,0.0298029802980298,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),2D Surface - Nanotopography (6),0.0077,0.0498049804980498,0.00941,0.0292029202920292,Average Maturation,0.0292029202920292,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Seeding Confluency 2D (%) - 95 to 100 (6),0.00703,0.0716071607160716,0.00869,0.0496049604960496,Average Maturation,0.0496049604960496,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00692,0.0567056705670567,0.00956,0.0272027202720272,Average Maturation,0.0272027202720272,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Insulin Start Day - 4 (11),0.0062,0.093009300930093,0.01109,0.02000200020002,Average Maturation,0.02000200020002,True,True
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00594,0.0891089108910891,0.00832,0.0475047504750475,Average Maturation,0.0475047504750475,True,False
Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),Pharmacological Intervention - QT-Prolonging Drugs (36),0.00532,0.1936193619361936,0.00978,0.0367036703670367,Average Maturation,0.0367036703670367,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Journal - Int J Mol Sci (3),0.03405,0.0009000900090009,0.03816,0.0006000600060006,Average Maturation,0.0006000600060006,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Electrophysiology Analysis Method - Patch Clamp (59),0.03287,0.0002000200020002,0.01423,0.0079007900790079,Average Maturation,0.0002000200020002,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.02373,0.0011001100110011,0.03012,0.0001000100010001,Average Maturation,0.0001000100010001,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Seeding Confluency (%) - 70 to 79 (11),0.02256,0.0026002600260026,0.01731,0.0063006300630063,Average Maturation,0.0026002600260026,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Journal - Am J Physiol Heart Circ Physiol (4),0.0216,0.0025002500250025,0.02182,0.0034003400340034,Average Maturation,0.0025002500250025,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),hiPSC Matrix Coating - EBs (18),0.01689,0.0105010501050105,0.01384,0.0147014701470147,Average Maturation,0.0105010501050105,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Cell Line - C25 (6),0.01617,0.0078007800780078,0.0209,0.0038003800380038,Average Maturation,0.0038003800380038,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Calcium Flux Amplitude (F/F0) Quantiles - Q2 (>1.6 and ≤2.3) (10),0.01615,0.0074007400740074,0.00901,0.0389038903890389,Average Maturation,0.0074007400740074,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Coating for Replating - Laminin (5),0.01472,0.009000900090009,0.01939,0.0029002900290029,Average Maturation,0.0029002900290029,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Wnt Inhibitor Duration (days) - 5 days (6),0.01371,0.013001300130013,0.00952,0.0489048904890489,Average Maturation,0.013001300130013,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Seeding Confluency 2D (%) - 70 to 79 (6),0.01312,0.0142014201420142,0.02034,0.0039003900390039,Average Maturation,0.0039003900390039,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01311,0.0144014401440144,0.01204,0.0181018101810181,Average Maturation,0.0144014401440144,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.01296,0.016001600160016,0.01128,0.0233023302330233,Average Maturation,0.016001600160016,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.01248,0.016001600160016,0.01792,0.0044004400440044,Average Maturation,0.0044004400440044,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Insulin Start Day - 3 (5),0.01206,0.0313031303130313,0.01259,0.0299029902990299,Average Maturation,0.0299029902990299,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Insulin Start Day - After 11 (7),0.0111,0.0215021502150215,0.00864,0.0533053305330533,Average Maturation,0.0215021502150215,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Cell Line - BJ RiPS (4),0.01035,0.0458045804580458,0.01132,0.0408040804080408,Average Maturation,0.0408040804080408,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.01002,0.0393039303930393,0.00983,0.0431043104310431,Average Maturation,0.0393039303930393,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),MYL2 Precentage (MYL7) Quantiles - Q1 (>30.1 and ≤45.7) (4),0.00997,0.0352035203520352,0.00765,0.0628062806280628,Average Maturation,0.0352035203520352,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00964,0.04000400040004,0.00486,0.1622162216221622,Average Maturation,0.04000400040004,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Seeding Confluency 2D (%) - 90 to 94 (12),0.00956,0.0432043204320432,0.00314,0.2231223122312231,Average Maturation,0.0432043204320432,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),hiPSC-CM Maturation Media - iCell Maintenance (83),0.00947,0.048004800480048,0.00542,0.2697269726972697,Average Maturation,0.048004800480048,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.00943,0.029002900290029,0.01048,0.023002300230023,Average Maturation,0.023002300230023,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Journal - PLoS One (9),0.00929,0.0342034203420342,0.00644,0.0923092309230923,Average Maturation,0.0342034203420342,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Cell Line - iCell (47),0.00878,0.0877087708770877,0.0112,0.0362036203620362,Average Maturation,0.0362036203620362,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),3D Platform - Matrigel (33),0.00622,0.1191119111911191,0.01047,0.0322032203220322,Average Maturation,0.0322032203220322,True,False
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Pharmacological Intervention - Carbamylcholine (6),0.00493,0.1179117911791179,0.01334,0.0131013101310131,Average Maturation,0.0131013101310131,True,True
Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),Journal - Circ Res (5),0.00374,0.1124112411241124,0.0126,0.0178017801780178,Average Maturation,0.0178017801780178,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Number of Cell Lines - 4 (11),0.0319,0.0005000500050005,0.03128,0.0005000500050005,Average Maturation,0.0005000500050005,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Electrophysiology Analysis Method - Patch Clamp (59),0.0286,0.0003000300030003,0.00865,0.0845084508450845,Average Maturation,0.0003000300030003,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Journal - Cell Stem Cell (6),0.02688,0.0017001700170017,0.02356,0.0036003600360036,Average Maturation,0.0017001700170017,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.02223,0.0055005500550055,0.01298,0.0244024402440244,Average Maturation,0.0055005500550055,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),hiPSC-CM Media Supplement - 1-thioglycerol (14),0.017,0.0115011501150115,0.01094,0.0357035703570357,Average Maturation,0.0115011501150115,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Pharmacological Intervention - Caffeine (4),0.01557,0.0048004800480048,0.02067,0.0024002400240024,Average Maturation,0.0024002400240024,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Calcium Handling Analysis Method - Seahorse (35),0.01479,0.0103010301030103,0.01163,0.0242024202420242,Average Maturation,0.0103010301030103,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Wnt Induction - BMP4 (74),0.01448,0.0178017801780178,0.00992,0.0551055105510551,Average Maturation,0.0178017801780178,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Wnt Inhibitor - Wnt-C59 (30),0.01405,0.0162016201620162,0.01286,0.0167016701670167,Average Maturation,0.0162016201620162,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.01365,0.0134013401340134,0.01169,0.0147014701470147,Average Maturation,0.0134013401340134,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Journal - Nat Commun (13),0.01331,0.0167016701670167,0.01491,0.0073007300730073,Average Maturation,0.0073007300730073,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),T-tubule Structures - Yes (18),0.01317,0.0156015601560156,0.01126,0.0245024502450245,Average Maturation,0.0156015601560156,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.01314,0.012001200120012,0.01241,0.0151015101510151,Average Maturation,0.012001200120012,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Maturation Strategy - Metabolic (33),0.01184,0.0305030503050305,0.00806,0.0803080308030803,Average Maturation,0.0305030503050305,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Max Capture Rate of Paced CMs (Hz) Quantiles - Q1 (>2.9 and ≤6.9) (7),0.01081,0.0214021402140214,0.00839,0.0521052105210521,Average Maturation,0.0214021402140214,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Metabolic Component - Palmitic Acid (11),0.01045,0.0304030403040304,0.0095,0.0409040904090409,Average Maturation,0.0304030403040304,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),3D Platform - Scaffold Free (43),0.01024,0.0484048404840484,0.01104,0.0304030403040304,Average Maturation,0.0304030403040304,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.0101,0.0381038103810381,0.0095,0.0389038903890389,Average Maturation,0.0381038103810381,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Disease Modelling - Genetic Disorders (18),0.01001,0.0396039603960396,0.00818,0.0605060506050605,Average Maturation,0.0396039603960396,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Seeding Confluency 3D (%) - 95 to 100 (13),0.00997,0.0254025402540254,0.01006,0.0258025802580258,Average Maturation,0.0254025402540254,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),3D Tissue Media - Growth Factor (12),0.00981,0.0294029402940294,0.00796,0.0531053105310531,Average Maturation,0.0294029402940294,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),3D Stromal Cell Source - Rare (4),0.00971,0.0346034603460346,0.00798,0.0565056505650565,Average Maturation,0.0346034603460346,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00964,0.0529052905290529,0.01275,0.0256025602560256,Average Maturation,0.0256025602560256,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.00963,0.0297029702970297,0.01345,0.0119011901190119,Average Maturation,0.0119011901190119,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.00933,0.0433043304330433,0.01085,0.0295029502950295,Average Maturation,0.0295029502950295,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Metabolic Component Category - Kinase Inhibitors (3),0.00892,0.0444044404440444,0.00844,0.0528052805280528,Average Maturation,0.0444044404440444,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Metabolic Component - Dexamethasone (7),0.00885,0.041004100410041,0.00786,0.0626062606260626,Average Maturation,0.041004100410041,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),hiPSC-CM Maturation Media - Rare (9),0.00867,0.0549054905490549,0.01014,0.033003300330033,Average Maturation,0.033003300330033,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Purification Protocol - Cell Sorting (7),0.0084,0.0621062106210621,0.01422,0.0143014301430143,Average Maturation,0.0143014301430143,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),0.00822,0.0611061106110611,0.01027,0.0348034803480348,Average Maturation,0.0348034803480348,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),hiPSC-CM Media Supplement - VEGF (4),0.00747,0.078007800780078,0.01127,0.0386038603860386,Average Maturation,0.0386038603860386,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),Wnt Inhibitor - bFGF (8),0.00737,0.0707070707070707,0.01127,0.0239023902390239,Average Maturation,0.0239023902390239,True,True
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),hiPSC Backbone Media - StemPro-34 (14),0.00731,0.0637063706370637,0.00987,0.0354035403540354,Average Maturation,0.0354035403540354,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),hiPSC-CM Maturation Media - F12 (10),0.00473,0.1707170717071707,0.00949,0.0452045204520452,Average Maturation,0.0452045204520452,True,False
Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),3D Tissue Media - Rare (13),0.00372,0.1928192819281928,0.00942,0.0402040204020402,Average Maturation,0.0402040204020402,True,False
Cell Line Sex - Both (118),Cell Line Ancestry - Caucasian (41),0.06009,0.0,0.05626,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line - Rare (132),0.0419,0.0,0.03516,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line - WTC11 (30),0.03085,0.0,0.0339,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line Ancestry - Asian (28),0.03054,0.0,0.03044,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line - IMR90 (19),0.02944,0.0,0.02879,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line - DF19-9-11T.H (16),0.01973,0.0,0.01771,0.0,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01384,0.0007000700070007,0.0152,0.0006000600060006,Other Applications,0.0006000600060006,True,True
Cell Line Sex - Both (118),hiPSC Matrix Coating - Matrigel (163),0.01312,0.0012001200120012,0.01632,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Cell Line Sex - Both (118),hiPSC Backbone Media - Embryonic Stem Cell (127),0.01264,0.0017001700170017,0.01135,0.004000400040004,Other Applications,0.0017001700170017,True,True
Cell Line Sex - Both (118),Cell Line - 201B7 (9),0.01256,0.0,0.01074,0.0009000900090009,Other Applications,0.0,True,True
Cell Line Sex - Both (118),Cell Line - PGP1 (11),0.01069,0.0004000400040004,0.00907,0.0018001800180018,Other Applications,0.0004000400040004,True,True
Cell Line Sex - Both (118),Wnt Inhibitor - IWP (112),0.01048,0.0038003800380038,0.01042,0.0055005500550055,Other Applications,0.0038003800380038,True,True
Cell Line Sex - Both (118),Wnt Induction - CHIR99021 (184),0.0098,0.0076007600760076,0.00976,0.0109010901090109,Other Applications,0.0076007600760076,True,True
Cell Line Sex - Both (118),Day of Insulin Addition - Known (177),0.00917,0.0116011601160116,0.0086,0.0175017501750175,Other Applications,0.0116011601160116,True,True
Cell Line Sex - Both (118),Wnt Inhibitor Duration (days) - Rare (173),0.00865,0.0202020202020202,0.00878,0.021002100210021,Other Applications,0.0202020202020202,True,True
Cell Line Sex - Both (118),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.00798,0.0267026702670267,0.00454,0.6356635663566357,Other Applications,0.0267026702670267,True,False
Cell Line Sex - Both (118),hiPSC Backbone Media - mTeSR (106),0.00634,0.1043104310431043,0.00861,0.0206020602060206,Other Applications,0.0206020602060206,True,True
Cell Line Sex - Both (118),Cell Line - iCell (47),0.00618,0.0365036503650365,0.00329,0.5715571557155715,Other Applications,0.0365036503650365,True,False
Cell Line Sex - Both (118),Publication Year - 2021 (43),0.00612,0.0335033503350335,0.00481,0.1073107310731073,Other Applications,0.0335033503350335,True,False
Cell Line Sex - Both (118),Wnt Induction - Activin A (80),0.00583,0.1142114211421142,0.00689,0.0453045304530453,Other Applications,0.0453045304530453,True,False
Cell Line Sex - Both (118),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.0058,0.0433043304330433,0.00505,0.0834083408340834,Other Applications,0.0433043304330433,True,False
Cell Line Sex - Both (118),Cell Line - C25 (6),0.00569,0.0039003900390039,0.00521,0.0095009500950095,Other Applications,0.0039003900390039,True,True
Cell Line Sex - Both (118),3D Tissue Media - RPMI-1640 (72),0.0049,0.2731273127312731,0.00731,0.0324032403240324,Other Applications,0.0324032403240324,True,False
Cell Line Sex - Both (118),Seeding Confluency 2D (%) - Rare (13),0.00415,0.0338033803380338,0.00329,0.0899089908990899,Other Applications,0.0338033803380338,True,False
Cell Line Sex - Both (118),Contractile Force (mN) Quantiles - Q2 (>0.43 and ≤1.04) (10),0.00392,0.0294029402940294,0.00612,0.0085008500850085,Other Applications,0.0085008500850085,True,True
Cell Line Sex - Both (118),hiPSC-CM Media Supplement - Mercaptoethanol (10),0.00381,0.0364036403640364,0.00585,0.0139013901390139,Other Applications,0.0139013901390139,True,True
Cell Line Sex - Both (118),Cell Line - BJ1 (7),0.00376,0.0195019501950195,0.00376,0.0317031703170317,Other Applications,0.0195019501950195,True,True
Cell Line Sex - Both (118),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.00333,0.0555055505550555,0.00417,0.04000400040004,Other Applications,0.04000400040004,True,False
Cell Line Sex - Both (118),Seeding Confluency 3D (%) - 85 to 89 (12),0.00329,0.0787078707870787,0.00425,0.0423042304230423,Other Applications,0.0423042304230423,True,False
Cell Line Sex - Both (118),3D Stromal Cell Source - hiPSC-MuralC (3),0.00258,0.0284028402840284,0.00175,0.08000800080008,Other Applications,0.0284028402840284,True,False
Cell Line Sex - Both (118),Beat Rate (bpm) Quantiles - Q2 (<38.8 and ≥27.6) (10),0.00237,0.1185118511851185,0.00443,0.0243024302430243,Other Applications,0.0243024302430243,True,True
Cell Line Sex - Both (118),hiPSC-CM Media Supplement - Selenium (7),0.00234,0.0834083408340834,0.00408,0.0288028802880288,Other Applications,0.0288028802880288,True,False
Cell Line Sex - Both (118),Cell Line - 201B6 (3),0.002,0.0418041804180418,0.00158,0.0872087208720872,Other Applications,0.0418041804180418,True,False
Cell Line Sex - Both (118),Pharmacological Intervention - Thalidomide (3),0.0019,0.0357035703570357,0.00234,0.0295029502950295,Other Applications,0.0295029502950295,True,False
Cell Line Sex - Male (64),Cell Line - WTC11 (30),0.05052,0.0,0.06276,0.0,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Cell Line Ancestry - Asian (28),0.04977,0.0,0.06229,0.0,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Cell Line - DF19-9-11T.H (16),0.0255,0.0,0.0296,0.0,Other Applications,0.0,True,True
Cell Line Sex - Male (64),3D Tissue Media - RPMI-1640 (72),0.02199,0.0,0.01886,0.0001000100010001,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Wnt Inhibitor - IWP (112),0.02198,0.0,0.01615,0.0,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Cell Line - Rare (132),0.02055,0.0,0.01393,0.0003000300030003,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Wnt Induction - CHIR99021 (184),0.01933,0.0001000100010001,0.01216,0.0009000900090009,Other Applications,0.0001000100010001,True,True
Cell Line Sex - Male (64),Cell Line - PGP1 (11),0.0187,0.0,0.02691,0.0,Other Applications,0.0,True,True
Cell Line Sex - Male (64),Day of Insulin Addition - Known (177),0.01819,0.0001000100010001,0.01359,0.0001000100010001,Other Applications,0.0001000100010001,True,True
Cell Line Sex - Male (64),hiPSC Matrix Coating - Matrigel (163),0.01808,0.0006000600060006,0.01531,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Cell Line Sex - Male (64),hiPSC Backbone Media - mTeSR (106),0.01651,0.0003000300030003,0.01008,0.0046004600460046,Other Applications,0.0003000300030003,True,True
Cell Line Sex - Male (64),hiPSC Backbone Media - Embryonic Stem Cell (127),0.01304,0.0027002700270027,0.00992,0.0045004500450045,Other Applications,0.0027002700270027,True,True
Cell Line Sex - Male (64),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.01276,0.0021002100210021,0.01066,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Cell Line Sex - Male (64),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01214,0.0048004800480048,0.00872,0.0121012101210121,Other Applications,0.0048004800480048,True,True
Cell Line Sex - Male (64),Purification Protocol - Glucose and Lactate (85),0.01196,0.0036003600360036,0.00941,0.0066006600660066,Other Applications,0.0036003600360036,True,True
Cell Line Sex - Male (64),hiPSC-CM Media Supplement - B27 (180),0.01183,0.0037003700370037,0.00841,0.0124012401240124,Other Applications,0.0037003700370037,True,True
Cell Line Sex - Male (64),Wnt Inhibitor Duration (days) - Rare (173),0.0106,0.0107010701070107,0.00828,0.0191019101910191,Other Applications,0.0107010701070107,True,True
Cell Line Sex - Male (64),Cell Line Ancestry - Caucasian (41),0.01018,0.0035003500350035,0.00776,0.0126012601260126,Other Applications,0.0035003500350035,True,True
Cell Line Sex - Male (64),Insulin Start Day - 9 (10),0.00743,0.0099009900990099,0.0102,0.0059005900590059,Other Applications,0.0059005900590059,True,True
Cell Line Sex - Male (64),Cell Line - BJ1 (7),0.0071,0.0065006500650065,0.00901,0.0052005200520052,Other Applications,0.0052005200520052,True,True
Cell Line Sex - Male (64),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.0069,0.0431043104310431,0.00752,0.0164016401640164,Other Applications,0.0164016401640164,True,True
Cell Line Sex - Male (64),Insulin Withdrawal Duration (days) - 4 days (18),0.00662,0.0173017301730173,0.00725,0.0162016201620162,Other Applications,0.0162016201620162,True,True
Cell Line Sex - Male (64),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.00635,0.0278027802780278,0.00511,0.0668066806680668,Other Applications,0.0278027802780278,True,False
Cell Line Sex - Male (64),hiPSC-CM Purification Duration (days) - 4 days (29),0.00634,0.0279027902790279,0.00829,0.0114011401140114,Other Applications,0.0114011401140114,True,True
Cell Line Sex - Male (64),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00629,0.2285228522852285,0.00736,0.0488048804880488,Other Applications,0.0488048804880488,True,False
Cell Line Sex - Male (64),Cell Line - IMR90 (19),0.0058,0.0254025402540254,0.00326,0.1612161216121612,Other Applications,0.0254025402540254,True,False
Cell Line Sex - Male (64),3D CM Ratio (CM-EC-SC) Quantiles - Q2 (>75 and ≤91) (28),0.00578,0.0493049304930493,0.00643,0.036003600360036,Other Applications,0.036003600360036,True,False
Cell Line Sex - Male (64),Publication Year - 2022 (20),0.00528,0.0361036103610361,0.00761,0.0125012501250125,Other Applications,0.0125012501250125,True,True
Cell Line Sex - Male (64),Calcium Handling Analysis Method - Genetical (23),0.00526,0.0483048304830483,0.00594,0.0332033203320332,Other Applications,0.0332033203320332,True,False
Cell Line Sex - Male (64),Seeding Confluency 3D (%) - 85 to 89 (12),0.0043,0.0522052205220522,0.00562,0.0399039903990399,Other Applications,0.0399039903990399,True,False
Cell Line Sex - Male (64),Day of Insulin Addition - not 13 (13),0.00326,0.1039103910391039,0.00551,0.0372037203720372,Other Applications,0.0372037203720372,True,False
Cell Line Sex - Male (64),Pharmacological Intervention - Thalidomide (3),0.0032,0.0365036503650365,0.00383,0.0443044304430443,Other Applications,0.0365036503650365,True,False
Cell Line Sex - Female (40),Cell Line - IMR90 (19),0.06793,0.0,0.0771,0.0,Other Applications,0.0,True,True
Cell Line Sex - Female (40),Cell Line Ancestry - Caucasian (41),0.04411,0.0,0.0405,0.0,Other Applications,0.0,True,True
Cell Line Sex - Female (40),Cell Line - 201B7 (9),0.04061,0.0,0.05931,0.0,Other Applications,0.0,True,True
Cell Line Sex - Female (40),Cell Line - Rare (132),0.01751,0.0008000800080008,0.01061,0.0012001200120012,Other Applications,0.0008000800080008,True,True
Cell Line Sex - Female (40),Wnt Induction - BMP4 (74),0.01595,0.0008000800080008,0.01238,0.0011001100110011,Other Applications,0.0008000800080008,True,True
Cell Line Sex - Female (40),Wnt Induction Duration (days) Quantiles - Q1 (>2 and ≤5) (61),0.01387,0.0033003300330033,0.0092,0.013001300130013,Other Applications,0.0033003300330033,True,True
Cell Line Sex - Female (40),Wnt Induction - Activin A (80),0.01233,0.0059005900590059,0.00919,0.0102010201020102,Other Applications,0.0059005900590059,True,True
Cell Line Sex - Female (40),Seeding Confluency (%) - Rare (43),0.01198,0.0026002600260026,0.01259,0.0014001400140014,Other Applications,0.0014001400140014,True,True
Cell Line Sex - Female (40),Seeding Confluency 2D (%) - Rare (13),0.01021,0.0047004700470047,0.01068,0.0053005300530053,Other Applications,0.0047004700470047,True,True
Cell Line Sex - Female (40),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.00841,0.0437043704370437,0.00669,0.0992099209920992,Other Applications,0.0437043704370437,True,False
Cell Line Sex - Female (40),3D Stromal Cell Source - hiPSC-MuralC (3),0.00784,0.012001200120012,0.00834,0.0268026802680268,Other Applications,0.012001200120012,True,True
Cell Line Sex - Female (40),Wnt Induction - Wnt3a (3),0.00776,0.0059005900590059,0.00892,0.0097009700970097,Other Applications,0.0059005900590059,True,True
Cell Line Sex - Female (40),Insulin Start Day - 5 (14),0.0075,0.0195019501950195,0.00931,0.0111011101110111,Other Applications,0.0111011101110111,True,True
Cell Line Sex - Female (40),hiPSC-CM Media Supplement - Lipids (9),0.0075,0.0134013401340134,0.00783,0.0164016401640164,Other Applications,0.0134013401340134,True,True
Cell Line Sex - Female (40),Journal - Stem Cell Res (8),0.00736,0.0129012901290129,0.00959,0.0084008400840084,Other Applications,0.0084008400840084,True,True
Cell Line Sex - Female (40),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00732,0.0267026702670267,0.00725,0.0219021902190219,Other Applications,0.0219021902190219,True,True
Cell Line Sex - Female (40),hiPSC-CM Media Supplement - L-glutamine (19),0.00706,0.0173017301730173,0.00286,0.225022502250225,Other Applications,0.0173017301730173,True,True
Cell Line Sex - Female (40),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00704,0.0156015601560156,0.00647,0.0279027902790279,Other Applications,0.0156015601560156,True,True
Cell Line Sex - Female (40),Wnt Inhibitor - XAV939 (24),0.00696,0.0218021802180218,0.00625,0.0323032303230323,Other Applications,0.0218021802180218,True,True
Cell Line Sex - Female (40),Cell Line - 201B6 (3),0.00671,0.0142014201420142,0.00889,0.0117011701170117,Other Applications,0.0117011701170117,True,True
Cell Line Sex - Female (40),Pharmacological Intervention - Carbamylcholine (6),0.00625,0.0191019101910191,0.0065,0.0253025302530253,Other Applications,0.0191019101910191,True,True
Cell Line Sex - Female (40),Cell Line - SCVI-273 (8),0.0061,0.0233023302330233,0.0082,0.0127012701270127,Other Applications,0.0127012701270127,True,True
Cell Line Sex - Female (40),hiPSC-CM Media Supplement - GlutaMax (8),0.00568,0.0296029602960296,0.00541,0.0435043504350435,Other Applications,0.0296029602960296,True,False
Cell Line Sex - Female (40),Journal - J Mol Cell Card (6),0.0056,0.0236023602360236,0.00551,0.0378037803780378,Other Applications,0.0236023602360236,True,True
Cell Line Sex - Female (40),hiPSC Backbone Media - DMEM (10),0.00558,0.0341034103410341,0.00635,0.0305030503050305,Other Applications,0.0305030503050305,True,False
Cell Line Sex - Female (40),Wnt Induction Duration (days) - 4 days (15),0.0054,0.0424042404240424,0.00583,0.0392039203920392,Other Applications,0.0392039203920392,True,False
Cell Line Sex - Female (40),Journal - Rare (104),0.0049,0.585058505850585,0.00775,0.0289028902890289,Other Applications,0.0289028902890289,True,False
Cell Line Sex - Female (40),hiPSC-CM Media Supplement - Selenium (7),0.00393,0.0648064806480648,0.00516,0.0494049404940494,Other Applications,0.0494049404940494,True,False
Cell Line Sex - Female (40),Metabolic Component - Ascorbic Acid (3),0.00388,0.0395039503950395,0.0053,0.0354035403540354,Other Applications,0.0354035403540354,True,False
Cell Line Sex - Female (40),Metabolic Component - KOSR (3),0.00328,0.0535053505350535,0.00425,0.0498049804980498,Other Applications,0.0498049804980498,True,False
Cell Line Sex - Female (40),hiPSC Backbone Media - Conditioned (12),0.0032,0.1239123912391239,0.00612,0.0263026302630263,Other Applications,0.0263026302630263,True,False
Cell Line Sex - Female (40),Journal - Stem Cells Int (3),0.00261,0.0807080708070807,0.00484,0.0397039703970397,Other Applications,0.0397039703970397,True,False
Cell Line Ancestry - Caucasian (41),Cell Line Sex - Both (118),0.08264,0.0,0.04827,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Caucasian (41),Cell Line - PGP1 (11),0.04411,0.0,0.04806,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Caucasian (41),Cell Line Sex - Female (40),0.04073,0.0,0.04628,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Caucasian (41),Cell Line - 201B7 (9),0.03185,0.0,0.04411,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Caucasian (41),Seeding Confluency (%) - Rare (43),0.01555,0.0015001500150015,0.01762,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Cell Line Ancestry - Caucasian (41),Wnt Induction - Activin A (80),0.01079,0.0146014601460146,0.00853,0.0152015201520152,Other Applications,0.0146014601460146,True,True
Cell Line Ancestry - Caucasian (41),Wnt Induction Duration (days) Quantiles - Q1 (>2 and ≤5) (61),0.00939,0.0153015301530153,0.00574,0.0865086508650865,Other Applications,0.0153015301530153,True,True
Cell Line Ancestry - Caucasian (41),Cell Line Sex - Male (64),0.00928,0.0148014801480148,0.00642,0.054005400540054,Other Applications,0.0148014801480148,True,True
Cell Line Ancestry - Caucasian (41),3D Estimated Tissue Size (mm2) Quantiles - Q1 (>26.2 and ≤3500) (27),0.00919,0.0086008600860086,0.01175,0.0025002500250025,Other Applications,0.0025002500250025,True,True
Cell Line Ancestry - Caucasian (41),Cell Line - C25 (6),0.00865,0.0043004300430043,0.01681,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Cell Line Ancestry - Caucasian (41),Publication Year - 2018 (45),0.00853,0.019001900190019,0.00824,0.0148014801480148,Other Applications,0.0148014801480148,True,True
Cell Line Ancestry - Caucasian (41),hiPSC Backbone Media - Essential 8 (82),0.00851,0.03000300030003,0.00637,0.0686068606860686,Other Applications,0.03000300030003,True,False
Cell Line Ancestry - Caucasian (41),Wnt Induction - bFGF (45),0.00738,0.0356035603560356,0.00827,0.0146014601460146,Other Applications,0.0146014601460146,True,True
Cell Line Ancestry - Caucasian (41),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.0071,0.0126012601260126,0.00767,0.0178017801780178,Other Applications,0.0126012601260126,True,True
Cell Line Ancestry - Caucasian (41),Wnt Induction - Wnt3a (3),0.00705,0.014001400140014,0.01032,0.0066006600660066,Other Applications,0.0066006600660066,True,True
Cell Line Ancestry - Caucasian (41),Wnt Induction - CHIR99021 (184),0.00691,0.1867186718671867,0.00983,0.003000300030003,Other Applications,0.003000300030003,True,True
Cell Line Ancestry - Caucasian (41),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.00658,0.0758075807580758,0.00672,0.0448044804480448,Other Applications,0.0448044804480448,True,False
Cell Line Ancestry - Caucasian (41),Seeding Confluency 2D (%) - Rare (13),0.00651,0.0147014701470147,0.00591,0.0244024402440244,Other Applications,0.0147014701470147,True,True
Cell Line Ancestry - Caucasian (41),Cell Line - WTC11 (30),0.00633,0.0357035703570357,0.00421,0.1338133813381338,Other Applications,0.0357035703570357,True,False
Cell Line Ancestry - Caucasian (41),hiPSC Backbone Media - Rare (19),0.00627,0.0293029302930293,0.00662,0.0248024802480248,Other Applications,0.0248024802480248,True,True
Cell Line Ancestry - Caucasian (41),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.00581,0.024002400240024,0.0049,0.0505050505050505,Other Applications,0.024002400240024,True,True
Cell Line Ancestry - Caucasian (41),Seeding Confluency 3D (%) - Rare (26),0.00581,0.04000400040004,0.00726,0.0201020102010201,Other Applications,0.0201020102010201,True,True
Cell Line Ancestry - Caucasian (41),hiPSC-CM Media Supplement - L-glutamine (19),0.00554,0.0412041204120412,0.00454,0.0816081608160816,Other Applications,0.0412041204120412,True,False
Cell Line Ancestry - Caucasian (41),hiPSC-CM Media Supplement - Lipids (9),0.00532,0.0339033903390339,0.00672,0.0251025102510251,Other Applications,0.0251025102510251,True,False
Cell Line Ancestry - Caucasian (41),Cell Line - IMR90 (19),0.00528,0.044004400440044,0.00503,0.059005900590059,Other Applications,0.044004400440044,True,False
Cell Line Ancestry - Caucasian (41),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.00528,0.0256025602560256,0.00913,0.0057005700570057,Other Applications,0.0057005700570057,True,True
Cell Line Ancestry - Caucasian (41),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.00527,0.0407040704070407,0.00341,0.1324132413241324,Other Applications,0.0407040704070407,True,False
Cell Line Ancestry - Caucasian (41),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00484,0.0244024402440244,0.00295,0.1138113811381138,Other Applications,0.0244024402440244,True,True
Cell Line Ancestry - Caucasian (41),3D Stromal Cell Source - hiPSC-MuralC (3),0.00471,0.0338033803380338,0.00391,0.0562056205620562,Other Applications,0.0338033803380338,True,False
Cell Line Ancestry - Caucasian (41),Cell Line - 201B6 (3),0.00448,0.0384038403840384,0.00596,0.0386038603860386,Other Applications,0.0384038403840384,True,False
Cell Line Ancestry - Caucasian (41),3D Endothelial Cell Source - hiPSC-EndothelialC (16),0.00438,0.0806080608060806,0.00755,0.0194019401940194,Other Applications,0.0194019401940194,True,True
Cell Line Ancestry - Asian (28),Cell Line - WTC11 (30),0.1493,0.0,0.16266,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Asian (28),Cell Line Sex - Male (64),0.06461,0.0,0.04623,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Asian (28),Cell Line Sex - Both (118),0.05001,0.0,0.02338,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Asian (28),3D Tissue Media - RPMI-1640 (72),0.02546,0.0,0.01666,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Asian (28),Calcium Handling Analysis Method - Genetical (23),0.02493,0.0,0.02498,0.0,Other Applications,0.0,True,True
Cell Line Ancestry - Asian (28),Cell Line - Rare (132),0.0227,0.0002000200020002,0.00802,0.0252025202520252,Other Applications,0.0002000200020002,True,True
Cell Line Ancestry - Asian (28),hiPSC Matrix Coating - Matrigel (163),0.01474,0.002000200020002,0.00539,0.3847384738473847,Other Applications,0.002000200020002,True,True
Cell Line Ancestry - Asian (28),Publication Year - 2022 (20),0.01389,0.0017001700170017,0.01469,0.0012001200120012,Other Applications,0.0012001200120012,True,True
Cell Line Ancestry - Asian (28),Day of Insulin Addition - not 20 (15),0.01325,0.0027002700270027,0.01576,0.0006000600060006,Other Applications,0.0006000600060006,True,True
Cell Line Ancestry - Asian (28),3D Estimated Cell Density (mil cells/mL) Quantiles - Q4 (>0.47 and ≤5) (25),0.01225,0.0029002900290029,0.01224,0.0014001400140014,Other Applications,0.0014001400140014,True,True
Cell Line Ancestry - Asian (28),Day of Insulin Addition - not 21 (14),0.01021,0.0075007500750075,0.01305,0.0023002300230023,Other Applications,0.0023002300230023,True,True
Cell Line Ancestry - Asian (28),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.0101,0.0103010301030103,0.00962,0.0087008700870087,Other Applications,0.0087008700870087,True,True
Cell Line Ancestry - Asian (28),Day of Insulin Addition - Known (177),0.00982,0.0405040504050405,0.00362,0.903090309030903,Other Applications,0.0405040504050405,True,False
Cell Line Ancestry - Asian (28),hiPSC-CM Purification Duration (days) - 4 days (29),0.00975,0.0137013701370137,0.00652,0.0447044704470447,Other Applications,0.0137013701370137,True,True
Cell Line Ancestry - Asian (28),hiPSC Backbone Media - Essential 8 (82),0.00837,0.0447044704470447,0.00874,0.0147014701470147,Other Applications,0.0147014701470147,True,True
Cell Line Ancestry - Asian (28),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.0081,0.0458045804580458,0.00701,0.0576057605760576,Other Applications,0.0458045804580458,True,False
Cell Line Ancestry - Asian (28),Day of Insulin Addition - not 22 (12),0.0081,0.0152015201520152,0.01211,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Cell Line Ancestry - Asian (28),Journal - Tissue Eng Part A (4),0.00755,0.0198019801980198,0.00998,0.013001300130013,Other Applications,0.013001300130013,True,True
Cell Line Ancestry - Asian (28),Pharmacological Intervention - Cardiotoxic Agents (3),0.00578,0.0221022102210221,0.00632,0.0273027302730273,Other Applications,0.0221022102210221,True,True
Cell Line Ancestry - Asian (28),Journal - Nat Biomed Eng (5),0.00506,0.0526052605260526,0.00851,0.0192019201920192,Other Applications,0.0192019201920192,True,True
Cell Line Ancestry - Asian (28),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00447,0.8173817381738174,0.00838,0.0158015801580158,Other Applications,0.0158015801580158,True,True
Cell Line Ancestry - Asian (28),Day of Insulin Addition - not 24 (9),0.00414,0.0794079407940794,0.00746,0.0192019201920192,Other Applications,0.0192019201920192,True,True
Cell Line Ancestry - Asian (28),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00376,0.0964096409640964,0.00551,0.048004800480048,Other Applications,0.048004800480048,True,False
Cell Line Ancestry - Asian (28),Day of Insulin Addition - not 23 (10),0.00352,0.1106110611061106,0.00545,0.0478047804780478,Other Applications,0.0478047804780478,True,False
Cell Line Ancestry - Asian (28),Contractile Analysis Method - Motion Tracking (93),0.00334,0.9193919391939194,0.00799,0.0282028202820282,Other Applications,0.0282028202820282,True,False
Cell Line Ancestry - Asian (28),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.00314,0.1322132213221322,0.00822,0.0145014501450145,Other Applications,0.0145014501450145,True,True
Disease Modelling - Genetic Disorders (18),Coating for Replating - Laminin (5),0.01928,0.0005000500050005,0.02367,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Disease Modelling - Genetic Disorders (18),2D Surface - ECM-coated (115),0.016,0.0037003700370037,0.01184,0.0015001500150015,Other Applications,0.0015001500150015,True,True
Disease Modelling - Genetic Disorders (18),Day of Insulin Addition - Known (177),0.01412,0.0064006400640064,0.01098,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Disease Modelling - Genetic Disorders (18),hiPSC Matrix Coating - Geltrex (33),0.01407,0.0066006600660066,0.00757,0.0489048904890489,Other Applications,0.0066006600660066,True,True
Disease Modelling - Genetic Disorders (18),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01396,0.0035003500350035,0.01377,0.0061006100610061,Other Applications,0.0035003500350035,True,True
Disease Modelling - Genetic Disorders (18),Purification Protocol - Cell Sorting (7),0.01348,0.0032003200320032,0.01218,0.0074007400740074,Other Applications,0.0032003200320032,True,True
Disease Modelling - Genetic Disorders (18),Cell Line - Rare (132),0.01296,0.0111011101110111,0.0064,0.1592159215921592,Other Applications,0.0111011101110111,True,True
Disease Modelling - Genetic Disorders (18),Electrophysiology Analysis Method - Patch Clamp (59),0.01158,0.0175017501750175,0.00987,0.017001700170017,Other Applications,0.017001700170017,True,True
Disease Modelling - Genetic Disorders (18),Immunofluorescent Imaging - Yes (268),0.01019,0.0256025602560256,0.00809,0.0367036703670367,Other Applications,0.0256025602560256,True,False
Disease Modelling - Genetic Disorders (18),Electrophysiology Analysis Method - Genetical (3),0.01006,0.0062006200620062,0.01598,0.003000300030003,Other Applications,0.003000300030003,True,True
Disease Modelling - Genetic Disorders (18),Number of Cell Lines - 1 (225),0.00989,0.0336033603360336,0.00651,0.176017601760176,Other Applications,0.0336033603360336,True,False
Disease Modelling - Genetic Disorders (18),Maturation Strategy - Tension (64),0.00979,0.027002700270027,0.00611,0.1386138613861386,Other Applications,0.027002700270027,True,False
Disease Modelling - Genetic Disorders (18),Journal - Am J Physiol Heart Circ Physiol (4),0.00937,0.0116011601160116,0.00764,0.0229022902290229,Other Applications,0.0116011601160116,True,True
Disease Modelling - Genetic Disorders (18),Cell Line - iCell (47),0.00917,0.0338033803380338,0.00818,0.0365036503650365,Other Applications,0.0338033803380338,True,False
Disease Modelling - Genetic Disorders (18),Contractile Force (mN) Quantiles - Q4 (>0.04 and ≤0.16) (10),0.00917,0.0156015601560156,0.00564,0.0683068306830683,Other Applications,0.0156015601560156,True,True
Disease Modelling - Genetic Disorders (18),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.00887,0.0199019901990199,0.0097,0.0179017901790179,Other Applications,0.0179017901790179,True,True
Disease Modelling - Genetic Disorders (18),Publication Year - 2017 (43),0.00859,0.0385038503850385,0.00643,0.0895089508950895,Other Applications,0.0385038503850385,True,False
Disease Modelling - Genetic Disorders (18),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.00832,0.0272027202720272,0.00732,0.0401040104010401,Other Applications,0.0272027202720272,True,False
Disease Modelling - Genetic Disorders (18),3D Platform - Matrigel (33),0.00817,0.0459045904590459,0.00506,0.1623162316231623,Other Applications,0.0459045904590459,True,False
Disease Modelling - Genetic Disorders (18),hiPSC-CM Purification Duration (days) - 4 days (29),0.00804,0.0432043204320432,0.00608,0.0858085808580858,Other Applications,0.0432043204320432,True,False
Disease Modelling - Genetic Disorders (18),Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),0.00789,0.0352035203520352,0.00655,0.0583058305830583,Other Applications,0.0352035203520352,True,False
Disease Modelling - Genetic Disorders (18),Coating for Replating - Gelatin (43),0.00788,0.0536053605360536,0.00922,0.0222022202220222,Other Applications,0.0222022202220222,True,True
Disease Modelling - Genetic Disorders (18),Contractile Force (mN) Quantiles - Q1 (>1.04 and ≤20) (10),0.00717,0.0352035203520352,0.00634,0.0509050905090509,Other Applications,0.0352035203520352,True,False
Disease Modelling - Genetic Disorders (18),Maturation Strategy - Electrical (39),0.00679,0.0599059905990599,0.00944,0.0149014901490149,Other Applications,0.0149014901490149,True,True
Disease Modelling - Genetic Disorders (18),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.00667,0.0299029902990299,0.007,0.0347034703470347,Other Applications,0.0299029902990299,True,False
Disease Modelling - Genetic Disorders (18),hiPSC Backbone Media - Rare (10),0.00665,0.0497049704970497,0.00639,0.0549054905490549,Other Applications,0.0497049704970497,True,False
Disease Modelling - Genetic Disorders (18),Journal - Circulation (11),0.00624,0.0473047304730473,0.00558,0.0633063306330633,Other Applications,0.0473047304730473,True,False
Disease Modelling - Genetic Disorders (18),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.00577,0.0481048104810481,0.01053,0.0138013801380138,Other Applications,0.0138013801380138,True,True
Disease Modelling - Genetic Disorders (18),Journal - Biosens Bioelectron (4),0.00575,0.0433043304330433,0.00685,0.0362036203620362,Other Applications,0.0362036203620362,True,False
Disease Modelling - Genetic Disorders (18),Insulin Start Day - 2 (4),0.00569,0.0353035303530353,0.00615,0.0405040504050405,Other Applications,0.0353035303530353,True,False
Disease Modelling - Genetic Disorders (18),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00554,0.0398039803980398,0.00563,0.0578057805780578,Other Applications,0.0398039803980398,True,False
Disease Modelling - Genetic Disorders (18),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.00469,0.0744074407440744,0.00787,0.0214021402140214,Other Applications,0.0214021402140214,True,True
Disease Modelling - Genetic Disorders (18),Pharmacological Intervention - Caffeine (4),0.00395,0.1069106910691069,0.00644,0.0423042304230423,Other Applications,0.0423042304230423,True,False
Disease Modelling - Genetic Disorders (18),Coating for Replating - Geltrex (10),0.00394,0.1071107110711071,0.00654,0.0411041104110411,Other Applications,0.0411041104110411,True,False
Disease Modelling - Genetic Disorders (18),Journal - Stem Cell Res Ther (3),0.00386,0.1247124712471247,0.00815,0.0313031303130313,Other Applications,0.0313031303130313,True,False
Disease Modelling - Arrhythmic (15),Coating for Replating - Laminin (5),0.02045,0.0003000300030003,0.02087,0.0004000400040004,Other Applications,0.0003000300030003,True,True
Disease Modelling - Arrhythmic (15),Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),0.01595,0.0022002200220022,0.0175,0.0009000900090009,Other Applications,0.0009000900090009,True,True
Disease Modelling - Arrhythmic (15),Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),0.01562,0.0053005300530053,0.01202,0.0096009600960096,Other Applications,0.0053005300530053,True,True
Disease Modelling - Arrhythmic (15),Publication Year - 2019 (57),0.0141,0.0069006900690069,0.00992,0.0167016701670167,Other Applications,0.0069006900690069,True,True
Disease Modelling - Arrhythmic (15),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01305,0.0079007900790079,0.01478,0.0069006900690069,Other Applications,0.0069006900690069,True,True
Disease Modelling - Arrhythmic (15),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.01237,0.0117011701170117,0.01605,0.0033003300330033,Other Applications,0.0033003300330033,True,True
Disease Modelling - Arrhythmic (15),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01204,0.0146014601460146,0.00694,0.0977097709770977,Other Applications,0.0146014601460146,True,True
Disease Modelling - Arrhythmic (15),Calcium Handling Analysis Method - Visual (104),0.01174,0.0243024302430243,0.00871,0.0332033203320332,Other Applications,0.0243024302430243,True,True
Disease Modelling - Arrhythmic (15),Insulin Start Day - 7 (85),0.01159,0.0275027502750275,0.00069,0.9985998599859988,Other Applications,0.0275027502750275,True,False
Disease Modelling - Arrhythmic (15),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.01095,0.0099009900990099,0.00829,0.0297029702970297,Other Applications,0.0099009900990099,True,True
Disease Modelling - Arrhythmic (15),Electrophysiology Analysis Method - Patch Clamp (59),0.00984,0.0349034903490349,0.00667,0.1105110511051105,Other Applications,0.0349034903490349,True,False
Disease Modelling - Arrhythmic (15),hiPSC-CM Purification Duration (days) - 4 days (29),0.00982,0.0294029402940294,0.0079,0.0442044204420442,Other Applications,0.0294029402940294,True,False
Disease Modelling - Arrhythmic (15),Electrophysiology Analysis Method - Genetical (3),0.00978,0.0114011401140114,0.01793,0.0032003200320032,Other Applications,0.0032003200320032,True,True
Disease Modelling - Arrhythmic (15),Journal - Am J Physiol Heart Circ Physiol (4),0.00958,0.0126012601260126,0.00948,0.0166016601660166,Other Applications,0.0126012601260126,True,True
Disease Modelling - Arrhythmic (15),Insulin Start Day - 11 (3),0.00939,0.0172017201720172,0.01389,0.007000700070007,Other Applications,0.007000700070007,True,True
Disease Modelling - Arrhythmic (15),Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),0.00921,0.0248024802480248,0.01237,0.0072007200720072,Other Applications,0.0072007200720072,True,True
Disease Modelling - Arrhythmic (15),3D Platform - Extracellular Scaffold (18),0.00894,0.028002800280028,0.00537,0.0998099809980998,Other Applications,0.028002800280028,True,False
Disease Modelling - Arrhythmic (15),MYH7 Percentage (MYH6) Quantiles - Q1 (>82.35 and ≤94.6) (4),0.00892,0.0152015201520152,0.00862,0.0236023602360236,Other Applications,0.0152015201520152,True,True
Disease Modelling - Arrhythmic (15),Pharmacological Intervention - QT-Prolonging Drugs (36),0.00852,0.0459045904590459,0.00544,0.1467146714671467,Other Applications,0.0459045904590459,True,False
Disease Modelling - Arrhythmic (15),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.00839,0.0308030803080308,0.00744,0.0398039803980398,Other Applications,0.0308030803080308,True,False
Disease Modelling - Arrhythmic (15),Journal - Circulation (11),0.00809,0.0308030803080308,0.01145,0.0087008700870087,Other Applications,0.0087008700870087,True,True
Disease Modelling - Arrhythmic (15),Coating for Replating - Fibronectin (32),0.00792,0.0486048604860486,0.00541,0.136013601360136,Other Applications,0.0486048604860486,True,False
Disease Modelling - Arrhythmic (15),Number of Cell Lines - 2 (50),0.00775,0.0683068306830683,0.01117,0.0099009900990099,Other Applications,0.0099009900990099,True,True
Disease Modelling - Arrhythmic (15),2D Surface - ECM-coated (115),0.00765,0.1383138313831383,0.0093,0.0146014601460146,Other Applications,0.0146014601460146,True,True
Disease Modelling - Arrhythmic (15),Maturation Strategy - ECM (21),0.00754,0.0528052805280528,0.00845,0.0339033903390339,Other Applications,0.0339033903390339,True,False
Disease Modelling - Arrhythmic (15),Pharmacological Intervention - Lidocaine (7),0.00748,0.0338033803380338,0.00525,0.0777077707770777,Other Applications,0.0338033803380338,True,False
Disease Modelling - Arrhythmic (15),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.0073,0.0431043104310431,0.00529,0.0855085508550855,Other Applications,0.0431043104310431,True,False
Disease Modelling - Arrhythmic (15),TNNI3 Precentage (TTNI1) Quantiles - Q2 (>6.5 and ≤16.15) (4),0.00663,0.0386038603860386,0.00868,0.0225022502250225,Other Applications,0.0225022502250225,True,True
Disease Modelling - Arrhythmic (15),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.00647,0.0425042504250425,0.00652,0.0456045604560456,Other Applications,0.0425042504250425,True,False
Disease Modelling - Arrhythmic (15),hiPSC-CM Maturation Media - Cor.4U Complete (6),0.00641,0.043004300430043,0.00555,0.0731073107310731,Other Applications,0.043004300430043,True,False
Disease Modelling - Arrhythmic (15),Journal - Cell Stem Cell (6),0.00609,0.0447044704470447,0.00148,0.2406240624062406,Other Applications,0.0447044704470447,True,False
Disease Modelling - Arrhythmic (15),hiPSC Backbone Media - Cor.4U Complete (6),0.00606,0.0403040304030403,0.00752,0.0301030103010301,Other Applications,0.0301030103010301,True,False
Disease Modelling - Arrhythmic (15),Contractile Analysis Method - Rare (7),0.00605,0.0419041904190419,0.00685,0.0393039303930393,Other Applications,0.0393039303930393,True,False
Disease Modelling - Arrhythmic (15),Seeding Confluency (%) - 80 to 84 (12),0.00589,0.0605060506050605,0.00873,0.021002100210021,Other Applications,0.021002100210021,True,True
Disease Modelling - Arrhythmic (15),Journal - Sci Transl Med (3),0.0054,0.0872087208720872,0.00874,0.0401040104010401,Other Applications,0.0401040104010401,True,False
Disease Modelling - Arrhythmic (15),Journal - Biosens Bioelectron (4),0.00537,0.0636063606360636,0.00894,0.0189018901890189,Other Applications,0.0189018901890189,True,True
Disease Modelling - Arrhythmic (15),Wnt Induction - Rare (4),0.00527,0.0902090209020902,0.00749,0.0437043704370437,Other Applications,0.0437043704370437,True,False
Disease Modelling - Arrhythmic (15),Maturation Strategy - Electrical (39),0.00455,0.1892189218921892,0.00767,0.0484048404840484,Other Applications,0.0484048404840484,True,False
Disease Modelling - Arrhythmic (15),Insulin Start Day - 9 (10),0.00445,0.0973097309730973,0.0094,0.0182018201820182,Other Applications,0.0182018201820182,True,True
Disease Modelling - Arrhythmic (15),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q2 (>8.53 and ≤17) (4),0.00421,0.1063106310631063,0.00667,0.048004800480048,Other Applications,0.048004800480048,True,False
Disease Modelling - Arrhythmic (15),Contractile Analysis Method - Motion Tracking (93),0.00363,0.7642764276427643,0.00851,0.0359035903590359,Other Applications,0.0359035903590359,True,False
Disease Modelling - Ischemic Infarction (9),Seeding Confluency 3D (%) - 90 to 94 (13),0.0223,0.0032003200320032,0.01417,0.0116011601160116,Other Applications,0.0032003200320032,True,True
Disease Modelling - Ischemic Infarction (9),Metabolic Component Category - Sugars and Carbohydrates (9),0.02009,0.0037003700370037,0.01835,0.0044004400440044,Other Applications,0.0037003700370037,True,True
Disease Modelling - Ischemic Infarction (9),Publication Year - 2024 (7),0.01729,0.0066006600660066,0.0167,0.0075007500750075,Other Applications,0.0066006600660066,True,True
Disease Modelling - Ischemic Infarction (9),Metabolic Component - Albumax (3),0.01527,0.0105010501050105,0.01506,0.013001300130013,Other Applications,0.0105010501050105,True,True
Disease Modelling - Ischemic Infarction (9),Publication Year - Late-2010s (196),0.0143,0.0102010201020102,0.01022,0.0186018601860186,Other Applications,0.0102010201020102,True,True
Disease Modelling - Ischemic Infarction (9),Metabolic Component - B27 (3),0.01347,0.0235023502350235,0.01532,0.0186018601860186,Other Applications,0.0186018601860186,True,True
Disease Modelling - Ischemic Infarction (9),Metabolic Component Category - Fatty Acids and Lipids (21),0.01316,0.0135013501350135,0.0083,0.0599059905990599,Other Applications,0.0135013501350135,True,True
Disease Modelling - Ischemic Infarction (9),Maturation Strategy - Metabolic (33),0.01239,0.0234023402340234,0.00762,0.0789078907890789,Other Applications,0.0234023402340234,True,True
Disease Modelling - Ischemic Infarction (9),New Media for Maturation - DMEM (21),0.01213,0.0318031803180318,0.00808,0.07000700070007,Other Applications,0.0318031803180318,True,False
Disease Modelling - Ischemic Infarction (9),Differentiation Purity Assessment - Rare (3),0.01212,0.0219021902190219,0.01358,0.0201020102010201,Other Applications,0.0201020102010201,True,True
Disease Modelling - Ischemic Infarction (9),3D SC Ratio (CM-EC-SC) Quantiles - Q3 (>0 and ≤0) (74),0.01105,0.0366036603660366,0.01128,0.02000200020002,Other Applications,0.02000200020002,True,True
Disease Modelling - Ischemic Infarction (9),Journal - Tissue Eng Part A (4),0.01068,0.0386038603860386,0.01439,0.0145014501450145,Other Applications,0.0145014501450145,True,True
Disease Modelling - Ischemic Infarction (9),Insulin Start Day - 9 (10),0.01051,0.0264026402640264,0.00598,0.1052105210521052,Other Applications,0.0264026402640264,True,False
Disease Modelling - Ischemic Infarction (9),Pharmacological Intervention - Epinephrine (11),0.01029,0.0294029402940294,0.00832,0.0503050305030503,Other Applications,0.0294029402940294,True,False
Disease Modelling - Ischemic Infarction (9),Cell Coculture - Endothelial Cell (35),0.01009,0.046004600460046,0.00668,0.144014401440144,Other Applications,0.046004600460046,True,False
Disease Modelling - Ischemic Infarction (9),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00994,0.0349034903490349,0.00811,0.0564056405640564,Other Applications,0.0349034903490349,True,False
Disease Modelling - Ischemic Infarction (9),Metabolic Component - Biotin (3),0.0097,0.0361036103610361,0.01469,0.0128012801280128,Other Applications,0.0128012801280128,True,True
Disease Modelling - Ischemic Infarction (9),Journal - Rare (104),0.00967,0.0434043404340434,0.00659,0.1988198819881988,Other Applications,0.0434043404340434,True,False
Disease Modelling - Ischemic Infarction (9),Metabolic Component - KOSR (3),0.00965,0.0319031903190319,0.00708,0.0616061606160616,Other Applications,0.0319031903190319,True,False
Disease Modelling - Ischemic Infarction (9),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.00955,0.0316031603160316,0.00879,0.0403040304030403,Other Applications,0.0316031603160316,True,False
Disease Modelling - Ischemic Infarction (9),Seeding Confluency 3D (%) - 85 to 89 (12),0.0089,0.0386038603860386,0.00407,0.1791179117911791,Other Applications,0.0386038603860386,True,False
Disease Modelling - Ischemic Infarction (9),Metabolic Component - Fatty Acid (13),0.00887,0.0464046404640464,0.00512,0.1337133713371337,Other Applications,0.0464046404640464,True,False
Disease Modelling - Ischemic Infarction (9),Metabolic Component - Ascorbic Acid (3),0.0088,0.0492049204920492,0.01996,0.0033003300330033,Other Applications,0.0033003300330033,True,True
Disease Modelling - Ischemic Infarction (9),Publication Year - 2022 (20),0.00826,0.0692069206920692,0.00931,0.0497049704970497,Other Applications,0.0497049704970497,True,False
Disease Modelling - Ischemic Infarction (9),MYL2 Precentage (MYL7) Quantiles - Q2 (>1.2 and ≤30.1) (4),0.00789,0.0633063306330633,0.01066,0.0377037703770377,Other Applications,0.0377037703770377,True,False
Disease Modelling - Ischemic Infarction (9),hiPSC-CM Purification Duration (days) - 7 days (6),0.00789,0.0529052905290529,0.00948,0.0371037103710371,Other Applications,0.0371037103710371,True,False
Disease Modelling - Ischemic Infarction (9),New Media for Maturation - Commercial Kit (5),0.00748,0.0677067706770677,0.00978,0.043004300430043,Other Applications,0.043004300430043,True,False
Disease Modelling - Ischemic Infarction (9),Cell Coculture - Stromal Cell (78),0.00662,0.1536153615361536,0.00949,0.0362036203620362,Other Applications,0.0362036203620362,True,False
Disease Modelling - Ischemic Infarction (9),Insulin Start Day - 3 (5),0.00655,0.0792079207920792,0.00895,0.047004700470047,Other Applications,0.047004700470047,True,False
Disease Modelling - Ischemic Infarction (9),Metabolic Component - Galactose (4),0.00606,0.0788078807880788,0.00872,0.0488048804880488,Other Applications,0.0488048804880488,True,False
Disease Modelling - Ischemic Infarction (9),Gene Analysis Method - RNA (169),0.00548,0.4749474947494749,0.00854,0.0391039103910391,Other Applications,0.0391039103910391,True,False
Disease Modelling - Ischemic Infarction (9),Wnt Induction Duration (days) - 3 days (38),0.00423,0.2357235723572357,0.0092,0.0491049104910491,Other Applications,0.0491049104910491,True,False
Disease Modelling - Dilated Cardiomyopathy (6),2D Surface - Micropatterned (27),0.03571,0.0001000100010001,0.03356,0.0001000100010001,Other Applications,0.0001000100010001,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.02535,0.002000200020002,0.01862,0.0047004700470047,Other Applications,0.002000200020002,True,True
Disease Modelling - Dilated Cardiomyopathy (6),3D Tissue Media - Iscove (5),0.02115,0.0053005300530053,0.02061,0.0077007700770077,Other Applications,0.0053005300530053,True,True
Disease Modelling - Dilated Cardiomyopathy (6),3D Stromal Cell Source - Mesenchymal Stem Cell (12),0.0201,0.0094009400940094,0.01647,0.0132013201320132,Other Applications,0.0094009400940094,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Number of Cell Lines - 3 (29),0.01773,0.0107010701070107,0.01639,0.0073007300730073,Other Applications,0.0073007300730073,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Publication Year - 2015 (19),0.01678,0.0167016701670167,0.01672,0.0103010301030103,Other Applications,0.0103010301030103,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Insulin Start Day - 7 (85),0.01674,0.0202020202020202,0.00891,0.0789078907890789,Other Applications,0.0202020202020202,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.01652,0.017001700170017,0.01461,0.0199019901990199,Other Applications,0.017001700170017,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Wnt Inhibitor - BMP4 (7),0.01566,0.0126012601260126,0.01121,0.0429042904290429,Other Applications,0.0126012601260126,True,True
Disease Modelling - Dilated Cardiomyopathy (6),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01528,0.0243024302430243,0.00851,0.1073107310731073,Other Applications,0.0243024302430243,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01514,0.0112011201120112,0.00839,0.0761076107610761,Other Applications,0.0112011201120112,True,True
Disease Modelling - Dilated Cardiomyopathy (6),hiPSC Matrix Coating - MEF feeder cells (8),0.01454,0.0227022702270227,0.01062,0.0592059205920592,Other Applications,0.0227022702270227,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Journal - Cell Stem Cell (6),0.01379,0.0192019201920192,0.01774,0.0079007900790079,Other Applications,0.0079007900790079,True,True
Disease Modelling - Dilated Cardiomyopathy (6),3D Platform - Collagen (38),0.01312,0.0353035303530353,0.01206,0.0351035103510351,Other Applications,0.0351035103510351,True,False
Disease Modelling - Dilated Cardiomyopathy (6),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01291,0.0308030803080308,0.01397,0.0186018601860186,Other Applications,0.0186018601860186,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.01275,0.0407040704070407,0.01308,0.0318031803180318,Other Applications,0.0318031803180318,True,False
Disease Modelling - Dilated Cardiomyopathy (6),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01234,0.0314031403140314,0.01416,0.0236023602360236,Other Applications,0.0236023602360236,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Maturation Strategy - Mechanical (36),0.01227,0.0389038903890389,0.00965,0.0688068806880688,Other Applications,0.0389038903890389,True,False
Disease Modelling - Dilated Cardiomyopathy (6),hiPSC Backbone Media - DMEM (10),0.01192,0.0387038703870387,0.01492,0.0168016801680168,Other Applications,0.0168016801680168,True,True
Disease Modelling - Dilated Cardiomyopathy (6),hiPSC-CM Purification Duration (days) - <3 days (31),0.01184,0.0411041104110411,0.01437,0.0157015701570157,Other Applications,0.0157015701570157,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Contractile Analysis Method - Traction Force Microscopy (9),0.01136,0.0359035903590359,0.00909,0.0683068306830683,Other Applications,0.0359035903590359,True,False
Disease Modelling - Dilated Cardiomyopathy (6),Deduced Culture Strategy - 2D Only (183),0.01129,0.0439043904390439,0.00836,0.0765076507650765,Other Applications,0.0439043904390439,True,False
Disease Modelling - Dilated Cardiomyopathy (6),Cell Line - PGP1 (11),0.01085,0.037003700370037,0.01161,0.0311031103110311,Other Applications,0.0311031103110311,True,False
Disease Modelling - Dilated Cardiomyopathy (6),Wnt Induction - Activin A (80),0.01023,0.0806080608060806,0.01188,0.0336033603360336,Other Applications,0.0336033603360336,True,False
Disease Modelling - Dilated Cardiomyopathy (6),3D Stromal Cell Source - Stromal Cell (35),0.01006,0.057005700570057,0.01301,0.0237023702370237,Other Applications,0.0237023702370237,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Pharmacological Intervention - Positive Inotropes (9),0.00996,0.0459045904590459,0.01143,0.0364036403640364,Other Applications,0.0364036403640364,True,False
Disease Modelling - Dilated Cardiomyopathy (6),Calcium Flux Amplitude (F/F0) Quantiles - Q1 (>2.3 and ≤8) (10),0.00854,0.0619061906190619,0.01016,0.0472047204720472,Other Applications,0.0472047204720472,True,False
Disease Modelling - Dilated Cardiomyopathy (6),3D Estimated Cell Density (mil cells/mL) Quantiles - Q4 (>0.47 and ≤5) (25),0.00792,0.1106110611061106,0.01439,0.0242024202420242,Other Applications,0.0242024202420242,True,True
Disease Modelling - Dilated Cardiomyopathy (6),Cell Area (um2) Quantiles - Q3 (>350 and ≤1800) (13),0.007,0.0994099409940994,0.01031,0.047004700470047,Other Applications,0.047004700470047,True,False
Disease Modelling - Dilated Cardiomyopathy (6),hiPSC-CM Maturation Media - RPMI-1640 (153),0.007,0.2475247524752475,0.01051,0.0264026402640264,Other Applications,0.0264026402640264,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC-CM Purification Duration (days) - <3 days (31),0.03443,0.0008000800080008,0.0217,0.0033003300330033,Other Applications,0.0008000800080008,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Insulin Start Day - 7 (85),0.02702,0.0037003700370037,0.02054,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Line Ancestry - Caucasian (41),0.02142,0.0095009500950095,0.01222,0.0484048404840484,Other Applications,0.0095009500950095,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),T-tubule Structures - Yes (18),0.02122,0.0022002200220022,0.01598,0.0094009400940094,Other Applications,0.0022002200220022,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Maturation Strategy - Cell Alignment (59),0.0193,0.012001200120012,0.01218,0.0318031803180318,Other Applications,0.012001200120012,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Line - PGP1 (11),0.01926,0.0086008600860086,0.02555,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC Backbone Media - iCell Maintenance (86),0.01862,0.0055005500550055,0.01461,0.0088008800880088,Other Applications,0.0055005500550055,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Journal - ACS Appl Mater Interfaces (4),0.0186,0.0137013701370137,0.01749,0.0184018401840184,Other Applications,0.0137013701370137,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC-CM Purification Duration (days) Quantiles - Q2 (>1 and ≤4) (61),0.01784,0.0093009300930093,0.01344,0.0153015301530153,Other Applications,0.0093009300930093,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),0.01767,0.0152015201520152,0.01194,0.0347034703470347,Other Applications,0.0152015201520152,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01734,0.0097009700970097,0.01347,0.0131013101310131,Other Applications,0.0097009700970097,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Journal - Circulation (11),0.01557,0.0123012301230123,0.01646,0.01000100010001,Other Applications,0.01000100010001,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Pharmacological Intervention - Lidocaine (7),0.01525,0.0183018301830183,0.01323,0.0269026902690269,Other Applications,0.0183018301830183,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC Backbone Media - RPMI-1640 (167),0.01508,0.0005000500050005,0.01399,0.0008000800080008,Other Applications,0.0005000500050005,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01441,0.0183018301830183,0.01375,0.0198019801980198,Other Applications,0.0183018301830183,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01421,0.0217021702170217,0.01502,0.0176017601760176,Other Applications,0.0176017601760176,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Journal - Circ Res (5),0.01407,0.021002100210021,0.01832,0.0101010101010101,Other Applications,0.0101010101010101,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Journal - Nat Biomed Eng (5),0.01401,0.0182018201820182,0.01815,0.0111011101110111,Other Applications,0.0111011101110111,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Area (um2) Quantiles - Q1 (>2850 and ≤9000) (11),0.01398,0.0257025702570257,0.01294,0.0282028202820282,Other Applications,0.0257025702570257,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Coating for Replating - Matrigel (65),0.01383,0.0245024502450245,0.01768,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Wnt Inhibitor Duration (days) - Rare (173),0.01356,0.0167016701670167,0.0035,0.7083708370837084,Other Applications,0.0167016701670167,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01253,0.0207020702070207,0.01119,0.0181018101810181,Other Applications,0.0181018101810181,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Line Sex - Male (64),0.01222,0.0473047304730473,0.00775,0.1362136213621362,Other Applications,0.0473047304730473,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Line - iCell2 (8),0.01183,0.0358035803580358,0.01202,0.0381038103810381,Other Applications,0.0358035803580358,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Line - BJ1 (7),0.01169,0.044004400440044,0.01811,0.011001100110011,Other Applications,0.011001100110011,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC-CM Maturation Media - RPMI-1640 (153),0.01146,0.0283028302830283,0.01785,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.01101,0.0382038203820382,0.00883,0.0717071707170717,Other Applications,0.0382038203820382,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),2D Surface - Micropatterned (27),0.0109,0.0444044404440444,0.00424,0.2442244224422442,Other Applications,0.0444044404440444,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Contractile Analysis Method - Motion Tracking (93),0.01055,0.0414041404140414,0.01442,0.0054005400540054,Other Applications,0.0054005400540054,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01053,0.0494049404940494,0.01259,0.0302030203020302,Other Applications,0.0302030203020302,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Insulin Start Day - 8 (15),0.01037,0.0474047404740474,0.00891,0.0825082508250825,Other Applications,0.0474047404740474,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Wnt Inhibitor - Wnt-C59 (30),0.01017,0.0493049304930493,0.01087,0.0465046504650465,Other Applications,0.0465046504650465,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC Backbone Media - mTeSR (106),0.01007,0.0492049204920492,0.01339,0.0108010801080108,Other Applications,0.0108010801080108,True,True
Disease Modelling - Hypertrophic Cardiomyopathy (6),Contractile Analysis Method - Traction Force Microscopy (9),0.00846,0.0775077507750775,0.01245,0.0292029202920292,Other Applications,0.0292029202920292,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),3D Platform - 3D printed (9),0.00827,0.0704070407040704,0.01302,0.0262026202620262,Other Applications,0.0262026202620262,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Electron Imaging - Transmission (62),0.00735,0.153015301530153,0.01113,0.0474047404740474,Other Applications,0.0474047404740474,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.00713,0.0959095909590959,0.00975,0.0493049304930493,Other Applications,0.0493049304930493,True,False
Disease Modelling - Hypertrophic Cardiomyopathy (6),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00665,0.236023602360236,0.0114,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Disease Modelling - Fibrotic (4),3D Tissue Media - Commercial Kit (21),0.02893,0.001000100010001,0.0313,0.0012001200120012,Other Applications,0.001000100010001,True,True
Disease Modelling - Fibrotic (4),3D Stromal Cell Source - Cardiac Fibroblast (32),0.02754,0.0053005300530053,0.01342,0.0428042804280428,Other Applications,0.0053005300530053,True,True
Disease Modelling - Fibrotic (4),3D Stromal Cell Source - Human Fibroblast (38),0.02604,0.0076007600760076,0.01609,0.033003300330033,Other Applications,0.0076007600760076,True,True
Disease Modelling - Fibrotic (4),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.02232,0.0162016201620162,0.01366,0.0323032303230323,Other Applications,0.0162016201620162,True,True
Disease Modelling - Fibrotic (4),Number of Cell Lines - 1 (225),0.02069,0.0008000800080008,0.00489,0.3389338933893389,Other Applications,0.0008000800080008,True,True
Disease Modelling - Fibrotic (4),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01904,0.0141014101410141,0.01688,0.0177017701770177,Other Applications,0.0141014101410141,True,True
Disease Modelling - Fibrotic (4),Journal - Biomaterials (16),0.01873,0.0215021502150215,0.02492,0.0052005200520052,Other Applications,0.0052005200520052,True,True
Disease Modelling - Fibrotic (4),Journal - Nat Commun (13),0.01767,0.0174017401740174,0.02217,0.0078007800780078,Other Applications,0.0078007800780078,True,True
Disease Modelling - Fibrotic (4),Differentiation Purity Assessment - Visual Inspection (6),0.01687,0.0231023102310231,0.01073,0.0488048804880488,Other Applications,0.0231023102310231,True,True
Disease Modelling - Fibrotic (4),Number of Cell Lines - 2 (50),0.01656,0.0179017901790179,0.01194,0.0567056705670567,Other Applications,0.0179017901790179,True,True
Disease Modelling - Fibrotic (4),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.01595,0.0227022702270227,0.00378,0.3532353235323532,Other Applications,0.0227022702270227,True,True
Disease Modelling - Fibrotic (4),Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),0.01577,0.0254025402540254,0.02058,0.0114011401140114,Other Applications,0.0114011401140114,True,True
Disease Modelling - Fibrotic (4),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.01524,0.0395039503950395,0.0186,0.0234023402340234,Other Applications,0.0234023402340234,True,True
Disease Modelling - Fibrotic (4),Differentiation Purity (%) Quantiles - Q1 (>95 and ≤99) (22),0.01491,0.0303030303030303,0.00937,0.0887088708870887,Other Applications,0.0303030303030303,True,False
Disease Modelling - Fibrotic (4),3D Endothelial Cell Source - Umbilical Vein EndothelialC (10),0.01429,0.0375037503750375,0.01117,0.0583058305830583,Other Applications,0.0375037503750375,True,False
Disease Modelling - Fibrotic (4),3D Platform - Matrigel (33),0.01378,0.0442044204420442,0.01065,0.1054105410541054,Other Applications,0.0442044204420442,True,False
Disease Modelling - Fibrotic (4),Insulin Start Day - After 11 (7),0.01367,0.048004800480048,0.0136,0.0469046904690469,Other Applications,0.0469046904690469,True,False
Disease Modelling - Fibrotic (4),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.0135,0.0472047204720472,0.01221,0.058005800580058,Other Applications,0.0472047204720472,True,False
Disease Modelling - Fibrotic (4),3D Platform - 3D printed (9),0.0133,0.0344034403440344,0.00944,0.0714071407140714,Other Applications,0.0344034403440344,True,False
Disease Modelling - Fibrotic (4),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.01295,0.0456045604560456,0.01773,0.0214021402140214,Other Applications,0.0214021402140214,True,True
Disease Modelling - Fibrotic (4),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.01283,0.0406040604060406,0.0076,0.0836083608360836,Other Applications,0.0406040604060406,True,False
Disease Modelling - Fibrotic (4),Maturation Strategy - Other Cells (80),0.01271,0.0384038403840384,0.00667,0.2259225922592259,Other Applications,0.0384038403840384,True,False
Disease Modelling - Fibrotic (4),Contractile Stress (mN/mm2) Quantiles - Q2 (>1.9 and ≤3.95) (9),0.01166,0.0511051105110511,0.02326,0.0057005700570057,Other Applications,0.0057005700570057,True,True
Disease Modelling - Fibrotic (4),Cell Line - BJ1 (7),0.01035,0.0637063706370637,0.01443,0.0375037503750375,Other Applications,0.0375037503750375,True,False
Disease Modelling - Fibrotic (4),Differentiation Purity (%) Quantiles - Q2 (>90 and ≤95) (27),0.00971,0.1288128812881288,0.0142,0.0365036503650365,Other Applications,0.0365036503650365,True,False
Disease Modelling - Fibrotic (4),New Media for Maturation - Rare (4),0.0095,0.0509050905090509,0.01017,0.0494049404940494,Other Applications,0.0494049404940494,True,False
Disease Modelling - Fibrotic (4),hiPSC Backbone Media - RPMI-1640 (167),0.00939,0.0094009400940094,0.01153,0.0105010501050105,Other Applications,0.0094009400940094,True,True
Disease Modelling - Fibrotic (4),3D Tissue Media - iCell Maintenance (12),0.00883,0.0931093109310931,0.01215,0.0449044904490449,Other Applications,0.0449044904490449,True,False
Disease Modelling - Fibrotic (4),Publication Year - 2017 (43),0.0073,0.1722172217221722,0.01414,0.0491049104910491,Other Applications,0.0491049104910491,True,False
Pharmacological Intervention - Adrenaline (83),Calcium Handling Analysis Method - Visual (104),0.02528,0.0,0.02599,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Adrenaline (83),Electrophysiology Analysis Method - Microelectrode (31),0.0172,0.0001000100010001,0.01646,0.0004000400040004,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - Adrenaline (83),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01068,0.0092009200920092,0.00855,0.0247024702470247,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Adrenaline (83),3D Tissue Media - DMEM (53),0.01035,0.0056005600560056,0.0112,0.0041004100410041,Other Applications,0.0041004100410041,True,True
Pharmacological Intervention - Adrenaline (83),Cell Coculture - Cardiomyocyte (157),0.01025,0.0137013701370137,0.00972,0.0088008800880088,Other Applications,0.0088008800880088,True,True
Pharmacological Intervention - Adrenaline (83),Contractile Analysis Method - Motion Tracking (93),0.00967,0.0124012401240124,0.00966,0.0094009400940094,Other Applications,0.0094009400940094,True,True
Pharmacological Intervention - Adrenaline (83),Gene Analysis Method - RNA (169),0.00919,0.0297029702970297,0.0072,0.0963096309630963,Other Applications,0.0297029702970297,True,False
Pharmacological Intervention - Adrenaline (83),Publication Year - 2016 (32),0.00875,0.0086008600860086,0.00949,0.0072007200720072,Other Applications,0.0072007200720072,True,True
Pharmacological Intervention - Adrenaline (83),Maturation Strategy - Cell Alignment (59),0.00788,0.0223022302230223,0.00428,0.3373337333733373,Other Applications,0.0223022302230223,True,True
Pharmacological Intervention - Adrenaline (83),Electrophysiology Analysis Method - Optical Mapping (39),0.0077,0.0151015101510151,0.00785,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Adrenaline (83),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.00765,0.0205020502050205,0.00438,0.1702170217021702,Other Applications,0.0205020502050205,True,True
Pharmacological Intervention - Adrenaline (83),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.00753,0.0053005300530053,0.00696,0.0126012601260126,Other Applications,0.0053005300530053,True,True
Pharmacological Intervention - Adrenaline (83),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00745,0.0058005800580058,0.00767,0.0109010901090109,Other Applications,0.0058005800580058,True,True
Pharmacological Intervention - Adrenaline (83),3D Tissue Media - MEM-α (60),0.00718,0.0391039103910391,0.00581,0.0884088408840884,Other Applications,0.0391039103910391,True,False
Pharmacological Intervention - Adrenaline (83),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.00716,0.0613061306130613,0.00706,0.0469046904690469,Other Applications,0.0469046904690469,True,False
Pharmacological Intervention - Adrenaline (83),Deduced Culture Strategy - 3D Only (157),0.00708,0.1462146214621462,0.00866,0.0281028102810281,Other Applications,0.0281028102810281,True,False
Pharmacological Intervention - Adrenaline (83),hiPSC-CM Purification Duration (days) - 5 days (6),0.00681,0.0068006800680068,0.00829,0.007000700070007,Other Applications,0.0068006800680068,True,True
Pharmacological Intervention - Adrenaline (83),3D Stromal Cell Source - Cardiac Fibroblast (32),0.00616,0.0337033703370337,0.00582,0.0436043604360436,Other Applications,0.0337033703370337,True,False
Pharmacological Intervention - Adrenaline (83),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.00582,0.0115011501150115,0.0076,0.0078007800780078,Other Applications,0.0078007800780078,True,True
Pharmacological Intervention - Adrenaline (83),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.00569,0.0146014601460146,0.00456,0.0543054305430543,Other Applications,0.0146014601460146,True,True
Pharmacological Intervention - Adrenaline (83),Journal - Sci Rep (24),0.00549,0.0435043504350435,0.00638,0.0321032103210321,Other Applications,0.0321032103210321,True,False
Pharmacological Intervention - Adrenaline (83),Time to Calcium Flux Peak (ms) Quantiles - Q2 (<200 and ≥154) (9),0.00548,0.0202020202020202,0.00589,0.0331033103310331,Other Applications,0.0202020202020202,True,True
Pharmacological Intervention - Adrenaline (83),Contractile Analysis Method - Deflection (39),0.00527,0.0796079607960796,0.00763,0.0147014701470147,Other Applications,0.0147014701470147,True,True
Pharmacological Intervention - Adrenaline (83),3D Tissue Media - Growth Factor (12),0.00421,0.0472047204720472,0.00374,0.1002100210021002,Other Applications,0.0472047204720472,True,False
Pharmacological Intervention - Adrenaline (83),Journal - Toxicological Sciences (4),0.0042,0.02000200020002,0.00451,0.0344034403440344,Other Applications,0.02000200020002,True,True
Pharmacological Intervention - Adrenaline (83),Cell Line - iCell2 (8),0.00414,0.0414041404140414,0.00539,0.0387038703870387,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Adrenaline (83),Journal - Lab Chip (4),0.00362,0.0341034103410341,0.00481,0.0329032903290329,Other Applications,0.0329032903290329,True,False
Pharmacological Intervention - Adrenaline (83),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00352,0.0438043804380438,0.00429,0.0464046404640464,Other Applications,0.0438043804380438,True,False
Pharmacological Intervention - Adrenaline (83),3D Platform - Gelatin (6),0.00325,0.0511051105110511,0.00424,0.0458045804580458,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Adrenaline (83),Gene Analysis Method - Rare (5),0.00252,0.0833083308330833,0.00469,0.0279027902790279,Other Applications,0.0279027902790279,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Calcium Handling Analysis Method - Visual (104),0.02673,0.0,0.02303,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Electrophysiology Analysis Method - Microelectrode (31),0.01282,0.0007000700070007,0.01278,0.0008000800080008,Other Applications,0.0007000700070007,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Contractile Analysis Method - Motion Tracking (93),0.01029,0.012001200120012,0.01083,0.0048004800480048,Other Applications,0.0048004800480048,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Cell Coculture - Cardiomyocyte (157),0.00982,0.0213021302130213,0.00885,0.0184018401840184,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),hiPSC Backbone Media - Essential 8 (82),0.00956,0.0146014601460146,0.00806,0.0242024202420242,Other Applications,0.0146014601460146,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D Tissue Media - DMEM (53),0.00952,0.0088008800880088,0.0127,0.0012001200120012,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Contractile Analysis Method - Deflection (39),0.00937,0.0053005300530053,0.00917,0.0061006100610061,Other Applications,0.0053005300530053,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00888,0.0399039903990399,0.00771,0.0474047404740474,Other Applications,0.0399039903990399,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Publication Year - 2016 (32),0.00849,0.0124012401240124,0.00887,0.0116011601160116,Other Applications,0.0116011601160116,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.00813,0.0023002300230023,0.00954,0.003000300030003,Other Applications,0.0023002300230023,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Electrophysiology Analysis Method - Optical Mapping (39),0.00769,0.0172017201720172,0.00762,0.0166016601660166,Other Applications,0.0166016601660166,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D Tissue Media - MEM-α (60),0.00727,0.0411041104110411,0.00784,0.0207020702070207,Other Applications,0.0207020702070207,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00718,0.0061006100610061,0.00621,0.0225022502250225,Other Applications,0.0061006100610061,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),hiPSC Matrix Coating - Geltrex (33),0.00694,0.0236023602360236,0.00594,0.0464046404640464,Other Applications,0.0236023602360236,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D Stromal Cell Source - Human Fibroblast (38),0.00656,0.0457045704570457,0.00682,0.0359035903590359,Other Applications,0.0359035903590359,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D Tissue Media - Growth Factor (12),0.00619,0.0156015601560156,0.0056,0.0342034203420342,Other Applications,0.0156015601560156,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.00609,0.042004200420042,0.00711,0.0251025102510251,Other Applications,0.0251025102510251,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.00584,0.0142014201420142,0.00851,0.006000600060006,Other Applications,0.006000600060006,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Journal - Sci Rep (24),0.00572,0.0434043404340434,0.00601,0.0421042104210421,Other Applications,0.0421042104210421,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Journal - Tissue Eng Part C Methods (6),0.00541,0.018001800180018,0.0056,0.0261026102610261,Other Applications,0.018001800180018,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Seeding Confluency (%) - 95 to 100 (23),0.00519,0.0445044504450445,0.00403,0.1241124112411241,Other Applications,0.0445044504450445,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),hiPSC-CM Purification Duration (days) - 5 days (6),0.00439,0.0287028702870287,0.00489,0.0394039403940394,Other Applications,0.0287028702870287,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),New Media for Maturation - Rare (4),0.00425,0.0287028702870287,0.00519,0.0319031903190319,Other Applications,0.0287028702870287,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),3D Platform - Gelatin (6),0.00423,0.0286028602860286,0.00435,0.0469046904690469,Other Applications,0.0286028602860286,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00404,0.056005600560056,0.00675,0.023002300230023,Other Applications,0.023002300230023,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Journal - Toxicological Sciences (4),0.00402,0.0261026102610261,0.00521,0.0257025702570257,Other Applications,0.0257025702570257,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00382,0.0408040804080408,0.00605,0.0223022302230223,Other Applications,0.0223022302230223,True,True
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Purification Protocol - Cell Sorting (7),0.00363,0.052005200520052,0.00505,0.0416041604160416,Other Applications,0.0416041604160416,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Seeding Confluency 3D (%) - 80 to 84 (5),0.0035,0.0463046304630463,0.00371,0.0681068106810681,Other Applications,0.0463046304630463,True,False
Pharmacological Intervention - β1/β2-Adrenergic Agonists (Pure β-Agonists) (73),Gene Analysis Method - Rare (5),0.00276,0.0793079307930793,0.00601,0.0196019601960196,Other Applications,0.0196019601960196,True,True
Pharmacological Intervention - Isoproterenol (71),Calcium Handling Analysis Method - Visual (104),0.02241,0.0001000100010001,0.01958,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Isoproterenol (71),Electrophysiology Analysis Method - Microelectrode (31),0.01354,0.0012001200120012,0.01246,0.0022002200220022,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - Isoproterenol (71),Contractile Analysis Method - Motion Tracking (93),0.012,0.0028002800280028,0.00985,0.0052005200520052,Other Applications,0.0028002800280028,True,True
Pharmacological Intervention - Isoproterenol (71),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01107,0.001000100010001,0.01179,0.0017001700170017,Other Applications,0.001000100010001,True,True
Pharmacological Intervention - Isoproterenol (71),3D Tissue Media - DMEM (53),0.01067,0.0064006400640064,0.00977,0.0069006900690069,Other Applications,0.0064006400640064,True,True
Pharmacological Intervention - Isoproterenol (71),Cell Coculture - Cardiomyocyte (157),0.01018,0.0161016101610161,0.00806,0.0342034203420342,Other Applications,0.0161016101610161,True,True
Pharmacological Intervention - Isoproterenol (71),Publication Year - 2016 (32),0.00817,0.0143014301430143,0.00859,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Isoproterenol (71),Electrophysiology Analysis Method - Optical Mapping (39),0.00815,0.0139013901390139,0.00881,0.0092009200920092,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Isoproterenol (71),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00769,0.0055005500550055,0.00648,0.0216021602160216,Other Applications,0.0055005500550055,True,True
Pharmacological Intervention - Isoproterenol (71),Contractile Analysis Method - Deflection (39),0.00767,0.015001500150015,0.01027,0.0031003100310031,Other Applications,0.0031003100310031,True,True
Pharmacological Intervention - Isoproterenol (71),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00751,0.09000900090009,0.00928,0.0119011901190119,Other Applications,0.0119011901190119,True,True
Pharmacological Intervention - Isoproterenol (71),3D Tissue Media - MEM-α (60),0.00718,0.0441044104410441,0.0082,0.0184018401840184,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - Isoproterenol (71),3D Stromal Cell Source - Human Fibroblast (38),0.00705,0.0363036303630363,0.0055,0.0789078907890789,Other Applications,0.0363036303630363,True,False
Pharmacological Intervention - Isoproterenol (71),Beat Rate (bpm) Quantiles - Q4 (<60 and ≥45) (11),0.00634,0.0115011501150115,0.00869,0.0062006200620062,Other Applications,0.0062006200620062,True,True
Pharmacological Intervention - Isoproterenol (71),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00617,0.015001500150015,0.00741,0.0152015201520152,Other Applications,0.015001500150015,True,True
Pharmacological Intervention - Isoproterenol (71),hiPSC Matrix Coating - Geltrex (33),0.00611,0.0444044404440444,0.00643,0.0359035903590359,Other Applications,0.0359035903590359,True,False
Pharmacological Intervention - Isoproterenol (71),Journal - Sci Rep (24),0.00608,0.0338033803380338,0.00476,0.0865086508650865,Other Applications,0.0338033803380338,True,False
Pharmacological Intervention - Isoproterenol (71),New Media for Maturation - Rare (4),0.00597,0.01000100010001,0.00513,0.0317031703170317,Other Applications,0.01000100010001,True,True
Pharmacological Intervention - Isoproterenol (71),hiPSC-CM Purification Duration (days) - <3 days (31),0.00589,0.046004600460046,0.0046,0.1023102310231023,Other Applications,0.046004600460046,True,False
Pharmacological Intervention - Isoproterenol (71),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.00585,0.0518051805180518,0.00762,0.0192019201920192,Other Applications,0.0192019201920192,True,True
Pharmacological Intervention - Isoproterenol (71),Cell Line - iCell (47),0.00578,0.0967096709670967,0.00678,0.04000400040004,Other Applications,0.04000400040004,True,False
Pharmacological Intervention - Isoproterenol (71),3D Tissue Media - Growth Factor (12),0.00549,0.0258025802580258,0.00619,0.0281028102810281,Other Applications,0.0258025802580258,True,False
Pharmacological Intervention - Isoproterenol (71),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00515,0.0211021102110211,0.00624,0.0229022902290229,Other Applications,0.0211021102110211,True,True
Pharmacological Intervention - Isoproterenol (71),Electron Imaging - Scanning (22),0.00508,0.0553055305530553,0.00608,0.0359035903590359,Other Applications,0.0359035903590359,True,False
Pharmacological Intervention - Isoproterenol (71),Seeding Confluency (%) - 80 to 84 (12),0.00471,0.0321032103210321,0.003,0.1476147614761476,Other Applications,0.0321032103210321,True,False
Pharmacological Intervention - Isoproterenol (71),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00442,0.049004900490049,0.00379,0.1026102610261026,Other Applications,0.049004900490049,True,False
Pharmacological Intervention - Isoproterenol (71),Gene Analysis Method - Rare (5),0.00422,0.0335033503350335,0.00506,0.0375037503750375,Other Applications,0.0335033503350335,True,False
Pharmacological Intervention - Isoproterenol (71),Cell Line - Cellapy (4),0.00421,0.0319031903190319,0.00491,0.0371037103710371,Other Applications,0.0319031903190319,True,False
Pharmacological Intervention - Isoproterenol (71),Purification Protocol - Cell Sorting (7),0.00396,0.0466046604660466,0.00518,0.0403040304030403,Other Applications,0.0403040304030403,True,False
Pharmacological Intervention - Isoproterenol (71),Maturation Strategy - ECM (21),0.00396,0.0929092909290929,0.00538,0.0415041504150415,Other Applications,0.0415041504150415,True,False
Pharmacological Intervention - Isoproterenol (71),Journal - Tissue Eng Part C Methods (6),0.00378,0.0493049304930493,0.00518,0.0385038503850385,Other Applications,0.0385038503850385,True,False
Pharmacological Intervention - Isoproterenol (71),hiPSC-CM Media Supplement - HEPES (16),0.00368,0.1035103510351035,0.00597,0.0358035803580358,Other Applications,0.0358035803580358,True,False
Pharmacological Intervention - Isoproterenol (71),Seeding Confluency 3D (%) - 80 to 84 (5),0.0035,0.0439043904390439,0.00249,0.1356135613561356,Other Applications,0.0439043904390439,True,False
Pharmacological Intervention - Isoproterenol (71),Journal - Toxicological Sciences (4),0.00343,0.0389038903890389,0.00455,0.0364036403640364,Other Applications,0.0364036403640364,True,False
Pharmacological Intervention - Isoproterenol (71),3D Platform - Gelatin (6),0.00318,0.0651065106510651,0.00542,0.0274027402740274,Other Applications,0.0274027402740274,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Electrophysiology Analysis Method - Microelectrode (31),0.02951,0.0,0.02781,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),2D Surface - Microelectrode Array (9),0.02457,0.0,0.02475,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Cell Line - iCell (47),0.01757,0.001000100010001,0.01672,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Cell Line - Cor.4U (16),0.01317,0.0021002100210021,0.01356,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.0124,0.0046004600460046,0.01066,0.0052005200520052,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Electrophysiology Analysis Method - Patch Clamp (59),0.01191,0.0086008600860086,0.01085,0.0058005800580058,Other Applications,0.0058005800580058,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Coating for Replating - Gelatin (43),0.01176,0.005000500050005,0.00975,0.0101010101010101,Other Applications,0.005000500050005,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Number of Cell Lines - 1 (225),0.01053,0.0216021602160216,0.00809,0.0367036703670367,Other Applications,0.0216021602160216,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00996,0.0041004100410041,0.01104,0.0049004900490049,Other Applications,0.0041004100410041,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Cell Line Sex - Both (118),0.00989,0.0338033803380338,0.00642,0.1847184718471847,Other Applications,0.0338033803380338,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Publication Year - 2016 (32),0.00975,0.0146014601460146,0.00909,0.0145014501450145,Other Applications,0.0145014501450145,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.00916,0.0075007500750075,0.00842,0.0124012401240124,Other Applications,0.0075007500750075,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.00796,0.024002400240024,0.00989,0.008000800080008,Other Applications,0.008000800080008,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),3D Platform - Extracellular Scaffold (18),0.0079,0.0195019501950195,0.00794,0.0202020202020202,Other Applications,0.0195019501950195,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Immunofluorescent Imaging - Yes (268),0.00773,0.0443044304430443,0.00918,0.0101010101010101,Other Applications,0.0101010101010101,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Electrophysiology Analysis Method - Optical Mapping (39),0.00702,0.0404040404040404,0.00417,0.2188218821882188,Other Applications,0.0404040404040404,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00699,0.0267026702670267,0.00477,0.0874087408740874,Other Applications,0.0267026702670267,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Maturation Strategy - ECM (21),0.00676,0.0299029902990299,0.00582,0.0523052305230523,Other Applications,0.0299029902990299,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Journal - Toxicological Sciences (4),0.00666,0.0141014101410141,0.00802,0.0159015901590159,Other Applications,0.0141014101410141,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Number of Cell Lines - >5 (9),0.00642,0.0261026102610261,0.00722,0.0273027302730273,Other Applications,0.0261026102610261,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Publication Year - 2017 (43),0.00625,0.0799079907990799,0.00765,0.031003100310031,Other Applications,0.031003100310031,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Journal - Biomaterials (16),0.00622,0.0367036703670367,0.00849,0.013001300130013,Other Applications,0.013001300130013,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Disease Modelling - Arrhythmic (15),0.00567,0.0419041904190419,0.00569,0.0478047804780478,Other Applications,0.0419041904190419,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),3D Platform - Nanotechnology (3),0.00551,0.0296029602960296,0.00807,0.0234023402340234,Other Applications,0.0234023402340234,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00531,0.0403040304030403,0.00299,0.1684168416841684,Other Applications,0.0403040304030403,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Sacromere or Cellular Alignment Analysis - Yes (72),0.00523,0.3087308730873087,0.0077,0.0348034803480348,Other Applications,0.0348034803480348,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.00512,0.061006100610061,0.00764,0.0287028702870287,Other Applications,0.0287028702870287,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Journal - Int J Mol Sci (3),0.0051,0.0297029702970297,0.00608,0.0323032303230323,Other Applications,0.0297029702970297,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Wnt Inhibitor - KY02111 (7),0.0051,0.0494049404940494,0.0038,0.1224122412241224,Other Applications,0.0494049404940494,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),hiPSC-CM Media Supplement - Lipid Mix (5),0.00502,0.0513051305130513,0.00752,0.0255025502550255,Other Applications,0.0255025502550255,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),3D Tissue Media - Rare (13),0.00499,0.0631063106310631,0.00617,0.0408040804080408,Other Applications,0.0408040804080408,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Gene Analysis Method - RNA (169),0.0049,0.8343834383438344,0.00944,0.0086008600860086,Other Applications,0.0086008600860086,True,True
Pharmacological Intervention - QT-Prolonging Drugs (36),hiPSC-CM Media Supplement - Selenium (7),0.00468,0.0473047304730473,0.00619,0.034003400340034,Other Applications,0.034003400340034,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Wnt Inhibitor Duration (days) - 4 days (19),0.00446,0.1032103210321032,0.00715,0.0321032103210321,Other Applications,0.0321032103210321,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Number of Cell Lines - 3 (29),0.00428,0.156015601560156,0.00682,0.0424042404240424,Other Applications,0.0424042404240424,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00284,0.1729172917291729,0.00636,0.0337033703370337,Other Applications,0.0337033703370337,True,False
Pharmacological Intervention - QT-Prolonging Drugs (36),Insulin Start Day - 11 (3),0.00254,0.1244124412441244,0.00492,0.048004800480048,Other Applications,0.048004800480048,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Electrophysiology Analysis Method - Microelectrode (31),0.02488,0.0001000100010001,0.02195,0.0002000200020002,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Journal - Toxicological Sciences (4),0.01539,0.0006000600060006,0.01801,0.0008000800080008,Other Applications,0.0006000600060006,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line - iCell (47),0.01452,0.0047004700470047,0.01472,0.0017001700170017,Other Applications,0.0017001700170017,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Calcium Handling Analysis Method - Visual (104),0.01261,0.0141014101410141,0.00954,0.0118011801180118,Other Applications,0.0118011801180118,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01201,0.0073007300730073,0.00886,0.0165016501650165,Other Applications,0.0073007300730073,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01177,0.0079007900790079,0.01005,0.0088008800880088,Other Applications,0.0079007900790079,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC Backbone Media - iCell Maintenance (86),0.01161,0.0094009400940094,0.00798,0.0323032303230323,Other Applications,0.0094009400940094,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01093,0.0046004600460046,0.01216,0.0054005400540054,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Electron Imaging - Scanning (22),0.01057,0.0096009600960096,0.00919,0.0136013601360136,Other Applications,0.0096009600960096,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line - Cellapy (4),0.01045,0.0056005600560056,0.01054,0.0112011201120112,Other Applications,0.0056005600560056,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Number of Cell Lines - 1 (225),0.0102,0.0264026402640264,0.00982,0.0097009700970097,Other Applications,0.0097009700970097,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),2D Surface - Decellularized ECM (3),0.00988,0.0043004300430043,0.01284,0.0029002900290029,Other Applications,0.0029002900290029,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00979,0.0092009200920092,0.00833,0.0175017501750175,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Contractile Analysis Method - Motion Tracking (93),0.00976,0.0302030203020302,0.0072,0.0673067306730673,Other Applications,0.0302030203020302,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Number of Cell Lines - 4 (11),0.00947,0.0099009900990099,0.01137,0.0066006600660066,Other Applications,0.0066006600660066,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),3D Platform - Scaffold Free (43),0.00935,0.0179017901790179,0.00548,0.1195119511951195,Other Applications,0.0179017901790179,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00917,0.0391039103910391,0.00487,0.5852585258525853,Other Applications,0.0391039103910391,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Journal - Nat Commun (13),0.00911,0.0148014801480148,0.00842,0.0209020902090209,Other Applications,0.0148014801480148,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line - iCell2 (8),0.0088,0.0164016401640164,0.01015,0.0142014201420142,Other Applications,0.0142014201420142,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Journal - Sci Rep (24),0.00869,0.0233023302330233,0.01,0.0126012601260126,Other Applications,0.0126012601260126,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Publication Year - 2017 (43),0.00835,0.0334033403340334,0.01274,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC-CM Maturation Media - Rare (9),0.00819,0.0179017901790179,0.0073,0.0337033703370337,Other Applications,0.0179017901790179,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Coating for Replating - Gelatin (43),0.00775,0.0362036203620362,0.01004,0.0085008500850085,Other Applications,0.0085008500850085,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line Ancestry - Caucasian (41),0.00742,0.0472047204720472,0.00711,0.0438043804380438,Other Applications,0.0438043804380438,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line - Cor.4U (16),0.00722,0.0276027602760276,0.00859,0.0145014501450145,Other Applications,0.0145014501450145,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00722,0.0355035503550355,0.0064,0.0486048604860486,Other Applications,0.0355035503550355,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Cell Line Ancestry - Asian (28),0.00721,0.0404040404040404,0.00572,0.0754075407540754,Other Applications,0.0404040404040404,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Sacromere or Cellular Alignment Analysis - Yes (72),0.00673,0.1181118111811181,0.00879,0.0194019401940194,Other Applications,0.0194019401940194,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),hiPSC Backbone Media - Rare (10),0.00661,0.0363036303630363,0.00996,0.0124012401240124,Other Applications,0.0124012401240124,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.00619,0.0971097109710971,0.00779,0.0318031803180318,Other Applications,0.0318031803180318,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00584,0.0487048704870487,0.00713,0.034003400340034,Other Applications,0.034003400340034,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.00583,0.0458045804580458,0.00366,0.1549154915491549,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Electrophysiology Analysis Method - Optical Mapping (39),0.00528,0.1214121412141214,0.00723,0.0389038903890389,Other Applications,0.0389038903890389,True,False
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),Number of Cell Lines - 3 (29),0.00482,0.1292129212921292,0.00979,0.0102010201020102,Other Applications,0.0102010201020102,True,True
Pharmacological Intervention - Cardioselective Ca Channel Blockers (31),3D Stromal Cell Source - hiPSC-CardiacF (8),0.0035,0.1334133413341334,0.00615,0.0494049404940494,Other Applications,0.0494049404940494,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Electrophysiology Analysis Method - Microelectrode (31),0.02712,0.0,0.02122,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Journal - Toxicological Sciences (4),0.01659,0.0007000700070007,0.01807,0.001000100010001,Other Applications,0.0007000700070007,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Calcium Handling Analysis Method - Visual (104),0.01362,0.0108010801080108,0.01187,0.0032003200320032,Other Applications,0.0032003200320032,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line - iCell (47),0.01317,0.0062006200620062,0.01118,0.0074007400740074,Other Applications,0.0062006200620062,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01153,0.008000800080008,0.00703,0.0453045304530453,Other Applications,0.008000800080008,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01124,0.0101010101010101,0.00745,0.0526052605260526,Other Applications,0.0101010101010101,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Electron Imaging - Scanning (22),0.01123,0.0083008300830083,0.01277,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line - iCell2 (8),0.01098,0.0058005800580058,0.0124,0.0048004800480048,Other Applications,0.0048004800480048,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),2D Surface - Decellularized ECM (3),0.01095,0.0014001400140014,0.01346,0.0017001700170017,Other Applications,0.0014001400140014,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01074,0.0063006300630063,0.01198,0.006000600060006,Other Applications,0.006000600060006,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line - Cellapy (4),0.01051,0.0056005600560056,0.01165,0.0078007800780078,Other Applications,0.0056005600560056,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Number of Cell Lines - 1 (225),0.01044,0.0224022402240224,0.01575,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.01,0.0099009900990099,0.00866,0.017001700170017,Other Applications,0.0099009900990099,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),hiPSC Backbone Media - iCell Maintenance (86),0.00992,0.0241024102410241,0.00669,0.1017101710171017,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Journal - Sci Rep (24),0.00943,0.0163016301630163,0.00995,0.0098009800980098,Other Applications,0.0098009800980098,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Number of Cell Lines - 4 (11),0.00903,0.0134013401340134,0.01499,0.0028002800280028,Other Applications,0.0028002800280028,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),hiPSC-CM Maturation Media - Rare (9),0.00874,0.0153015301530153,0.0089,0.0192019201920192,Other Applications,0.0153015301530153,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Publication Year - 2017 (43),0.0086,0.0322032203220322,0.01323,0.0024002400240024,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Coating for Replating - Matrigel (65),0.00829,0.0435043504350435,0.00717,0.0547054705470547,Other Applications,0.0435043504350435,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line - Cor.4U (16),0.00802,0.0236023602360236,0.00751,0.0284028402840284,Other Applications,0.0236023602360236,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),hiPSC Backbone Media - Rare (10),0.0075,0.0249024902490249,0.00897,0.0151015101510151,Other Applications,0.0151015101510151,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Number of Cell Lines - 3 (29),0.00705,0.0401040104010401,0.00985,0.0091009100910091,Other Applications,0.0091009100910091,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00704,0.0384038403840384,0.00678,0.0381038103810381,Other Applications,0.0381038103810381,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.0064,0.0274027402740274,0.00517,0.0654065406540654,Other Applications,0.0274027402740274,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00639,0.037003700370037,0.00377,0.1463146314631463,Other Applications,0.037003700370037,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line Ancestry - Asian (28),0.00624,0.0626062606260626,0.00714,0.0363036303630363,Other Applications,0.0363036303630363,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.00594,0.047004700470047,0.00506,0.0766076607660766,Other Applications,0.047004700470047,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Electrophysiology Analysis Method - Optical Mapping (39),0.00582,0.0933093309330933,0.00722,0.0438043804380438,Other Applications,0.0438043804380438,True,False
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Journal - Nat Commun (13),0.00581,0.0543054305430543,0.00887,0.0185018501850185,Other Applications,0.0185018501850185,True,True
Pharmacological Intervention - Class IV Antiarrhythmics (Ca2+ Channel Blockers - AV Nodal Block) (30),Cell Line - Rare (132),0.00553,0.6156615661566157,0.00847,0.025002500250025,Other Applications,0.025002500250025,True,False
Pharmacological Intervention - Verapamil (27),Electrophysiology Analysis Method - Microelectrode (31),0.02421,0.0001000100010001,0.02258,0.0001000100010001,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - Verapamil (27),Journal - Toxicological Sciences (4),0.0162,0.0006000600060006,0.02137,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Verapamil (27),hiPSC-CM Maturation Media - iCell Maintenance (83),0.0129,0.0063006300630063,0.01291,0.0011001100110011,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Verapamil (27),Number of Cell Lines - 4 (11),0.01097,0.008000800080008,0.01381,0.0047004700470047,Other Applications,0.0047004700470047,True,True
Pharmacological Intervention - Verapamil (27),hiPSC Backbone Media - mTeSR (106),0.01067,0.0259025902590259,0.003,0.9467946794679468,Other Applications,0.0259025902590259,True,False
Pharmacological Intervention - Verapamil (27),2D Surface - Decellularized ECM (3),0.01055,0.0048004800480048,0.01311,0.0042004200420042,Other Applications,0.0042004200420042,True,True
Pharmacological Intervention - Verapamil (27),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01027,0.0092009200920092,0.01046,0.0123012301230123,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Verapamil (27),Gene Analysis Method - RNA (169),0.01022,0.0448044804480448,0.00636,0.2716271627162716,Other Applications,0.0448044804480448,True,False
Pharmacological Intervention - Verapamil (27),Number of Cell Lines - 3 (29),0.00995,0.0151015101510151,0.00995,0.0104010401040104,Other Applications,0.0104010401040104,True,True
Pharmacological Intervention - Verapamil (27),Cell Line - iCell (47),0.00981,0.0242024202420242,0.00878,0.024002400240024,Other Applications,0.024002400240024,True,True
Pharmacological Intervention - Verapamil (27),Number of Cell Lines - 1 (225),0.00949,0.0456045604560456,0.01323,0.0009000900090009,Other Applications,0.0009000900090009,True,True
Pharmacological Intervention - Verapamil (27),Cell Line - Cor.4U (16),0.00921,0.0145014501450145,0.00965,0.0116011601160116,Other Applications,0.0116011601160116,True,True
Pharmacological Intervention - Verapamil (27),Cell Line - Cellapy (4),0.00917,0.0127012701270127,0.01205,0.0081008100810081,Other Applications,0.0081008100810081,True,True
Pharmacological Intervention - Verapamil (27),3D Platform - Scaffold Free (43),0.00914,0.024002400240024,0.00931,0.0161016101610161,Other Applications,0.0161016101610161,True,True
Pharmacological Intervention - Verapamil (27),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.00912,0.0266026602660266,0.00846,0.0237023702370237,Other Applications,0.0237023702370237,True,True
Pharmacological Intervention - Verapamil (27),Calcium Handling Analysis Method - Visual (104),0.0091,0.0674067406740674,0.01184,0.0027002700270027,Other Applications,0.0027002700270027,True,True
Pharmacological Intervention - Verapamil (27),hiPSC Backbone Media - iCell Maintenance (86),0.00898,0.0346034603460346,0.00874,0.0198019801980198,Other Applications,0.0198019801980198,True,True
Pharmacological Intervention - Verapamil (27),Publication Year - 2017 (43),0.00862,0.0372037203720372,0.01285,0.0027002700270027,Other Applications,0.0027002700270027,True,True
Pharmacological Intervention - Verapamil (27),Contractile Analysis Method - Motion Tracking (93),0.00854,0.0636063606360636,0.00832,0.0305030503050305,Other Applications,0.0305030503050305,True,False
Pharmacological Intervention - Verapamil (27),Coating for Replating - Matrigel (65),0.00849,0.044004400440044,0.00545,0.1997199719971997,Other Applications,0.044004400440044,True,False
Pharmacological Intervention - Verapamil (27),Cell Line - WTC11 (30),0.00824,0.0341034103410341,0.00427,0.1947194719471947,Other Applications,0.0341034103410341,True,False
Pharmacological Intervention - Verapamil (27),3D SC Ratio (CM-EC-SC) Quantiles - Q1 (>10 and ≤50) (47),0.00813,0.0416041604160416,0.00382,0.3741374137413741,Other Applications,0.0416041604160416,True,False
Pharmacological Intervention - Verapamil (27),3D Estimated Tissue Size (mm2) Quantiles - Q5 (>0.01 and ≤0.13) (28),0.00793,0.0297029702970297,0.00833,0.02000200020002,Other Applications,0.02000200020002,True,True
Pharmacological Intervention - Verapamil (27),Journal - Nat Commun (13),0.00787,0.0276027602760276,0.00638,0.0528052805280528,Other Applications,0.0276027602760276,True,False
Pharmacological Intervention - Verapamil (27),Coating for Replating - Gelatin (43),0.00786,0.0365036503650365,0.00811,0.0284028402840284,Other Applications,0.0284028402840284,True,False
Pharmacological Intervention - Verapamil (27),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00782,0.0216021602160216,0.00419,0.119011901190119,Other Applications,0.0216021602160216,True,True
Pharmacological Intervention - Verapamil (27),Journal - Sci Rep (24),0.00781,0.0357035703570357,0.00867,0.0208020802080208,Other Applications,0.0208020802080208,True,True
Pharmacological Intervention - Verapamil (27),Cell Line Ancestry - Asian (28),0.00749,0.0369036903690369,0.00668,0.0486048604860486,Other Applications,0.0369036903690369,True,False
Pharmacological Intervention - Verapamil (27),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.00718,0.035003500350035,0.0058,0.0657065706570657,Other Applications,0.035003500350035,True,False
Pharmacological Intervention - Verapamil (27),Cell Line - iCell2 (8),0.00701,0.0296029602960296,0.00516,0.0811081108110811,Other Applications,0.0296029602960296,True,False
Pharmacological Intervention - Verapamil (27),Contractile Stress (mN/mm2) Quantiles - Q1 (>3.95 and ≤50) (10),0.00696,0.0326032603260326,0.00631,0.0454045404540454,Other Applications,0.0326032603260326,True,False
Pharmacological Intervention - Verapamil (27),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00643,0.0424042404240424,0.00668,0.0389038903890389,Other Applications,0.0389038903890389,True,False
Pharmacological Intervention - Verapamil (27),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00586,0.043004300430043,0.00425,0.0927092709270927,Other Applications,0.043004300430043,True,False
Pharmacological Intervention - Verapamil (27),Electron Imaging - Scanning (22),0.00549,0.0837083708370837,0.00846,0.0215021502150215,Other Applications,0.0215021502150215,True,True
Pharmacological Intervention - Verapamil (27),Seeding Confluency 3D (%) - 70 to 79 (3),0.00321,0.1251125112511251,0.00601,0.0414041404140414,Other Applications,0.0414041404140414,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Wnt Inhibitor - KY02111 (7),0.01607,0.0026002600260026,0.01412,0.0047004700470047,Other Applications,0.0026002600260026,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Journal - Toxicological Sciences (4),0.01539,0.0015001500150015,0.01991,0.0006000600060006,Other Applications,0.0006000600060006,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Wnt Inhibitor - Others (9),0.0132,0.0038003800380038,0.01721,0.001000100010001,Other Applications,0.001000100010001,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Number of Cell Lines - 1 (225),0.01188,0.0195019501950195,0.01284,0.0012001200120012,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Journal - Int J Mol Sci (3),0.01122,0.0056005600560056,0.01194,0.0093009300930093,Other Applications,0.0056005600560056,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01093,0.0178017801780178,0.00925,0.0188018801880188,Other Applications,0.0178017801780178,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Number of Cell Lines - 3 (29),0.01051,0.0155015501550155,0.01123,0.0088008800880088,Other Applications,0.0088008800880088,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Maturation Strategy - ECM (21),0.0105,0.0108010801080108,0.00924,0.0167016701670167,Other Applications,0.0108010801080108,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Seeding Confluency 2D (%) - 80 to 84 (5),0.01046,0.011001100110011,0.01563,0.0031003100310031,Other Applications,0.0031003100310031,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),3D Stromal Cell Source - Cardiac Fibroblast (32),0.0104,0.0161016101610161,0.00574,0.1059105910591059,Other Applications,0.0161016101610161,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Gene Analysis Method - RNA (169),0.01028,0.0415041504150415,0.00782,0.0674067406740674,Other Applications,0.0415041504150415,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Electrophysiology Analysis Method - Patch Clamp (59),0.01002,0.0256025602560256,0.00966,0.0171017101710171,Other Applications,0.0171017101710171,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC-CM Media Supplement - HEPES (16),0.00985,0.0173017301730173,0.00802,0.0324032403240324,Other Applications,0.0173017301730173,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),2D Surface - ECM-coated (115),0.00936,0.0317031703170317,0.00634,0.1577157715771577,Other Applications,0.0317031703170317,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00917,0.0153015301530153,0.00976,0.0154015401540154,Other Applications,0.0153015301530153,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Seeding Confluency (%) - 80 to 84 (12),0.00912,0.019001900190019,0.00887,0.0191019101910191,Other Applications,0.019001900190019,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),3D Stromal Cell Source - Human Fibroblast (38),0.00907,0.0397039703970397,0.00833,0.0393039303930393,Other Applications,0.0393039303930393,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Number of Cell Lines - 4 (11),0.009,0.0205020502050205,0.00715,0.0394039403940394,Other Applications,0.0205020502050205,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Seeding Confluency 3D (%) - 90 to 94 (13),0.00817,0.0276027602760276,0.01012,0.0123012301230123,Other Applications,0.0123012301230123,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.00759,0.0224022402240224,0.00681,0.0349034903490349,Other Applications,0.0224022402240224,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00755,0.0298029802980298,0.00753,0.0356035603560356,Other Applications,0.0298029802980298,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),New Media for Maturation - Rare (4),0.00729,0.024002400240024,0.0103,0.0177017701770177,Other Applications,0.0177017701770177,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Cell Line - Cor.4U (16),0.00728,0.0413041304130413,0.00427,0.1378137813781378,Other Applications,0.0413041304130413,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC-CM Media Supplement - GlutaMax (8),0.00713,0.0387038703870387,0.00484,0.0903090309030903,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Number of Cell Lines - >5 (9),0.00711,0.0378037803780378,0.00856,0.0228022802280228,Other Applications,0.0228022802280228,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Journal - Rare (104),0.00703,0.1761176117611761,0.00907,0.0187018701870187,Other Applications,0.0187018701870187,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),3D Platform - Extracellular Scaffold (18),0.00699,0.0494049404940494,0.00661,0.054005400540054,Other Applications,0.0494049404940494,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.00672,0.0376037603760376,0.00612,0.0544054405440544,Other Applications,0.0376037603760376,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Cell Line - Cellapy (4),0.00668,0.0296029602960296,0.0052,0.077007700770077,Other Applications,0.0296029602960296,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Journal - Cell Rep (6),0.00664,0.0373037303730373,0.01058,0.0104010401040104,Other Applications,0.0104010401040104,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00649,0.0451045104510451,0.00326,0.1894189418941894,Other Applications,0.0451045104510451,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Immunofluorescent Imaging - Yes (268),0.00587,0.1527152715271527,0.00788,0.0479047904790479,Other Applications,0.0479047904790479,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC Backbone Media - Cor.4U Complete (6),0.0056,0.0464046404640464,0.00649,0.0429042904290429,Other Applications,0.0429042904290429,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Cell Line - iCell (47),0.00559,0.1669166916691669,0.00806,0.0437043704370437,Other Applications,0.0437043704370437,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00523,0.0618061806180618,0.0072,0.0321032103210321,Other Applications,0.0321032103210321,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),Seeding Confluency 3D (%) - 80 to 84 (5),0.00508,0.0468046804680468,0.00437,0.0889088908890889,Other Applications,0.0468046804680468,True,False
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),hiPSC Backbone Media - DMEM (10),0.0048,0.0923092309230923,0.01126,0.0091009100910091,Other Applications,0.0091009100910091,True,True
Pharmacological Intervention - Dihydropyridines (Vascular Selective Ca Channel Blockers) (22),2D Surface - Decellularized ECM (3),0.00402,0.0865086508650865,0.00594,0.0444044404440444,Other Applications,0.0444044404440444,True,False
Pharmacological Intervention - E4031 (22),Electrophysiology Analysis Method - Microelectrode (31),0.02089,0.0004000400040004,0.02197,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - E4031 (22),Maturation Strategy - Electrical (39),0.01528,0.004000400040004,0.01293,0.0037003700370037,Other Applications,0.0037003700370037,True,True
Pharmacological Intervention - E4031 (22),Action Potential Amplitude (mV) Quantiles - Q2 (>100 and ≤110) (10),0.01343,0.0025002500250025,0.01304,0.0031003100310031,Other Applications,0.0025002500250025,True,True
Pharmacological Intervention - E4031 (22),Publication Year - 2016 (32),0.01118,0.0196019601960196,0.00804,0.0403040304030403,Other Applications,0.0196019601960196,True,True
Pharmacological Intervention - E4031 (22),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.01096,0.0234023402340234,0.01073,0.011001100110011,Other Applications,0.011001100110011,True,True
Pharmacological Intervention - E4031 (22),Cell Line - Cor.4U (16),0.01091,0.0124012401240124,0.00596,0.0696069606960696,Other Applications,0.0124012401240124,True,True
Pharmacological Intervention - E4031 (22),Wnt Inhibitor Duration (days) Quantiles - Q1 (>2 and ≤9) (58),0.01085,0.0208020802080208,0.0101,0.0119011901190119,Other Applications,0.0119011901190119,True,True
Pharmacological Intervention - E4031 (22),Cell Line - Rare (132),0.01072,0.0284028402840284,0.00743,0.0923092309230923,Other Applications,0.0284028402840284,True,False
Pharmacological Intervention - E4031 (22),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01057,0.0213021302130213,0.00678,0.1565156515651565,Other Applications,0.0213021302130213,True,True
Pharmacological Intervention - E4031 (22),Cell Line Sex - Both (118),0.01006,0.047004700470047,0.00693,0.1425142514251425,Other Applications,0.047004700470047,True,False
Pharmacological Intervention - E4031 (22),3D Estimated Cell Density (mil cells/mL) Quantiles - Q4 (>0.47 and ≤5) (25),0.00973,0.0147014701470147,0.01113,0.0066006600660066,Other Applications,0.0066006600660066,True,True
Pharmacological Intervention - E4031 (22),Electrophysiology Analysis Method - Patch Clamp (59),0.00947,0.0325032503250325,0.00985,0.016001600160016,Other Applications,0.016001600160016,True,True
Pharmacological Intervention - E4031 (22),Electron Imaging - Transmission (62),0.00931,0.041004100410041,0.00467,0.3428342834283428,Other Applications,0.041004100410041,True,False
Pharmacological Intervention - E4031 (22),Wnt Inhibitor Duration (days) - 4 days (19),0.00906,0.0207020702070207,0.01002,0.0122012201220122,Other Applications,0.0122012201220122,True,True
Pharmacological Intervention - E4031 (22),Electron Imaging - Scanning (22),0.00904,0.0271027102710271,0.00823,0.0304030403040304,Other Applications,0.0271027102710271,True,False
Pharmacological Intervention - E4031 (22),Journal - Stem Cell Reports (23),0.00874,0.0253025302530253,0.00674,0.0534053405340534,Other Applications,0.0253025302530253,True,False
Pharmacological Intervention - E4031 (22),2D Surface - Electrospun (13),0.00856,0.0288028802880288,0.00553,0.081008100810081,Other Applications,0.0288028802880288,True,False
Pharmacological Intervention - E4031 (22),Cell Line - 253G1 (10),0.00823,0.0187018701870187,0.0083,0.0202020202020202,Other Applications,0.0187018701870187,True,True
Pharmacological Intervention - E4031 (22),Journal - Int J Mol Sci (3),0.00816,0.0117011701170117,0.00843,0.0153015301530153,Other Applications,0.0117011701170117,True,True
Pharmacological Intervention - E4031 (22),2D Surface - Microelectrode Array (9),0.00785,0.0224022402240224,0.00699,0.0356035603560356,Other Applications,0.0224022402240224,True,True
Pharmacological Intervention - E4031 (22),Seeding Confluency 3D (%) - 85 to 89 (12),0.00752,0.0363036303630363,0.00912,0.0218021802180218,Other Applications,0.0218021802180218,True,True
Pharmacological Intervention - E4031 (22),3D Platform - Extracellular Scaffold (18),0.00738,0.0417041704170417,0.00616,0.0657065706570657,Other Applications,0.0417041704170417,True,False
Pharmacological Intervention - E4031 (22),3D Tissue Media - MEM-α (60),0.00731,0.0892089208920892,0.00813,0.0428042804280428,Other Applications,0.0428042804280428,True,False
Pharmacological Intervention - E4031 (22),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.00687,0.0435043504350435,0.00644,0.0556055605560556,Other Applications,0.0435043504350435,True,False
Pharmacological Intervention - E4031 (22),hiPSC-CM Media Supplement - Transferrin (11),0.00657,0.0401040104010401,0.00725,0.0329032903290329,Other Applications,0.0329032903290329,True,False
Pharmacological Intervention - E4031 (22),Wnt Inhibitor - KY02111 (7),0.00644,0.0462046204620462,0.00845,0.0238023802380238,Other Applications,0.0238023802380238,True,True
Pharmacological Intervention - E4031 (22),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.00636,0.0375037503750375,0.00822,0.0185018501850185,Other Applications,0.0185018501850185,True,True
Pharmacological Intervention - E4031 (22),Coating for Replating - Fibronectin (32),0.00631,0.0792079207920792,0.01031,0.0096009600960096,Other Applications,0.0096009600960096,True,True
Pharmacological Intervention - E4031 (22),Wnt Induction - bFGF (45),0.0062,0.1156115611561156,0.00859,0.0298029802980298,Other Applications,0.0298029802980298,True,False
Pharmacological Intervention - E4031 (22),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.00618,0.0788078807880788,0.00813,0.0299029902990299,Other Applications,0.0299029902990299,True,False
Pharmacological Intervention - E4031 (22),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.00611,0.0576057605760576,0.00808,0.0292029202920292,Other Applications,0.0292029202920292,True,False
Pharmacological Intervention - E4031 (22),Wnt Inhibitor - XAV939 (24),0.00476,0.1418141814181418,0.00911,0.0216021602160216,Other Applications,0.0216021602160216,True,True
Pharmacological Intervention - E4031 (22),hiPSC Backbone Media - Cor.4U Complete (6),0.00446,0.0728072807280728,0.00637,0.0489048904890489,Other Applications,0.0489048904890489,True,False
Pharmacological Intervention - E4031 (22),Time from Calcium Peak to Relaxation (ms) Quantiles - Q1 (<310 and ≥0.2) (5),0.00396,0.0904090409040904,0.00775,0.0324032403240324,Other Applications,0.0324032403240324,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Electrophysiology Analysis Method - Microelectrode (31),0.03314,0.0,0.03191,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Journal - Biomaterials (16),0.01998,0.0019001900190019,0.01896,0.0013001300130013,Other Applications,0.0013001300130013,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Calcium Handling Analysis Method - Visual (104),0.01863,0.0038003800380038,0.01511,0.0001000100010001,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01743,0.0107010701070107,0.00914,0.0277027702770277,Other Applications,0.0107010701070107,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Cell Line - iCell (47),0.01705,0.0045004500450045,0.01421,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Number of Cell Lines - 3 (29),0.01533,0.0038003800380038,0.01307,0.0048004800480048,Other Applications,0.0038003800380038,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Wnt Inhibitor Duration (days) - Rare (173),0.01527,0.008000800080008,0.00785,0.0729072907290729,Other Applications,0.008000800080008,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01304,0.0084008400840084,0.01363,0.001000100010001,Other Applications,0.001000100010001,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Number of Cell Lines - 1 (225),0.01294,0.0139013901390139,0.01056,0.0117011701170117,Other Applications,0.0117011701170117,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Journal - Toxicological Sciences (4),0.01238,0.007000700070007,0.01418,0.006000600060006,Other Applications,0.006000600060006,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.01189,0.0138013801380138,0.00823,0.037003700370037,Other Applications,0.0138013801380138,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.01145,0.0085008500850085,0.0144,0.0076007600760076,Other Applications,0.0076007600760076,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.011,0.0347034703470347,0.00715,0.1206120612061206,Other Applications,0.0347034703470347,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),3D Tissue Media - Commercial Kit (21),0.01077,0.0165016501650165,0.01276,0.005000500050005,Other Applications,0.005000500050005,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),hiPSC Backbone Media - iCell Maintenance (86),0.00979,0.0341034103410341,0.0124,0.0021002100210021,Other Applications,0.0021002100210021,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Immunofluorescent Imaging - Yes (268),0.00952,0.0339033903390339,0.00933,0.028002800280028,Other Applications,0.028002800280028,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.00946,0.0234023402340234,0.00857,0.0308030803080308,Other Applications,0.0234023402340234,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Publication Year - 2016 (32),0.00939,0.0393039303930393,0.0061,0.107010701070107,Other Applications,0.0393039303930393,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Journal - Nat Commun (13),0.00939,0.0326032603260326,0.00769,0.0455045504550455,Other Applications,0.0326032603260326,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Gene Analysis Method - RNA (169),0.00929,0.0856085608560856,0.00962,0.0095009500950095,Other Applications,0.0095009500950095,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Journal - Rare (104),0.00905,0.0593059305930593,0.0087,0.0334033403340334,Other Applications,0.0334033403340334,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Electrophysiology Analysis Method - Optical Mapping (39),0.00897,0.033003300330033,0.01044,0.0121012101210121,Other Applications,0.0121012101210121,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),2D Surface - ECM-coated (115),0.00839,0.0664066406640664,0.01233,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Cell Line - Rare (132),0.00816,0.1319131913191319,0.01002,0.0076007600760076,Other Applications,0.0076007600760076,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Publication Year - Post 2020 (122),0.0074,0.2174217421742174,0.00976,0.0115011501150115,Other Applications,0.0115011501150115,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Number of Cell Lines - 4 (11),0.00734,0.0457045704570457,0.01751,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Contractile Analysis Method - Motion Tracking (93),0.00733,0.1503150315031503,0.00876,0.0411041104110411,Other Applications,0.0411041104110411,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),3D Platform - Polyethylene Glycol (8),0.00724,0.0437043704370437,0.00772,0.0413041304130413,Other Applications,0.0413041304130413,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Disease Modelling - Arrhythmic (15),0.00684,0.0525052505250525,0.00821,0.0283028302830283,Other Applications,0.0283028302830283,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00677,0.0514051405140514,0.00836,0.0364036403640364,Other Applications,0.0364036403640364,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Publication Year - Late-2010s (196),0.00676,0.2659265926592659,0.00895,0.0218021802180218,Other Applications,0.0218021802180218,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.0067,0.2377237723772377,0.00832,0.0369036903690369,Other Applications,0.0369036903690369,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Coating for Replating - Gelatin (43),0.00655,0.0954095409540954,0.01047,0.0156015601560156,Other Applications,0.0156015601560156,True,True
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Journal - Cell Rep (6),0.00652,0.0408040804080408,0.00421,0.123012301230123,Other Applications,0.0408040804080408,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Wnt Inhibitor - BMP4 (7),0.00642,0.0436043604360436,0.00483,0.0828082808280828,Other Applications,0.0436043604360436,True,False
Pharmacological Intervention - β-Adrenergic Antagonists (β-Blockers) (18),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00497,0.0983098309830983,0.00716,0.045004500450045,Other Applications,0.045004500450045,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Sci Rep (24),0.0242,0.0005000500050005,0.02873,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Immunofluorescent Imaging - Yes (268),0.0167,0.003000300030003,0.01658,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Cell Line - iCell (47),0.01536,0.0069006900690069,0.01609,0.0012001200120012,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01518,0.0058005800580058,0.01143,0.0089008900890089,Other Applications,0.0058005800580058,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01464,0.0039003900390039,0.01008,0.0138013801380138,Other Applications,0.0039003900390039,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.01458,0.0034003400340034,0.01547,0.004000400040004,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Toxicological Sciences (4),0.01396,0.0038003800380038,0.01548,0.004000400040004,Other Applications,0.0038003800380038,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Coating for Replating - Matrigel (65),0.0139,0.0063006300630063,0.01469,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC Backbone Media - iCell Maintenance (86),0.01351,0.0076007600760076,0.0088,0.0386038603860386,Other Applications,0.0076007600760076,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Contractile Analysis Method - Deflection (39),0.01316,0.0059005900590059,0.01129,0.008000800080008,Other Applications,0.0059005900590059,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Publication Year - Post 2020 (122),0.01273,0.0206020602060206,0.01376,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.0124,0.0088008800880088,0.01153,0.007000700070007,Other Applications,0.007000700070007,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.01219,0.0126012601260126,0.01055,0.0137013701370137,Other Applications,0.0126012601260126,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D Tissue Media - Rare (13),0.01158,0.0114011401140114,0.01283,0.0062006200620062,Other Applications,0.0062006200620062,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Cell Coculture - Endothelial Cell (35),0.01128,0.0248024802480248,0.01002,0.0234023402340234,Other Applications,0.0234023402340234,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01034,0.0562056205620562,0.00965,0.0159015901590159,Other Applications,0.0159015901590159,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Tissue Eng Part C Methods (6),0.01032,0.0178017801780178,0.00995,0.0225022502250225,Other Applications,0.0178017801780178,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC Backbone Media - mTeSR (106),0.01023,0.0459045904590459,0.00279,0.9213921392139214,Other Applications,0.0459045904590459,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Rare (104),0.01003,0.036003600360036,0.00878,0.0312031203120312,Other Applications,0.0312031203120312,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00993,0.0345034503450345,0.00305,0.9270927092709272,Other Applications,0.0345034503450345,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Publication Year - 2020 (51),0.0098,0.0353035303530353,0.01257,0.0049004900490049,Other Applications,0.0049004900490049,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Nat Commun (13),0.00919,0.0275027502750275,0.00665,0.062006200620062,Other Applications,0.0275027502750275,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Publication Year - Late-2010s (196),0.00899,0.0772077207720772,0.01136,0.0016001600160016,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC-CM Purification Duration (days) - 8 days (4),0.00886,0.0192019201920192,0.00908,0.025002500250025,Other Applications,0.0192019201920192,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Insulin Withdrawal Duration (days) - 8 days (3),0.00886,0.0143014301430143,0.00803,0.0347034703470347,Other Applications,0.0143014301430143,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Calcium Handling Analysis Method - Visual (104),0.00855,0.1116111611161116,0.00967,0.015001500150015,Other Applications,0.015001500150015,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),hiPSC-CM Purification Duration (days) - >9 days (5),0.00783,0.0241024102410241,0.00718,0.0367036703670367,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Biomaterials (16),0.00752,0.0454045404540454,0.0069,0.055005500550055,Other Applications,0.0454045404540454,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Electrophysiology Analysis Method - Optical Mapping (39),0.00738,0.0605060506050605,0.00815,0.0396039603960396,Other Applications,0.0396039603960396,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Wnt Inhibitor - VEGF (3),0.00676,0.0422042204220422,0.00633,0.0787078707870787,Other Applications,0.0422042204220422,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.00673,0.0959095909590959,0.00821,0.0454045404540454,Other Applications,0.0454045404540454,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),2D Surface - ECM-coated (115),0.00661,0.2038203820382038,0.00929,0.0123012301230123,Other Applications,0.0123012301230123,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D Endothelial Cell Source - Rare (3),0.00631,0.0435043504350435,0.00515,0.1019101910191019,Other Applications,0.0435043504350435,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),T-tubule Structures - Yes (18),0.00626,0.0782078207820782,0.00798,0.044004400440044,Other Applications,0.044004400440044,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Cell Line - Rare (132),0.0062,0.4178417841784178,0.0085,0.0368036803680368,Other Applications,0.0368036803680368,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Maturation Strategy - Mechanical (36),0.00576,0.1183118311831183,0.01217,0.0057005700570057,Other Applications,0.0057005700570057,True,True
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Insulin Start Day - 0 (7),0.00514,0.0669066906690669,0.00903,0.0265026502650265,Other Applications,0.0265026502650265,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Journal - Sci Transl Med (3),0.0051,0.0755075507550755,0.0086,0.0276027602760276,Other Applications,0.0276027602760276,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.0048,0.2282228222822282,0.00809,0.0493049304930493,Other Applications,0.0493049304930493,True,False
Pharmacological Intervention - Traditional Chemotherapy Agents (18),Electrophysiology Analysis Method - Microelectrode (31),0.00439,0.2004200420042004,0.00984,0.0184018401840184,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - Doxorubicin (17),Journal - Sci Rep (24),0.0255,0.0003000300030003,0.02506,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Doxorubicin (17),Coating for Replating - Matrigel (65),0.0166,0.0026002600260026,0.01471,0.0016001600160016,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Doxorubicin (17),3D EC Ratio (CM-EC-SC) Quantiles - Q1 (>0 and ≤91) (31),0.01497,0.0071007100710071,0.01029,0.0203020302030203,Other Applications,0.0071007100710071,True,True
Pharmacological Intervention - Doxorubicin (17),Journal - Toxicological Sciences (4),0.01471,0.003000300030003,0.0173,0.002000200020002,Other Applications,0.002000200020002,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Maturation Media - iCell Maintenance (83),0.0144,0.0046004600460046,0.00795,0.0595059505950595,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - Doxorubicin (17),Publication Year - Late-2010s (196),0.01367,0.0095009500950095,0.01009,0.0084008400840084,Other Applications,0.0084008400840084,True,True
Pharmacological Intervention - Doxorubicin (17),Immunofluorescent Imaging - Yes (268),0.01322,0.0096009600960096,0.01298,0.0044004400440044,Other Applications,0.0044004400440044,True,True
Pharmacological Intervention - Doxorubicin (17),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.01282,0.0113011301130113,0.01214,0.0083008300830083,Other Applications,0.0083008300830083,True,True
Pharmacological Intervention - Doxorubicin (17),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.01262,0.0056005600560056,0.01662,0.0022002200220022,Other Applications,0.0022002200220022,True,True
Pharmacological Intervention - Doxorubicin (17),Cell Line - iCell (47),0.01232,0.0215021502150215,0.01278,0.0082008200820082,Other Applications,0.0082008200820082,True,True
Pharmacological Intervention - Doxorubicin (17),Cell Coculture - Endothelial Cell (35),0.01207,0.021002100210021,0.00873,0.0419041904190419,Other Applications,0.021002100210021,True,True
Pharmacological Intervention - Doxorubicin (17),Contractile Analysis Method - Motion Tracking (93),0.01115,0.0279027902790279,0.01217,0.0038003800380038,Other Applications,0.0038003800380038,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Media Supplement - B27 (180),0.01094,0.0406040604060406,0.00546,0.4423442344234423,Other Applications,0.0406040604060406,True,False
Pharmacological Intervention - Doxorubicin (17),Publication Year - 2020 (51),0.01091,0.0259025902590259,0.01273,0.0056005600560056,Other Applications,0.0056005600560056,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC Backbone Media - Embryonic Stem Cell (127),0.0109,0.0196019601960196,0.00313,0.91009100910091,Other Applications,0.0196019601960196,True,True
Pharmacological Intervention - Doxorubicin (17),2D Surface - ECM-coated (115),0.0109,0.0182018201820182,0.01159,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - Doxorubicin (17),Journal - Rare (104),0.01079,0.0273027302730273,0.01073,0.0069006900690069,Other Applications,0.0069006900690069,True,True
Pharmacological Intervention - Doxorubicin (17),Publication Year - Post 2020 (122),0.0105,0.0549054905490549,0.01289,0.0011001100110011,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC Backbone Media - mTeSR (106),0.01048,0.0423042304230423,0.00404,0.6582658265826583,Other Applications,0.0423042304230423,True,False
Pharmacological Intervention - Doxorubicin (17),Insulin Withdrawal Duration (days) - 8 days (3),0.00992,0.0092009200920092,0.00988,0.0171017101710171,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Doxorubicin (17),Journal - Nat Commun (13),0.00984,0.0281028102810281,0.0061,0.0885088508850885,Other Applications,0.0281028102810281,True,False
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Purification Duration (days) - 8 days (4),0.00944,0.0186018601860186,0.00962,0.0242024202420242,Other Applications,0.0186018601860186,True,True
Pharmacological Intervention - Doxorubicin (17),Journal - Tissue Eng Part C Methods (6),0.00937,0.0272027202720272,0.01046,0.0225022502250225,Other Applications,0.0225022502250225,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC Backbone Media - iCell Maintenance (86),0.00922,0.0489048904890489,0.01045,0.0125012501250125,Other Applications,0.0125012501250125,True,True
Pharmacological Intervention - Doxorubicin (17),Calcium Handling Analysis Method - Visual (104),0.0089,0.1042104210421042,0.00846,0.0438043804380438,Other Applications,0.0438043804380438,True,False
Pharmacological Intervention - Doxorubicin (17),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.00882,0.116011601160116,0.01074,0.0076007600760076,Other Applications,0.0076007600760076,True,True
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.00871,0.0472047204720472,0.00887,0.0306030603060306,Other Applications,0.0306030603060306,True,False
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Purification Duration (days) - >9 days (5),0.00821,0.0226022602260226,0.00797,0.0274027402740274,Other Applications,0.0226022602260226,True,True
Pharmacological Intervention - Doxorubicin (17),Coating for Replating - Gelatin (43),0.00777,0.0646064606460646,0.0091,0.0363036303630363,Other Applications,0.0363036303630363,True,False
Pharmacological Intervention - Doxorubicin (17),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.00775,0.143014301430143,0.01079,0.0071007100710071,Other Applications,0.0071007100710071,True,True
Pharmacological Intervention - Doxorubicin (17),Publication Year - 2016 (32),0.00724,0.0767076707670767,0.00892,0.0343034303430343,Other Applications,0.0343034303430343,True,False
Pharmacological Intervention - Doxorubicin (17),Maturation Strategy - Other Cells (80),0.00723,0.1276127612761276,0.01016,0.0175017501750175,Other Applications,0.0175017501750175,True,True
Pharmacological Intervention - Doxorubicin (17),3D Endothelial Cell Source - Rare (3),0.007,0.0333033303330333,0.00482,0.1083108310831083,Other Applications,0.0333033303330333,True,False
Pharmacological Intervention - Doxorubicin (17),hiPSC-CM Purification Duration (days) Quantiles - Q1 (>4 and ≤20) (31),0.00686,0.0722072207220722,0.00885,0.0306030603060306,Other Applications,0.0306030603060306,True,False
Pharmacological Intervention - Doxorubicin (17),3D CM Ratio (CM-EC-SC) Quantiles - Q3 (>9 and ≤75) (48),0.00679,0.0981098109810981,0.00849,0.0392039203920392,Other Applications,0.0392039203920392,True,False
Pharmacological Intervention - Doxorubicin (17),Wnt Inhibitor - VEGF (3),0.00679,0.0457045704570457,0.008,0.0466046604660466,Other Applications,0.0457045704570457,True,False
Pharmacological Intervention - Doxorubicin (17),3D Tissue Media - Commercial Kit (21),0.0066,0.0733073307330733,0.0082,0.0357035703570357,Other Applications,0.0357035703570357,True,False
Pharmacological Intervention - Doxorubicin (17),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.00656,0.1018101810181018,0.00855,0.0442044204420442,Other Applications,0.0442044204420442,True,False
Pharmacological Intervention - Doxorubicin (17),Wnt Inhibitor - Wnt-C59 (30),0.00647,0.0966096609660966,0.00957,0.027002700270027,Other Applications,0.027002700270027,True,False
Pharmacological Intervention - Doxorubicin (17),Insulin Start Day - 0 (7),0.006,0.0576057605760576,0.0072,0.0477047704770477,Other Applications,0.0477047704770477,True,False
Pharmacological Intervention - Doxorubicin (17),Publication Year - 2019 (57),0.00597,0.1611161116111611,0.00882,0.0384038403840384,Other Applications,0.0384038403840384,True,False
Pharmacological Intervention - Doxorubicin (17),Journal - Sci Transl Med (3),0.00555,0.0708070807080708,0.00776,0.0465046504650465,Other Applications,0.0465046504650465,True,False
Pharmacological Intervention - Doxorubicin (17),Electrophysiology Analysis Method - Microelectrode (31),0.00484,0.1721172117211721,0.01073,0.0128012801280128,Other Applications,0.0128012801280128,True,True
Pharmacological Intervention - Doxorubicin (17),3D Tissue Media - Rare (13),0.0045,0.1311131113111311,0.00817,0.0387038703870387,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Doxorubicin (17),3D Tissue Media - Growth Factor (12),0.004,0.1435143514351435,0.00725,0.0475047504750475,Other Applications,0.0475047504750475,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Electrophysiology Analysis Method - Microelectrode (31),0.04077,0.0,0.03755,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Cell Line - iCell (47),0.02629,0.0005000500050005,0.01814,0.0008000800080008,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.0192,0.0092009200920092,0.01222,0.0016001600160016,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Calcium Handling Analysis Method - Visual (104),0.01765,0.0069006900690069,0.01459,0.0007000700070007,Other Applications,0.0007000700070007,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Journal - Biomaterials (16),0.01652,0.0036003600360036,0.01689,0.002000200020002,Other Applications,0.002000200020002,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Journal - Toxicological Sciences (4),0.01578,0.0031003100310031,0.02121,0.0011001100110011,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Number of Cell Lines - 3 (29),0.01515,0.0075007500750075,0.0127,0.0098009800980098,Other Applications,0.0075007500750075,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Wnt Inhibitor Duration (days) - Rare (173),0.01482,0.01000100010001,0.00656,0.2521252125212521,Other Applications,0.01000100010001,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Electrophysiology Analysis Method - Optical Mapping (39),0.01464,0.0075007500750075,0.01509,0.0014001400140014,Other Applications,0.0014001400140014,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Journal - Nat Commun (13),0.01319,0.0125012501250125,0.01241,0.0113011301130113,Other Applications,0.0113011301130113,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),hiPSC Backbone Media - iCell Maintenance (86),0.01297,0.0121012101210121,0.01197,0.0064006400640064,Other Applications,0.0064006400640064,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01215,0.0166016601660166,0.0138,0.0009000900090009,Other Applications,0.0009000900090009,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.01196,0.0314031403140314,0.00746,0.1377137713771377,Other Applications,0.0314031403140314,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Immunofluorescent Imaging - Yes (268),0.01149,0.0223022302230223,0.00864,0.0564056405640564,Other Applications,0.0223022302230223,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.01065,0.0293029302930293,0.00783,0.0596059605960596,Other Applications,0.0293029302930293,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),3D Platform - Polyethylene Glycol (8),0.01058,0.0211021102110211,0.01057,0.02000200020002,Other Applications,0.02000200020002,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Cell Line - DF19-9-11T.H (16),0.01039,0.0241024102410241,0.00457,0.1561156115611561,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Number of Cell Lines - 4 (11),0.01032,0.0232023202320232,0.01315,0.0092009200920092,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Publication Year - 2016 (32),0.00988,0.0401040104010401,0.01253,0.0081008100810081,Other Applications,0.0081008100810081,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Journal - Rare (104),0.0097,0.0501050105010501,0.00876,0.0397039703970397,Other Applications,0.0397039703970397,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Number of Cell Lines - 1 (225),0.00952,0.0542054205420542,0.01348,0.0021002100210021,Other Applications,0.0021002100210021,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Publication Year - 2021 (43),0.00947,0.0419041904190419,0.01061,0.0183018301830183,Other Applications,0.0183018301830183,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),3D Tissue Media - Commercial Kit (21),0.00897,0.0381038103810381,0.01471,0.0036003600360036,Other Applications,0.0036003600360036,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Coating for Replating - Rare (6),0.00869,0.0367036703670367,0.00958,0.0317031703170317,Other Applications,0.0317031703170317,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),hiPSC-CM Purification Duration (days) - 5 days (6),0.00838,0.0286028602860286,0.00827,0.0334033403340334,Other Applications,0.0286028602860286,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Cell Line - 253G1 (10),0.00784,0.0383038303830383,0.00404,0.1425142514251425,Other Applications,0.0383038303830383,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),0.00743,0.0388038803880388,0.00821,0.0321032103210321,Other Applications,0.0321032103210321,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00727,0.0436043604360436,0.00817,0.0379037903790379,Other Applications,0.0379037903790379,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Coating for Replating - Gelatin (43),0.00672,0.1057105710571057,0.00947,0.0373037303730373,Other Applications,0.0373037303730373,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Cell Line - Rare (132),0.00668,0.3179317931793179,0.01196,0.0021002100210021,Other Applications,0.0021002100210021,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Journal - Cell Rep (6),0.00665,0.0431043104310431,0.01092,0.0164016401640164,Other Applications,0.0164016401640164,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00661,0.0442044204420442,0.01195,0.0092009200920092,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Cell Line Ancestry - Caucasian (41),0.00628,0.1259125912591259,0.01104,0.0174017401740174,Other Applications,0.0174017401740174,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00575,0.0632063206320632,0.00846,0.0279027902790279,Other Applications,0.0279027902790279,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00569,0.0544054405440544,0.00716,0.0385038503850385,Other Applications,0.0385038503850385,True,False
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.00561,0.0873087308730873,0.01071,0.0163016301630163,Other Applications,0.0163016301630163,True,True
Pharmacological Intervention - Class II Antiarrhythmics (β-Blockers for Arrhythmia) (14),Number of Cell Lines - >5 (9),0.00548,0.0827082708270827,0.00997,0.0267026702670267,Other Applications,0.0267026702670267,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Number of Cell Lines - 3 (29),0.02011,0.0029002900290029,0.01799,0.0013001300130013,Other Applications,0.0013001300130013,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Journal - Toxicological Sciences (4),0.01974,0.0017001700170017,0.0225,0.0016001600160016,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Number of Cell Lines - 1 (225),0.01818,0.0043004300430043,0.01657,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Wnt Inhibitor Duration (days) - >6 days (12),0.01459,0.0074007400740074,0.01347,0.0061006100610061,Other Applications,0.0061006100610061,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01343,0.0165016501650165,0.01039,0.0223022302230223,Other Applications,0.0165016501650165,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Cell Line - Cor.4U (16),0.01311,0.0143014301430143,0.01218,0.0139013901390139,Other Applications,0.0139013901390139,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC-CM Purification Duration (days) - 3 days (13),0.01296,0.0102010201020102,0.01249,0.0102010201020102,Other Applications,0.0102010201020102,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Coating for Replating - Rare (6),0.0128,0.0158015801580158,0.00984,0.0302030203020302,Other Applications,0.0158015801580158,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01276,0.0085008500850085,0.01304,0.0064006400640064,Other Applications,0.0064006400640064,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Publication Year - 2019 (57),0.01265,0.0162016201620162,0.01412,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Cell Line - iCell (47),0.01219,0.0251025102510251,0.00912,0.0463046304630463,Other Applications,0.0251025102510251,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Immunofluorescent Imaging - Yes (268),0.01214,0.0206020602060206,0.01486,0.0037003700370037,Other Applications,0.0037003700370037,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC Matrix Coating - Matrigel (163),0.01076,0.0298029802980298,0.00575,0.4524452445244524,Other Applications,0.0298029802980298,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Journal - Sci Rep (24),0.01046,0.0331033103310331,0.01216,0.0143014301430143,Other Applications,0.0143014301430143,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Wnt Inhibitor - DS-I-7 (9),0.00997,0.022002200220022,0.01265,0.0092009200920092,Other Applications,0.0092009200920092,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC Backbone Media - Rare (19),0.0097,0.0263026302630263,0.00532,0.1291129112911291,Other Applications,0.0263026302630263,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00967,0.042004200420042,0.00433,0.6512651265126512,Other Applications,0.042004200420042,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Cell Line - iCell2 (8),0.00937,0.0328032803280328,0.0123,0.0186018601860186,Other Applications,0.0186018601860186,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Number of Cell Lines - 4 (11),0.00921,0.04000400040004,0.00902,0.039003900390039,Other Applications,0.039003900390039,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Journal - Cell Rep (6),0.00895,0.026002600260026,0.00933,0.0278027802780278,Other Applications,0.026002600260026,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Maturation Strategy - ECM (21),0.00894,0.0306030603060306,0.00944,0.0253025302530253,Other Applications,0.0253025302530253,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Insulin Withdrawal Duration (days) Quantiles - Q2 (>2 and ≤4) (25),0.00873,0.0499049904990499,0.009,0.0421042104210421,Other Applications,0.0421042104210421,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),3D Estimated Tissue Size (mm2) Quantiles - Q2 (>9.12 and ≤26.2) (26),0.00871,0.0503050305030503,0.01018,0.0239023902390239,Other Applications,0.0239023902390239,True,True
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Action Potential Amplitude (mV) Quantiles - Q4 (>50 and ≤97) (12),0.00843,0.0402040204020402,0.00557,0.0928092809280928,Other Applications,0.0402040204020402,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.0081,0.0348034803480348,0.00917,0.027002700270027,Other Applications,0.027002700270027,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Insulin Start Day - 6 (20),0.00751,0.0613061306130613,0.00958,0.0277027702770277,Other Applications,0.0277027702770277,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),hiPSC-CM Media Supplement - Lipid Mix (5),0.00726,0.0475047504750475,0.00766,0.0516051605160516,Other Applications,0.0475047504750475,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.007,0.0664066406640664,0.01026,0.0271027102710271,Other Applications,0.0271027102710271,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.00614,0.0696069606960696,0.00915,0.0296029602960296,Other Applications,0.0296029602960296,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Wnt Inhibitor - KY02111 (7),0.00576,0.0768076807680768,0.00923,0.03000300030003,Other Applications,0.03000300030003,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Journal - Cell Stem Cell (6),0.00443,0.1366136613661366,0.00798,0.0403040304030403,Other Applications,0.0403040304030403,True,False
Pharmacological Intervention - Other Antiarrhythmic Agents (13),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.00366,0.2608260826082608,0.00898,0.0352035203520352,Other Applications,0.0352035203520352,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Immunofluorescent Imaging - Yes (268),0.02299,0.0012001200120012,0.01215,0.0113011301130113,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),hiPSC-CM Maturation Media - iCell Maintenance (83),0.02289,0.0006000600060006,0.01334,0.0015001500150015,Other Applications,0.0006000600060006,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Journal - Nat Commun (13),0.01975,0.0031003100310031,0.02229,0.0013001300130013,Other Applications,0.0013001300130013,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Cell Line - iCell2 (8),0.01891,0.0031003100310031,0.02655,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Wnt Inhibitor Duration (days) - Rare (173),0.01732,0.0054005400540054,0.00789,0.0872087208720872,Other Applications,0.0054005400540054,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01628,0.0085008500850085,0.00903,0.0441044104410441,Other Applications,0.0085008500850085,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Journal - Toxicological Sciences (4),0.01519,0.004000400040004,0.02516,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Journal - Lab Chip (4),0.01315,0.0084008400840084,0.01199,0.0126012601260126,Other Applications,0.0084008400840084,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.01205,0.0327032703270327,0.00482,0.6543654365436543,Other Applications,0.0327032703270327,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Electrophysiology Analysis Method - Microelectrode (31),0.01197,0.0226022602260226,0.01826,0.0006000600060006,Other Applications,0.0006000600060006,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Calcium Handling Analysis Method - Visual (104),0.01185,0.0447044704470447,0.0106,0.0142014201420142,Other Applications,0.0142014201420142,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),2D Surface - ECM-coated (115),0.01163,0.0152015201520152,0.01147,0.0026002600260026,Other Applications,0.0026002600260026,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Disease Modelling - Ischemic Infarction (9),0.01138,0.0237023702370237,0.0125,0.0155015501550155,Other Applications,0.0155015501550155,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01137,0.0319031903190319,0.01154,0.0162016201620162,Other Applications,0.0162016201620162,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),hiPSC Backbone Media - iCell Maintenance (86),0.01136,0.0261026102610261,0.00632,0.2231223122312231,Other Applications,0.0261026102610261,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Coating for Replating - Matrigel (65),0.0107,0.0334033403340334,0.01109,0.0185018501850185,Other Applications,0.0185018501850185,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),3D Tissue Media - Rare (13),0.01041,0.0314031403140314,0.01243,0.0138013801380138,Other Applications,0.0138013801380138,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Publication Year - 2020 (51),0.00929,0.0637063706370637,0.01094,0.0249024902490249,Other Applications,0.0249024902490249,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.00917,0.0312031203120312,0.00929,0.0282028202820282,Other Applications,0.0282028202820282,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Electrophysiology Analysis Method - Optical Mapping (39),0.00883,0.0449044904490449,0.01544,0.0018001800180018,Other Applications,0.0018001800180018,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Maturation Strategy - Electrical (39),0.0088,0.0648064806480648,0.00989,0.0378037803780378,Other Applications,0.0378037803780378,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00872,0.0247024702470247,0.01066,0.0174017401740174,Other Applications,0.0174017401740174,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),3D Platform - Extracellular Scaffold (18),0.00848,0.0504050405040504,0.00883,0.039003900390039,Other Applications,0.039003900390039,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Maturation Strategy - ECM (21),0.00847,0.0446044604460446,0.00678,0.0845084508450845,Other Applications,0.0446044604460446,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),hiPSC-CM Purification Duration (days) - 5 days (6),0.00838,0.0348034803480348,0.009,0.0335033503350335,Other Applications,0.0335033503350335,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Contractile Analysis Method - Motion Tracking (93),0.00825,0.1149114911491149,0.01201,0.0097009700970097,Other Applications,0.0097009700970097,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Differentiation Purity Assessment - Flow Cytometry VCAM1+ (4),0.00811,0.0305030503050305,0.00562,0.101010101010101,Other Applications,0.0305030503050305,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),2D Surface - Microelectrode Array (9),0.00804,0.0419041904190419,0.00803,0.0411041104110411,Other Applications,0.0411041104110411,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Sarcomere Length (um) Quantiles - Q4 (>1.64 and ≤1.75) (14),0.00795,0.0574057405740574,0.01112,0.0201020102010201,Other Applications,0.0201020102010201,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Wnt Inhibitor - BMP4 (7),0.00786,0.0317031703170317,0.00542,0.0981098109810981,Other Applications,0.0317031703170317,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Publication Year - 2017 (43),0.00712,0.121012101210121,0.01083,0.0281028102810281,Other Applications,0.0281028102810281,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),hiPSC-CM Media Supplement - B27 (180),0.00698,0.2961296129612961,0.01026,0.0091009100910091,Other Applications,0.0091009100910091,True,True
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Publication Year - Late-2010s (196),0.00604,0.3889388938893889,0.0095,0.0253025302530253,Other Applications,0.0253025302530253,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Publication Year - Post 2020 (122),0.00557,0.5512551255125513,0.00949,0.0291029102910291,Other Applications,0.0291029102910291,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00548,0.0671067106710671,0.00778,0.0387038703870387,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.00501,0.0853085308530853,0.0081,0.0312031203120312,Other Applications,0.0312031203120312,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00465,0.1254125412541254,0.00772,0.0486048604860486,Other Applications,0.0486048604860486,True,False
Pharmacological Intervention - Mixed α/β-Adrenergic Agonists (12),3D Estimated Cell Density (mil cells/mL) Quantiles - Q4 (>0.47 and ≤5) (25),0.00438,0.1774177417741774,0.01249,0.0097009700970097,Other Applications,0.0097009700970097,True,True
Pharmacological Intervention - Epinephrine (11),Immunofluorescent Imaging - Yes (268),0.02714,0.0003000300030003,0.0154,0.0036003600360036,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Epinephrine (11),Cell Line - iCell2 (8),0.02419,0.0023002300230023,0.0308,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Epinephrine (11),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01925,0.0044004400440044,0.01052,0.0194019401940194,Other Applications,0.0044004400440044,True,True
Pharmacological Intervention - Epinephrine (11),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01841,0.0019001900190019,0.01333,0.0024002400240024,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - Epinephrine (11),Journal - Toxicological Sciences (4),0.01783,0.0028002800280028,0.02558,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Epinephrine (11),Journal - Nat Commun (13),0.01744,0.0073007300730073,0.0186,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Epinephrine (11),Electrophysiology Analysis Method - Microelectrode (31),0.01701,0.0075007500750075,0.01943,0.0015001500150015,Other Applications,0.0015001500150015,True,True
Pharmacological Intervention - Epinephrine (11),Wnt Inhibitor Duration (days) - Rare (173),0.01693,0.0066006600660066,0.0082,0.073007300730073,Other Applications,0.0066006600660066,True,True
Pharmacological Intervention - Epinephrine (11),hiPSC Backbone Media - iCell Maintenance (86),0.01618,0.0054005400540054,0.01274,0.0059005900590059,Other Applications,0.0054005400540054,True,True
Pharmacological Intervention - Epinephrine (11),hiPSC Backbone Media - RPMI-1640 (167),0.01329,0.0124012401240124,0.00732,0.1114111411141114,Other Applications,0.0124012401240124,True,True
Pharmacological Intervention - Epinephrine (11),Journal - Lab Chip (4),0.01295,0.0078007800780078,0.01475,0.0075007500750075,Other Applications,0.0075007500750075,True,True
Pharmacological Intervention - Epinephrine (11),Disease Modelling - Ischemic Infarction (9),0.01239,0.0214021402140214,0.01445,0.0116011601160116,Other Applications,0.0116011601160116,True,True
Pharmacological Intervention - Epinephrine (11),Journal - Rare (104),0.01227,0.023002300230023,0.00999,0.0241024102410241,Other Applications,0.023002300230023,True,True
Pharmacological Intervention - Epinephrine (11),Coating for Replating - Matrigel (65),0.01211,0.0206020602060206,0.01202,0.0108010801080108,Other Applications,0.0108010801080108,True,True
Pharmacological Intervention - Epinephrine (11),Cell Line - Rare (132),0.01205,0.0218021802180218,0.01015,0.0242024202420242,Other Applications,0.0218021802180218,True,True
Pharmacological Intervention - Epinephrine (11),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.01195,0.0367036703670367,0.00473,0.6551655165516551,Other Applications,0.0367036703670367,True,False
Pharmacological Intervention - Epinephrine (11),Maturation Strategy - Electrical (39),0.01179,0.0339033903390339,0.01311,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Epinephrine (11),Differentiation Purity Assessment - Flow Cytometry cTnT+ (135),0.01118,0.0243024302430243,0.00638,0.2463246324632463,Other Applications,0.0243024302430243,True,True
Pharmacological Intervention - Epinephrine (11),2D Surface - ECM-coated (115),0.01105,0.0189018901890189,0.01133,0.0045004500450045,Other Applications,0.0045004500450045,True,True
Pharmacological Intervention - Epinephrine (11),Electrophysiology Analysis Method - Optical Mapping (39),0.01052,0.0294029402940294,0.01574,0.0025002500250025,Other Applications,0.0025002500250025,True,True
Pharmacological Intervention - Epinephrine (11),Cell Coculture - Endothelial Cell (35),0.01052,0.0502050205020502,0.01188,0.0241024102410241,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Epinephrine (11),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01006,0.0255025502550255,0.01238,0.0136013601360136,Other Applications,0.0136013601360136,True,True
Pharmacological Intervention - Epinephrine (11),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00992,0.0184018401840184,0.00959,0.0254025402540254,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - Epinephrine (11),Publication Year - 2020 (51),0.00974,0.0537053705370537,0.01073,0.0282028202820282,Other Applications,0.0282028202820282,True,False
Pharmacological Intervention - Epinephrine (11),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.00972,0.048004800480048,0.00835,0.0634063406340634,Other Applications,0.048004800480048,True,False
Pharmacological Intervention - Epinephrine (11),3D Platform - Extracellular Scaffold (18),0.0097,0.0413041304130413,0.00929,0.0395039503950395,Other Applications,0.0395039503950395,True,False
Pharmacological Intervention - Epinephrine (11),3D Tissue Media - Rare (13),0.00954,0.0425042504250425,0.00833,0.0537053705370537,Other Applications,0.0425042504250425,True,False
Pharmacological Intervention - Epinephrine (11),Calcium Handling Analysis Method - Visual (104),0.00899,0.1099109910991099,0.00882,0.0499049904990499,Other Applications,0.0499049904990499,True,False
Pharmacological Intervention - Epinephrine (11),Contraction Upstroke Velocity (um/s) Quantiles - Q3 (>10 and ≤31.5) (7),0.00881,0.0367036703670367,0.0061,0.0932093209320932,Other Applications,0.0367036703670367,True,False
Pharmacological Intervention - Epinephrine (11),2D Surface - Microelectrode Array (9),0.00861,0.035003500350035,0.01031,0.0233023302330233,Other Applications,0.0233023302330233,True,True
Pharmacological Intervention - Epinephrine (11),Publication Year - 2017 (43),0.00844,0.083008300830083,0.01251,0.0143014301430143,Other Applications,0.0143014301430143,True,True
Pharmacological Intervention - Epinephrine (11),hiPSC-CM Purification Duration (days) - 5 days (6),0.00827,0.0398039803980398,0.00973,0.0272027202720272,Other Applications,0.0272027202720272,True,False
Pharmacological Intervention - Epinephrine (11),Wnt Inhibitor - BMP4 (7),0.00806,0.0304030403040304,0.008,0.0411041104110411,Other Applications,0.0304030403040304,True,False
Pharmacological Intervention - Epinephrine (11),Cell Line - iCell (47),0.00732,0.1205120512051205,0.01179,0.0221022102210221,Other Applications,0.0221022102210221,True,True
Pharmacological Intervention - Epinephrine (11),Contractile Analysis Method - Motion Tracking (93),0.0071,0.1804180418041804,0.01091,0.023002300230023,Other Applications,0.023002300230023,True,True
Pharmacological Intervention - Epinephrine (11),Publication Year - Late-2010s (196),0.00625,0.341034103410341,0.00898,0.0432043204320432,Other Applications,0.0432043204320432,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Number of Cell Lines - 3 (29),0.02611,0.0008000800080008,0.0225,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Cell Line - Cor.4U (16),0.02424,0.0021002100210021,0.02574,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Number of Cell Lines - 1 (225),0.02402,0.0007000700070007,0.02129,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.02318,0.0024002400240024,0.02396,0.0025002500250025,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Cell Line - iCell (47),0.02283,0.0042004200420042,0.01414,0.0103010301030103,Other Applications,0.0042004200420042,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.02241,0.0015001500150015,0.00873,0.0772077207720772,Other Applications,0.0015001500150015,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Disease Modelling - Arrhythmic (15),0.02066,0.0029002900290029,0.01828,0.0039003900390039,Other Applications,0.0029002900290029,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Electrophysiology Analysis Method - Microelectrode (31),0.01997,0.0031003100310031,0.01947,0.0014001400140014,Other Applications,0.0014001400140014,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),2D Surface - Microelectrode Array (9),0.01858,0.0024002400240024,0.01806,0.0026002600260026,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Journal - Cell Rep (6),0.01769,0.0064006400640064,0.02526,0.0013001300130013,Other Applications,0.0013001300130013,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01626,0.0101010101010101,0.01263,0.0115011501150115,Other Applications,0.0101010101010101,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01583,0.0088008800880088,0.02169,0.002000200020002,Other Applications,0.002000200020002,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01405,0.0169016901690169,0.01602,0.0072007200720072,Other Applications,0.0072007200720072,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Journal - Toxicological Sciences (4),0.01373,0.0086008600860086,0.01574,0.0078007800780078,Other Applications,0.0078007800780078,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),hiPSC-CM Media Supplement - Rare (5),0.01331,0.0106010601060106,0.00955,0.0377037703770377,Other Applications,0.0106010601060106,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Immunofluorescent Imaging - Yes (268),0.01195,0.0275027502750275,0.00928,0.0652065206520652,Other Applications,0.0275027502750275,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Insulin Start Day - 1 (19),0.01193,0.0225022502250225,0.00402,0.2187218721872187,Other Applications,0.0225022502250225,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),hiPSC Backbone Media - iCell Maintenance (86),0.01162,0.0245024502450245,0.01029,0.0337033703370337,Other Applications,0.0245024502450245,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01109,0.0273027302730273,0.01082,0.0155015501550155,Other Applications,0.0155015501550155,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Coating for Replating - Gelatin (43),0.011,0.0355035503550355,0.01304,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01049,0.0219021902190219,0.00899,0.04000400040004,Other Applications,0.0219021902190219,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Coating for Replating - Geltrex (10),0.00977,0.0345034503450345,0.01252,0.018001800180018,Other Applications,0.018001800180018,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Electrophysiology Analysis Method - Motion-Contrast Reconstruction (5),0.00959,0.0328032803280328,0.00769,0.0672067206720672,Other Applications,0.0328032803280328,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Coating for Replating - Rare (6),0.00929,0.0402040204020402,0.01311,0.0149014901490149,Other Applications,0.0149014901490149,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Number of Cell Lines - 4 (11),0.00925,0.0438043804380438,0.01112,0.0306030603060306,Other Applications,0.0306030603060306,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),2D Surface - ECM-coated (115),0.00886,0.0566056605660566,0.01069,0.0199019901990199,Other Applications,0.0199019901990199,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00882,0.0404040404040404,0.00832,0.0574057405740574,Other Applications,0.0404040404040404,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Disease Modelling - Genetic Disorders (18),0.00769,0.0735073507350735,0.01114,0.0227022702270227,Other Applications,0.0227022702270227,True,True
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),hiPSC-CM Maturation Media - Cor.4U Complete (6),0.00764,0.0429042904290429,0.00757,0.054005400540054,Other Applications,0.0429042904290429,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Journal - Rare (104),0.00756,0.1351135113511351,0.01024,0.0272027202720272,Other Applications,0.0272027202720272,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Insulin Start Day - 11 (3),0.00736,0.0566056605660566,0.00908,0.046004600460046,Other Applications,0.046004600460046,True,False
Pharmacological Intervention - Class III Antiarrhythmics (K+ Channel Blockers - Prolong Repolarization) (10),Electrophysiology Analysis Method - Genetical (3),0.00538,0.0762076207620762,0.01014,0.0429042904290429,Other Applications,0.0429042904290429,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Cell Line - Cor.4U (16),0.03972,0.0002000200020002,0.02847,0.0004000400040004,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Number of Cell Lines - 1 (225),0.02601,0.0005000500050005,0.021,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Cell Line - iCell (47),0.02588,0.0017001700170017,0.02219,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Journal - Cell Rep (6),0.02512,0.001000100010001,0.02812,0.0007000700070007,Other Applications,0.0007000700070007,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Number of Cell Lines - 3 (29),0.02433,0.0016001600160016,0.01946,0.003000300030003,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Journal - Toxicological Sciences (4),0.0231,0.0016001600160016,0.02916,0.0007000700070007,Other Applications,0.0007000700070007,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Journal - Int J Mol Sci (3),0.02002,0.0018001800180018,0.02673,0.0016001600160016,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01903,0.0046004600460046,0.01465,0.0138013801380138,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Journal - Acta Biomater (10),0.01827,0.0086008600860086,0.01752,0.0072007200720072,Other Applications,0.0072007200720072,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Number of Cell Lines - >5 (9),0.01727,0.011001100110011,0.02124,0.0033003300330033,Other Applications,0.0033003300330033,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01519,0.0176017601760176,0.01971,0.0041004100410041,Other Applications,0.0041004100410041,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.01515,0.008000800080008,0.01444,0.0102010201020102,Other Applications,0.008000800080008,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Coating for Replating - Gelatin (43),0.01488,0.0164016401640164,0.00795,0.1000100010001,Other Applications,0.0164016401640164,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01239,0.0271027102710271,0.00572,0.3673367336733673,Other Applications,0.0271027102710271,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Disease Modelling - Arrhythmic (15),0.0117,0.0295029502950295,0.0141,0.0135013501350135,Other Applications,0.0135013501350135,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),hiPSC Backbone Media - Cor.4U Complete (6),0.01142,0.0175017501750175,0.01407,0.0122012201220122,Other Applications,0.0122012201220122,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Journal - Rare (104),0.00976,0.0478047804780478,0.00799,0.1112111211121112,Other Applications,0.0478047804780478,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Number of Cell Lines - 4 (11),0.00968,0.0404040404040404,0.01193,0.0279027902790279,Other Applications,0.0279027902790279,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),3D Tissue Media - Rare (13),0.00921,0.0551055105510551,0.01186,0.0285028502850285,Other Applications,0.0285028502850285,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),hiPSC-CM Maturation Media - Cor.4U Complete (6),0.00917,0.029002900290029,0.00972,0.0294029402940294,Other Applications,0.029002900290029,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Seeding Confluency 2D (%) - 80 to 84 (5),0.00916,0.0498049804980498,0.00578,0.1046104610461046,Other Applications,0.0498049804980498,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Calcium Handling Analysis Method - Visual (104),0.00916,0.1179117911791179,0.0106,0.0329032903290329,Other Applications,0.0329032903290329,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Contractile Analysis Method - Traction Force Microscopy (9),0.00864,0.0394039403940394,0.01222,0.0174017401740174,Other Applications,0.0174017401740174,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Disease Modelling - Hypertrophic Cardiomyopathy (6),0.00743,0.0622062206220622,0.01615,0.0059005900590059,Other Applications,0.0059005900590059,True,True
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.00722,0.0674067406740674,0.00892,0.0485048504850485,Other Applications,0.0485048504850485,True,False
Pharmacological Intervention - Class Ib Antiarrhythmics (Na+ Channel Blockers - Weak Blockade) (9),2D Surface - Microelectrode Array (9),0.00721,0.0676067606760676,0.00878,0.0465046504650465,Other Applications,0.0465046504650465,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Journal - Toxicological Sciences (4),0.05645,0.0,0.06783,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Cell Line - iCell (47),0.02265,0.0044004400440044,0.0201,0.0012001200120012,Other Applications,0.0012001200120012,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Number of Cell Lines - 4 (11),0.02152,0.0034003400340034,0.0212,0.0037003700370037,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),2D Surface - Decellularized ECM (3),0.01893,0.0018001800180018,0.0191,0.0027002700270027,Other Applications,0.0018001800180018,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Number of Cell Lines - 1 (225),0.01591,0.0095009500950095,0.01195,0.0109010901090109,Other Applications,0.0095009500950095,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Immunofluorescent Imaging - Yes (268),0.01543,0.01000100010001,0.01772,0.0018001800180018,Other Applications,0.0018001800180018,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Gene Analysis Method - RNA (169),0.01512,0.0123012301230123,0.01356,0.0014001400140014,Other Applications,0.0014001400140014,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Insulin Start Day - 6 (20),0.01492,0.0129012901290129,0.00923,0.052005200520052,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),3D Tissue Media - Commercial Kit (21),0.01459,0.0133013301330133,0.01495,0.0088008800880088,Other Applications,0.0088008800880088,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Journal - Sci Rep (24),0.0144,0.0185018501850185,0.01301,0.0184018401840184,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Publication Year - 2019 (57),0.01246,0.0257025702570257,0.00699,0.1542154215421542,Other Applications,0.0257025702570257,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),hiPSC-CM Media Supplement - Nonessential Amino Acids (8),0.01213,0.0187018701870187,0.00675,0.0867086708670867,Other Applications,0.0187018701870187,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01199,0.016001600160016,0.01272,0.0179017901790179,Other Applications,0.016001600160016,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Coating for Replating - Gelatin (43),0.01166,0.0357035703570357,0.0112,0.03000300030003,Other Applications,0.03000300030003,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Number of Cell Lines - 2 (50),0.01146,0.0458045804580458,0.00815,0.0907090709070907,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Wnt Inhibitor Duration (days) - >6 days (12),0.01103,0.0266026602660266,0.00591,0.1128112811281128,Other Applications,0.0266026602660266,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Contractile Analysis Method - Deflection (39),0.01043,0.042004200420042,0.01011,0.0463046304630463,Other Applications,0.042004200420042,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),hiPSC-CM Media Supplement - Polyvinylalchohol (6),0.01008,0.0375037503750375,0.0056,0.1188118811881188,Other Applications,0.0375037503750375,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Publication Year - 2017 (43),0.00998,0.0615061506150615,0.0115,0.0289028902890289,Other Applications,0.0289028902890289,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Wnt Inhibitor Duration (days) - 3 days (17),0.0098,0.0519051905190519,0.01333,0.0172017201720172,Other Applications,0.0172017201720172,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Cell Line Ancestry - Caucasian (41),0.0091,0.0778077807780778,0.01017,0.0478047804780478,Other Applications,0.0478047804780478,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Number of Cell Lines - 3 (29),0.00906,0.0643064306430643,0.01332,0.0148014801480148,Other Applications,0.0148014801480148,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.0082,0.0478047804780478,0.00829,0.0526052605260526,Other Applications,0.0478047804780478,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Cell Line - Cor.4U (16),0.00809,0.0744074407440744,0.01053,0.0374037403740374,Other Applications,0.0374037403740374,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),2D Surface - Microelectrode Array (9),0.00723,0.0653065306530653,0.01133,0.0195019501950195,Other Applications,0.0195019501950195,True,True
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.00718,0.092009200920092,0.00961,0.0438043804380438,Other Applications,0.0438043804380438,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Journal - Nat Biomed Eng (5),0.00697,0.0838083808380838,0.01053,0.0388038803880388,Other Applications,0.0388038803880388,True,False
Pharmacological Intervention - Class Ic Antiarrhythmics (Na+ Channel Blockers - Strong Blockade) (9),Number of Cell Lines - >5 (9),0.00484,0.1573157315731573,0.01112,0.0291029102910291,Other Applications,0.0291029102910291,True,False
Pharmacological Intervention - Positive Inotropes (9),Journal - Nat Commun (13),0.04353,0.0,0.04053,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Positive Inotropes (9),Journal - Toxicological Sciences (4),0.03559,0.0003000300030003,0.04268,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Positive Inotropes (9),Immunofluorescent Imaging - Yes (268),0.02137,0.0024002400240024,0.01415,0.0085008500850085,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Positive Inotropes (9),3D Platform - Fibrin (50),0.01943,0.0027002700270027,0.00875,0.0831083108310831,Other Applications,0.0027002700270027,True,True
Pharmacological Intervention - Positive Inotropes (9),3D Stromal Cell Source - Human Fibroblast (38),0.01706,0.0154015401540154,0.01509,0.0136013601360136,Other Applications,0.0136013601360136,True,True
Pharmacological Intervention - Positive Inotropes (9),Electrophysiology Analysis Method - Optical Mapping (39),0.01647,0.0088008800880088,0.01726,0.0015001500150015,Other Applications,0.0015001500150015,True,True
Pharmacological Intervention - Positive Inotropes (9),Contractile Analysis Method - Deflection (39),0.01638,0.0091009100910091,0.01217,0.0233023302330233,Other Applications,0.0091009100910091,True,True
Pharmacological Intervention - Positive Inotropes (9),Contractile Force (mN) Quantiles - Q5 (>0 and ≤0.04) (10),0.01442,0.0158015801580158,0.01321,0.0163016301630163,Other Applications,0.0158015801580158,True,True
Pharmacological Intervention - Positive Inotropes (9),3D Stromal Cell Source - Cardiac Fibroblast (32),0.0143,0.0157015701570157,0.00627,0.1567156715671567,Other Applications,0.0157015701570157,True,True
Pharmacological Intervention - Positive Inotropes (9),Coating for Replating - Matrigel (65),0.0142,0.0121012101210121,0.01155,0.0183018301830183,Other Applications,0.0121012101210121,True,True
Pharmacological Intervention - Positive Inotropes (9),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.01333,0.0085008500850085,0.01132,0.0216021602160216,Other Applications,0.0085008500850085,True,True
Pharmacological Intervention - Positive Inotropes (9),Wnt Inhibitor Duration (days) - >6 days (12),0.01319,0.0189018901890189,0.00835,0.0657065706570657,Other Applications,0.0189018901890189,True,True
Pharmacological Intervention - Positive Inotropes (9),hiPSC Backbone Media - Commercial CM Kit (12),0.0128,0.0198019801980198,0.00899,0.0475047504750475,Other Applications,0.0198019801980198,True,True
Pharmacological Intervention - Positive Inotropes (9),Calcium Handling Analysis Method - Visual (104),0.01238,0.0433043304330433,0.01027,0.0265026502650265,Other Applications,0.0265026502650265,True,False
Pharmacological Intervention - Positive Inotropes (9),Cell Line - iCell (47),0.01215,0.041004100410041,0.01506,0.0085008500850085,Other Applications,0.0085008500850085,True,True
Pharmacological Intervention - Positive Inotropes (9),Gene Analysis Method - RNA (169),0.012,0.0357035703570357,0.01336,0.0006000600060006,Other Applications,0.0006000600060006,True,True
Pharmacological Intervention - Positive Inotropes (9),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01155,0.0435043504350435,0.01012,0.0355035503550355,Other Applications,0.0355035503550355,True,False
Pharmacological Intervention - Positive Inotropes (9),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01093,0.0421042104210421,0.01553,0.0043004300430043,Other Applications,0.0043004300430043,True,True
Pharmacological Intervention - Positive Inotropes (9),Publication Year - 2020 (51),0.01087,0.0468046804680468,0.01398,0.0117011701170117,Other Applications,0.0117011701170117,True,True
Pharmacological Intervention - Positive Inotropes (9),3D Platform - Matrigel (33),0.01085,0.0357035703570357,0.01454,0.0077007700770077,Other Applications,0.0077007700770077,True,True
Pharmacological Intervention - Positive Inotropes (9),Cell Line - Rare (132),0.01075,0.0414041404140414,0.01242,0.005000500050005,Other Applications,0.005000500050005,True,True
Pharmacological Intervention - Positive Inotropes (9),Wnt Inhibitor - DS-I-7 (9),0.00985,0.0289028902890289,0.00538,0.1241124112411241,Other Applications,0.0289028902890289,True,False
Pharmacological Intervention - Positive Inotropes (9),hiPSC-CM Maturation Media - iCell Maintenance (83),0.00912,0.0554055405540554,0.01094,0.0166016601660166,Other Applications,0.0166016601660166,True,True
Pharmacological Intervention - Positive Inotropes (9),Contractile Analysis Method - Traction Force Microscopy (9),0.00905,0.0341034103410341,0.0081,0.0514051405140514,Other Applications,0.0341034103410341,True,False
Pharmacological Intervention - Positive Inotropes (9),Disease Modelling - Dilated Cardiomyopathy (6),0.00873,0.0361036103610361,0.00869,0.0461046104610461,Other Applications,0.0361036103610361,True,False
Pharmacological Intervention - Positive Inotropes (9),3D SC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤10) (29),0.00774,0.092009200920092,0.01108,0.0302030203020302,Other Applications,0.0302030203020302,True,False
Pharmacological Intervention - Positive Inotropes (9),3D Platform - Collagen (38),0.00593,0.1565156515651565,0.01068,0.0338033803380338,Other Applications,0.0338033803380338,True,False
Pharmacological Intervention - Positive Inotropes (9),Publication Year - 2019 (57),0.0055,0.2207220722072207,0.01173,0.0227022702270227,Other Applications,0.0227022702270227,True,True
Pharmacological Intervention - Positive Inotropes (9),Contractile Analysis Method - Motion Tracking (93),0.00547,0.3668366836683668,0.00968,0.0497049704970497,Other Applications,0.0497049704970497,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Cell Line - iCell (47),0.04031,0.0004000400040004,0.02014,0.003000300030003,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Journal - Toxicological Sciences (4),0.03969,0.0002000200020002,0.05417,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.03843,0.0003000300030003,0.01941,0.0012001200120012,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Number of Cell Lines - 1 (225),0.03728,0.0,0.02925,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),hiPSC-CM Media Supplement - B27 (180),0.02533,0.0008000800080008,0.00853,0.1046104610461046,Other Applications,0.0008000800080008,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Disease Modelling - Arrhythmic (15),0.025,0.0014001400140014,0.01774,0.0051005100510051,Other Applications,0.0014001400140014,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Number of Cell Lines - 3 (29),0.02375,0.0039003900390039,0.02615,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Cell Line - Cor.4U (16),0.02242,0.0037003700370037,0.03367,0.0001000100010001,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Maturation Strategy - ECM (21),0.02082,0.0019001900190019,0.01895,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.0169,0.0119011901190119,0.01877,0.0049004900490049,Other Applications,0.0049004900490049,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01614,0.0118011801180118,0.02052,0.0053005300530053,Other Applications,0.0053005300530053,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01495,0.0374037403740374,0.00658,0.3421342134213421,Other Applications,0.0374037403740374,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),3D Tissue Media - Iscove (5),0.01449,0.0067006700670067,0.00699,0.082008200820082,Other Applications,0.0067006700670067,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Coating for Replating - Gelatin (43),0.01335,0.0242024202420242,0.01152,0.0255025502550255,Other Applications,0.0242024202420242,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Disease Modelling - Fibrotic (4),0.01325,0.0226022602260226,0.01816,0.0075007500750075,Other Applications,0.0075007500750075,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Wnt Induction - Rare (4),0.01323,0.0248024802480248,0.01422,0.0238023802380238,Other Applications,0.0238023802380238,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Gene Analysis Method - RNA (169),0.01322,0.0242024202420242,0.01509,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Journal - Cell Rep (6),0.01303,0.0104010401040104,0.02033,0.003000300030003,Other Applications,0.003000300030003,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),hiPSC Backbone Media - iCell Maintenance (86),0.01227,0.0303030303030303,0.00885,0.1019101910191019,Other Applications,0.0303030303030303,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),2D Surface - ECM-coated (115),0.01205,0.0146014601460146,0.0145,0.0017001700170017,Other Applications,0.0017001700170017,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01204,0.0257025702570257,0.0165,0.0083008300830083,Other Applications,0.0083008300830083,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01197,0.0432043204320432,0.00864,0.1225122512251225,Other Applications,0.0432043204320432,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Electrophysiology Analysis Method - Microelectrode (31),0.01151,0.0356035603560356,0.01083,0.0381038103810381,Other Applications,0.0356035603560356,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Day of Insulin Addition - Known (177),0.01145,0.0245024502450245,0.0077,0.134013401340134,Other Applications,0.0245024502450245,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Wnt Induction - CHIR99021 (184),0.01119,0.0464046404640464,0.01088,0.0129012901290129,Other Applications,0.0129012901290129,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Journal - Sci Rep (24),0.01111,0.049004900490049,0.0116,0.0363036303630363,Other Applications,0.0363036303630363,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),3D Endothelial Cell Source - Cardiac Microvascular EndothelialC (5),0.00984,0.0358035803580358,0.01432,0.01000100010001,Other Applications,0.01000100010001,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Number of Cell Lines - 4 (11),0.0098,0.0443044304430443,0.00965,0.0527052705270527,Other Applications,0.0443044304430443,True,False
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Number of Cell Lines - >5 (9),0.00958,0.0477047704770477,0.01562,0.0101010101010101,Other Applications,0.0101010101010101,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),3D Platform - Extracellular Scaffold (18),0.00952,0.0567056705670567,0.01395,0.0186018601860186,Other Applications,0.0186018601860186,True,True
Pharmacological Intervention - Class Ia Antiarrhythmics (Na+ Channel Blockers - Moderate Blockade) (8),Coating for Replating - Rare (6),0.00649,0.109010901090109,0.01139,0.0385038503850385,Other Applications,0.0385038503850385,True,False
Pharmacological Intervention - Cisapride (8),Cell Line - iCell (47),0.05522,0.0,0.02732,0.0001000100010001,Other Applications,0.0,True,True
Pharmacological Intervention - Cisapride (8),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.0432,0.0001000100010001,0.02332,0.0003000300030003,Other Applications,0.0001000100010001,True,True
Pharmacological Intervention - Cisapride (8),Coating for Replating - Gelatin (43),0.02481,0.0024002400240024,0.01866,0.0025002500250025,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Cisapride (8),Cell Line - Cor.4U (16),0.02324,0.0028002800280028,0.02126,0.0026002600260026,Other Applications,0.0026002600260026,True,True
Pharmacological Intervention - Cisapride (8),2D Surface - Microelectrode Array (9),0.02286,0.002000200020002,0.02167,0.0019001900190019,Other Applications,0.0019001900190019,True,True
Pharmacological Intervention - Cisapride (8),Number of Cell Lines - 3 (29),0.02208,0.0045004500450045,0.03984,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Cisapride (8),hiPSC Backbone Media - iCell Maintenance (86),0.02183,0.0009000900090009,0.00809,0.1433143314331433,Other Applications,0.0009000900090009,True,True
Pharmacological Intervention - Cisapride (8),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.01898,0.0082008200820082,0.01688,0.0096009600960096,Other Applications,0.0082008200820082,True,True
Pharmacological Intervention - Cisapride (8),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.0179,0.008000800080008,0.02134,0.0032003200320032,Other Applications,0.0032003200320032,True,True
Pharmacological Intervention - Cisapride (8),hiPSC-CM Maturation Media - iCell Maintenance (83),0.0173,0.0046004600460046,0.0105,0.0286028602860286,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - Cisapride (8),Number of Cell Lines - 1 (225),0.01671,0.0088008800880088,0.02553,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Cisapride (8),Insulin Start Day - 11 (3),0.01637,0.0059005900590059,0.01344,0.02000200020002,Other Applications,0.0059005900590059,True,True
Pharmacological Intervention - Cisapride (8),Publication Year - 2020 (51),0.01569,0.0144014401440144,0.01568,0.0078007800780078,Other Applications,0.0078007800780078,True,True
Pharmacological Intervention - Cisapride (8),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.01473,0.0149014901490149,0.01334,0.0147014701470147,Other Applications,0.0147014701470147,True,True
Pharmacological Intervention - Cisapride (8),Journal - Toxicological Sciences (4),0.01452,0.0089008900890089,0.02099,0.0036003600360036,Other Applications,0.0036003600360036,True,True
Pharmacological Intervention - Cisapride (8),Coating for Replating - Rare (6),0.01446,0.0151015101510151,0.01842,0.0061006100610061,Other Applications,0.0061006100610061,True,True
Pharmacological Intervention - Cisapride (8),3D Platform - Nanotechnology (3),0.01443,0.0135013501350135,0.01538,0.0169016901690169,Other Applications,0.0135013501350135,True,True
Pharmacological Intervention - Cisapride (8),Electrophysiology Analysis Method - Patch Clamp (59),0.01412,0.0233023302330233,0.01794,0.0025002500250025,Other Applications,0.0025002500250025,True,True
Pharmacological Intervention - Cisapride (8),Maturation Strategy - ECM (21),0.01362,0.0137013701370137,0.01549,0.0067006700670067,Other Applications,0.0067006700670067,True,True
Pharmacological Intervention - Cisapride (8),Immunofluorescent Imaging - Yes (268),0.01306,0.0221022102210221,0.00771,0.1283128312831283,Other Applications,0.0221022102210221,True,True
Pharmacological Intervention - Cisapride (8),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01258,0.0354035403540354,0.00559,0.3955395539553955,Other Applications,0.0354035403540354,True,False
Pharmacological Intervention - Cisapride (8),Calcium Flux Amplitude (F/F0) Quantiles - Q4 (>0.25 and ≤0.9) (10),0.01238,0.0195019501950195,0.00885,0.0537053705370537,Other Applications,0.0195019501950195,True,True
Pharmacological Intervention - Cisapride (8),Electrophysiology Analysis Method - Microelectrode (31),0.01146,0.0353035303530353,0.01407,0.0121012101210121,Other Applications,0.0121012101210121,True,True
Pharmacological Intervention - Cisapride (8),3D Stromal Cell Source - hiPSC-CardiacF (8),0.01115,0.0485048504850485,0.01249,0.0387038703870387,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Cisapride (8),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.01109,0.0324032403240324,0.01098,0.0331033103310331,Other Applications,0.0324032403240324,True,False
Pharmacological Intervention - Cisapride (8),Number of Cell Lines - 4 (11),0.01003,0.0426042604260426,0.0093,0.0605060506050605,Other Applications,0.0426042604260426,True,False
Pharmacological Intervention - Cisapride (8),Number of Cell Lines - >5 (9),0.01002,0.0457045704570457,0.01151,0.0304030403040304,Other Applications,0.0304030403040304,True,False
Pharmacological Intervention - Cisapride (8),Journal - Nano Lett (3),0.00967,0.0424042404240424,0.01219,0.0311031103110311,Other Applications,0.0311031103110311,True,False
Pharmacological Intervention - Cisapride (8),Cell Coculture - Cardiomyocyte (157),0.00924,0.0795079507950795,0.01095,0.0102010201020102,Other Applications,0.0102010201020102,True,True
Pharmacological Intervention - Cisapride (8),Differentiation Purity Assessment - IHC a-actinin (8),0.00915,0.0447044704470447,0.01055,0.034003400340034,Other Applications,0.034003400340034,True,False
Pharmacological Intervention - Cisapride (8),Electrophysiology Analysis Method - Genetical (3),0.00908,0.0493049304930493,0.00875,0.0584058405840584,Other Applications,0.0493049304930493,True,False
Pharmacological Intervention - Cisapride (8),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.0074,0.0784078407840784,0.01222,0.0223022302230223,Other Applications,0.0223022302230223,True,True
Pharmacological Intervention - Ranolazine (7),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.02718,0.0019001900190019,0.02043,0.0018001800180018,Other Applications,0.0018001800180018,True,True
Pharmacological Intervention - Ranolazine (7),Cell Line - Cor.4U (16),0.02462,0.0034003400340034,0.0283,0.0009000900090009,Other Applications,0.0009000900090009,True,True
Pharmacological Intervention - Ranolazine (7),Number of Cell Lines - 1 (225),0.02419,0.0011001100110011,0.01614,0.0015001500150015,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Ranolazine (7),Cell Line - iCell (47),0.02236,0.0089008900890089,0.02033,0.0035003500350035,Other Applications,0.0035003500350035,True,True
Pharmacological Intervention - Ranolazine (7),Journal - Sci Rep (24),0.01984,0.0098009800980098,0.01523,0.0146014601460146,Other Applications,0.0098009800980098,True,True
Pharmacological Intervention - Ranolazine (7),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.01928,0.0059005900590059,0.01937,0.005000500050005,Other Applications,0.005000500050005,True,True
Pharmacological Intervention - Ranolazine (7),Number of Cell Lines - 3 (29),0.01881,0.0108010801080108,0.01971,0.0059005900590059,Other Applications,0.0059005900590059,True,True
Pharmacological Intervention - Ranolazine (7),Differentiation Purity Assessment - IHC a-actinin (8),0.01846,0.0066006600660066,0.01726,0.0075007500750075,Other Applications,0.0066006600660066,True,True
Pharmacological Intervention - Ranolazine (7),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01716,0.0106010601060106,0.01072,0.0503050305030503,Other Applications,0.0106010601060106,True,True
Pharmacological Intervention - Ranolazine (7),Immunofluorescent Imaging - Yes (268),0.01704,0.009000900090009,0.02221,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Ranolazine (7),Calcium Handling Analysis Method - Genetical (23),0.01684,0.0203020302030203,0.01484,0.0191019101910191,Other Applications,0.0191019101910191,True,True
Pharmacological Intervention - Ranolazine (7),Journal - Cell Rep (6),0.0161,0.0064006400640064,0.01521,0.0118011801180118,Other Applications,0.0064006400640064,True,True
Pharmacological Intervention - Ranolazine (7),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01609,0.0195019501950195,0.00966,0.0481048104810481,Other Applications,0.0195019501950195,True,True
Pharmacological Intervention - Ranolazine (7),Journal - Toxicological Sciences (4),0.01433,0.0162016201620162,0.02161,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Ranolazine (7),2D Surface - Microelectrode Array (9),0.01327,0.0192019201920192,0.0152,0.0141014101410141,Other Applications,0.0141014101410141,True,True
Pharmacological Intervention - Ranolazine (7),Differentiation Purity Assessment - Visual Inspection (6),0.01287,0.022002200220022,0.0139,0.0208020802080208,Other Applications,0.0208020802080208,True,True
Pharmacological Intervention - Ranolazine (7),Wnt Inhibitor - KY02111 (7),0.01261,0.0241024102410241,0.00696,0.095009500950095,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Ranolazine (7),Cell Line Sex - Both (118),0.01255,0.0308030803080308,0.01226,0.0179017901790179,Other Applications,0.0179017901790179,True,True
Pharmacological Intervention - Ranolazine (7),Number of Cell Lines - 4 (11),0.01245,0.0294029402940294,0.01736,0.0111011101110111,Other Applications,0.0111011101110111,True,True
Pharmacological Intervention - Ranolazine (7),hiPSC Matrix Coating - Matrigel (163),0.01158,0.0186018601860186,0.01085,0.0495049504950495,Other Applications,0.0186018601860186,True,True
Pharmacological Intervention - Ranolazine (7),Number of Cell Lines - >5 (9),0.01145,0.0388038803880388,0.01442,0.0185018501850185,Other Applications,0.0185018501850185,True,True
Pharmacological Intervention - Ranolazine (7),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01144,0.0357035703570357,0.00689,0.1337133713371337,Other Applications,0.0357035703570357,True,False
Pharmacological Intervention - Ranolazine (7),Electrophysiology Analysis Method - Microelectrode (31),0.0112,0.0426042604260426,0.01231,0.0254025402540254,Other Applications,0.0254025402540254,True,False
Pharmacological Intervention - Ranolazine (7),Gene Analysis Method - RNA (169),0.01115,0.0506050605060506,0.01139,0.023002300230023,Other Applications,0.023002300230023,True,True
Pharmacological Intervention - Ranolazine (7),Coating for Replating - Gelatin (43),0.01109,0.0534053405340534,0.01725,0.0044004400440044,Other Applications,0.0044004400440044,True,True
Pharmacological Intervention - Ranolazine (7),Insulin Start Day - 4 (11),0.01081,0.0346034603460346,0.00847,0.075007500750075,Other Applications,0.0346034603460346,True,False
Pharmacological Intervention - Ranolazine (7),Coating for Replating - Rare (6),0.0101,0.0602060206020602,0.01174,0.0425042504250425,Other Applications,0.0425042504250425,True,False
Pharmacological Intervention - Ranolazine (7),Publication Year - 2019 (57),0.01005,0.0651065106510651,0.0143,0.0171017101710171,Other Applications,0.0171017101710171,True,True
Pharmacological Intervention - Ranolazine (7),Maturation Strategy - ECM (21),0.00992,0.0459045904590459,0.00768,0.0811081108110811,Other Applications,0.0459045904590459,True,False
Pharmacological Intervention - Ranolazine (7),Journal - Rare (104),0.00971,0.0666066606660666,0.01124,0.03000300030003,Other Applications,0.03000300030003,True,False
Pharmacological Intervention - Ranolazine (7),New Media for Maturation - Rare (4),0.00947,0.0521052105210521,0.01544,0.0158015801580158,Other Applications,0.0158015801580158,True,True
Pharmacological Intervention - Lidocaine (7),Cell Line - Cor.4U (16),0.02844,0.0027002700270027,0.01786,0.0101010101010101,Other Applications,0.0027002700270027,True,True
Pharmacological Intervention - Lidocaine (7),Journal - Int J Mol Sci (3),0.02645,0.0006000600060006,0.03456,0.0004000400040004,Other Applications,0.0004000400040004,True,True
Pharmacological Intervention - Lidocaine (7),Journal - Toxicological Sciences (4),0.02313,0.0026002600260026,0.02585,0.0021002100210021,Other Applications,0.0021002100210021,True,True
Pharmacological Intervention - Lidocaine (7),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.02115,0.007000700070007,0.0128,0.0353035303530353,Other Applications,0.007000700070007,True,True
Pharmacological Intervention - Lidocaine (7),Cell Line - iCell (47),0.02079,0.0111011101110111,0.02359,0.0009000900090009,Other Applications,0.0009000900090009,True,True
Pharmacological Intervention - Lidocaine (7),Number of Cell Lines - 1 (225),0.01972,0.005000500050005,0.01565,0.0018001800180018,Other Applications,0.0018001800180018,True,True
Pharmacological Intervention - Lidocaine (7),Number of Cell Lines - >5 (9),0.01912,0.0097009700970097,0.01929,0.007000700070007,Other Applications,0.007000700070007,True,True
Pharmacological Intervention - Lidocaine (7),Journal - Acta Biomater (10),0.01898,0.0102010201020102,0.01391,0.0174017401740174,Other Applications,0.0102010201020102,True,True
Pharmacological Intervention - Lidocaine (7),Resting Membrane Potential (mV) Quantiles - Q4 (<-60 and ≥-66) (9),0.01846,0.0064006400640064,0.01907,0.0046004600460046,Other Applications,0.0046004600460046,True,True
Pharmacological Intervention - Lidocaine (7),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01747,0.0196019601960196,0.01529,0.0245024502450245,Other Applications,0.0196019601960196,True,True
Pharmacological Intervention - Lidocaine (7),hiPSC-CM Maturation Media - Cor.4U Complete (6),0.01502,0.0076007600760076,0.01778,0.0045004500450045,Other Applications,0.0045004500450045,True,True
Pharmacological Intervention - Lidocaine (7),Number of Cell Lines - 4 (11),0.01494,0.0197019701970197,0.0133,0.0275027502750275,Other Applications,0.0197019701970197,True,True
Pharmacological Intervention - Lidocaine (7),Number of Cell Lines - 2 (50),0.01493,0.0241024102410241,0.01481,0.0123012301230123,Other Applications,0.0123012301230123,True,True
Pharmacological Intervention - Lidocaine (7),Publication Year - 2017 (43),0.01462,0.0306030603060306,0.01409,0.017001700170017,Other Applications,0.017001700170017,True,True
Pharmacological Intervention - Lidocaine (7),Wnt Inhibitor Duration (days) Quantiles - Q3 (>1 and ≤1) (108),0.01439,0.0282028202820282,0.0068,0.2881288128812881,Other Applications,0.0282028202820282,True,False
Pharmacological Intervention - Lidocaine (7),Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),0.01399,0.0191019101910191,0.0111,0.0364036403640364,Other Applications,0.0191019101910191,True,True
Pharmacological Intervention - Lidocaine (7),Publication Year - 2019 (57),0.01373,0.0262026202620262,0.00936,0.0876087608760876,Other Applications,0.0262026202620262,True,False
Pharmacological Intervention - Lidocaine (7),Calcium Handling Analysis Method - Visual (104),0.01345,0.0398039803980398,0.01219,0.0164016401640164,Other Applications,0.0164016401640164,True,True
Pharmacological Intervention - Lidocaine (7),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01301,0.0264026402640264,0.01457,0.0258025802580258,Other Applications,0.0258025802580258,True,False
Pharmacological Intervention - Lidocaine (7),Cell Line Ancestry - Caucasian (41),0.01289,0.0398039803980398,0.01261,0.0324032403240324,Other Applications,0.0324032403240324,True,False
Pharmacological Intervention - Lidocaine (7),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.0127,0.0405040504050405,0.00683,0.151015101510151,Other Applications,0.0405040504050405,True,False
Pharmacological Intervention - Lidocaine (7),2D Surface - Nanotopography (6),0.01242,0.0262026202620262,0.0104,0.0474047404740474,Other Applications,0.0262026202620262,True,False
Pharmacological Intervention - Lidocaine (7),Journal - Rare (104),0.01175,0.0312031203120312,0.00987,0.0551055105510551,Other Applications,0.0312031203120312,True,False
Pharmacological Intervention - Lidocaine (7),2D Surface - Microelectrode Array (9),0.01168,0.023002300230023,0.01761,0.0065006500650065,Other Applications,0.0065006500650065,True,True
Pharmacological Intervention - Lidocaine (7),3D Tissue Media - Rare (13),0.01121,0.0387038703870387,0.01209,0.0359035903590359,Other Applications,0.0359035903590359,True,False
Pharmacological Intervention - Lidocaine (7),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.01054,0.0538053805380538,0.01695,0.0076007600760076,Other Applications,0.0076007600760076,True,True
Pharmacological Intervention - Lidocaine (7),hiPSC-CM Media Supplement - Albumin (28),0.00991,0.0621062106210621,0.01029,0.0487048704870487,Other Applications,0.0487048704870487,True,False
Pharmacological Intervention - Lidocaine (7),Disease Modelling - Arrhythmic (15),0.00947,0.0551055105510551,0.01088,0.045004500450045,Other Applications,0.045004500450045,True,False
Pharmacological Intervention - Lidocaine (7),Gene Analysis Method - RNA (169),0.00935,0.1204120412041204,0.0118,0.0146014601460146,Other Applications,0.0146014601460146,True,True
Pharmacological Intervention - Lidocaine (7),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.00751,0.0913091309130913,0.01175,0.037003700370037,Other Applications,0.037003700370037,True,False
Pharmacological Intervention - Lidocaine (7),2D Surface - ECM-coated (115),0.00751,0.0941094109410941,0.01285,0.0067006700670067,Other Applications,0.0067006700670067,True,True
Pharmacological Intervention - Lidocaine (7),Action Potential Amplitude (mV) Quantiles - Q1 (>110 and ≤170) (10),0.0069,0.0915091509150915,0.00944,0.0494049404940494,Other Applications,0.0494049404940494,True,False
Pharmacological Intervention - Carbamylcholine (6),Seeding Confluency (%) - 85 to 89 (43),0.02951,0.0022002200220022,0.01924,0.0048004800480048,Other Applications,0.0022002200220022,True,True
Pharmacological Intervention - Carbamylcholine (6),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.02836,0.004000400040004,0.02837,0.0024002400240024,Other Applications,0.0024002400240024,True,True
Pharmacological Intervention - Carbamylcholine (6),3D Tissue Media - Iscove (5),0.02001,0.0039003900390039,0.01791,0.0101010101010101,Other Applications,0.0039003900390039,True,True
Pharmacological Intervention - Carbamylcholine (6),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01995,0.0079007900790079,0.01819,0.0128012801280128,Other Applications,0.0079007900790079,True,True
Pharmacological Intervention - Carbamylcholine (6),Seeding Confluency 2D (%) - 85 to 89 (26),0.01928,0.0104010401040104,0.01473,0.0161016101610161,Other Applications,0.0104010401040104,True,True
Pharmacological Intervention - Carbamylcholine (6),Cell Line - SCVI-273 (8),0.01926,0.0124012401240124,0.01703,0.0157015701570157,Other Applications,0.0124012401240124,True,True
Pharmacological Intervention - Carbamylcholine (6),Wnt Inhibitor Duration (days) - 4 days (19),0.01809,0.0132013201320132,0.01875,0.008000800080008,Other Applications,0.008000800080008,True,True
Pharmacological Intervention - Carbamylcholine (6),Insulin Start Day - 5 (14),0.01773,0.013001300130013,0.01336,0.0245024502450245,Other Applications,0.013001300130013,True,True
Pharmacological Intervention - Carbamylcholine (6),Wnt Inhibitor - Others (9),0.01687,0.0119011901190119,0.02311,0.004000400040004,Other Applications,0.004000400040004,True,True
Pharmacological Intervention - Carbamylcholine (6),Resting Membrane Potential (mV) Quantiles - Q2 (<-74 and ≥-78) (8),0.01611,0.0176017601760176,0.01265,0.0446044604460446,Other Applications,0.0176017601760176,True,True
Pharmacological Intervention - Carbamylcholine (6),Electrophysiology Analysis Method - Optical Mapping (39),0.01583,0.0227022702270227,0.01241,0.054005400540054,Other Applications,0.0227022702270227,True,True
Pharmacological Intervention - Carbamylcholine (6),Journal - Cell Stem Cell (6),0.01556,0.0235023502350235,0.00743,0.088008800880088,Other Applications,0.0235023502350235,True,True
Pharmacological Intervention - Carbamylcholine (6),Differentiation Purity Assessment - IHC cTnT (7),0.01523,0.0203020302030203,0.01215,0.041004100410041,Other Applications,0.0203020302030203,True,True
Pharmacological Intervention - Carbamylcholine (6),hiPSC-CM Purification Duration (days) - 5 days (6),0.01493,0.0241024102410241,0.01187,0.0439043904390439,Other Applications,0.0241024102410241,True,True
Pharmacological Intervention - Carbamylcholine (6),Wnt Inhibitor - bFGF (8),0.01366,0.0286028602860286,0.00981,0.0601060106010601,Other Applications,0.0286028602860286,True,False
Pharmacological Intervention - Carbamylcholine (6),Cell Line - C25 (6),0.01305,0.0299029902990299,0.00914,0.0648064806480648,Other Applications,0.0299029902990299,True,False
Pharmacological Intervention - Carbamylcholine (6),Insulin Start Day - 3 (5),0.01237,0.0295029502950295,0.01057,0.0463046304630463,Other Applications,0.0295029502950295,True,False
Pharmacological Intervention - Carbamylcholine (6),hiPSC-CM Purification Duration (days) - 3 days (13),0.01212,0.0302030203020302,0.01234,0.0328032803280328,Other Applications,0.0302030203020302,True,False
Pharmacological Intervention - Carbamylcholine (6),Publication Year - 2018 (45),0.01206,0.0486048604860486,0.01159,0.0552055205520552,Other Applications,0.0486048604860486,True,False
Pharmacological Intervention - Carbamylcholine (6),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01165,0.0453045304530453,0.01386,0.0311031103110311,Other Applications,0.0311031103110311,True,False
Pharmacological Intervention - Carbamylcholine (6),Action Potential Conduction Velocity (cm/s) Quantiles - Q4 (>2.5 and ≤10.75) (7),0.01132,0.0547054705470547,0.01531,0.0207020702070207,Other Applications,0.0207020702070207,True,True
Pharmacological Intervention - Carbamylcholine (6),hiPSC-CM Purification Duration (days) - <3 days (31),0.0113,0.0654065406540654,0.01507,0.0278027802780278,Other Applications,0.0278027802780278,True,False
Pharmacological Intervention - Carbamylcholine (6),Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),0.01031,0.0483048304830483,0.0139,0.0237023702370237,Other Applications,0.0237023702370237,True,True
Pharmacological Intervention - Carbamylcholine (6),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.01015,0.0673067306730673,0.01648,0.0103010301030103,Other Applications,0.0103010301030103,True,True
Pharmacological Intervention - Carbamylcholine (6),Differentiation Purity Assessment - IHC a-actinin (8),0.01011,0.0504050405040504,0.01382,0.0271027102710271,Other Applications,0.0271027102710271,True,False
Pharmacological Intervention - Carbamylcholine (6),Seeding Confluency 2D (%) - 95 to 100 (6),0.01003,0.0737073707370737,0.01313,0.0377037703770377,Other Applications,0.0377037703770377,True,False
Pharmacological Intervention - Carbamylcholine (6),Sarcomere Length (um) Quantiles - Q5 (>1.01 and ≤1.64) (14),0.00975,0.0529052905290529,0.01211,0.0362036203620362,Other Applications,0.0362036203620362,True,False
Pharmacological Intervention - Carbamylcholine (6),Publication Year - 2016 (32),0.00822,0.1228122812281228,0.01402,0.0315031503150315,Other Applications,0.0315031503150315,True,False
Pharmacological Intervention - Propranolol (5),Differentiation Purity (%) Quantiles - Q5 (>30 and ≤79) (32),0.03826,0.0003000300030003,0.03747,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Propranolol (5),Journal - Biomaterials (16),0.02914,0.0042004200420042,0.03636,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Propranolol (5),Cell Line - IMR90 (19),0.02791,0.0023002300230023,0.02628,0.0027002700270027,Other Applications,0.0023002300230023,True,True
Pharmacological Intervention - Propranolol (5),hiPSC-CM Purification Duration (days) - 5 days (6),0.02669,0.0047004700470047,0.02592,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Propranolol (5),Publication Year - 2016 (32),0.02642,0.0061006100610061,0.01907,0.0091009100910091,Other Applications,0.0061006100610061,True,True
Pharmacological Intervention - Propranolol (5),Electrophysiology Analysis Method - Microelectrode (31),0.02388,0.0059005900590059,0.02627,0.0011001100110011,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Propranolol (5),Calcium Handling Analysis Method - Visual (104),0.02081,0.01000100010001,0.00921,0.0998099809980998,Other Applications,0.01000100010001,True,True
Pharmacological Intervention - Propranolol (5),hiPSC Matrix Coating - Vitronectin (10),0.02043,0.0066006600660066,0.021,0.0061006100610061,Other Applications,0.0061006100610061,True,True
Pharmacological Intervention - Propranolol (5),3D Platform - Polyethylene Glycol (8),0.02006,0.0096009600960096,0.02785,0.0022002200220022,Other Applications,0.0022002200220022,True,True
Pharmacological Intervention - Propranolol (5),Cell Line - 253G1 (10),0.01843,0.0121012101210121,0.01134,0.0571057105710571,Other Applications,0.0121012101210121,True,True
Pharmacological Intervention - Propranolol (5),Beat Rate (bpm) Quantiles - Q3 (<45 and ≥38.8) (13),0.01813,0.0199019901990199,0.01366,0.0429042904290429,Other Applications,0.0199019901990199,True,True
Pharmacological Intervention - Propranolol (5),2D Surface - Electrospun (13),0.01729,0.0184018401840184,0.01034,0.0538053805380538,Other Applications,0.0184018401840184,True,True
Pharmacological Intervention - Propranolol (5),Cell Line - DF19-9-11T.H (16),0.01703,0.018001800180018,0.0183,0.0152015201520152,Other Applications,0.0152015201520152,True,True
Pharmacological Intervention - Propranolol (5),Cell Area (um2) Quantiles - Q2 (>1800 and ≤2850) (10),0.01645,0.0201020102010201,0.01636,0.0213021302130213,Other Applications,0.0201020102010201,True,True
Pharmacological Intervention - Propranolol (5),Wnt Inhibitor - BMP4 (7),0.01615,0.0202020202020202,0.01783,0.0183018301830183,Other Applications,0.0183018301830183,True,True
Pharmacological Intervention - Propranolol (5),Electron Imaging - Transmission (62),0.01586,0.026002600260026,0.00863,0.1722172217221722,Other Applications,0.026002600260026,True,False
Pharmacological Intervention - Propranolol (5),Wnt Inhibitor - IWP (112),0.01584,0.017001700170017,0.00901,0.0773077307730773,Other Applications,0.017001700170017,True,True
Pharmacological Intervention - Propranolol (5),hiPSC Backbone Media - Essential 8 (82),0.01584,0.0277027702770277,0.01311,0.0234023402340234,Other Applications,0.0234023402340234,True,True
Pharmacological Intervention - Propranolol (5),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01571,0.0321032103210321,0.01324,0.0291029102910291,Other Applications,0.0291029102910291,True,False
Pharmacological Intervention - Propranolol (5),Conduction Velocity from Calcium Imaging (cm/s) Quantiles - Q1 (>17 and ≤44) (5),0.01556,0.0293029302930293,0.01646,0.0226022602260226,Other Applications,0.0226022602260226,True,True
Pharmacological Intervention - Propranolol (5),Beat Rate (bpm) Quantiles - Q1 (<27.6 and ≥7) (11),0.01552,0.0203020302030203,0.01832,0.0174017401740174,Other Applications,0.0174017401740174,True,True
Pharmacological Intervention - Propranolol (5),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01494,0.0304030403040304,0.01024,0.095009500950095,Other Applications,0.0304030403040304,True,False
Pharmacological Intervention - Propranolol (5),Publication Year - 2020 (51),0.01309,0.0461046104610461,0.01668,0.0143014301430143,Other Applications,0.0143014301430143,True,True
Pharmacological Intervention - Propranolol (5),Publication Year - 2021 (43),0.01296,0.0427042704270427,0.018,0.0132013201320132,Other Applications,0.0132013201320132,True,True
Pharmacological Intervention - Propranolol (5),Insulin Start Day - 8 (15),0.01218,0.0424042404240424,0.01627,0.0251025102510251,Other Applications,0.0251025102510251,True,False
Pharmacological Intervention - Propranolol (5),Gene Analysis Method - RNA (169),0.01199,0.0435043504350435,0.00689,0.3785378537853785,Other Applications,0.0435043504350435,True,False
Pharmacological Intervention - Propranolol (5),Differentiation Purity (%) Quantiles - Q4 (>79 and ≤85) (40),0.00999,0.0713071307130713,0.01274,0.0298029802980298,Other Applications,0.0298029802980298,True,False
Pharmacological Intervention - Propranolol (5),Sarcomere Length (um) Quantiles - Q3 (>1.75 and ≤1.88) (13),0.00971,0.069006900690069,0.01294,0.0363036303630363,Other Applications,0.0363036303630363,True,False
Pharmacological Intervention - Propranolol (5),3D Stromal Cell Source - Cardiac Fibroblast (32),0.00904,0.1007100710071007,0.01368,0.0417041704170417,Other Applications,0.0417041704170417,True,False
Pharmacological Intervention - Propranolol (5),Differentiation Purity Assessment - Flow Cytometry a-actinin+ (9),0.00738,0.0844084408440844,0.0107,0.0485048504850485,Other Applications,0.0485048504850485,True,False
Pharmacological Intervention - Blebbistatin (5),Journal - Tissue Eng Part C Methods (6),0.02788,0.0033003300330033,0.02347,0.0057005700570057,Other Applications,0.0033003300330033,True,True
Pharmacological Intervention - Blebbistatin (5),3D Tissue Media - Growth Factor (12),0.0181,0.0119011901190119,0.01483,0.0243024302430243,Other Applications,0.0119011901190119,True,True
Pharmacological Intervention - Blebbistatin (5),Journal - ACS Appl Mater Interfaces (4),0.01804,0.0203020302030203,0.01641,0.0298029802980298,Other Applications,0.0203020302030203,True,True
Pharmacological Intervention - Blebbistatin (5),Wnt Inhibitor - Others (9),0.01779,0.0173017301730173,0.02103,0.01000100010001,Other Applications,0.01000100010001,True,True
Pharmacological Intervention - Blebbistatin (5),Beat Rate (bpm) Quantiles - Q5 (>108 and ≤60) (12),0.01762,0.0142014201420142,0.01926,0.0132013201320132,Other Applications,0.0132013201320132,True,True
Pharmacological Intervention - Blebbistatin (5),Day of Insulin Addition - not 25 (3),0.01699,0.0176017601760176,0.01519,0.0273027302730273,Other Applications,0.0176017601760176,True,True
Pharmacological Intervention - Blebbistatin (5),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01694,0.0112011201120112,0.01276,0.0287028702870287,Other Applications,0.0112011201120112,True,True
Pharmacological Intervention - Blebbistatin (5),hiPSC-CM Media Supplement - HEPES (16),0.01683,0.0194019401940194,0.0119,0.0561056105610561,Other Applications,0.0194019401940194,True,True
Pharmacological Intervention - Blebbistatin (5),3D EC Ratio (CM-EC-SC) Quantiles - Q2 (>0 and ≤0) (119),0.01611,0.0189018901890189,0.00515,0.4274427442744274,Other Applications,0.0189018901890189,True,True
Pharmacological Intervention - Blebbistatin (5),Seeding Confluency 3D (%) - 95 to 100 (13),0.01578,0.0293029302930293,0.01043,0.082008200820082,Other Applications,0.0293029302930293,True,False
Pharmacological Intervention - Blebbistatin (5),Insulin Withdrawal Duration (days) - 6 days (3),0.01541,0.0224022402240224,0.01725,0.0217021702170217,Other Applications,0.0217021702170217,True,True
Pharmacological Intervention - Blebbistatin (5),3D Estimated Cell Density (mil cells/mL) Quantiles - Q5 (>0.01 and ≤0.47) (24),0.01432,0.035003500350035,0.01138,0.0568056805680568,Other Applications,0.035003500350035,True,False
Pharmacological Intervention - Blebbistatin (5),Calcium Flux Amplitude (F/F0) Quantiles - Q5 (>0.03 and ≤0.25) (11),0.0143,0.0341034103410341,0.00789,0.1073107310731073,Other Applications,0.0341034103410341,True,False
Pharmacological Intervention - Blebbistatin (5),Day of Insulin Addition - not 9 (3),0.0142,0.0225022502250225,0.01882,0.016001600160016,Other Applications,0.016001600160016,True,True
Pharmacological Intervention - Blebbistatin (5),Publication Year - 2020 (51),0.014,0.0357035703570357,0.00824,0.1536153615361536,Other Applications,0.0357035703570357,True,False
Pharmacological Intervention - Blebbistatin (5),2D Surface - Nanotopography (6),0.01399,0.0325032503250325,0.01619,0.0233023302330233,Other Applications,0.0233023302330233,True,True
Pharmacological Intervention - Blebbistatin (5),Seeding Confluency 2D (%) - 95 to 100 (6),0.01378,0.0458045804580458,0.01272,0.0491049104910491,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Blebbistatin (5),Seeding Confluency (%) - 95 to 100 (23),0.01226,0.0388038803880388,0.01044,0.0706070607060706,Other Applications,0.0388038803880388,True,False
Pharmacological Intervention - Blebbistatin (5),Day of Insulin Addition - not 10 (4),0.01213,0.0468046804680468,0.00952,0.0547054705470547,Other Applications,0.0468046804680468,True,False
Pharmacological Intervention - Blebbistatin (5),hiPSC Matrix Coating - Geltrex (33),0.01126,0.0721072107210721,0.01541,0.0296029602960296,Other Applications,0.0296029602960296,True,False
Pharmacological Intervention - Blebbistatin (5),Insulin Start Day - 9 (10),0.01029,0.0748074807480748,0.01253,0.0474047404740474,Other Applications,0.0474047404740474,True,False
Pharmacological Intervention - Blebbistatin (5),Publication Year - 2015 (19),0.01,0.0844084408440844,0.01232,0.0469046904690469,Other Applications,0.0469046904690469,True,False
Pharmacological Intervention - Blebbistatin (5),Contractile Analysis Method - Motion Tracking (93),0.00878,0.1108110811081108,0.01124,0.0405040504050405,Other Applications,0.0405040504050405,True,False
Pharmacological Intervention - Blebbistatin (5),Coating for Replating - Synthemax (3),0.00874,0.0373037303730373,0.01643,0.0195019501950195,Other Applications,0.0195019501950195,True,True
Pharmacological Intervention - Blebbistatin (5),3D CM Ratio (CM-EC-SC) Quantiles - Q1 (>91 and ≤100) (74),0.00694,0.1909190919091909,0.01241,0.0376037603760376,Other Applications,0.0376037603760376,True,False
Pharmacological Intervention - Blebbistatin (5),Maturation Strategy - ECM (21),0.00265,0.2484248424842484,0.01045,0.0445044504450445,Other Applications,0.0445044504450445,True,False
Pharmacological Intervention - Blebbistatin (5),Journal - Nano Lett (3),0.00086,0.0498049804980498,0.00164,0.0517051705170517,Other Applications,0.0498049804980498,True,False
Pharmacological Intervention - Metoprolol (5),Cell Line - iCell (47),0.03827,0.0008000800080008,0.02974,0.0003000300030003,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Metoprolol (5),Journal - Sci Rep (24),0.02935,0.0035003500350035,0.03224,0.0005000500050005,Other Applications,0.0005000500050005,True,True
Pharmacological Intervention - Metoprolol (5),Electrophysiology Analysis Method - Microelectrode (31),0.02885,0.0023002300230023,0.02371,0.0022002200220022,Other Applications,0.0022002200220022,True,True
Pharmacological Intervention - Metoprolol (5),Action Potential Conduction Velocity (cm/s) Quantiles - Q1 (>28.5 and ≤41) (7),0.02561,0.0044004400440044,0.02701,0.0034003400340034,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Metoprolol (5),Journal - Cell Rep (6),0.02526,0.0027002700270027,0.02229,0.0058005800580058,Other Applications,0.0027002700270027,True,True
Pharmacological Intervention - Metoprolol (5),2D Surface - Hydrogel (17),0.01931,0.0128012801280128,0.02364,0.003000300030003,Other Applications,0.003000300030003,True,True
Pharmacological Intervention - Metoprolol (5),hiPSC-CM Maturation Media - iCell Maintenance (83),0.01913,0.0047004700470047,0.01514,0.0055005500550055,Other Applications,0.0047004700470047,True,True
Pharmacological Intervention - Metoprolol (5),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01817,0.0217021702170217,0.00794,0.2293229322932293,Other Applications,0.0217021702170217,True,True
Pharmacological Intervention - Metoprolol (5),Coating for Replating - Gelatin (43),0.01802,0.0166016601660166,0.01056,0.0609060906090609,Other Applications,0.0166016601660166,True,True
Pharmacological Intervention - Metoprolol (5),Wnt Inhibitor Duration (days) - Rare (173),0.01727,0.0015001500150015,0.00693,0.158015801580158,Other Applications,0.0015001500150015,True,True
Pharmacological Intervention - Metoprolol (5),Coating for Replating - Rare (6),0.0168,0.0284028402840284,0.00974,0.0705070507050705,Other Applications,0.0284028402840284,True,False
Pharmacological Intervention - Metoprolol (5),Number of Cell Lines - 3 (29),0.0167,0.0241024102410241,0.0219,0.0065006500650065,Other Applications,0.0065006500650065,True,True
Pharmacological Intervention - Metoprolol (5),Resting Membrane Potential (mV) Quantiles - Q1 (<-78 and ≥-85) (12),0.01646,0.0177017701770177,0.02324,0.0038003800380038,Other Applications,0.0038003800380038,True,True
Pharmacological Intervention - Metoprolol (5),Maturation Strategy - Elastomeric (33),0.01643,0.019001900190019,0.01082,0.0496049604960496,Other Applications,0.019001900190019,True,True
Pharmacological Intervention - Metoprolol (5),Publication Year - 2021 (43),0.01541,0.0275027502750275,0.01438,0.0314031403140314,Other Applications,0.0275027502750275,True,False
Pharmacological Intervention - Metoprolol (5),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.01516,0.0312031203120312,0.01202,0.0431043104310431,Other Applications,0.0312031203120312,True,False
Pharmacological Intervention - Metoprolol (5),Contraction Upstroke Velocity (um/s) Quantiles - Q4 (>1.2 and ≤10) (11),0.0149,0.0187018701870187,0.0193,0.0083008300830083,Other Applications,0.0083008300830083,True,True
Pharmacological Intervention - Metoprolol (5),Publication Year - Late-2010s (196),0.01442,0.0117011701170117,0.01196,0.0219021902190219,Other Applications,0.0117011701170117,True,True
Pharmacological Intervention - Metoprolol (5),Maturation Strategy - Electrical (39),0.01432,0.0514051405140514,0.01424,0.0458045804580458,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Metoprolol (5),Seeding Confluency 3D (%) - 85 to 89 (12),0.01398,0.0427042704270427,0.01094,0.0647064706470647,Other Applications,0.0427042704270427,True,False
Pharmacological Intervention - Metoprolol (5),Cell Line - Cor.4U (16),0.0136,0.0381038103810381,0.01387,0.0404040404040404,Other Applications,0.0381038103810381,True,False
Pharmacological Intervention - Metoprolol (5),Number of Cell Lines - 1 (225),0.01343,0.0302030203020302,0.02045,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Pharmacological Intervention - Metoprolol (5),hiPSC Backbone Media - iCell Maintenance (86),0.01341,0.0251025102510251,0.01386,0.0206020602060206,Other Applications,0.0206020602060206,True,True
Pharmacological Intervention - Metoprolol (5),Publication Year - Post 2020 (122),0.01326,0.0429042904290429,0.01211,0.0257025702570257,Other Applications,0.0257025702570257,True,False
Pharmacological Intervention - Metoprolol (5),Wnt Inhibitor Duration (days) Quantiles - Q2 (>1 and ≤2) (156),0.01307,0.0189018901890189,0.004,0.6469646964696469,Other Applications,0.0189018901890189,True,True
Pharmacological Intervention - Metoprolol (5),3D Platform - Extracellular Scaffold (18),0.01276,0.0431043104310431,0.00649,0.1642164216421642,Other Applications,0.0431043104310431,True,False
Pharmacological Intervention - Metoprolol (5),Publication Year - 2018 (45),0.01256,0.047004700470047,0.00867,0.1371137113711371,Other Applications,0.047004700470047,True,False
Pharmacological Intervention - Metoprolol (5),hiPSC-CM Media Supplement - B27 (180),0.01225,0.04000400040004,0.00853,0.0896089608960896,Other Applications,0.04000400040004,True,False
Pharmacological Intervention - Metoprolol (5),Maturation Strategy - ECM (21),0.0119,0.0362036203620362,0.01814,0.0106010601060106,Other Applications,0.0106010601060106,True,True
Pharmacological Intervention - Metoprolol (5),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.0114,0.0498049804980498,0.00807,0.0921092109210921,Other Applications,0.0498049804980498,True,False
Pharmacological Intervention - Metoprolol (5),Electrophysiology Analysis Method - Patch Clamp (59),0.01117,0.0785078507850785,0.01418,0.0368036803680368,Other Applications,0.0368036803680368,True,False
Pharmacological Intervention - Metoprolol (5),Calcium Handling Analysis Method - Visual (104),0.01017,0.1221122112211221,0.01513,0.0123012301230123,Other Applications,0.0123012301230123,True,True
Pharmacological Intervention - Metoprolol (5),Sacromere or Cellular Alignment Analysis - Yes (72),0.01011,0.0961096109610961,0.01509,0.0147014701470147,Other Applications,0.0147014701470147,True,True
Pharmacological Intervention - Metoprolol (5),hiPSC Backbone Media - RPMI-1640 (167),0.01006,0.0425042504250425,0.00876,0.0896089608960896,Other Applications,0.0425042504250425,True,False
Pharmacological Intervention - Metoprolol (5),Seeding Confluency 3D (%) - 90 to 94 (13),0.00893,0.085008500850085,0.01221,0.0458045804580458,Other Applications,0.0458045804580458,True,False
Pharmacological Intervention - Metoprolol (5),hiPSC Backbone Media - Embryonic Stem Cell (127),0.00751,0.1672167216721672,0.01195,0.0283028302830283,Other Applications,0.0283028302830283,True,False
Pharmacological Intervention - Metoprolol (5),hiPSC-CM Maturation Media - RPMI-1640 (153),0.00684,0.2717271727172717,0.01038,0.0276027602760276,Other Applications,0.0276027602760276,True,False
Pharmacological Intervention - Metoprolol (5),2D Surface - Decellularized ECM (3),0.0,0.09000900090009,0.00136,0.0484048404840484,Other Applications,0.0484048404840484,True,False
Pharmacological Intervention - Caffeine (4),Metabolic Component - Dexamethasone (7),0.05601,0.0003000300030003,0.04726,0.0007000700070007,Other Applications,0.0003000300030003,True,True
Pharmacological Intervention - Caffeine (4),T-tubule Structures - Yes (18),0.04911,0.0002000200020002,0.03094,0.0029002900290029,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Caffeine (4),Metabolic Component - T3 (14),0.0434,0.0011001100110011,0.02638,0.0058005800580058,Other Applications,0.0011001100110011,True,True
Pharmacological Intervention - Caffeine (4),Metabolic Component Category - Hormonal Stimulation (14),0.02918,0.0055005500550055,0.02027,0.0159015901590159,Other Applications,0.0055005500550055,True,True
Pharmacological Intervention - Caffeine (4),Insulin Start Day - 2 (4),0.02899,0.0046004600460046,0.0431,0.0008000800080008,Other Applications,0.0008000800080008,True,True
Pharmacological Intervention - Caffeine (4),Wnt Inhibitor - Wnt-C59 (30),0.02742,0.0078007800780078,0.01823,0.0231023102310231,Other Applications,0.0078007800780078,True,True
Pharmacological Intervention - Caffeine (4),Wnt Inhibitor - bFGF (8),0.02403,0.0167016701670167,0.02598,0.009000900090009,Other Applications,0.009000900090009,True,True
Pharmacological Intervention - Caffeine (4),hiPSC-CM Maturation Media - F12 (10),0.02388,0.0146014601460146,0.01884,0.0324032403240324,Other Applications,0.0146014601460146,True,True
Pharmacological Intervention - Caffeine (4),Cell Line - Cellapy (4),0.02276,0.0193019301930193,0.02409,0.0186018601860186,Other Applications,0.0186018601860186,True,True
Pharmacological Intervention - Caffeine (4),Coating for Replating - Matrigel (65),0.02053,0.0064006400640064,0.01185,0.0721072107210721,Other Applications,0.0064006400640064,True,True
Pharmacological Intervention - Caffeine (4),Insulin Start Day - After 11 (7),0.02041,0.0328032803280328,0.01776,0.037003700370037,Other Applications,0.0328032803280328,True,False
Pharmacological Intervention - Caffeine (4),hiPSC-CM Purification Duration (days) - 5 days (6),0.0196,0.0344034403440344,0.01582,0.0453045304530453,Other Applications,0.0344034403440344,True,False
Pharmacological Intervention - Caffeine (4),Wnt Induction Duration (days) Quantiles - Q3 (>1 and ≤1) (186),0.01954,0.0144014401440144,0.0162,0.0086008600860086,Other Applications,0.0086008600860086,True,True
Pharmacological Intervention - Caffeine (4),hiPSC-CM Media Supplement - Albumin (28),0.01948,0.0206020602060206,0.02318,0.0074007400740074,Other Applications,0.0074007400740074,True,True
Pharmacological Intervention - Caffeine (4),Action Potential Conduction Velocity (cm/s) Quantiles - Q3 (>10.75 and ≤16) (8),0.01816,0.0356035603560356,0.01618,0.0418041804180418,Other Applications,0.0356035603560356,True,False
Pharmacological Intervention - Caffeine (4),Purification Protocol - Cell Sorting (7),0.01699,0.0354035403540354,0.02152,0.0132013201320132,Other Applications,0.0132013201320132,True,True
Pharmacological Intervention - Caffeine (4),Publication Year - 2019 (57),0.01649,0.0161016101610161,0.01854,0.0117011701170117,Other Applications,0.0117011701170117,True,True
Pharmacological Intervention - Caffeine (4),Number of Cell Lines - 4 (11),0.01627,0.0384038403840384,0.01876,0.02000200020002,Other Applications,0.02000200020002,True,True
Pharmacological Intervention - Caffeine (4),Maturation Strategy - Metabolic (33),0.01624,0.0402040204020402,0.00802,0.1581158115811581,Other Applications,0.0402040204020402,True,False
Pharmacological Intervention - Caffeine (4),Action Potential Amplitude (mV) Quantiles - Q3 (>97 and ≤100) (10),0.01574,0.0627062706270627,0.02002,0.016001600160016,Other Applications,0.016001600160016,True,True
Pharmacological Intervention - Caffeine (4),Time to Calcium Flux Peak (ms) Quantiles - Q1 (<154 and ≥0.06) (10),0.01543,0.0392039203920392,0.01104,0.0648064806480648,Other Applications,0.0392039203920392,True,False
Pharmacological Intervention - Caffeine (4),Journal - Circ Res (5),0.01541,0.0406040604060406,0.01771,0.0332033203320332,Other Applications,0.0332033203320332,True,False
Pharmacological Intervention - Caffeine (4),Resting Membrane Potential (mV) Quantiles - Q3 (<-66 and ≥-74) (8),0.01456,0.0406040604060406,0.0187,0.0215021502150215,Other Applications,0.0215021502150215,True,True
Pharmacological Intervention - Caffeine (4),Sarcomere Length (um) Quantiles - Q1 (>1.95 and ≤2.5) (13),0.01446,0.0299029902990299,0.01193,0.0549054905490549,Other Applications,0.0299029902990299,True,False
Pharmacological Intervention - Caffeine (4),hiPSC Backbone Media - Rare (19),0.01415,0.0288028802880288,0.01735,0.0214021402140214,Other Applications,0.0214021402140214,True,True
Pharmacological Intervention - Caffeine (4),Differentiation Purity Assessment - Flow Cytometry SIRPA+ (4),0.01364,0.0349034903490349,0.01156,0.037003700370037,Other Applications,0.0349034903490349,True,False
Pharmacological Intervention - Caffeine (4),New Media for Maturation - F12 (7),0.01196,0.0425042504250425,0.01304,0.0386038603860386,Other Applications,0.0386038603860386,True,False
Pharmacological Intervention - Caffeine (4),hiPSC-CM Media Supplement - bFGF (3),0.00763,0.038003800380038,0.01001,0.0367036703670367,Other Applications,0.0367036703670367,True,False
Pharmacological Intervention - Caffeine (4),Publication Year - Late-2010s (196),0.00746,0.1882188218821882,0.01239,0.0393039303930393,Other Applications,0.0393039303930393,True,False
Pharmacological Intervention - Caffeine (4),Metabolic Component - Albumax (3),0.00199,0.0367036703670367,0.00471,0.0367036703670367,Other Applications,0.0367036703670367,True,False
Pharmacological Intervention - Caffeine (4),Metabolic Component - Ascorbic Acid (3),0.0013,0.0387038703870387,0.00266,0.039003900390039,Other Applications,0.0387038703870387,True,False
Pharmacological Intervention - Caffeine (4),Differentiation Purity Assessment - Flow Cytometry cTnI+ (3),0.00062,0.0459045904590459,0.00119,0.0467046704670467,Other Applications,0.0459045904590459,True,False
Pharmacological Intervention - Carbenoxolone (4),Publication Year - 2015 (19),0.04982,0.0004000400040004,0.06093,0.0,Other Applications,0.0,True,True
Pharmacological Intervention - Carbenoxolone (4),Cell Line - iCell (47),0.0471,0.0002000200020002,0.02443,0.0046004600460046,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Carbenoxolone (4),hiPSC-CM Media Supplement - iCell Maintenance Medium (41),0.03856,0.001000100010001,0.0176,0.0164016401640164,Other Applications,0.001000100010001,True,True
Pharmacological Intervention - Carbenoxolone (4),Electrophysiology Analysis Method - Optical Mapping (39),0.03368,0.0013001300130013,0.0368,0.0002000200020002,Other Applications,0.0002000200020002,True,True
Pharmacological Intervention - Carbenoxolone (4),Journal - Nano Lett (3),0.03189,0.0034003400340034,0.03471,0.004000400040004,Other Applications,0.0034003400340034,True,True
Pharmacological Intervention - Carbenoxolone (4),3D Platform - Nanotechnology (3),0.02519,0.0096009600960096,0.02714,0.0101010101010101,Other Applications,0.0096009600960096,True,True
Pharmacological Intervention - Carbenoxolone (4),2D Surface - Microelectrode Array (9),0.02388,0.0082008200820082,0.02302,0.0107010701070107,Other Applications,0.0082008200820082,True,True
Pharmacological Intervention - Carbenoxolone (4),3D Estimated Cell Density (mil cells/mL) Quantiles - Q1 (>21 and ≤150) (24),0.02357,0.0143014301430143,0.02176,0.0097009700970097,Other Applications,0.0097009700970097,True,True
Pharmacological Intervention - Carbenoxolone (4),Journal - Rare (104),0.02315,0.0016001600160016,0.01978,0.0019001900190019,Other Applications,0.0016001600160016,True,True
Pharmacological Intervention - Carbenoxolone (4),Time to Calcium Flux Peak (ms) Quantiles - Q3 (<254 and ≥200) (8),0.0225,0.0189018901890189,0.0206,0.023002300230023,Other Applications,0.0189018901890189,True,True
Pharmacological Intervention - Carbenoxolone (4),3D Stromal Cell Source - hiPSC-CardiacF (8),0.02218,0.023002300230023,0.0159,0.0497049704970497,Other Applications,0.023002300230023,True,True
Pharmacological Intervention - Carbenoxolone (4),Coating for Replating - Gelatin (43),0.02068,0.0166016601660166,0.01825,0.015001500150015,Other Applications,0.015001500150015,True,True
Pharmacological Intervention - Carbenoxolone (4),Time from Calcium Peak to Relaxation (ms) Quantiles - Q2 (>1000 and ≤310) (6),0.01942,0.0256025602560256,0.02104,0.0206020602060206,Other Applications,0.0206020602060206,True,True
Pharmacological Intervention - Carbenoxolone (4),Differentiation Purity Assessment - IHC a-actinin (8),0.01888,0.0195019501950195,0.02085,0.0145014501450145,Other Applications,0.0145014501450145,True,True
Pharmacological Intervention - Carbenoxolone (4),Action Potential Conduction Velocity (cm/s) Quantiles - Q2 (>16 and ≤28.5) (6),0.01774,0.0307030703070307,0.01523,0.0408040804080408,Other Applications,0.0307030703070307,True,False
Pharmacological Intervention - Carbenoxolone (4),hiPSC-CM Media Supplement - B27 (180),0.0175,0.0074007400740074,0.00562,0.4625462546254625,Other Applications,0.0074007400740074,True,True
Pharmacological Intervention - Carbenoxolone (4),Publication Year - 2020 (51),0.01734,0.0223022302230223,0.01988,0.0096009600960096,Other Applications,0.0096009600960096,True,True
Pharmacological Intervention - Carbenoxolone (4),Sarcomere Length (um) Quantiles - Q2 (>1.88 and ≤1.95) (14),0.01568,0.0455045504550455,0.01414,0.0535053505350535,Other Applications,0.0455045504550455,True,False
Pharmacological Intervention - Carbenoxolone (4),3D Estimated Tissue Size (mm2) Quantiles - Q4 (>0.13 and ≤2) (31),0.01414,0.0538053805380538,0.01593,0.0285028502850285,Other Applications,0.0285028502850285,True,False
Pharmacological Intervention - Carbenoxolone (4),3D Tissue Media - Commercial Kit (21),0.01389,0.0447044704470447,0.01933,0.0152015201520152,Other Applications,0.0152015201520152,True,True
Pharmacological Intervention - Carbenoxolone (4),Resting Membrane Potential (mV) Quantiles - Q5 (>-35 and ≤-60) (9),0.01257,0.0697069706970697,0.01675,0.0377037703770377,Other Applications,0.0377037703770377,True,False
Pharmacological Intervention - Carbenoxolone (4),3D Tissue Media - Iscove (5),0.01247,0.0442044204420442,0.01219,0.0477047704770477,Other Applications,0.0442044204420442,True,False
Pharmacological Intervention - Carbenoxolone (4),Publication Year - Late-2010s (196),0.01238,0.0274027402740274,0.01514,0.007000700070007,Other Applications,0.007000700070007,True,True
Pharmacological Intervention - Carbenoxolone (4),hiPSC Backbone Media - iCell Maintenance (86),0.01208,0.0454045404540454,0.00878,0.1528152815281528,Other Applications,0.0454045404540454,True,False
Pharmacological Intervention - Carbenoxolone (4),Sacromere or Cellular Alignment Analysis - Yes (72),0.01195,0.0631063106310631,0.01527,0.0245024502450245,Other Applications,0.0245024502450245,True,True
Pharmacological Intervention - Carbenoxolone (4),Publication Year - Post 2020 (122),0.01027,0.1023102310231023,0.01546,0.0093009300930093,Other Applications,0.0093009300930093,True,True
Pharmacological Intervention - Carbenoxolone (4),Publication Year - 2019 (57),0.00916,0.1128112811281128,0.01833,0.0122012201220122,Other Applications,0.0122012201220122,True,True
Pharmacological Intervention - Carbenoxolone (4),Contractile Analysis Method - Motion Tracking (93),0.00915,0.1029102910291029,0.01643,0.0073007300730073,Other Applications,0.0073007300730073,True,True
Pharmacological Intervention - Carbenoxolone (4),Time to Calcium Flux Peak (ms) Quantiles - Q4 (<365 and ≥254) (11),0.00874,0.1048104810481048,0.01421,0.0495049504950495,Other Applications,0.0495049504950495,True,False
Pharmacological Intervention - Carbenoxolone (4),3D Tissue Media - iCell Maintenance (12),0.00823,0.1021102110211021,0.01399,0.0418041804180418,Other Applications,0.0418041804180418,True,False
Pharmacological Intervention - Carbenoxolone (4),Differentiation Purity (%) Quantiles - Q3 (>85 and ≤90) (34),0.00814,0.1147114711471147,0.01237,0.0416041604160416,Other Applications,0.0416041604160416,True,False
Pharmacological Intervention - Carbenoxolone (4),3D Platform - Fibronectin (3),0.00055,0.047004700470047,0.00114,0.0431043104310431,Other Applications,0.0431043104310431,True,False
